Please wait a moment until all data is loaded. This message will disappear when all data is loaded.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
6-phosphofructokinase deficiency
Frequency of five disease-causing genetic mutations in a large mixed-breed dog population (2011-2012).
Abortion, Habitual
Correlation between factor VII and PAI-1 genetic variants and recurrent miscarriage.
Abortion, Habitual
The -323P0/P10 factor VII gene polymorphism and the risk of recurrent miscarriage.
Abortion, Habitual
[The connection between Arg353Gln polymorphism of coagulation factor VII and recurrent miscarriages]
Abortion, Spontaneous
Influence of hemostatic factors on spontaneous abortion.
Abortion, Spontaneous
Septic miscarriage with toxic shock syndrome and disseminated intravascular coagulation (DIC): The role of surgery, recombinant activated factor VII and intravenous immunoglobulin (IVIG).
Abortion, Spontaneous
Sex hormones, hemostasis and early pregnancy loss.
Abortion, Spontaneous
[The connection between Arg353Gln polymorphism of coagulation factor VII and recurrent miscarriages]
Acidosis
A review of recombinant factor VII for refractory bleeding in nonhemophilic trauma patients.
Acidosis
Acidosis and correction of acidosis does not affect rFVIIa function in swine.
Acidosis
Acidosis and impaired blood coagulation: what and how to correct before using recombinant human factor VIIa.
Acidosis
Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis.
Acidosis
Concentration-dependent effect of hypocalcaemia on mortality of patients with critical bleeding requiring massive transfusion: a cohort study.
Acidosis
Damage control resuscitation: a sensible approach to the exsanguinating surgical patient.
Acidosis
Determinants of futility of administration of recombinant factor VIIa in trauma.
Acidosis
Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven).
Acidosis
Effect of recombinant factor VIIa as an adjunctive therapy in damage control for wartime vascular injuries: a case control study.
Acidosis
Near fatal hemorrhage in traumatic bilateral leg amputation with coagulopathy, acidosis, and hypothermia and salvage therapy with recombinant factor VIIa.
Acidosis
Recombinant activated coagulation factor VII and bleeding trauma patients.
Acidosis
Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Acidosis
Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Acidosis
Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand.
Acidosis
Recombinant factor VIIa in trauma patients with the 'triad of death'
Acidosis
Recombinant factor VIIa is effective at reversing coagulopathy in a lactic acidosis model.
Acidosis
Resuscitation and transfusion principles for traumatic hemorrhagic shock.
Acidosis
The effect of temperature and pH on the activity of factor VIIa: implications for the efficacy of high-dose factor VIIa in hypothermic and acidotic patients.
Acidosis
The effects of acidosis and hypothermia on blood transfusion requirements following factor VII administration.
Acidosis
The utility of recombinant factor VIIa as a last resort in trauma.
Acidosis
Trends in trauma transfusion.
Acidosis
Use of Activated Recombinant Factor VII in Severe Bleeding - Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding.
Acidosis
Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis.
Acidosis
[Trauma-induced coagulopathy--mechanisms and state of the art treatment].
Acidosis, Lactic
Recombinant factor VIIa is effective at reversing coagulopathy in a lactic acidosis model.
Acquired Immunodeficiency Syndrome
Lupus anticoagulant associated with specific inhibition of factor VII in a patient with AIDS.
Activated Protein C Resistance
Associations between blood coagulation markers, NT-proBNP and risk of incident heart failure in older men: The British Regional Heart Study.
Activated Protein C Resistance
Atherogenic, hemostatic, and other potential risk markers in subjects with previous isolated myocardial infarction compared with long-standing uncomplicated stable angina.
Activated Protein C Resistance
Drospirenone as estrogen-free pill and hemostasis: coagulatory study results comparing a novel 4?mg formulation in a 24?+?4 cycle with desogestrel 75??g per day.
Activated Protein C Resistance
Effects of vaginally administered high estradiol doses on hormonal pharmacokinetics and hemostasis in postmenopausal women.
Activated Protein C Resistance
Physical activity and hemostatic and inflammatory variables in elderly men.
Acute Coronary Syndrome
A novel specific immunoassay for plasma two-chain factor VIIa: investigation of FVIIa levels in normal individuals and in patients with acute coronary syndromes.
Acute Coronary Syndrome
Comparative effects of unfractionated heparin and low molecular weight heparin on vascular endothelial cell tissue factor pathway inhibitor release: a model for assessing intrinsic thromboresistance.
Acute Coronary Syndrome
Early effects of low versus high dose atorvastatin treatment on coagulation and inflammation parameters in patients with acute coronary syndromes.
Acute Coronary Syndrome
Factor VII levels, R353Q and -323P0/10 Factor VII variants, and the risk of acute coronary syndrome among Arab-African Tunisians.
Acute Coronary Syndrome
Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes.
Acute Coronary Syndrome
Low plasma concentrations of coagulation factors II, VII and XI indicate increased risk among elderly with symptoms of heart failure.
Acute Coronary Syndrome
Myocardial infarctions and other acute coronary syndromes in rare congenital bleeding disorders: a critical analysis of all reported cases.
Acute Coronary Syndrome
Novel anticoagulant therapy: principle and practice.
Acute Coronary Syndrome
Relationships between homocysteine, factor VIIa, and thrombin generation in acute coronary syndromes.
Acute Coronary Syndrome
The decanucleotide polymorphism in the factor VII promoter predicts factor VII plasma levels but not the risk of acute coronary syndromes.
Acute Kidney Injury
Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery.
Acute Kidney Injury
Recombinant Activated Factor VII Use in Critically Ill Patients: Clinical Outcomes and Thromboembolic Events (April).
Acute Kidney Injury
Recombinant factor VIIa treatment of bleeding associated with acute renal failure.
Acute Kidney Injury
Viscoelastic haemostatic assays in the perioperative period of surgical procedures: Systematic review and meta-analysis.
Acute Kidney Injury
[Acquired hemophilia complicated with hemorrhage induced acute renal failure]
Acute Lung Injury
A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome*
Acute Lung Injury
Extrinsic coagulation blockade attenuates lung injury and proinflammatory cytokine release after intratracheal lipopolysaccharide.
Adrenal Insufficiency
Medication-related complications in the trauma patient.
Afibrinogenemia
Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.
Afibrinogenemia
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
Afibrinogenemia
Bleeding characteristics and management of minor surgeries in rare bleeding disorders: report from a Turkish Pediatric Hematology Center.
Afibrinogenemia
Clinical audit of inherited bleeding disorders in a developing country.
Afibrinogenemia
Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience.
Afibrinogenemia
Factor deficiencies in pregnancy.
Afibrinogenemia
Inherited bleeding disorders: a 14-year retrospective study.
Afibrinogenemia
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Afibrinogenemia
Prenatal diagnosis in rare bleeding disorders-An unresolved issue?
Afibrinogenemia
Rare bleeding disorders.
Afibrinogenemia
Surgical interventions in childhood rare factor deficiencies: a single-center experience from Turkey.
Afibrinogenemia
The animal models for hemorrhage and thrombosis in the neonate.
Afibrinogenemia
Thrombosis in rare bleeding disorders.
Afibrinogenemia
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
Albuminuria
Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients.
Albuminuria
Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria.
Amyloidosis
Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.
Amyloidosis
[Case of factor VII deficiency with systemic amyloidosis having a unique clinical course such as splenic rupture]
Amyloidosis
[Combined deficiency of factor VII and X in a patient with multiple myeloma and amyloidosis]
Anaphylaxis
Allergy and inhibitors in hemophilia - a rare complication with potential novel solutions.
Anaphylaxis
IgG4: a possible mediator of anaphylaxis in a haemophiliac patient.
Anaphylaxis
Immune tolerance induction with mycophenolate-mofetil in two children with haemophilia B and inhibitor.
Anaphylaxis
Peri-interventional control of haemostasis in a patient with combined coagulation factor V- and factor VIII-deficiency and anaphylaxis to fresh frozen plasma - a rare indication for recombinant factor VIIa.
Anaphylaxis
Possible Anaphylaxis Due to Recombinant Factor VIIa Administration During Thoracic Aortic Surgery.
Anaphylaxis
Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors.
Anemia
A novel homozygous missense mutation in the factor VII gene of severe factor VII deficiency in a newborn baby.
Anemia
Alternatives to allogeneic platelet transfusion.
Anemia
Bleeding Gastric Heterotopic Polyp in the Duodenum of a Teenager with Severe Factor VII Deficiency.
Anemia
Effect of recombinant factor VIIa as an adjunctive therapy in damage control for wartime vascular injuries: a case control study.
Anemia
Macrohematuria as initial presentation in a girl with factor VIII and factor IX inhibitors associated with systemic lupus erythematosus.
Anemia
Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report.
Anemia
Severe menorrhagia due to factor VII deficiency successfully treated by thermal balloon endometrial ablation.
Anemia
Substitutes and alternatives to platelet transfusions in thrombocytopenic patients.
Anemia
Two elderly patients with difficult-to-treat acquired hemophilia A.
Anemia
[Thrombasthenia of Glanzmann. Vaginal hysterectomy treated with recombinant factor VIIa]
Anemia, Aplastic
Acquired factor VII deficiency associated with aplastic anaemia: correction with bone marrow transplantation.
Anemia, Aplastic
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Anemia, Aplastic
Deficiency of fibrinogen and factor VII following treatment of severe aplastic anaemia with anti-thymocyte globulin and high-dose methylprednisolone.
Anemia, Aplastic
Efficacy and safety of recombinant factor VIIa in the treatment of bleeding episodes in patients with aplastic anemia.
Anemia, Iron-Deficiency
Bleeding Gastric Heterotopic Polyp in the Duodenum of a Teenager with Severe Factor VII Deficiency.
Anemia, Sickle Cell
Elevated urinary levels of thromboxane and prostacyclin metabolities in sickle cell disease reflects activated platelets in the circulation.
Anemia, Sickle Cell
Plasma factor VII and thrombin-antithrombin III levels indicate increased tissue factor activity in sickle cell patients.
Aneurysm
Bilateral total knee arthroplasty in a patient with hemophilia A, high inhibitor titre and aneurysma spurium of the popliteal artery. A case report.
Aneurysm
Investigation of Outcomes Following Recombinant Activated FVII Use for Refractory Bleeding During Abdominal Aortic Aneurysm Repair.
Aneurysm
Perioperative Use of Recombinant Factor VII to Prevent Intraoperative Aneurysm Rupture in High Risk Patients: A Preliminary Safety Evaluation.
Aneurysm
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.
Aneurysm
[Congenital factor VII deficiency and subarachnoidal haemorrhage due to intracranial aneurysm: a case report]
Aneurysm, Dissecting
A review of the off-label use of recombinant activated factor VII in a developing country tertiary care center.
Aneurysm, Dissecting
Case 5-2006: recombinant factor VIIa in the management of postoperative bleeding after repair for inadvertently thrombolysed acute type A aortic dissection.
Aneurysm, Dissecting
Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations.
Aneurysm, Dissecting
Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection.
Aneurysm, Dissecting
Recombinant activated factor VII for refractory bleeding after acute aortic dissection surgery: a propensity score analysis.
Aneurysm, Dissecting
Recombinant activated factor VII for treatment of refractory hemorrhage after surgery for acute aortic dissection.
Aneurysm, Dissecting
Recombinant factor VIIa use in acute type A aortic dissection repair: A multicenter propensity-score-matched report from the Nordic Consortium for Acute Type A Aortic Dissection.
Aneurysm, Dissecting
Successful Intraoperative Reversal of Heparin With Factor VII in a Patient With Protamine Reaction.
Aneurysm, Dissecting
The prophylactic use of recombinant factor VIIa in a patient with DeBakey type III aortic dissection -A case report-.
Aneurysm, Dissecting
[Treatment with activated factor VII after acute bleeding due to aortic dissection]
Aneurysm, False
Recombinant activated factor VII for false aneurysms in patients with normal haemostatic mechanisms.
Aneurysm, False
Use of recombinant activated factor VII after axillofemoral bypass grafting.
Aneurysm, False
[Reversal of acenocoumarol anticoagulation with activated factor VII in massive hemorrhage following rupture of a splenic artery pseudoaneurysm]
Aneurysm, Ruptured
Investigation of Outcomes Following Recombinant Activated FVII Use for Refractory Bleeding During Abdominal Aortic Aneurysm Repair.
Angina Pectoris
Coagulation factor VII and the risk of coronary heart disease in healthy men.
Angina Pectoris
Factor VII and extrinsic pathway inhibitor in acute coronary disease.
Angina Pectoris
[The alpha-defensins, peptides and proteins synthesized and liberated by neutrophils under atherosclerosis of different localization].
Angina, Stable
A protective contribution of the Q allele of the R353Q polymorphism of the Factor VII gene in individuals with chronic stable angina?
Angina, Stable
C-reactive protein plasma levels but not factor VII activity predict clinical outcome in patients undergoing elective coronary intervention.
Angina, Stable
Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis.
Angina, Stable
Early changes in local hemostasis activation following percutaneous coronary intervention in stable angina patients: a comparison between drug-eluting and bare metal stents.
Angina, Stable
Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes.
Angina, Stable
Role of coagulation factor VII in pathogenesis of ischemic heart disease.
Angina, Stable
[Factor VII detection and its association with lipid in ischaemic heart disease.]
Angina, Unstable
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Angina, Unstable
Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation.
Angina, Unstable
Gender difference in factor VII and in activated factor VII levels in unstable angina.
Angina, Unstable
Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes.
Angina, Unstable
Inhibition of factor VIIa generation and prothrombin activation by treatment with enoxaparin in patients with unstable angina.
Angina, Unstable
Role of coagulation factor VII in pathogenesis of ischemic heart disease.
Angina, Unstable
[Factor VII detection and its association with lipid in ischaemic heart disease.]
Angiodysplasia
Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa.
Antiphospholipid Syndrome
Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level.
Antiphospholipid Syndrome
Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous?
Antiphospholipid Syndrome
[Diagnosis and treatment of coagulation disorders]
Antithrombin III Deficiency
[Gene diagnosis of antithrombin deficiency and factor VII deficiency]
Antithrombin III Deficiency
[Hemostasis anomalies and prognosis during severe infectious purpura in children. Retrospective study in 69 cases]
Anus, Imperforate
Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature.
Aortic Aneurysm
Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.
Aortic Aneurysm, Abdominal
Association analysis of genetic polymorphisms of factor V, factor VII and fibrinogen ? chain genes with human abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Congenital factor VII deficiency in a patient with an abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
Investigation of Outcomes Following Recombinant Activated FVII Use for Refractory Bleeding During Abdominal Aortic Aneurysm Repair.
Aortic Aneurysm, Abdominal
Repair of abdominal aortic aneurysm in severe Factor VII deficiency.
Aortic Aneurysm, Abdominal
Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
Aortic Aneurysm, Abdominal
The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm.
Aortic Aneurysm, Abdominal
The use of recombinant-activated factor VII to successfully control postoperative critical bleeding after emergency repair of ruptured abdominal aortic aneurysm in a noncoagulopathic patient.
Aortic Aneurysm, Abdominal
[Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures]
Aortic Aneurysm, Thoracic
Role of recombinant factor VIIa in the treatment of intractable bleeding in vascular surgery.
Aortic Aneurysm, Thoracic
[Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures]
Aortic Coarctation
Recombinant factor VIIa for treatment of a child with severe factor VII deficiency and coarctation of the aorta.
Aortic Valve Stenosis
Aortic valve and coronary artery bypass surgery in a patient with factor VII deficiency.
Aortic Valve Stenosis
Intra-Pericardial Use of Recombinant Factor VIIa in a Patient With Acute Hemorrhagic Pericardial Effusion Following Transcutaneous Aortic Valve Replacement-A Case Report.
Aphasia
[Complications during epilepsy surgery. Experience after 102 interventions between 1997 and 2001]
Appendicitis
Two-incision laparoscopic appendectomy for a severe hemophilia A child patient with coagulation factor VII deficiency: Case report and review of literature.
Appendicitis
[Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
Arterial Occlusive Diseases
Predictive value of coagulation tests in arterial thrombosis.
Arteriosclerosis
Homocysteine, factor VII and antithrombin III in subjects with different gene dosage for cystathionine beta-synthase.
Arteriosclerosis
Levels of haemostatic factors, arteriosclerosis and cardiovascular disease.
Arteriovenous Malformations
[Recombinant activated factor VII and intraoperative use of cell saver in neurosurgical treatment of arteriovenous malformation]
Arteriovenous Malformations
[Recombinant factor VII (NovoSeven) in intraoperative blood saving during neurosurgical treatment of the brain arteriovenous malformation]
Arthralgia
Demonstration of reactivity to airborne and food allergens in cutaneous vasculitis by variations in fibrinopeptide A and other blood coagulation, fibrinolysis and complement parameters.
Arthritis
Altered regulation of in-vivo coagulation in orthopedic patients prior to knee or hip replacement surgery.
Arthritis
Increase of activated factor VIIA and haemostatic molecular markers in juvenile chronic arthritis.
Arthritis
Role of the tissue factor pathway in synovial inflammation.
Arthritis, Juvenile
Increase of activated factor VIIA and haemostatic molecular markers in juvenile chronic arthritis.
Arthritis, Rheumatoid
A case of acquired hemophilia caused by factor VIII inhibitor with rheumatoid arthritis, successfully treated with immunosuppressive treatment and recombinant activated factor VII.
Aspergillosis
Recombinant factor VIIa in massive haemoptysis associated with chronic necrotising aspergillosis.
Aspergillosis
Successful use of recombinant FVIIa (Novoseven) in the management of pulmonary haemorrhage secondary to Aspergillus infection in a patient with leukaemia and acquired FVII deficiency.
Asthma
Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales.
Ataxia
Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors.
Atherosclerosis
A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men.
Atherosclerosis
Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
Atherosclerosis
Assessment of coronary heart disease risk by combined analysis of coagulation factors.
Atherosclerosis
Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study Investigators.
Atherosclerosis
Associations of fish intake and dietary n-3 polyunsaturated fatty acids with a hypocoagulable profile. The Atherosclerosis Risk in Communities (ARIC) Study.
Atherosclerosis
Atherogenic effects in a non-human primate of Fusarium moniliforme cultures added to a carbohydrate diet.
Atherosclerosis
Atherosclerosis and coronary bypass surgery in hereditary factor VII deficiency.
Atherosclerosis
Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
Atherosclerosis
Constitutional, biochemical and lifestyle correlates of fibrinogen and factor VII activity in Polish urban and rural populations.
Atherosclerosis
Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis.
Atherosclerosis
Determinants of population changes in fibrinogen and factor VII over 6 years: the Atherosclerosis Risk in Communities (ARIC) Study.
Atherosclerosis
Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis.
Atherosclerosis
Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.
Atherosclerosis
Extrahepatic synthesis of factor VII in human atherosclerotic vessels.
Atherosclerosis
Factor VII hyperactivity in the elderly.
Atherosclerosis
Fibrinogen, factor VII and PAI-1 genotypes and the risk of coronary and peripheral atherosclerosis: Edinburgh Artery Study.
Atherosclerosis
Hemostasis and atherosclerosis.
Atherosclerosis
Pleiotropic actions of factor Xa inhibition in cardiovascular prevention - mechanistic insights and implications for anti-thrombotic treatment.
Atherosclerosis
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.
Atherosclerosis
Risk factors, interventions and therapeutic agents in the prevention of atherosclerosis-related ischaemic diseases.
Atherosclerosis
The possible role of hemorheology in atherothrombogenesis.
Atherosclerosis
Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
Atherosclerosis
Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation.
Atherosclerosis
Tissue factor isoforms in cancer and coagulation: may the best isoform win.
Atherosclerosis
Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells.
Atherosclerosis
[Coagulation factor VII--new physiopathological and therapeutic aspects]
Atherosclerosis
[The alpha-defensins, peptides and proteins synthesized and liberated by neutrophils under atherosclerosis of different localization].
Atrial Fibrillation
Anticoagulation Therapy Considerations in Factor VII Deficiency.
Atrial Fibrillation
Aortic valve and coronary artery bypass surgery in a patient with factor VII deficiency.
Atrial Fibrillation
D-dimer and factor VIIa in atrial fibrillation - prognostic values for cardiovascular events and effects of anticoagulation therapy. A RE-LY substudy.
Atrial Fibrillation
Direct oral anticoagulants for atrial fibrillation in patients with congenital factor VII deficiency.
Atrial Fibrillation
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk.
Atrial Fibrillation
Influence of warfarin therapy on activated factor VII clotting activity.
Atrial Fibrillation
Management of a patient with atrial fibrillation and factor VII deficiency.
Atrial Fibrillation
Medication-related complications in the trauma patient.
Atrial Fibrillation
Mitral valve surgery in severe congenital factor VII deficiency.
Atrial Fibrillation
Novel anticoagulant therapy: principle and practice.
Atrial Fibrillation
Therapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolism.
Bacteremia
Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock.
Bacterial Infections
Cytochemical determination of intracellular polymorphonuclear leukocyte elastase content in patients with severe bacterial infection and septicaemia correlated with coagulation parameters.
Beckwith-Wiedemann Syndrome
11p15 duplication and 13q34 deletion with Beckwith-Wiedemann syndrome and factor VII deficiency.
Bernard-Soulier Syndrome
A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies.
Bernard-Soulier Syndrome
Clinical and laboratory features of 178 children with recurrent epistaxis.
Bernard-Soulier Syndrome
Clinical benefit of recombinant factor VIIa in management of bleeds and surgery in two brothers suffering from the Bernard-Soulier syndrome.
Bernard-Soulier Syndrome
Complementary effect of fibrinogen and rFVIIa on clotting ex vivo in Bernard-Soulier syndrome and combined use during three deliveries.
Bernard-Soulier Syndrome
Hemostatic effect of activated recombinant factor VIIa in Bernard-Soulier syndrome: studies in an in vitro model.
Bernard-Soulier Syndrome
Inherited Bleeding Disorders in the Obstetric Patient.
Bernard-Soulier Syndrome
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Bernard-Soulier Syndrome
Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.
Bernard-Soulier Syndrome
Screening bleeding disorders in adolescents and young women with menorrhagia.
Bernard-Soulier Syndrome
The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia.
Bernard-Soulier Syndrome
To general haemostasis--the evidence-based route.
Bernard-Soulier Syndrome
Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa.
Bernard-Soulier Syndrome
Use of recombinant factor VIIa in the management and prophylaxis of bleeding episodes in two patients with Bernard-Soulier syndrome.
Bernard-Soulier Syndrome
Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
Bernard-Soulier Syndrome
[Recombinant factor VIIa in patients with platelet function disorders or thrombocytopenia]
beta-Thalassemia
Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology.
Bicuspid Aortic Valve Disease
Congenital Factor VII Deficiency in Association With Bicuspid Aortic Valve and Multicystic Dysplastic Kidney Disease in a Child.
Blindness, Cortical
Migraine, cortical blindness, multiple cerebral infarctions and hypocoagulopathy in celiac disease.
Blood Coagulation Disorders
[Homocystinuria. A type with vascular thrombosis and factor VII deficiency]
Blood Coagulation Disorders, Inherited
A rare inherited coagulation disorder: combined homozygous factor VII and factor X deficiency.
Blood Coagulation Disorders, Inherited
Advances in the treatment of inherited coagulation disorders.
Blood Coagulation Disorders, Inherited
An overview of inherited factor VII deficiency.
Blood Coagulation Disorders, Inherited
Clinical problems and surgical interventions in inherited factor VII deficiency.
Blood Coagulation Disorders, Inherited
Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.
Blood Coagulation Disorders, Inherited
Factor VII deficiency detected in pregnancy: a case report.
Blood Coagulation Disorders, Inherited
[Hemophilia and other inherited blood coagulation disorders in Poland]
Blood Coagulation Disorders, Inherited
[Use of recombinant, activated Factor VII in the treatment and prevention of bleeding complications in two female patients suffering from congenital XI factor deficiency during orthopedic and traumatology intervention. Case reports]
Blood Platelet Disorders
Effective treatment with recombinant factor VIIa of severe bleeding due to acquired factor VIII inhibitor and acquired thrombocytopathy.
Blood Platelet Disorders
Is the use of rFVIIa safe and effective in bleeding neonates? A retrospective series of 8 cases.
Blood Platelet Disorders
Modification of biological parameters after treatment with recombinant factor VIIa in a patient with thrombocytopathy due to storage pool disease.
Blood Platelet Disorders
Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Blood Platelet Disorders
Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia.
Blood Platelet Disorders
[New possibilities in the management of hemorrhagic diathesis caused by factor deficiency and thrombocytopenia: recombinant active factor VII concentrate]
Blood-Borne Infections
Recombinant factor VIIa in joint and muscle bleeding episodes.
Bone Marrow Failure Disorders
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
Bone Marrow Failure Disorders
Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review.
Brain Contusion
Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy.
Brain Contusion
FVIIa prevents the progressive hemorrhaging of a brain contusion by protecting microvessels via formation of the TF-FVIIa-FXa complex.
Brain Contusion
Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs.
Brain Death
Hypercoagulation following brain death cannot be reversed by the neutralization of systemic tissue factor.
Brain Death
Use of recombinant factor VIIa to facilitate organ donation in trauma patients with devastating neurologic injury.
Brain Diseases
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Brain Diseases
Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis.
Brain Diseases
The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy.
Brain Diseases
[Predictive value of changes in the hemostasis system in patients with ischemic brain diseases]
Brain Edema
Liver transplantation in acute liver failure.
Brain Injuries
Extrapolation of battlefield resuscitative care to the civilian setting.
Brain Injuries
Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.
Brain Injuries
The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications.
Brain Injuries
[Use of activated recombinant factor VII in patients with brain injury or undergoing brain surgery]
Brain Injuries, Traumatic
Activity of factor VII in patients with isolated blunt traumatic brain injury: association with coagulopathy and progressive hemorrhagic injury.
Brain Injuries, Traumatic
Blood component therapy in trauma guided with the utilization of the perfusionist and thromboelastography.
Brain Injuries, Traumatic
Contribution of factor VII polymorphisms to coagulopathy in patients with isolated traumatic brain injury.
Brain Injuries, Traumatic
Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage.
Brain Injuries, Traumatic
Factor VII and the brain: time to get this research done!
Brain Injuries, Traumatic
Factor VIIa administration in traumatic brain injury: an AAST-MITC propensity score analysis.
Brain Injuries, Traumatic
Factor VIIa for correction of traumatic coagulopathy.
Brain Injuries, Traumatic
Haemostatic drugs for traumatic brain injury.
Brain Injuries, Traumatic
Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs.
Brain Injuries, Traumatic
Low-dose recombinant factor VIIa for reversing coagulopathy in patients with isolated traumatic brain injury.
Brain Injuries, Traumatic
Recombinant Activated Factor VII Use in Critically Ill Patients: Clinical Outcomes and Thromboembolic Events (April).
Brain Injuries, Traumatic
Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients.
Brain Injuries, Traumatic
Recombinant factor VIIa to correct coagulopathy in patients with traumatic brain injury presenting to outlying facilities before transfer to the regional trauma center.
Brain Injuries, Traumatic
Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury.
Brain Injuries, Traumatic
Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.
Brain Injuries, Traumatic
Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial.
Brain Injuries, Traumatic
The effect of rFVIIa on pro- and anti-inflamatory cytokines in serum and cerebrospinal fluid in a swine model of traumatic brain injury.
Brain Injuries, Traumatic
The role of recombinant-activated factor VII in bleeding trauma patients.
Brain Injuries, Traumatic
The role of thromboelastometry and recombinant factor VIIa in trauma.
Brain Injuries, Traumatic
The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial?
Brain Injuries, Traumatic
The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications.
Brain Injuries, Traumatic
The use of recombinant factor VIIa in warfarin patients with traumatic brain injury: a retrospective case-control study.
Brain Injuries, Traumatic
Use of recombinant factor VIIa (rFVIIa) as pre-hospital treatment in a swine model of fluid percussion traumatic brain injury.
Brain Injuries, Traumatic
Uses of recombinant factor VIIa in trauma.
Brain Injuries, Traumatic
[Activity of factor VII in patients with isolated blunt traumatic brain injury: association with coagulopathy and progressive hemorrhagic injury].
Brain Injuries, Traumatic
[Role of small-dose recombinant human coagulation factor VIIa for coagulopathy in patients with isolated traumatic brain injury].
Brain Injuries, Traumatic
[The use of recombinant activated factor VII in traumatic intracranial haemorrhage]
Brain Ischemia
Cerebral ischemia and livedo reticularis in a patient with impairment of coagulation factor VII and free protein S.
Brain Ischemia
Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
Brain Neoplasms
Intractable blood loss during brain tumour surgery in a child: effect of recombinant activated factor VII.
Brain Neoplasms
Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature.
Brain Neoplasms
Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery.
Brain Neoplasms
Use of activated recombinant Factor VII (NovoSeven) during neurosurgery.
Brain Neoplasms
Use of recombinant factor VIIa (rFVIIa) to control intraoperative bleeding in pediatric brain tumor patients.
Brain Neoplasms
[Intraoperative use of activated recombinant factor VII in a patient with brain cancer]
Breast Neoplasms
Activation of ?1 integrins and caveolin-1 by TF/FVIIa promotes IGF-1R signaling and cell survival.
Breast Neoplasms
Association between the -402GA, -401GT, and -323ins10-bp polymorphisms of factor VII gene and breast cancer.
Breast Neoplasms
Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.
Breast Neoplasms
Coagulation factor VII is regulated by androgen receptor in breast cancer.
Breast Neoplasms
Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to ?-catenin accumulation via the AKT/GSK3? pathway and contributes to breast cancer progression.
Breast Neoplasms
Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial.
Breast Neoplasms
Formation of tissue factor-factor VIIa-factor Xa complex prevents apoptosis in human breast cancer cells.
Breast Neoplasms
Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Breast Neoplasms
Hepatocyte nuclear factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases.
Breast Neoplasms
Interaction of human tumor cells with human platelets and the coagulation system.
Breast Neoplasms
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Breast Neoplasms
Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer.
Breast Neoplasms
Simvastatin induces apoptosis in human breast cancer cells in a NFkappaB-dependent manner and abolishes the anti-apoptotic signaling of TF/FVIIa and TF/FVIIa/FXa.
Breast Neoplasms
Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.
Breast Neoplasms
TFPI? and TFPI? are expressed at the surface of breast cancer cells and inhibit TF-FVIIa activity.
Breast Neoplasms
The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
Breast Neoplasms
Tissue factor as a novel target for treatment of breast cancer.
Breast Neoplasms
Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.
Breast Neoplasms
Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor.
Breast Neoplasms
Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
Budd-Chiari Syndrome
Association of factor VII gene polymorphisms with Budd Chiari syndrome.
Budd-Chiari Syndrome
Hematological problems and liver disease.
Burkitt Lymphoma
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Burkitt Lymphoma
Successful Control of Massive Bleeding in a Child with Burkitt's Lymphoma via a Biosimilar Recombinant Activated Factor VII (AryoSeven).
Burkitt Lymphoma
Successful management of bleeding with recombinant factor VIIa (NovoSeven) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins.
Carcinogenesis
Blood coagulation factors as inflammatory mediators.
Carcinogenesis
Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases.
Carcinogenesis
Ovarian cancer, the coagulation pathway, and inflammation.
Carcinoid Tumor
Role of factor VII in correcting dilutional coagulopathy and reducing re-operations for bleeding following non-traumatic major gastrointestinal and abdominal surgery.
Carcinoma
Activation of factor VII in patients with carcinoma of the prostate. A preliminary report.
Carcinoma
Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells.
Carcinoma
Anti-apoptotic genes are synergistically activated in OVSAYO cells cultured under conditions of serum starvation and hypoxia.
Carcinoma
Binding of human factors VII and VIIa to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation.
Carcinoma
Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles.
Carcinoma
Comparison of properties of cancer procoagulant and human amnion-chorion procoagulant.
Carcinoma
Computer-assisted image analysis of neovascularization in thyroid neoplasms from dogs.
Carcinoma
Cooperative interaction between factor VII and cell surface-expressed tissue factor.
Carcinoma
Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: a kinetic study.
Carcinoma
Human plasma and recombinant factor VII. Characterization of O-glycosylations at serine residues 52 and 60 and effects of site-directed mutagenesis of serine 52 to alanine.
Carcinoma
Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor.
Carcinoma
Inhibition of recombinant human blood coagulation factor VIIa amidolytic and proteolytic activity by zinc ions.
Carcinoma
Initiation of the extrinsic pathway of blood coagulation: evidence for the tissue factor dependent autoactivation of human coagulation factor VII.
Carcinoma
Lipid starvation and hypoxia synergistically activate ICAM1 and multiple genes in an Sp1-dependent manner to promote the growth of ovarian cancer.
Carcinoma
Plasma-dependent and -independent mechanisms of platelet aggregation induced by human tumour cell lines.
Carcinoma
Recombinant human extrinsic pathway inhibitor. Production, isolation, and characterization of its inhibitory activity on tissue factor-initiated coagulation reactions.
Carcinoma
Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Carcinoma
Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
Carcinoma
Studies of the activation of factor VII bound to tissue factor.
Carcinoma
The gamma-carboxyglutamic acid domain of human factor VIIa is essential for its interaction with cell surface tissue factor.
Carcinoma
Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.
Carcinoma
Unforeseen encounter of acquired hemophilia A in a preoperative case of periampullary carcinoma: A case report.
Carcinoma
USE OF RECOMBINANT ACTIVATED FACTOR VIIa IN A-SIX-MONTH-OLD CHILD DUE TO MASSIVE HEMORRHAGE DURING ELECTIVE SURGERY FOR CHOROID PLEXUS CARCINOMA: CASE REPORT.
Carcinoma
Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody.
Carcinoma, Bronchogenic
Acquired Factor VII Deficiency Associated with Bronchogenic Carcinoma: A Case Report.
Carcinoma, Bronchogenic
Factor VII inhibitor.
Carcinoma, Bronchogenic
[Acquired isolated factor VII deficiency and bronchogenic carcinoma. A case report]
Carcinoma, Hepatocellular
Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Carcinoma, Hepatocellular
An engineered tale-transcription factor rescues transcription of factor VII impaired by promoter mutations and enhances its endogenous expression in hepatocytes.
Carcinoma, Hepatocellular
Biosynthesis and secretion of factor VII, protein C, protein S, and the Protein C inhibitor from a human hepatoma cell line.
Carcinoma, Hepatocellular
CCAAT/Enhancer-binding Protein-beta Participates in Insulin-responsive Expression of the Factor VII Gene.
Carcinoma, Hepatocellular
Coagulation factor VII and malignant progression of hepatocellular carcinoma.
Carcinoma, Hepatocellular
Coagulation factor VII gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma: a report of 37 cases.
Carcinoma, Hepatocellular
Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis.
Carcinoma, Hepatocellular
Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling.
Carcinoma, Hepatocellular
Factor VII Tokushima: the first case of factor VII Cys22Gly with the development of myocardial infarction in the proband receiving recombinant factor VIIa replacement therapy.
Carcinoma, Hepatocellular
Factor VIIa binding and internalization in hepatocytes.
Carcinoma, Hepatocellular
Internalization and degradation of recombinant human coagulation factor VIIa by the human hepatoma cell line HuH7.
Carcinoma, Hepatocellular
Perioperative pharmacokinetics of factor VII concentrate during liver surgery in a patient with congenital factor VII deficiency: an individual mathematical model.
Carcinoma, Hepatocellular
Transforming growth factor beta (TGF-beta) inhibits expression of fibrinogen and factor VII in a hepatoma cell line.
Carcinoma, Hepatocellular
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.
Carcinoma, Squamous Cell
Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody.
Cardiac Tamponade
Hemophilia A and concurrent factor VII deficiency. Studies of a patient with complicating cardiac tamponade.
Cardiomyopathy, Dilated
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Cardiomyopathy, Hypertrophic
Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency.
Cardiomyopathy, Restrictive
Severe deficiency of coagulation Factor VII results in spontaneous cardiac fibrosis in mice.
Cardiovascular Diseases
A chromogenic assay for coagulation factor VII: analytical performance characteristics and application in several diseases.
Cardiovascular Diseases
A new form of coagulation factor VII in plasma.
Cardiovascular Diseases
A novel form of factor VII in plasma from men at risk for cardiovascular disease.
Cardiovascular Diseases
Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients.
Cardiovascular Diseases
Alcohol consumption and hemostatic factors: analysis of the Framingham Offspring cohort.
Cardiovascular Diseases
An association between clotting factor VII and carotid intima-media thickness: the CARDIA study.
Cardiovascular Diseases
Association of blood pressure with fibrinolytic potential in the Framingham offspring population.
Cardiovascular Diseases
Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.
Cardiovascular Diseases
Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.
Cardiovascular Diseases
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Cardiovascular Diseases
Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.
Cardiovascular Diseases
Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.
Cardiovascular Diseases
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
Cardiovascular Diseases
Coagulation factor VII, serum-triglycerides and the R/Q353 polymorphism: differences between older men and women.
Cardiovascular Diseases
Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.
Cardiovascular Diseases
Contribution of factor VII genotype to activated FVII levels. Differences in genotype frequencies between northern and southern European populations.
Cardiovascular Diseases
Dietary fatty acids, hemostasis, and cardiovascular disease risk.
Cardiovascular Diseases
Effect of alteration in triglyceride levels on factor VII-phospholipid complexes in plasma.
Cardiovascular Diseases
Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study.
Cardiovascular Diseases
Effects of Different Protein Sources on Plasminogen Inhibitor-1 and Factor VII Coagulant Activity Added to a Fat-Rich Meal in Type 2 Diabetes.
Cardiovascular Diseases
Effects of HMG-CoA reductase inhibitors on coagulation and fibrinolysis processes.
Cardiovascular Diseases
Environmental and genetic determinants of the hypercoagulable state and cardiovascular disease in renal transplant recipients.
Cardiovascular Diseases
Experimental thrombosis I: relation with fibrinogen and other haemostatic parameters.
Cardiovascular Diseases
Factor VII activity state in coronary artery disease.
Cardiovascular Diseases
Factor VII and ischaemic heart disease: epidemiological evidence.
Cardiovascular Diseases
Factor VII assays, plasma triglyceride levels, and cardiovascular disease risk.
Cardiovascular Diseases
Factor VII assays.
Cardiovascular Diseases
Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype.
Cardiovascular Diseases
Factor VII gene polymorphism, factor VII levels, and prevalent cardiovascular disease: the Framingham Heart Study.
Cardiovascular Diseases
Factor VII polymorphisms associated with plasma factor VII coagulant activity levels in healthy Tunisians.
Cardiovascular Diseases
Factor VII polymorphisms in populations with different risks of cardiovascular disease.
Cardiovascular Diseases
Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls.
Cardiovascular Diseases
Factor VII-phospholipid complex in male survivors of acute myocardial infarction.
Cardiovascular Diseases
Fibrinogen and factor VII in male neonates.
Cardiovascular Diseases
Fibrinogen and factor VII levels are related to adiposity but not to fetal growth or social class in children aged 10-11 years.
Cardiovascular Diseases
Fibrinogen and factor VIII, but not factor VII, are associated with measures of subclinical cardiovascular disease in the elderly. Results from The Cardiovascular Health Study.
Cardiovascular Diseases
Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
Cardiovascular Diseases
Functional analysis of the genetic variability in the F7 gene promoter.
Cardiovascular Diseases
Genetic architecture of the F7 gene in a Spanish population: implication for mapping complex diseases and for functional assays.
Cardiovascular Diseases
Genetic determinants of plasma factor VII activity in the Japanese.
Cardiovascular Diseases
Genetic effects for plasma factor VII levels independent of and in common with triglycerides.
Cardiovascular Diseases
Genetic polymorphisms modify the response of factor VII to oral contraceptive use: an example of gene-environment interaction.
Cardiovascular Diseases
Haemostatic parameters and vascular risk.
Cardiovascular Diseases
Hemostatic factors as predictors of stroke and cardiovascular diseases: the FINRISK '92 Hemostasis Study.
Cardiovascular Diseases
Hemostatic factors as triggers of cardiovascular events.
Cardiovascular Diseases
Ixolaris, a novel recombinant tissue factor pathway inhibitor (TFPI) from the salivary gland of the tick, Ixodes scapularis: identification of factor X and factor Xa as scaffolds for the inhibition of factor VIIa/tissue factor complex.
Cardiovascular Diseases
Lack of association between polymorphisms of the coagulation factor VII and myocardial infarction in middle-aged Spanish men.
Cardiovascular Diseases
Long-term anticoagulant treatment after acute myocardial infarction. The Warfarin Re-Infarction Study.
Cardiovascular Diseases
Overview of hemostatic factors involved in atherosclerotic cardiovascular disease.
Cardiovascular Diseases
Phospholipase C mediated inhibition of factor VII requires triglyceride-rich lipoproteins.
Cardiovascular Diseases
Physical excercise and thrombotic risk in the elderly.
Cardiovascular Diseases
Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
Cardiovascular Diseases
Plasma phospholipid fatty acid composition and factor VII coagulant activity.
Cardiovascular Diseases
Population correlates of plasma fibrinogen and factor VII, putative cardiovascular risk factors.
Cardiovascular Diseases
Probing the S2 site of factor VIIa to generate potent and selective inhibitors: the structure of BCX-3607 in complex with tissue factor-factor VIIa.
Cardiovascular Diseases
Prothrombin fragment F1 + 2: correlations with cardiovascular risk factors.
Cardiovascular Diseases
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study.
Cardiovascular Diseases
Reduced factor VII and factor VIII levels and prolonged thrombin-generation times during a healthy diet in middle-aged women with mild to moderate cardiovascular disease risk.
Cardiovascular Diseases
Relation of plasma coagulation factor VII and fibrinogen to carotid artery intima-media thickness.
Cardiovascular Diseases
Risk factors of ischemic cardiac disease in patients on continuous ambulatory peritoneal dialysis.
Cardiovascular Diseases
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease.
Cardiovascular Diseases
Suppression of plasma-activated factor VII levels by warfarin therapy.
Cardiovascular Diseases
The effect of phospholipase C on plasma factor VII.
Cardiovascular Diseases
The F7 gene and clotting factor VII levels: dissection of a human quantitative trait locus.
Cardiovascular Diseases
The genetics of haemostasis: a twin study.
Cardiovascular Diseases
The relation of prothrombin times to coronary heart disease risk factors among men aged 31-45 years.
Cardiovascular Diseases
The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study.
Cardiovascular Diseases
Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC).
Cardiovascular Diseases
Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?
Cardiovascular Diseases
[Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease]
Cardiovascular Diseases
[Estrogen replacement in postmenopause, blood coagulation and fibrinolysis: comparison of a new kind of transdermal estradiol treatment with oral therapy with conjugated estrogens]
Cardiovascular Diseases
[Role of newly developed technology in blood coagulation disorders]
Carotid Artery Diseases
Correlation of factor VIIa values with factor VII gene polymorphism, fasting and postprandial triglyceride levels, and subclinical carotid atherosclerosis.
Carotid Artery Diseases
Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease.
Carotid Artery Thrombosis
Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.
Carotid Artery Thrombosis
Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction.
Carotid Stenosis
Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction.
Carotid Stenosis
Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency.
Cataract
A successful use of recombinant factor VIIa in a patient with inhibitors, for bilateral cataract operation and circumcision.
Cataract
Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries.
Cataract
Successful use of recombinant factor VIIa in a haemophiliac with inhibitor undergoing cataract surgery.
Cataract
Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency.
Celiac Disease
Migraine, cortical blindness, multiple cerebral infarctions and hypocoagulopathy in celiac disease.
Cerebral Hemorrhage
801 Effects of Recombinant Activated Factor VII on Perilesional Edema in Patients with Acute Intracerebral Hemorrhage.
Cerebral Hemorrhage
A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
Cerebral Hemorrhage
A review of the off-label use of recombinant activated factor VII in a developing country tertiary care center.
Cerebral Hemorrhage
Advances in the treatment of hemorrhagic stroke: a possible new treatment.
Cerebral Hemorrhage
Association of protein Z and factor VII gene polymorphisms with risk of cerebral hemorrhage: a case-control and a family-based association study in a Chinese Han population.
Cerebral Hemorrhage
Best evidence in anesthetic practice: Recombinant activated factor VII for acute intracerebral hemorrhage: a promising therapy for a devastating problem?
Cerebral Hemorrhage
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?
Cerebral Hemorrhage
Cerebral hemorrhage treated with NovoSeven in acute promyelocytic leukemia.
Cerebral Hemorrhage
Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.
Cerebral Hemorrhage
Clinical Strategies Against Early Hematoma Expansion Following Intracerebral Hemorrhage.
Cerebral Hemorrhage
Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa.
Cerebral Hemorrhage
Complications in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
Cerebral Hemorrhage
Controversies of anticoagulation reversal in life-threatening bleeds.
Cerebral Hemorrhage
Cost effectiveness of recombinant factor VIIa for treatment of intracerebral hemorrhage.
Cerebral Hemorrhage
Cost-effectiveness of recombinant activated factor VII in the treatment of intracerebral hemorrhage.
Cerebral Hemorrhage
Determinants of intracerebral hemorrhage growth: an exploratory analysis.
Cerebral Hemorrhage
Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery.
Cerebral Hemorrhage
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.
Cerebral Hemorrhage
Early hemostatic therapy using recombinant factor VIIa in a collagenase-induced intracerebral hemorrhage model in rats.
Cerebral Hemorrhage
Early recombinant activated factor VII for intracerebral hemorrhage reduced hematoma growth and mortality, while improving functional outcomes.
Cerebral Hemorrhage
Early recombinant factor VIIa therapy in acute intracerebral hemorrhage: promising approach.
Cerebral Hemorrhage
Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
Cerebral Hemorrhage
Effects of recombinant activated coagulation factor VII on apoptosis and expressions of Bcl-2 and Bax in rats with intracerebral hemorrhage.
Cerebral Hemorrhage
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
Cerebral Hemorrhage
Emerging therapies for acute ischemic stroke.
Cerebral Hemorrhage
Evidence for the use of recombinant factor VIIa in the prevention and treatment of bleeding in patients without hemophilia.
Cerebral Hemorrhage
Generation of a human induced pluripotent stem cell line, YCMi002-A, from a Factor VII deficiency patient carrying F7 mutations.
Cerebral Hemorrhage
Hemostatic therapy for the treatment of intracranial hemorrhage.
Cerebral Hemorrhage
Hemostatic treatment in the early stage of intracerebral hemorrhage: the recombinant factor VIIa experience.
Cerebral Hemorrhage
Impact of recombinant activated factor VII on health-related quality of life after intracerebral hemorrhage.
Cerebral Hemorrhage
Intracerebral hemorrhage.
Cerebral Hemorrhage
Intracerebral hemorrhage: outcomes and eligibility for factor VIIa treatment in a National Stroke Registry.
Cerebral Hemorrhage
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study.
Cerebral Hemorrhage
Is "compassionate use" compassionate?: rFVIIa for intracerebral hemorrhage.
Cerebral Hemorrhage
Multiple intracranial hemorrhages at the time of a transiently prolonged activated partial thromboplastin time in an infant with congenital factor VII deficiency.
Cerebral Hemorrhage
Myocardial injury in patients with intracerebral hemorrhage treated with recombinant factor VIIa.
Cerebral Hemorrhage
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic.
Cerebral Hemorrhage
Polymorphisms in the coagulation factor VII gene and risk of primary intracerebral hemorrhage.
Cerebral Hemorrhage
Potential applicability of recombinant factor VIIa for intracerebral hemorrhage.
Cerebral Hemorrhage
Primary intracerebral hemorrhage.
Cerebral Hemorrhage
Radiologic estimation of hematoma volume in intracerebral hemorrhage trial by CT scan.
Cerebral Hemorrhage
Rapid warfarin reversal: a 3-factor prothrombin complex concentrate and recombinant factor VIIa cocktail for intracerebral hemorrhage.
Cerebral Hemorrhage
Recombinant activated coagulation factor VII and prothrombin complex concentrates are equally effective in reducing hematoma volume in experimental warfarin-associated intracerebral hemorrhage.
Cerebral Hemorrhage
Recombinant activated factor VII for acute intracerebral hemorrhage.
Cerebral Hemorrhage
Recombinant Activated Factor VII for Acute Intracerebral Hemorrhage.
Cerebral Hemorrhage
Recombinant activated factor VII for acute intracerebral hemorrhage.
Cerebral Hemorrhage
Recombinant activated factor VII for acute intracerebral hemorrhage: US phase IIA trial.
Cerebral Hemorrhage
Recombinant activated factor VII for bleeding in patients without inherited bleeding disorders.
Cerebral Hemorrhage
Recombinant activated factor VII given within 4 hours of intracerebral hemorrhage reduced hematoma growth.
Cerebral Hemorrhage
Recombinant factor VIIa and the surgical patient.
Cerebral Hemorrhage
Recombinant factor VIIa plus surgery for intracerebral hemorrhage.
Cerebral Hemorrhage
Recombinant Human Coagulation Factor VIIa for Intracerebral Hemorrhage.
Cerebral Hemorrhage
Risk of thromboembolic events in controlled trials of rFVIIa in spontaneous intracerebral hemorrhage.
Cerebral Hemorrhage
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
Cerebral Hemorrhage
Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system.
Cerebral Hemorrhage
Successful treatment with rFVIIa of spontaneous intracerebral hemorrhage in a patient with mechanical prosthetic heart valves.
Cerebral Hemorrhage
The effect of activated factor VII for intracerebral hemorrhage beyond 3 hours versus within 3 hours.
Cerebral Hemorrhage
The effect of recombinant activated factor VII in the treatment of intracerebral hemorrhage on health plan budgets.
Cerebral Hemorrhage
The practical management of intracerebral hemorrhage associated with oral anticoagulant therapy.
Cerebral Hemorrhage
Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
Cerebral Hemorrhage
Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study.
Cerebral Hemorrhage
Tissue factor in brain is not saturated with factor VIIa: implications for factor VIIa dosing in intracerebral hemorrhage.
Cerebral Hemorrhage
Use of Recombinant Factor VIIa in Symptomatic Intracerebral Hemorrhage Following Intravenous Thrombolysis.
Cerebral Hemorrhage
[Acute stroke therapy : Current developments.]
Cerebral Hemorrhage
[Ethical and legal aspects of including patients unable to consent in acute therapy studies. Example of a medication study for the treatment of intracerebral hemorrhage--the Heidelberg procedure]
Cerebral Hemorrhage
[Pharmacotherapy of stroke]
Cerebral Hemorrhage
[Recombinant activated factor VII for spontaneous cerebral hemorrhage]
Cerebral Hemorrhage, Traumatic
Expansion of traumatic intracerebral hemorrhage: treatment implications with recombinant factor VIIa.
Cerebral Hemorrhage, Traumatic
Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial.
Cerebral Infarction
Association of beta-fibrinogen and factor VII polymorphism with plasma fibrinogen and factor VII levels, and no association of PAI-1 polymorphism with plasma PAI-1 levels in hemodialysis patients.
Cerebral Infarction
Polymorphisms of the coagulation factor VII gene and its plasma levels in relation to acute cerebral infarction differences in allelic frequencies between Chinese Han and European populations.
Cerebral Infarction
Prothrombotic gene polymorphisms and atherothrombotic cerebral infarction.
Cerebral Infarction
Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity.
Cerebral Infarction
[Polimorfismos asociados a disfunción endotelial y a un estado protrombótico en jóvenes mexicanos con infarto cerebral].
Cerebral Infarction
[Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction]
Cerebrovascular Disorders
Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls.
Cerebrovascular Disorders
Inhibitory activity of unsaturated fatty acids and anacardic acids toward soluble tissue factor-factor VIIa complex.
Cerebrovascular Disorders
Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality.
Cerebrovascular Disorders
Prothrombotic genetic risk factors in patients with coexisting migraine and ischemic cerebrovascular disease.
Cerebrovascular Disorders
Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis.
Cerebrovascular Disorders
[The thrombophilic status and ischemic cardiopathy]
Chagas Disease
Human acute Chagas disease: changes in factor VII, activated protein C and hepatic enzymes from patients of oral outbreaks in Pará State (Brazilian Amazon).
Cholangitis, Sclerosing
Segmental liver transplantation from non-heart beating donors-an early experience with implications for the future.
Cholecystitis
A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
Cholecystolithiasis
A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
Choledocholithiasis
Recombinant Factor VIIa Use for Endoscopic Retrograde Cholangiopancreatography With Sphincterotomy in a Patient With Choledocholithiasis and Unusual Coagulopathy.
Cholestasis, Intrahepatic
Hepatocyte transplantation for liver-based metabolic disorders.
Cholestasis, Intrahepatic
Liver after hepatocyte transplantation for liver-based metabolic disorders in children.
Cholestasis, Intrahepatic
Segmental liver transplantation from non-heart beating donors-an early experience with implications for the future.
Cholesteatoma
A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug.
Choriocarcinoma
Recombinant factor VIIa in the management of pulmonary hemorrhage associated with metastatic choriocarcinoma.
Choroidal Neovascularization
Factor VII-verteporfin for Targeted Photodynamic Therapy in a Rat Model of Choroidal Neovascularization.
Chronic Urticaria
Interaction between C1-INA, coagulation, fibrinolysis and kinin system in hereditary angioneurotic edema (HANE) and urticaria.
Chronic Urticaria
The relationship between the severity of clinical symptoms of chronic urticaria and serum D-dimer levels.
Cleft Lip
Bilateral Cleft Lip and Palate Accompanied by 13q- Syndrome with Deficiencies of FVII and FX: A Case Report.
Cleft Palate
Bleeding Prophylaxis in a Child With Cleft Palate and Factor VII Deficiency: A Case Report.
Cleft Palate
Congenital combined defects of factor VII: a critical review.
coagulation factor ixa deficiency
A Candidate Activation Pathway for Coagulation Factor VII.
coagulation factor ixa deficiency
Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency.
coagulation factor ixa deficiency
Clinical and laboratory features of 178 children with recurrent epistaxis.
coagulation factor ixa deficiency
Iron studies in hemophilia.
coagulation factor ixa deficiency
Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
coagulation factor ixa deficiency
Pharmacokinetics and pharmacodynamics of recombinant factor VIIa.
coagulation factor viia deficiency
"Case report". A case of haemorrhagic diathesis due to factor VII deficiency.
coagulation factor viia deficiency
"Noninfective Endocarditis": A Case Report of Hereditary Coagulation Disorders in a 28-Year-Old Male.
coagulation factor viia deficiency
11p15 duplication and 13q34 deletion with Beckwith-Wiedemann syndrome and factor VII deficiency.
coagulation factor viia deficiency
3 ANESTHETIC MANAGEMENT OF LIVER TRANSPLANTATION FOR FACTOR VII DEFICIENCY IN A 6-MONTH-OLD CHILD-THROMBOELASTOGRAPHY-GUIDED INTRA-OPERATIVE REPLACEMENT OF RECOMBINANT FACTOR VIIa.
coagulation factor viia deficiency
A case of heterozygous factor VII deficiency in pregnancy.
coagulation factor viia deficiency
A case of intracranial hemorrhage in a neonate with congenital factor VII deficiency.
coagulation factor viia deficiency
A case presenting concurrence of Marfan syndrome, Basedow's disease and Arg353Gln polymorphism-related factor VII deficiency.
coagulation factor viia deficiency
A clinical evaluation of automated chromogenic tests as substitutes for conventional prothrombin time and activated partial thromboplastin time tests.
coagulation factor viia deficiency
A coagulation factor VII deficiency protects against acute inflammatory responses in mice.
coagulation factor viia deficiency
A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII Deficiency.
coagulation factor viia deficiency
A comprehensive review of rFVIIa use in a tertiary care pediatric center.
coagulation factor viia deficiency
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma.
coagulation factor viia deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
coagulation factor viia deficiency
A Neonate with Acquired Factor VII Deficiency Successfully Managed with Immunomodulatory Therapy.
coagulation factor viia deficiency
A new mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency.
coagulation factor viia deficiency
A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
coagulation factor viia deficiency
A new report of FVII-inhibitor in a patient suffering from severe congenital FVII deficiency.
coagulation factor viia deficiency
A NlaIII polymorphism within the human factor VII gene.
coagulation factor viia deficiency
A novel factor X mutation Cys81 by Arg and a reported factor VII polymorphism Arg353 replaced by Gln co-occured in a patient.
coagulation factor viia deficiency
A novel gene insertion combined with a missense mutation causing factor VII deficiency in two unrelated Chinese families.
coagulation factor viia deficiency
A novel homozygous missense mutation in the factor VII gene of severe factor VII deficiency in a newborn baby.
coagulation factor viia deficiency
A novel homozygous missense mutation in the factor VII gene of severe factor VII deficiency in a pedigree: a description of two cases.
coagulation factor viia deficiency
A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency.
coagulation factor viia deficiency
A novel missense mutation responsible for factor VII deficiency in research Beagle colonies.
coagulation factor viia deficiency
A Novel Presentation of Metaphyseal Chondrodysplasia, Schmid Type with Factor VII Deficiency.
coagulation factor viia deficiency
A randomized, double-blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25 degrees C stable formulation.
coagulation factor viia deficiency
A rare case of Glanzmann's thrombasthenia and factor VII deficiency due to a combination of pathogenic and non-pathogenic gene variants.
coagulation factor viia deficiency
A Rare Case Report of Multiple Intracranial Aneurysms with Factor VII Deficiency.
coagulation factor viia deficiency
A rare combination: congenital factor VII deficiency with Chiari malformation.
coagulation factor viia deficiency
A rare inherited coagulation disorder: combined homozygous factor VII and factor X deficiency.
coagulation factor viia deficiency
A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience.
coagulation factor viia deficiency
A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies.
coagulation factor viia deficiency
A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies.
coagulation factor viia deficiency
A syndrome of factor VII deficiency and abnormal platelet release reaction.
coagulation factor viia deficiency
A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule.
coagulation factor viia deficiency
Abnormalities in liver function and coagulation profile following the Fontan procedure.
coagulation factor viia deficiency
Acquired bleeding disorder in a patient with congenital factor VII deficiency.
coagulation factor viia deficiency
Acquired Factor VII deficiency - a rare but important consideration.
coagulation factor viia deficiency
Acquired factor VII deficiency associated with acute myeloid leukemia.
coagulation factor viia deficiency
Acquired factor VII deficiency associated with aplastic anaemia: correction with bone marrow transplantation.
coagulation factor viia deficiency
Acquired Factor VII Deficiency Associated with Bronchogenic Carcinoma: A Case Report.
coagulation factor viia deficiency
Acquired factor VII deficiency associated with pleural liposarcoma.
coagulation factor viia deficiency
Acquired factor VII deficiency associated with Wilms tumor.
coagulation factor viia deficiency
Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.
coagulation factor viia deficiency
Acquired factor VII deficiency following FOLFOX in a patient with colorectal cancer who was also DPD deficient.
coagulation factor viia deficiency
Acquired Factor VII Deficiency in Association with Pyelonephritis.
coagulation factor viia deficiency
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients.
coagulation factor viia deficiency
Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven).
coagulation factor viia deficiency
Acquired isolated factor VII deficiency during sepsis.
coagulation factor viia deficiency
Acquired Isolated FVII Deficiency: An Underestimated and Potentially Important Laboratory Finding.
coagulation factor viia deficiency
Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
coagulation factor viia deficiency
Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes.
coagulation factor viia deficiency
Activation of Endoplasmic Reticulum Stress and Unfolded Protein Response in Congenital Factor VII Deficiency.
coagulation factor viia deficiency
Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency.
coagulation factor viia deficiency
Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations.
coagulation factor viia deficiency
Ala244Val is a common, probably ancient mutation causing factor VII deficiency in Moroccan and Iranian Jews.
coagulation factor viia deficiency
An immunological investigation of hemophilia B with a tentative classification of the disease into five variants.
coagulation factor viia deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
coagulation factor viia deficiency
An overview of inherited factor VII deficiency.
coagulation factor viia deficiency
An unusual complication of ice skating and the emergence of a previously undiagnosed bleeding disorder.
coagulation factor viia deficiency
Anaesthetic management of a parturient with factor VII deficiency and sepsis.
coagulation factor viia deficiency
Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?
coagulation factor viia deficiency
Analysis of Phenotype and Genotypein an Inherited Coagulation Factor VII Deficiency Pedigree.
coagulation factor viia deficiency
Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency.
coagulation factor viia deficiency
Anesthetic management of a patient with factor VII deficiency undergoing laparoscopic colectomy: a case report.
coagulation factor viia deficiency
Another patient with a congenital hemorrhagic disorder intermediate between factor X and factor VII deficiency.
coagulation factor viia deficiency
Anterior segment dysgenesis in a child with factor VII deficiency.
coagulation factor viia deficiency
Anti- and procoagulant activities in factor VII-deficient subjects.
coagulation factor viia deficiency
Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency.
coagulation factor viia deficiency
Anticoagulation Therapy Considerations in Factor VII Deficiency.
coagulation factor viia deficiency
Aortic valve and coronary artery bypass surgery in a patient with factor VII deficiency.
coagulation factor viia deficiency
Application of radioisotope synovectomy in the ankle joint in a child with congenital factor VII deficiency.
coagulation factor viia deficiency
Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis.
coagulation factor viia deficiency
Arthropathies in factor VII deficiency: a case report.
coagulation factor viia deficiency
Arthropathy and surgery in congenital factor VII deficiency.
coagulation factor viia deficiency
Assessing efficacy and therapeutic claims in emerging indications for recombinant factor VIIa: regulatory perspectives.
coagulation factor viia deficiency
Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.
coagulation factor viia deficiency
Asymptomatic factor VII deficiency in African Americans.
coagulation factor viia deficiency
Asymptomatic factor VII deficiency: gene analysis and structure-function relationships.
coagulation factor viia deficiency
Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
coagulation factor viia deficiency
Atherosclerosis and coronary bypass surgery in hereditary factor VII deficiency.
coagulation factor viia deficiency
Automated synthetic substrate assays for coagulopathies of dogs.
coagulation factor viia deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
coagulation factor viia deficiency
Avoiding Cardiovascular Collapse: Pediatric Cutaneous Mastocytosis and Anesthetic Challenges.
coagulation factor viia deficiency
Bilateral Subdural Hematomas in an Adult With Hereditary Factor VII Deficiency: A Complication of Sit-ups and Inversion?
coagulation factor viia deficiency
Bilateral subdural hematomas, an unusual vaso-occlusive event and prolonged prothrombin time in a 58-year-old victim of an armed robbery.
coagulation factor viia deficiency
Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.
coagulation factor viia deficiency
Bleeding Gastric Heterotopic Polyp in the Duodenum of a Teenager with Severe Factor VII Deficiency.
coagulation factor viia deficiency
Bleeding manifestations in heterozygotes with congenital FVII deficiency: a comparison with unaffected family members during a long observation period.
coagulation factor viia deficiency
Bleeding Prophylaxis in a Child With Cleft Palate and Factor VII Deficiency: A Case Report.
coagulation factor viia deficiency
Bleeding symptoms at disease presentation and prediction of ensuing bleeding in inherited FVII deficiency.
coagulation factor viia deficiency
Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran.
coagulation factor viia deficiency
Bloody tears due to congenital factor VII deficiency.
coagulation factor viia deficiency
Canine factor VII deficiency: lessons learned in applying methods-based laboratory proficiency testing.
coagulation factor viia deficiency
Canine specific ELISA for coagulation factor VII.
coagulation factor viia deficiency
Cardiac surgery with extracorporeal circulation in severe factor VII deficiency.
coagulation factor viia deficiency
Cardiac Surgery Without Blood Products in a Jehovah's Witness Child With Factor VII Deficiency.
coagulation factor viia deficiency
Carriers of factor VII deficiency are not always asymptomatic.
coagulation factor viia deficiency
Case report of factor VII deficiency.
coagulation factor viia deficiency
Case Report: A 70-Year-Old Man with Undiagnosed Factor VII Deficiency Presented with Acute Ischemic Stroke.
coagulation factor viia deficiency
Case Report: Factor VII deficiency in an obstetrical patient.
coagulation factor viia deficiency
Cerebral Venous Sinus Thrombosis in a Patient with Undiagnosed Factor VII Deficiency.
coagulation factor viia deficiency
Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
coagulation factor viia deficiency
Changes in haemostasis and thrombosis associated with thyroid disease: Presentation of 2 cases.
coagulation factor viia deficiency
Characterisation of a large complex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency.
coagulation factor viia deficiency
Characterization of a Cys329Gly mutation causing hereditary factor VII deficiency.
coagulation factor viia deficiency
Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).
coagulation factor viia deficiency
Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients.
coagulation factor viia deficiency
Characterization of thrombin generation potential of leukemic and solid tumor cells by the calibrated automated thrombography.
coagulation factor viia deficiency
Characterization of two novel splice site mutations in human factor VII gene causing severe plasma factor VII deficiency and bleeding diathesis.
coagulation factor viia deficiency
Christmas disease associated with factor VII deficiency; case report with family survey.
coagulation factor viia deficiency
Clinical and laboratory features of 178 children with recurrent epistaxis.
coagulation factor viia deficiency
Clinical and Laboratory Findings in Jewish and Bedouin Patients in Southern Israel Who Were Diagnosed with Factor VII Deficiency.
coagulation factor viia deficiency
CLINICAL ASPECTS OF CONGENITAL FACTOR VII DEFICIENCY.
coagulation factor viia deficiency
Clinical audit of inherited bleeding disorders in a developing country.
coagulation factor viia deficiency
Clinical efficacy and recovery levels of recombinant FVIIa (NovoSeven) in the treatment of intracranial haemorrhage in severe neonatal FVII deficiency.
coagulation factor viia deficiency
Clinical experience with activated factor VII: focus on safety aspects.
coagulation factor viia deficiency
Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.
coagulation factor viia deficiency
Clinical management of thrombosis in inherited factor VII deficiency: a description of two cases.
coagulation factor viia deficiency
Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency.
coagulation factor viia deficiency
Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)
coagulation factor viia deficiency
Clinical phenotypes and factor VII genotype in congenital factor VII deficiency.
coagulation factor viia deficiency
Clinical picture and management of congenital factor VII deficiency.
coagulation factor viia deficiency
Clinical picture and treatment strategies in factor VII deficiency.
coagulation factor viia deficiency
Clinical pictures and prevalence of factor VII deficiency in Northeastern of Iran.
coagulation factor viia deficiency
Clinical problems and surgical interventions in inherited factor VII deficiency.
coagulation factor viia deficiency
Clinical study of recovery and half-life of vapor-heated factor VII concentrate.
coagulation factor viia deficiency
Coagulation factor activity and clinical bleeding severity in rare bleeding disorders: results from the european network of rare bleeding disorders.
coagulation factor viia deficiency
Coagulation factor VII Gln100 --> Arg. Amino acid substitution at the epidermal growth factor 2-protease domain interface results in severely reduced tissue factor binding and procoagulant function.
coagulation factor viia deficiency
Coagulation studies in patients with trisomy 8 syndrome.
coagulation factor viia deficiency
Coexistence of Factor VII Deficiency and Hereditary Spastic Paraplegia in Two Siblings.
coagulation factor viia deficiency
Coinheritance of Factor V (FV) Leiden enhances thrombin formation and is associated with a mild bleeding phenotype in patients homozygous for the FVII 9726+5G>A (FVII Lazio) mutation.
coagulation factor viia deficiency
Color vision disturbances secondary to oral tranexamic acid.
coagulation factor viia deficiency
Combined congenital dysfibrinogenemia and factor VII deficiency from mutations in the FGB and F7 genes.
coagulation factor viia deficiency
Combined factor V and factor VII deficiency due to an independent segregation of the two defects.
coagulation factor viia deficiency
Combined factor V and factor VII deficiency. Report of a case with a record on combined defects and considerations on the relevance of partial deficiency of coagulation factors.
coagulation factor viia deficiency
Combined factor VII and factor VIII deficiency due to a casual association of heterozygosis for factor VII deficiency and hemophilia A.
coagulation factor viia deficiency
Combined factor VII/protein C deficiency results in intrauterine coagulopathy in mice.
coagulation factor viia deficiency
Combined mild PTC (plasma thromboplastin component) and factor VII deficiencies.
coagulation factor viia deficiency
Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation.
coagulation factor viia deficiency
Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.
coagulation factor viia deficiency
Compound heterozygous mutations (p.Leu13Pro and p.Tyr294*) associated with factor VII deficiency cause impaired secretion through ineffective translocation and extensive intracellular degradation of factor VII.
coagulation factor viia deficiency
Compound heterozygous mutations in severe factor VII deficiency including a novel nonsense mutation.
coagulation factor viia deficiency
Compound Heterozygous Mutations in the F7 Gene in 2 Unrelated Families With Congenital Factor VII Deficiency.
coagulation factor viia deficiency
Congenital Combined Bleeding Disorders, a Comprehensive Study of a Large Number of Iranian Patients.
coagulation factor viia deficiency
Congenital combined defects of factor VII: a critical review.
coagulation factor viia deficiency
Congenital deficiency of factor VII in subarachnoid hemorrhage.
coagulation factor viia deficiency
Congenital deficiency of factor VII.
coagulation factor viia deficiency
Congenital factor V deficiency: comparison of the severity of clinical presentations among patients with rare bleeding disorders.
coagulation factor viia deficiency
Congenital factor VII abnormality discovered in an infant at a routine checkup.
coagulation factor viia deficiency
Congenital factor VII deficiency and cerebrovascular stroke.
coagulation factor viia deficiency
Congenital factor VII deficiency complicated with hemoperitoneum and intracranial hemorrhage: report of a case.
coagulation factor viia deficiency
Congenital factor VII deficiency in a patient with an abdominal aortic aneurysm.
coagulation factor viia deficiency
Congenital Factor VII Deficiency in Association With Bicuspid Aortic Valve and Multicystic Dysplastic Kidney Disease in a Child.
coagulation factor viia deficiency
Congenital Factor VII Deficiency in Children at Tertiary Health Care Facility in Pakistan.
coagulation factor viia deficiency
Congenital factor VII deficiency in Iraqi children (Single Centre Experience).
coagulation factor viia deficiency
Congenital factor VII deficiency presenting as delayed bleeding following dental extraction. A review of the role of factor VII in coagulation.
coagulation factor viia deficiency
Congenital factor VII deficiency presenting as iron deficiency anaemia--Case report.
coagulation factor viia deficiency
Congenital factor VII deficiency presenting first time as isolated recurrent hematuria at late age.
coagulation factor viia deficiency
Congenital factor VII deficiency with cerebral haemorrhage treated with prothrombin concentrate.
coagulation factor viia deficiency
Congenital factor VII deficiency with normal Stuart activity: clinical, genetic and experimental observations.
coagulation factor viia deficiency
Congenital factor VII deficiency.
coagulation factor viia deficiency
Congenital factor VII deficiency. A case report.
coagulation factor viia deficiency
Congenital factor VII deficiency. A report of four new cases.
coagulation factor viia deficiency
Congenital factor VII deficiency. Clinical and laboratory characteristics of a newly discovered kindred.
coagulation factor viia deficiency
Congenital factor VII deficiency. Two cases in children of cousins.
coagulation factor viia deficiency
Congenital factor VII deficiency: a case report.
coagulation factor viia deficiency
Congenital factor VII deficiency: haematological and genetic aspects.
coagulation factor viia deficiency
Congenital factor VII deficiency: Multidisciplinary approach is the key to successful perioperative outcome.
coagulation factor viia deficiency
Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
coagulation factor viia deficiency
Congenital factor VII deficiency; a review with a report of a case in an Indian infant.
coagulation factor viia deficiency
Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observation.
coagulation factor viia deficiency
Congenital FVII Deficiency and Pulmonary Embolism : A Critical Appraisal of All Reported Cases.
coagulation factor viia deficiency
Congenital FVII deficiency and thrombotic events after replacement therapy.
coagulation factor viia deficiency
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
coagulation factor viia deficiency
Considerations on a Tentative Classification of FVII Deficiency Suited for Practical Clinical Purposes.
coagulation factor viia deficiency
Constrictive pericarditis in a patient with inherited factor VII deficiency.
coagulation factor viia deficiency
Continuous infusion of human prothrombin complex in a patient with congenital factor VII deficiency undergoing laparoscopic cholecystectomy: A case report from China.
coagulation factor viia deficiency
Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency.
coagulation factor viia deficiency
Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.
coagulation factor viia deficiency
Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency.
coagulation factor viia deficiency
Continuous infusion of recombinant factor VIIa for surgery in patients with deficiency of factor VII.
coagulation factor viia deficiency
Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand?
coagulation factor viia deficiency
Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan.
coagulation factor viia deficiency
Decreasing the Need for Transfusion: Infant Cardiac Surgery Using Hemodilution and Recombinant Factor VIIa.
coagulation factor viia deficiency
Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency.
coagulation factor viia deficiency
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
coagulation factor viia deficiency
Descriptive epidemiology of hemophilia and other coagulation disorders in mansoura, egypt: retrospective analysis.
coagulation factor viia deficiency
Detecting coagulopathy in pediatric patients with post-tonsillectomy hemorrhage.
coagulation factor viia deficiency
Detection of factor X activation in humans.
coagulation factor viia deficiency
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7).
coagulation factor viia deficiency
Determinants of coagulation activation in humans.
coagulation factor viia deficiency
Determinants of plasma factor VIIa levels in humans.
coagulation factor viia deficiency
Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deficient infant.
coagulation factor viia deficiency
Diagnosis and treatment discussion of congenital factor VII deficiency in pregnancy: A case report.
coagulation factor viia deficiency
Diagnosis and treatment of a patient with gallstone ileus.
coagulation factor viia deficiency
Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran.
coagulation factor viia deficiency
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency.
coagulation factor viia deficiency
Direct oral anticoagulants for atrial fibrillation in patients with congenital factor VII deficiency.
coagulation factor viia deficiency
Direct oral anticoagulants in factor VII deficiency patient.
coagulation factor viia deficiency
Discrepancies in FVII:C levels depending on the thromboplastin: about a case.
coagulation factor viia deficiency
Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency.
coagulation factor viia deficiency
Disorders of menstruation and their effect on the quality of life in women with congenital factor VII deficiency.
coagulation factor viia deficiency
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
coagulation factor viia deficiency
Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery.
coagulation factor viia deficiency
Double heterozygous mutations Gln100Leu and His348Gln of the F7 gene in a patient with factor VII deficiency.
coagulation factor viia deficiency
Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
coagulation factor viia deficiency
Electroimmunoassay of factor VII antigen.
coagulation factor viia deficiency
Elevated prothrombin time on routine preoperative laboratory results in a healthy infant undergoing craniosynostosis repair: Diagnosis and perioperative management of congenital factor VII deficiency.
coagulation factor viia deficiency
Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience.
coagulation factor viia deficiency
Entering new areas in known fields: recombinant fusion protein linking recombinant factor VIIa with recombinant albumin (rVIIa-FP) - advancing the journey.
coagulation factor viia deficiency
Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
coagulation factor viia deficiency
Ethnic Differences in Coagulation Factor Abnormalities After the Fontan Procedure.
coagulation factor viia deficiency
Evaluation of a new chromogenic assay for factor VII and its application in patients on oral anticoagulant treatment.
coagulation factor viia deficiency
Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study).
coagulation factor viia deficiency
Evaluation of Bleeding Phenotype of Inherited Factor VII Deficiency in Children With a Bleeding Assessment Tool and Global Assays.
coagulation factor viia deficiency
Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human Primate.
coagulation factor viia deficiency
Evidence for the presence of tissue factor activity on subendothelium.
coagulation factor viia deficiency
Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds.
coagulation factor viia deficiency
Exclusion of the first EGF domain of factor VII by a splice site mutation causes lethal factor VII deficiency.
coagulation factor viia deficiency
Expanded carrier screening and preimplantation genetic diagnosis in a couple who delivered a baby affected with congenital factor VII deficiency.
coagulation factor viia deficiency
Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
coagulation factor viia deficiency
F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study.
coagulation factor viia deficiency
Factor IX is activated in vivo by the tissue factor mechanism.
coagulation factor viia deficiency
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo.
coagulation factor viia deficiency
Factor VII and haemostasis.
coagulation factor viia deficiency
Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiency.
coagulation factor viia deficiency
Factor VII central. A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa, and abolishes amidolytic and coagulant activity.
coagulation factor viia deficiency
Factor VII congenital deficiency. Clinical picture and classification of the variants.
coagulation factor viia deficiency
Factor VII deficiency - an enigma; clinicohematological profile in 12 cases.
coagulation factor viia deficiency
Factor VII deficiency and a copper metabolism disorder in a patient with Klippel-Trenaunay syndrome.
coagulation factor viia deficiency
Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature.
coagulation factor viia deficiency
Factor VII deficiency and its treatment in delivery with recombinant factor VII.
coagulation factor viia deficiency
Factor VII deficiency and pregnancy.
coagulation factor viia deficiency
Factor VII deficiency and pregnancy: a case report and review of literature.
coagulation factor viia deficiency
Factor VII deficiency and surgery. Is preoperative replacement therapy necessary?
coagulation factor viia deficiency
Factor VII deficiency and the FVII mutation database.
coagulation factor viia deficiency
Factor VII deficiency associated with nephrotic syndrome.
coagulation factor viia deficiency
Factor VII deficiency associated with valproate treatment.
coagulation factor viia deficiency
Factor VII deficiency caused by a structural variant N57D of the first epidermal growth factor domain.
coagulation factor viia deficiency
Factor VII deficiency detected in pregnancy: a case report.
coagulation factor viia deficiency
Factor VII deficiency diagnosed after minor genital trauma.
coagulation factor viia deficiency
Factor VII Deficiency due to Compound Heterozygosity for Leu-48Pro Mutation and a Novel Pro260Leu Mutation.
coagulation factor viia deficiency
Factor VII deficiency first observed at preoperative routine clotting test.
coagulation factor viia deficiency
Factor VII deficiency impairs cutaneous wound healing in mice.
coagulation factor viia deficiency
Factor VII deficiency in a mixed breed dog.
coagulation factor viia deficiency
Factor VII deficiency in a patient with retinal arteriolar tortuosity syndrome.
coagulation factor viia deficiency
Factor VII deficiency in an Alaskan malamute.
coagulation factor viia deficiency
Factor VII deficiency in an East Indian family.
coagulation factor viia deficiency
Factor VII deficiency in beagle dog plasma and its use in the assay of human factor VII.
coagulation factor viia deficiency
Factor VII deficiency in major artery occlusion stroke.
coagulation factor viia deficiency
Factor VII Deficiency in Patients Receiving Chronic Packed Cell Transfusions.
coagulation factor viia deficiency
Factor VII deficiency in pregnancy and delivery: a case report.
coagulation factor viia deficiency
Factor VII deficiency in pregnancy treated with recombinant factor VIIa.
coagulation factor viia deficiency
Factor VII deficiency presenting as a possible child abuse.
coagulation factor viia deficiency
Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.
coagulation factor viia deficiency
Factor VII Deficiency Resulting in Acute Hemorrhage in Orthognathic Surgery: A Case Report.
coagulation factor viia deficiency
Factor VII deficiency with intracranial hemorrhage: a case report.
coagulation factor viia deficiency
Factor VII Deficiency, Masked by Warfarin Therapy, as a Cause of Bleeding After Cardiovascular Intervention.
coagulation factor viia deficiency
Factor VII deficiency.
coagulation factor viia deficiency
Factor VII Deficiency.
coagulation factor viia deficiency
Factor VII deficiency.
coagulation factor viia deficiency
Factor VII Deficiency.
coagulation factor viia deficiency
Factor VII deficiency: a double heterozygote of an Arg402Stop with a deletion of the C-terminal five amino acids and a Thr359Met.
coagulation factor viia deficiency
Factor VII deficiency: a novel missense variant and genotype-phenotype correlation in patients from Southern Italy.
coagulation factor viia deficiency
Factor VII Deficiency: A Rare Case Report.
coagulation factor viia deficiency
Factor VII Deficiency: A Single-Center Experience.
coagulation factor viia deficiency
Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.
coagulation factor viia deficiency
Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy.
coagulation factor viia deficiency
Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.
coagulation factor viia deficiency
Factor VII deficiency: do all need replacement for cardiac surgery?
coagulation factor viia deficiency
Factor VII deficiency: immunological characterization of genetic variants and detection of carriers.
coagulation factor viia deficiency
Factor VII deficiency: Unveiling the cellular and molecular mechanisms underlying three model alterations of the enzyme catalytic domain.
coagulation factor viia deficiency
Factor VII Gene Defects: Review of Functional Studies and Their Clinical Implications
coagulation factor viia deficiency
Factor VII gene intronic mutation in a lethal factor VII deficiency: effects on splice-site selection.
coagulation factor viia deficiency
Factor VII half-life after transfusion of a steam-treated prothrombin complex concentrate in a patient with homozygous factor VII deficiency.
coagulation factor viia deficiency
Factor VII Mie: homozygous asymptomatic type I deficiency caused by an amino acid substitution of His (CAC) for Arg(247) (CGC) in the catalytic domain.
coagulation factor viia deficiency
Factor VII Morioka (FVII L-26P): a homozygous missense mutation in the signal sequence identified in a patient with factor VII deficiency.
coagulation factor viia deficiency
Factor VII Padua 2: another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern.
coagulation factor viia deficiency
Factor VII R110C: a novel missense mutation (Arg110Cys) in the second epidermal growth factor-like domain causing factor VII deficiency in members of a Japanese family.
coagulation factor viia deficiency
Factor VII Toyama (Thr 359 Met): a homozygous missense mutation causing severe type I deficiency.
coagulation factor viia deficiency
Factor VII verona coagulation disorder: double heterozygosis with an abnormal factor VII and heterozygous factor VII deficiency.
coagulation factor viia deficiency
Factor VIIa for correction of traumatic coagulopathy.
coagulation factor viia deficiency
Factor VIIa replacement therapy in factor VII deficiency.
coagulation factor viia deficiency
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis.
coagulation factor viia deficiency
Familial factor VII deficiency with foetal and neonatal fatal cerebral haemorrhage associated with homozygosis to Gly180Arg mutation.
coagulation factor viia deficiency
Familial haemophilia and factor VII deficiency.
coagulation factor viia deficiency
Fatal intracranial hemorrhage in a newborn with factor VII deficiency.
coagulation factor viia deficiency
First living-related liver transplant to cure factor VII deficiency.
coagulation factor viia deficiency
First manifestation of a hereditary homozygous factor VII deficiency in a 3-year-old girl suspected as purpura fulminans.
coagulation factor viia deficiency
First molecular characterization of a patient with combined factor V and factor VII deficiency.
coagulation factor viia deficiency
Frequencies of mild factor V, VII and X deficiencies in a Japanese population.
coagulation factor viia deficiency
Frequency of five disease-causing genetic mutations in a large mixed-breed dog population (2011-2012).
coagulation factor viia deficiency
Functional and Molecular Characterization of C91S Mutation in the Second Epidermal Growth Factor-Like Domain of Factor VII.
coagulation factor viia deficiency
Gene targeting of tissue factor, factor X, and factor VII in mice: their involvement in embryonic development.
coagulation factor viia deficiency
Gene Therapy for Inherited Bleeding Disorders.
coagulation factor viia deficiency
Generation of a human induced pluripotent stem cell line, YCMi002-A, from a Factor VII deficiency patient carrying F7 mutations.
coagulation factor viia deficiency
Generation of genetically-altered mice producing very low levels of coagulation factorVII.
coagulation factor viia deficiency
Genetic deficiency of factor VII and hemorrhagic diathesis. A case report and literature review.
coagulation factor viia deficiency
Genetic diagnosis of haemophilia and other inherited bleeding disorders.
coagulation factor viia deficiency
Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders.
coagulation factor viia deficiency
Genotype and phenotype correlation in intracranial hemorrhage in neonatal factor VII deficiency among Thai children.
coagulation factor viia deficiency
Genotype and phenotype relationships in 10 Pakistani unrelated patients with inherited factor VII deficiency.
coagulation factor viia deficiency
Genotypic heterogeneity may explain phenotypic variations in inherited factor VII deficiency.
coagulation factor viia deficiency
Glomerulitis and factor vii deficiency in Familial Mediterranean fever.
coagulation factor viia deficiency
Granulomatous Pneumocystis carinii pneumonia in a non-AIDS patient: an atypical presentation.
coagulation factor viia deficiency
HAART and Mycobacterium avium complex in an HIV infected patient with severe factor VII deficiency.
coagulation factor viia deficiency
Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill.
coagulation factor viia deficiency
Hematology of experimental acute Sarcocystis bovicanis infection in calves. II. Serum biochemistry and hemostasis studies.
coagulation factor viia deficiency
Hemipelvectomy after severe pelvic injury in Factor VII deficiency toddler.
coagulation factor viia deficiency
Hemophagocytic lymphohistiocytosis and congenital factor VII deficiency: a case report.
coagulation factor viia deficiency
Hemophilia A and concurrent factor VII deficiency. Studies of a patient with complicating cardiac tamponade.
coagulation factor viia deficiency
Hemophilia B with associated factor VII deficiency: a distinct variant of hemophilia B with low factor VII activity and normal factor VII antigen.
coagulation factor viia deficiency
Hemorrhagic diathesis due to factor VII deficiency.
coagulation factor viia deficiency
Hemorrhagic stroke in a child with protein S and factor VII deficiencies.
coagulation factor viia deficiency
Hepatocyte transplantation for inherited factor VII deficiency.
coagulation factor viia deficiency
Hepatocyte transplantation for liver-based metabolic disorders.
coagulation factor viia deficiency
Hereditary bleeding disorders in Riyadh, Saudi Arabia.
coagulation factor viia deficiency
Hereditary factor VII deficiency and increased contact activation time.
coagulation factor viia deficiency
Hereditary factor VII deficiency in a Chinese family.
coagulation factor viia deficiency
Hereditary Factor VII deficiency in newborns.
coagulation factor viia deficiency
Hereditary factor VII deficiency in pregnancy: peripartum treatment with factor VII concentrate.
coagulation factor viia deficiency
Hereditary factor VII deficiency in the Alaskan Klee Kai dog.
coagulation factor viia deficiency
HEREDITARY FACTOR VII DEFICIENCY IN THE ASIAN ELEPHANT (ELEPHAS MAXIMUS) CAUSED BY A F7 MISSENSE MUTATION.
coagulation factor viia deficiency
Hereditary factor VII deficiency in two siblings: two different clinical presentation.
coagulation factor viia deficiency
Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis.
coagulation factor viia deficiency
Hereditary factor VII deficiency: report of a case of intracranial hemorrhage.
coagulation factor viia deficiency
Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.
coagulation factor viia deficiency
Heterozygous factor VII deficiency and severe hemophilia A in the same kindred.
coagulation factor viia deficiency
Hip surgery in a patient with severe factor VII deficiency.
coagulation factor viia deficiency
Hobby-induced factor VII deficiency.
coagulation factor viia deficiency
Home treatment for patients with congenital bleeding disorders in a developing country.
coagulation factor viia deficiency
Homozygous 2bp deletion in the human factor VII gene: a non-lethal mutation that is associated with a complete absence of circulating factor VII.
coagulation factor viia deficiency
Homozygous congenital factor VII deficiency with a novel mutation, associated with severe spontaneous intracranial bleeding in a neonate.
coagulation factor viia deficiency
Homozygous FVII deficiencies with different reactivity towards tissue thromboplastins of different origin.
coagulation factor viia deficiency
How to evaluate phenotype-genotype relationship in rare coagulation haemorrhagic disorders: examples from FVII deficiency.
coagulation factor viia deficiency
Human factor VII deficiency caused by S339C mutation located adjacent to the specificity pocket of the catalytic domain.
coagulation factor viia deficiency
Identification of genetic defects underlying FVII deficiency in 10 patients belonging to eight unrelated families of the North provinces from Tunisia.
coagulation factor viia deficiency
Identification of two novel mutations in three children with congenital factor VII deficiency.
coagulation factor viia deficiency
Impact of Telemedicine Tools on Record Keeping and Compliance in Haemophilia Care.
coagulation factor viia deficiency
Impaired secretion of carboxyl-terminal truncated factor VII due to an F7 nonsense mutation associated with FVII deficiency.
coagulation factor viia deficiency
In vivo studies of the role of factor VII in hemostasis.
coagulation factor viia deficiency
Inadvertent propagation of factor VII deficiency in a canine mucopolysaccharidosis type I research breeding colony.
coagulation factor viia deficiency
Incidence of hereditary bleeding disorders in Bradford, UK: variation with ethnic group.
coagulation factor viia deficiency
Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level.
coagulation factor viia deficiency
Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect.
coagulation factor viia deficiency
Influence of factor V HR2 on thrombin generation and clinical manifestation in rare bleeding disorders.
coagulation factor viia deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
coagulation factor viia deficiency
Inherited bleeding disorders in the Eastern Province of Saudi Arabia.
coagulation factor viia deficiency
Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding.
coagulation factor viia deficiency
Inherited factor VII deficiency: genetics and molecular pathology.
coagulation factor viia deficiency
Inherited factor VII deficiency: identification of two novel mutations (A191V and T239P) in the catalytic domain.
coagulation factor viia deficiency
Inherited factor VII deficiency: molecular genetics and pathophysiology.
coagulation factor viia deficiency
Inhibitor development after liver transplantation in congenital factor VII deficiency.
coagulation factor viia deficiency
Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients.
coagulation factor viia deficiency
Inhibitor in Congenital Factor VII Deficiency; a Rare but Serious Therapeutic Challenge-A Systematic Literature Review.
coagulation factor viia deficiency
Inhibitor to factor VII in severe factor VII deficiency: detection and course of the inhibitory response.
coagulation factor viia deficiency
Inhibitors against rFVIIa in patients with severe congenital FVII deficiency: A case series.
coagulation factor viia deficiency
Inhibitors to factor VII in congenital factor VII deficiency.
coagulation factor viia deficiency
Intracellular evaluation of ER targeting elucidates a mild form of inherited coagulation deficiency.
coagulation factor viia deficiency
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII.
coagulation factor viia deficiency
Intracranial bleeding following soccer-related head trauma in a young student with occult factor VII deficiency.
coagulation factor viia deficiency
Intracranial hemorrhage in congenital factor VII deficiency.
coagulation factor viia deficiency
Intraoperative use of recombinant activated factor VII (rFVIIa).
coagulation factor viia deficiency
Invasive EEG-electrodes in presurgical evaluation of epilepsies: Systematic analysis of implantation-, video-EEG-monitoring- and explantation-related complications, and review of literature.
coagulation factor viia deficiency
Invasive procedures and minor surgery in factor VII deficiency.
coagulation factor viia deficiency
In vitro expression of mutant factor VII proteins and characterization of their clinical significance.
coagulation factor viia deficiency
Is prophylaxis required for delivery in women with factor VII deficiency?
coagulation factor viia deficiency
Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous?
coagulation factor viia deficiency
Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency.
coagulation factor viia deficiency
Ischemic strokes in congenital bleeding disorders: comparison with myocardial infarction and other acute coronary syndromes.
coagulation factor viia deficiency
Isolated acquired factor VII deficiency: review of the literature.
coagulation factor viia deficiency
Isolated factor VII deficiency diagnosed after a life-threatening brain haemorrhage.
coagulation factor viia deficiency
Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation.
coagulation factor viia deficiency
Isotypic analysis of antibodies against activated Factor VII in patients with Factor VII deficiency using the x-MAP technology.
coagulation factor viia deficiency
Japanese collaborative study to assess inter-laboratory variation in factor VII activity assays.
coagulation factor viia deficiency
Japanese family with congenital factor VII deficiency.
coagulation factor viia deficiency
Kidney Transplant in a Patient With Factor VII Deficiency: Case Report.
coagulation factor viia deficiency
Laboratory evaluation of hemorrhagic coagulopathies in small animal practice.
coagulation factor viia deficiency
Lack of bleeding in patients with severe factor VII deficiency.
coagulation factor viia deficiency
Lethal factor VII deficiency due to novel mutations in the F7 promoter: Functional analysis reveals disruption of HNF4 binding site.
coagulation factor viia deficiency
Life-threatening bleeding in a case of autoantibody-induced factor VII deficiency.
coagulation factor viia deficiency
Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency.
coagulation factor viia deficiency
Life-threatening bleeding in factor VII deficiency: the role of prenatal diagnosis and primary prophylaxis.
coagulation factor viia deficiency
Life-threatening menorrhagia secondary to Factor VII deficiency and leiomyomata.
coagulation factor viia deficiency
Liver after hepatocyte transplantation for liver-based metabolic disorders in children.
coagulation factor viia deficiency
Liver cell transplantation.
coagulation factor viia deficiency
Liver transplant for congenital factor VII deficiency.
coagulation factor viia deficiency
Liver transplantation for factor VII deficiency.
coagulation factor viia deficiency
Liver transplantation for treatment of severe S-adenosylhomocysteine hydrolase deficiency.
coagulation factor viia deficiency
Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency.
coagulation factor viia deficiency
Long-term FVII substitution in a preterm infant with severe gastrointestinal bleeding and FVII deficiency due to a homozygous donor splice mutation IVS4+1G-->A.
coagulation factor viia deficiency
Long-term prophylaxis in severe factor VII deficiency.
coagulation factor viia deficiency
Long-term successful percutaneous coronary intervention in factor VII deficiency.
coagulation factor viia deficiency
Low endoscopy bleeding risk in patients with congenital bleeding disorders.
coagulation factor viia deficiency
Lower extremity compartment syndrome in the setting of iliofemoral deep vein thrombosis, phlegmasia cerulea dolens and factor VII deficiency.
coagulation factor viia deficiency
Lower extremity salvage complicated by recurrent microvascular thrombosis in a patient with congenital factor VII deficiency.
coagulation factor viia deficiency
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B.
coagulation factor viia deficiency
Management of a patient with atrial fibrillation and factor VII deficiency.
coagulation factor viia deficiency
Management of a patient with Factor VII deficiency.
coagulation factor viia deficiency
Management of concomitant factor VII deficiency and Factor V Leiden mutation.
coagulation factor viia deficiency
Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots.
coagulation factor viia deficiency
Management of intracranial surgery for refractory epilepsy in severe factor VII deficiency: choosing the optimal dosing regimen.
coagulation factor viia deficiency
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report.
coagulation factor viia deficiency
Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
coagulation factor viia deficiency
Management of Pregnancy in a Chilean Patient with Congenital Deficiency of Factor VII and Glanzmann's Thrombasthenia Variant.
coagulation factor viia deficiency
Management of pregnancy in women with factor VII deficiency: A case series.
coagulation factor viia deficiency
Management of Surgical Third Lower Molar Extraction and Postoperative Progress in Patients With Factor VII Deficiency: A Clinical Protocol and Focus on This Rare Pathologic Entity.
coagulation factor viia deficiency
Managing incidentally diagnosed isolated factor VII deficiency perioperatively: a brief expert consensus report.
coagulation factor viia deficiency
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk.
coagulation factor viia deficiency
Mechanism underlying factor VII deficiency in Jewish populations with the Ala244Val mutation.
coagulation factor viia deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
coagulation factor viia deficiency
Menorrhagia caused by severe hereditary factor VII deficiency. Case 1.
coagulation factor viia deficiency
Migraine, cortical blindness, multiple cerebral infarctions and hypocoagulopathy in celiac disease.
coagulation factor viia deficiency
Mild factor VII deficiency due to heterozygosis is not associated with a bleeding tendency.
coagulation factor viia deficiency
Mitral valve surgery in severe congenital factor VII deficiency.
coagulation factor viia deficiency
Models of blood coagulation.
coagulation factor viia deficiency
Modulation of factor VII levels by intron 7 polymorphisms: population and in vitro studies.
coagulation factor viia deficiency
Molecular analysis in a patient with severe factor VII deficiency and an inhibitor: report of a novel mutation (S103G).
coagulation factor viia deficiency
Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region.
coagulation factor viia deficiency
Molecular analysis of Polish patients with factor VII deficiency.
coagulation factor viia deficiency
Molecular analysis of the genotype-phenotype relationship in factor VII deficiency.
coagulation factor viia deficiency
Molecular and clinical aspects of factor VII deficiency.
coagulation factor viia deficiency
Molecular basis of hereditary factor VII deficiency in India: five novel mutations including a double missense mutation (Ala191Glu; Trp364Cys) in 11 unrelated patients.
coagulation factor viia deficiency
Molecular biology and clinical manifestation of hereditary factor VII deficiency.
coagulation factor viia deficiency
Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency.
coagulation factor viia deficiency
Molecular characterization of four novel mutations causing factor VII deficiency.
coagulation factor viia deficiency
Molecular Characterization of Iranian Patients with Inherited Coagulation Factor VII Deficiency.
coagulation factor viia deficiency
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII.
coagulation factor viia deficiency
Molecular determination of the breakpoints of a 161 556 bp deletion at chromosome 13q34 that presented as severe factor VII deficiency in a neonate.
coagulation factor viia deficiency
Molecular mechanism of dysfunctional factor VII associated with the homozygous missense mutation 331Gly to Ser.
coagulation factor viia deficiency
Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene.
coagulation factor viia deficiency
Molecular variant of factor VII.
coagulation factor viia deficiency
Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa.
coagulation factor viia deficiency
Multiple cerebral aneurysms in factor VII deficiency.
coagulation factor viia deficiency
Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
coagulation factor viia deficiency
Multiple extractions in a patient with factor VII deficiency.
coagulation factor viia deficiency
Multiple intracranial hemorrhages at the time of a transiently prolonged activated partial thromboplastin time in an infant with congenital factor VII deficiency.
coagulation factor viia deficiency
Mutation in the factor VII hepatocyte nuclear factor 4?-binding site contributes to factor VII deficiency.
coagulation factor viia deficiency
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency.
coagulation factor viia deficiency
National survey of patients with hemophilia and other congenital bleeding disorders in Thailand.
coagulation factor viia deficiency
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency.
coagulation factor viia deficiency
Neonatal intracranial hemorrhage secondary to congenital factor VII deficiency: two case reports.
coagulation factor viia deficiency
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®)).
coagulation factor viia deficiency
Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency.
coagulation factor viia deficiency
Novel factor VII gene mutations in six families with hereditary coagulation factor VII deficiency.
coagulation factor viia deficiency
Novel IVS7+1G>T mutation of life-threatening congenital factor VII deficiency in neonates: A retrospective study in China.
coagulation factor viia deficiency
Novel mutation in coagulation factor VII (Carmel mutation): Identification and characterization.
coagulation factor viia deficiency
NovoSeven (recombinant factor VIIa) in centeral nervous systems bleeds.
coagulation factor viia deficiency
NovoSeven as a universal haemostatic agent.
coagulation factor viia deficiency
Obstetric analgesia and anaesthesia in women with inherited bleeding disorders.
coagulation factor viia deficiency
Occult hemophilia as a cause of postoperative and postpartum hemorrhage. With special reference to factor VII deficiency.
coagulation factor viia deficiency
Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
coagulation factor viia deficiency
Occurrence of hereditary leaky red cell syndrome and partial coagulation factor VII deficiency in a Spanish family.
coagulation factor viia deficiency
Of four mutations in the factor VII gene in Tunisian patients, one novel mutation (Ser339Phe) in three unrelated families abrogates factor X activation.
coagulation factor viia deficiency
Off-Label Recombinant Factor VIIa Use and Thrombosis in Children: A Multi-center Cohort Study.
coagulation factor viia deficiency
Off-label use of rFVIIa in children with excessive bleeding: A consecutive study of 153 off-label uses in 139 children.
coagulation factor viia deficiency
On a case of-Christmas disease associated with factor VII deficiency.
coagulation factor viia deficiency
One-step chromogenic equivalent of activated partial thromboplastin time evaluated for clinical application.
coagulation factor viia deficiency
Open heart surgery with factor VII deficiency.
coagulation factor viia deficiency
Open-heart surgery in an infant with heterozygous factor VII deficiency.
coagulation factor viia deficiency
Orbital Compartment Syndrome Following Post-Traumatic Subgaleal Hematoma.
coagulation factor viia deficiency
Orthopaedic surgery in severe bleeding disorders: a low-volume, high-cost procedure.
coagulation factor viia deficiency
Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency.
coagulation factor viia deficiency
Outcome of laparoscopic ovariohysterectomy or ovariectomy in dogs with von Willebrand disease or factor VII deficiency: 20 cases (2012-2014).
coagulation factor viia deficiency
Overview of the human pharmacokinetics of recombinant activated factor VII.
coagulation factor viia deficiency
Palliative open heart surgery in an infant with factor VII deficiency.
coagulation factor viia deficiency
Paracetamol poisoning unmasking factor VII deficiency.
coagulation factor viia deficiency
Pathogenetic role of Factor VII deficiency and thrombosis in cross-reactive material positive patients.
coagulation factor viia deficiency
Pediatric cardiac intervention in a case of congenital factor VII deficiency: a challenge to overcome.
coagulation factor viia deficiency
Pediatric cardiac surgery under cardiopulmonary bypass in factor VII deficiency.
coagulation factor viia deficiency
Percutaneous Nephrolithotomy in Rare Bleeding Disorders: A Case Report and Review of the Literature.
coagulation factor viia deficiency
Peri-operative replacement therapy with factor VII concentrate in a patient with severe factor VII deficiency.
coagulation factor viia deficiency
Perioperative pharmacokinetics of factor VII concentrate during liver surgery in a patient with congenital factor VII deficiency: an individual mathematical model.
coagulation factor viia deficiency
Persistent uterine and vaginal hemorrhage in a beagle with factor VII deficiency.
coagulation factor viia deficiency
Persistent validity of a classification of congenital factor X defects based on clotting, chromogenic and immunological assays even in the molecular biology era.
coagulation factor viia deficiency
Pharmacodynamics of recombinant activated factor VII and plasma-derived factor VII in a cohort of severe FVII deficient patients.
coagulation factor viia deficiency
Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.
coagulation factor viia deficiency
Pharmacokinetic properties of recombinant FVIIa in inherited FVII deficiency account for a large volume of distribution at steady state and a prolonged pharmacodynamic effect.
coagulation factor viia deficiency
Pharmacokinetic properties of two different recombinant activated factor VII formulations.
coagulation factor viia deficiency
Pharmacokinetics and pharmacodynamics of a recombinant fusion protein linking activated coagulation factor VII with human albumin (rVIIa-FP) in patients with congenital FVII deficiency.
coagulation factor viia deficiency
Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog.
coagulation factor viia deficiency
Pharmacology and clinical use of recombinant activated factor seven in neurosciences.
coagulation factor viia deficiency
Phenotypic and genotypic characterization of Factor VII deficiency patients from Western India.
coagulation factor viia deficiency
Phenotypic and genotypic characterization of four factor VII deficiency patients from central China.
coagulation factor viia deficiency
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic.
coagulation factor viia deficiency
Plasma thromboplastin antecedent (Factor XI) deficiency in a black family.
coagulation factor viia deficiency
Plummer-Vinson Syndrome With Concomitant Factor VII Deficiency.
coagulation factor viia deficiency
Point-of-Care Thromboelastography for Intrathecal Drain Management in Patients With Coagulopathy and Thoracic Aorta Surgery: A Case Report.
coagulation factor viia deficiency
Possible homozygous factor VIIR disorder associated with fibrinolytic hyperactivity.
coagulation factor viia deficiency
Posterior reversible encephalopathy syndrome (PRES) in pregnancy: a diagnostic challenge to obstetricians.
coagulation factor viia deficiency
Postoperative bleeding with factor VII deficiency: case report.
coagulation factor viia deficiency
Potential predictors of bleeding risk in inherited factorVII deficiency. Clinical, biological and molecular criteria.
coagulation factor viia deficiency
Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors.
coagulation factor viia deficiency
Pregnancy in women with congenital factor VII deficiency.
coagulation factor viia deficiency
Prenatal diagnosis in rare bleeding disorders-An unresolved issue?
coagulation factor viia deficiency
Prenatal diagnosis of severe factor VII deficiency using mutation detection and linkage analysis.
coagulation factor viia deficiency
Prenatal exclusion of severe factor VII deficiency by DNA sequencing.
coagulation factor viia deficiency
Prenatal exclusion of severe factor VII deficiency.
coagulation factor viia deficiency
Preparation of factor VII concentrate using CNBr-activated Sepharose 4B immunoaffinity chromatography.
coagulation factor viia deficiency
Prevalence of factor VII deficiency and molecular characterization of the F7 gene in Brazilian patients.
coagulation factor viia deficiency
Prevalence of HIV infection in a cohort of patients with congenital coagulation defects of the prothrombin complex factors.
coagulation factor viia deficiency
Preventing Surgical and Postpartum Hemorrhage in an Active Duty Patient With an Undiagnosed Coagulopathy at a Military Treatment Facility.
coagulation factor viia deficiency
Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
coagulation factor viia deficiency
Prevention of Bleeding Complications in Neonates With Liver Failure Undergoing Surgery Using Recombinant Factor VIIa.
coagulation factor viia deficiency
Primary factor VII deficiency.
coagulation factor viia deficiency
Primary prophylaxis for children with severe congenital factor VII deficiency - Clinical and laboratory assessment.
coagulation factor viia deficiency
Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?
coagulation factor viia deficiency
Prophylactic effect of recombinant factor VIIa in factor VII deficient patients.
coagulation factor viia deficiency
Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency.
coagulation factor viia deficiency
Prophylactic therapy in a pregnant woman with severe factor VII deficiency.
coagulation factor viia deficiency
Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII.
coagulation factor viia deficiency
Prophylactic treatment of hereditary severe factor VII deficiency in pregnancy.
coagulation factor viia deficiency
Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports.
coagulation factor viia deficiency
Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).
coagulation factor viia deficiency
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
coagulation factor viia deficiency
Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa.
coagulation factor viia deficiency
Prophylaxis with rFVIIa before third molar extraction in a patient with factor VII deficiency.
coagulation factor viia deficiency
Prostate surgery in severe congenital factor VII deficiency: A case report.
coagulation factor viia deficiency
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
coagulation factor viia deficiency
Prothrombin complex concentrate for factor VII replacement in a patient undergoing left ventricular assist device implantation with factor VII deficiency.
coagulation factor viia deficiency
Psychosocial Impact and Disease Management in Patients with Congenital Factor VII Deficiency.
coagulation factor viia deficiency
Pulmonary embolism in a patient with mild factor VII deficiency after administration of recombinant activated factor VII during a urological procedure.
coagulation factor viia deficiency
Pulmonary embolism in congenital bleeding disorders: intriguing discrepancies among different clotting factors deficiencies.
coagulation factor viia deficiency
Radiographic abnormalities in coagulation factor VII deficiency.
coagulation factor viia deficiency
Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias.
coagulation factor viia deficiency
Rare bleeding disorders-old diseases in the era of novel options for therapy.
coagulation factor viia deficiency
Rare bleeding disorders: spectrum of disease and clinical manifestations in the Pakistani population.
coagulation factor viia deficiency
Rare factor VII variant inherited through genetic variant in proband's mother and another genetic variant in proband's father.
coagulation factor viia deficiency
Rare inherited coagulation disorders in India.
coagulation factor viia deficiency
Rare inherited coagulation disorders in young children in Oman.
coagulation factor viia deficiency
Rational Use of Recombinant Factor VIIa in Clinical Practice.
coagulation factor viia deficiency
Recombinant Activated Factor VII (Eptacog Alfa Activated, NovoSeven®) in Patients with Rare Congenital Bleeding Disorders. A Systematic Review on its Use in Surgical Procedures.
coagulation factor viia deficiency
Recombinant activated factor VII (rFVIIa, NovoSeven).
coagulation factor viia deficiency
Recombinant activated factor VII as a universal haemostatic agent.
coagulation factor viia deficiency
Recombinant activated factor VII for a patient with factor VII deficiency undergoing urgent intracerebral haematoma evacuation with underlying cavernous angioma.
coagulation factor viia deficiency
Recombinant activated factor VII in clinical practice: a 2014 update.
coagulation factor viia deficiency
Recombinant activated factor VII in patients at high risk of bleeding.
coagulation factor viia deficiency
Recombinant activated factor VII: 30 years of research and innovation.
coagulation factor viia deficiency
Recombinant activated factor VII: mechanisms of action and current indications.
coagulation factor viia deficiency
Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.
coagulation factor viia deficiency
Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders.
coagulation factor viia deficiency
Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.
coagulation factor viia deficiency
Recombinant factor VIIa for long-term replacement therapy in patients with congenital factor VII deficiency.
coagulation factor viia deficiency
Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
coagulation factor viia deficiency
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
coagulation factor viia deficiency
Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
coagulation factor viia deficiency
Recombinant factor VIIa for treatment of a child with severe factor VII deficiency and coarctation of the aorta.
coagulation factor viia deficiency
Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.
coagulation factor viia deficiency
Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery.
coagulation factor viia deficiency
Recombinant Factor VIIa Use for Endoscopic Retrograde Cholangiopancreatography With Sphincterotomy in a Patient With Choledocholithiasis and Unusual Coagulopathy.
coagulation factor viia deficiency
Recombinant factor VIIa: a universal hemostatic agent?
coagulation factor viia deficiency
Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias.
coagulation factor viia deficiency
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.
coagulation factor viia deficiency
Rectus muscle sheath haematoma in a patient with congenital FX deficiency and in another with congenital FVII deficiency.
coagulation factor viia deficiency
Recurrent Bleedings in Newborn: A Factor VII Deficiency Case Report.
coagulation factor viia deficiency
Recurrent intracranial hemorrhage in an infant with congenital factor VII deficiency.
coagulation factor viia deficiency
Recurrent mutations and genotype-phenotype correlations in hereditary factor VII deficiency in Korea.
coagulation factor viia deficiency
Recurrent pre-retinal haemorrhages associated with coagulation factor VII deficiency.
coagulation factor viia deficiency
Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.
coagulation factor viia deficiency
Registry of Hemophilia and other bleeding disorders in Syria.
coagulation factor viia deficiency
Regulatory polymorphisms underlying complex disease traits.
coagulation factor viia deficiency
Repair of abdominal aortic aneurysm in severe Factor VII deficiency.
coagulation factor viia deficiency
Repeated recombinant activated factor VII administration in a patient with congenital factor VII deficiency undergoing modified radical hysterectomy: a case report.
coagulation factor viia deficiency
Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
coagulation factor viia deficiency
Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery.
coagulation factor viia deficiency
Residual factor VII activity and different hemorrhagic phenotypes in CRM(+) factor VII deficiencies (Gly331Ser and Gly283Ser).
coagulation factor viia deficiency
Resistance to activated protein C: evaluation of three functional assays.
coagulation factor viia deficiency
Response to treatment and adverse events associated with use of recombinant activated factor VII in children: a retrospective cohort study.
coagulation factor viia deficiency
Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.
coagulation factor viia deficiency
rFVIIa administered by continuous infusion during surgery in patients with severe congenital FVII deficiency.
coagulation factor viia deficiency
Robustness of factor assays following cordocentesis in the prenatal diagnosis of haemophilia and other bleeding disorders.
coagulation factor viia deficiency
Role of clinical and laboratory parameters for treatment choice in patients with inherited FVII deficiency undergoing surgical procedures: evidence from the STER registry.
coagulation factor viia deficiency
Role of the 2 adenine (g.11293_11294insAA) insertion polymorphism in the 3' untranslated region of the factor VII (FVII) gene: molecular characterization of a patient with severe FVII deficiency.
coagulation factor viia deficiency
Second trimester antenatal diagnosis in rare coagulation factor deficiencies.
coagulation factor viia deficiency
Segmental liver transplantation from non-heart beating donors-an early experience with implications for the future.
coagulation factor viia deficiency
Selection of replacement therapy for patients with severe factor VII deficiency.
coagulation factor viia deficiency
Sensitivities of thromboplastins to factor VII deficiency.
coagulation factor viia deficiency
Sensitivity of different prothrombin time assays to factor VII deficiency in canine plasma.
coagulation factor viia deficiency
Sensitivity of different thromboplastin reagents to factor VII deficiency in the blood of beagle dogs.
coagulation factor viia deficiency
Serendipitous Discovery of Factor VII Deficiency and the Ensuing Dilemma.
coagulation factor viia deficiency
Severe arterial thrombosis in a congenitally factor VII deficient patient.
coagulation factor viia deficiency
Severe coagulation factor VII deficiency caused by a novel homozygous mutation (p. Trp284Gly) in loop 140s.
coagulation factor viia deficiency
Severe congenital Factor VII deficiency associated with the 13q deletion syndrome.
coagulation factor viia deficiency
Severe Congenital Factor VII Deficiency with Normal Perioperative Coagulation Profile Based on ROTEM Analysis in a Hepatectomy.
coagulation factor viia deficiency
Severe deficiency of coagulation Factor VII results in spontaneous cardiac fibrosis in mice.
coagulation factor viia deficiency
Severe factor VII deficiency caused by a novel mutation His348 to Gln in the catalytic domain.
coagulation factor viia deficiency
Severe factor VII deficiency caused by a novel point mutation (Arg353Pro) combined with a rare Cys22Arg mutation.
coagulation factor viia deficiency
Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor.
coagulation factor viia deficiency
Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter.
coagulation factor viia deficiency
Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter.
coagulation factor viia deficiency
Severe factor VII deficiency with recurrent intracranial haemorrhages owing to double heterozygosity for a splice site mutation of an IVS4 and a novel nonsense mutation in exon 8 (Gln211-->Term).
coagulation factor viia deficiency
Severe FVII deficiency caused by a new point mutation combined with a previously undetected gene deletion.
coagulation factor viia deficiency
Severe menorrhagia due to factor VII deficiency successfully treated by thermal balloon endometrial ablation.
coagulation factor viia deficiency
Significance and causes of abnormal preoperative coagulation test results in children.
coagulation factor viia deficiency
Spectrum of factor X gene mutations in Iranian patients with congenital factor X deficiency.
coagulation factor viia deficiency
Spontaneous chronic subdural hematoma in young adult: the role of missing coagulation facto.
coagulation factor viia deficiency
Spontaneous hemorrhage after external ventricular drain placement in the setting of low factor VII secondary to liver cirrhosis.
coagulation factor viia deficiency
Spontaneous umbilical cord haematoma and congenital factor VII deficiency.
coagulation factor viia deficiency
Steps towards an effective treatment strategy in congenital factor VII deficiency.
coagulation factor viia deficiency
Studies on a family with the factor VII defect.
coagulation factor viia deficiency
Studies on immunological assay of vitamin K dependent factors. I. Measurement of factor VII antigen by radioimmunoassay.
coagulation factor viia deficiency
Study of different factor VII deficiency variants in nine families from Spain.
coagulation factor viia deficiency
Subdural Hematoma From an Acquired Factor VII Deficiency: Is It the Lupus or the Anticoagulant?
coagulation factor viia deficiency
Subgaleal hematoma with delayed proptosis and corneal ulceration.
coagulation factor viia deficiency
Substitution therapy of congenital factor VII deficiency at an extended operation with extracorporeal circulation.
coagulation factor viia deficiency
Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
coagulation factor viia deficiency
Successful coronary artery bypass graft surgery in severe congenital factor VII deficiency: Perioperative treatment with factor VII concentrate.
coagulation factor viia deficiency
Successful coronary artery bypass graft surgery in severe congenital factor VII deficiency: Perioperative treatment with pd-factor VII concentrate.
coagulation factor viia deficiency
Successful coronary artery bypass grafting in a patient with severe FVII deficiency and minimal use of recombinant FVIIa.
coagulation factor viia deficiency
Successful excision of hemorrhagic cavernous angioma in a patient with severe factor VII deficiency: perioperative treatment with factor VII concentrate.
coagulation factor viia deficiency
Successful management of maternal factor VII deficiency in a cesarean section.
coagulation factor viia deficiency
Successful prophylactic use of recombinant activated factor VII (rFVIIa) in a patient with congenital FVII deficiency and inhibitors to FVII.
coagulation factor viia deficiency
Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency.
coagulation factor viia deficiency
Successful prophylaxis of intracranial hemorrhage in infants with severe congenital factor VII deficiency.
coagulation factor viia deficiency
Successful short-term oral surgery prophylaxis with rFVIIa in severe congenital factor VII deficiency.
coagulation factor viia deficiency
Successful Splenectomy Management in a Patient With Moderate Factor VII Deficiency and Concomitant Severe Hereditary Spherocytosis.
coagulation factor viia deficiency
Successful treatment of hereditary factor VII deficiency presented for the first time with epistaxis in pregnancy: a case report.
coagulation factor viia deficiency
Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature.
coagulation factor viia deficiency
Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation.
coagulation factor viia deficiency
Successful use of recombinant activated factor VII administered via automated bolus pump following emergency laparoscopic appendectomy in a patient with mild congenital FVII deficiency: Case report.
coagulation factor viia deficiency
Successful use of recombinant FVIIa (Novoseven) in the management of pulmonary haemorrhage secondary to Aspergillus infection in a patient with leukaemia and acquired FVII deficiency.
coagulation factor viia deficiency
Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency.
coagulation factor viia deficiency
Successful use of rFVIIa for major breast surgery prophylaxis in congenital factor VII deficiency.
coagulation factor viia deficiency
Successful use of rFVIIa for major breast surgery prophylaxis in congenital factor VII deficiency: a case report.
coagulation factor viia deficiency
Surgery for scoliosis in congenital factor VII deficiency.
coagulation factor viia deficiency
SURGERY IN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY (CONGENITAL HYPOPROCONVERTINEMIA). EXPERIENCE WITH ONE CASE AND REVIEW OF THE LITERATURE.
coagulation factor viia deficiency
Surgery in patients with congenital factor VII deficiency - a single center study.
coagulation factor viia deficiency
Surgery in patients with congenital factor VII deficiency: A single center experience.
coagulation factor viia deficiency
Surgical Aortic Valve Replacement in an Adult Patient With Congenital Factor VII Deficiency: A Case Report of Perioperative Coagulation Management.
coagulation factor viia deficiency
Surgical interventions in childhood rare factor deficiencies: a single-center experience from Turkey.
coagulation factor viia deficiency
Sustained correction of FVII deficiency in dogs using AAV-mediated expression of zymogen FVII.
coagulation factor viia deficiency
Synergistic effect of factor VII gene polymorphisms causing mild factor VII deficiency in a case of severe factor X deficiency.
coagulation factor viia deficiency
Synovectomy for haemophilic arthropathy: 6-21 years of follow-up in 16 patients.
coagulation factor viia deficiency
Synovectomy of the elbow in a patient with factor VII deficiency (hypoconvertinemia).
coagulation factor viia deficiency
Takayasu Arteritis Presenting as Renovascular Hypertension and Renal Failure in a Patient with Factor VII Deficiency.
coagulation factor viia deficiency
The clinical and laboratory significance of cases of congenital FX deficiency due to defects in the Gla-domain.
coagulation factor viia deficiency
The clinical significance of the lack of arterial or venous thrombosis in patients with congenital prothrombin or FX deficiency.
coagulation factor viia deficiency
The clotting action of Russell viper venom. 1954.
coagulation factor viia deficiency
The congenital factor VII abnormalities (dysproconvertinemias). The genetic plot thickens.
coagulation factor viia deficiency
The danger of using a sledgehammer to crack a nut: ROTEM-guided administration of recombinant activated factor VII in a patient with refractory bleeding post-ventricular assist device implantation.
coagulation factor viia deficiency
The importance of tissue factor source in the management of Factor VII deficiency.
coagulation factor viia deficiency
The K-test (trypsin clotting time) in coumarin treated patients and in congenital deficiencies and abnormalities of the prothrombin complex.
coagulation factor viia deficiency
The molecular basis of low activity levels of coagulation factor VII: a Brazilian cohort.
coagulation factor viia deficiency
The paradoxical association between inherited factor VII deficiency and venous thrombosis.
coagulation factor viia deficiency
The role of tissue factor in the production of thrombin.
coagulation factor viia deficiency
The significance of published polymorphisms in 14 cases of mild factor VII deficiency.
coagulation factor viia deficiency
The spectrum of factor VII deficiencies and abnormalities.
coagulation factor viia deficiency
The Story of Serum Prothrombin Conversion Accelerator, Proconvertin, Stable Factor, Cothromboplastin, Prothrombin Accelerator or Autoprothrombin I, and Their Subsequent Merging into Factor VII.
coagulation factor viia deficiency
The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding.
coagulation factor viia deficiency
The use of recombinant activated factor VII in congenital and acquired factor VII deficiencies.
coagulation factor viia deficiency
The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
coagulation factor viia deficiency
The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
coagulation factor viia deficiency
Thromboelastographic monitoring of the efficacy of recombinant factor VIIa administration in a parturient with factor VII deficiency.
coagulation factor viia deficiency
Thromboembolism in congenital factor VII deficiency.
coagulation factor viia deficiency
Thromboembolism in patients with hereditary deficiency of coagulation factors.
coagulation factor viia deficiency
Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency.
coagulation factor viia deficiency
Thrombosis in inherited factor VII deficiency.
coagulation factor viia deficiency
Thrombosis in rare bleeding disorders.
coagulation factor viia deficiency
Thrombosis: a study of coagulation parameters and mechanisms during allograft rejection.
coagulation factor viia deficiency
Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC).
coagulation factor viia deficiency
Tissue factor pathway inhibitor activity in factor VII deficiency.
coagulation factor viia deficiency
Total hip arthroplasty in severe congenital factor VII deficiency: successful use of recombinant activated factor VII for hemostasis.
coagulation factor viia deficiency
Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study.
coagulation factor viia deficiency
Transmission of factor VII deficiency through liver transplantation.
coagulation factor viia deficiency
Treatment of bleeding after kidney biopsy with recombinant activated factor VII.
coagulation factor viia deficiency
Treatment of congenital factor VII deficiency with a new concentrate.
coagulation factor viia deficiency
Treatment of factor VII deficiency with recombinant factor VIIa.
coagulation factor viia deficiency
Treatment of factor XI inhibitor using recombinant activated factor VIIa.
coagulation factor viia deficiency
Triple coronary artery bypass graft surgery in a patient with factor VII deficiency: a case report.
coagulation factor viia deficiency
Twenty two novel mutations of the factor VII gene in factor VII deficiency.
coagulation factor viia deficiency
Two new double mutant alleles of the F7 gene and a literature review on alleles with two mutations in FVII deficiency.
coagulation factor viia deficiency
Two novel cases of cerebral haemorrhages at the neonatal period associated with inherited factor VII deficiency, one of them revealing a new nonsense mutation (Ser52Stop).
coagulation factor viia deficiency
Two novel factor VII gene mutations in a Chinese family with factor VII deficiency.
coagulation factor viia deficiency
Two novel mutations in severe factor VII deficiency.
coagulation factor viia deficiency
Two typical hereditary charts of congenital factor VII deficiency.
coagulation factor viia deficiency
Two-incision laparoscopic appendectomy for a severe hemophilia A child patient with coagulation factor VII deficiency: Case report and review of literature.
coagulation factor viia deficiency
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.
coagulation factor viia deficiency
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency.
coagulation factor viia deficiency
Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
coagulation factor viia deficiency
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
coagulation factor viia deficiency
Use of global assays to understand clinical phenotype in congenital factor VII deficiency.
coagulation factor viia deficiency
Use of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case report.
coagulation factor viia deficiency
Use of recombinant factor VIIa in hereditary bleeding disorders.
coagulation factor viia deficiency
Use of recombinant factor VIIa in surgery in factor-VII-deficient patients.
coagulation factor viia deficiency
Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies.
coagulation factor viia deficiency
Use of thromboelastography and thrombin generation assay to predict clinical phenotype in patients with severe FVII deficiency.
coagulation factor viia deficiency
Using a minigene approach to characterize a novel splice site mutation in human F7 gene causing inherited factor VII deficiency in a Chinese pedigree.
coagulation factor viia deficiency
Variation of factor VII 140s and 170s loops in fishes: evolutionary aspects and comparison with mutations found in FVII deficiency.
coagulation factor viia deficiency
Vena porta thrombosis in patient with inherited factor VII deficiency.
coagulation factor viia deficiency
Visually Disabling Non-Traumatic Orbital Hemorrhage in an Anticoagulated Patient with Factor VII Deficiency.
coagulation factor viia deficiency
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX).
coagulation factor viia deficiency
Warfarin management in the setting of FVII deficiency and mechanical circulatory support.
coagulation factor viia deficiency
Warfarin-induced factor VII deficiency and the bleeding time.
coagulation factor viia deficiency
Whole-exome sequencing provides insights into monogenic disease prevalence in Northwest Russia.
coagulation factor viia deficiency
Women and inherited bleeding disorders: menstrual issues.
coagulation factor viia deficiency
Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
coagulation factor viia deficiency
[A case of congenital factor VII deficiency (author's transl)]
coagulation factor viia deficiency
[A case of congenital hemorrhagic diathesis due to factor VII deficiency (hypoproconvertinemia)]
coagulation factor viia deficiency
[A family of congenital factor VII deficiency (author's transl)]
coagulation factor viia deficiency
[A new case of homozygous congenital factor VII deficiency. Associated factor X deficiency in some members of the family]
coagulation factor viia deficiency
[A Quebec family with factor VII deficiency]
coagulation factor viia deficiency
[Acquired and repeated factor VII deficiency during infections outbreaks: case-report]
coagulation factor viia deficiency
[Acquired factor VII deficiency]
coagulation factor viia deficiency
[Acquired isolated factor VII deficiency and bronchogenic carcinoma. A case report]
coagulation factor viia deficiency
[An acquired isolated transitory factor VII deficiency]
coagulation factor viia deficiency
[An inherited coagulation factor VII deficiency pedigree caused by homozygous mutation of His348Gln].
coagulation factor viia deficiency
[Anaesthetic management of a parturient with a severe factor VII deficiency: was activated factor VII really necessary?].
coagulation factor viia deficiency
[Analysis of a Chinese pedigree affected with hereditary factor VII deficiency caused by compound heterozygous variants of F7 gene].
coagulation factor viia deficiency
[Analysis of an inherited FVII deficiency pedigree caused by homozygosity of Thr359Met]
coagulation factor viia deficiency
[Analysis of Phenotype and L12R Mutation in Signal Peptide and 3' Non-translation Region c11814-insAA Mutation of F7 Gene in a Family with Hereditary Coagulation Factor VII Deficiency].
coagulation factor viia deficiency
[Analysis of the gene mutation in an inherited FVII deficiency patient].
coagulation factor viia deficiency
[Anesthesia and coagulation factor VII deficiency]
coagulation factor viia deficiency
[Anesthesia and factor VII deficiency]
coagulation factor viia deficiency
[Anesthesia in a patient with hereditary factor VII deficiency]
coagulation factor viia deficiency
[Anesthesia in congenital factor VII deficiency]
coagulation factor viia deficiency
[Application of heat-treated factor VII concentrates in a patient with congenital factor VII deficiency during labor]
coagulation factor viia deficiency
[Assay of factor VII antigen by enzyme-linked immunosorbent assay (ELISA)]
coagulation factor viia deficiency
[Bleeding after cardiac surgery: the role of recombinant factor VIIa]
coagulation factor viia deficiency
[Blood transfusion as substitution therapy in factor V- and factor VII deficiency.]
coagulation factor viia deficiency
[Case of congenital factor VII deficiency]
coagulation factor viia deficiency
[Case of factor VII deficiency with systemic amyloidosis having a unique clinical course such as splenic rupture]
coagulation factor viia deficiency
[Classical factor VII deficiency: biological and genetic evaluation of 3 families]
coagulation factor viia deficiency
[Clinical and blood coagulation studies in patients with congenital factor VII deficiency]
coagulation factor viia deficiency
[Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group.]
coagulation factor viia deficiency
[Clinical studies of familial hereditary factor VII deficiency (author's transl)]
coagulation factor viia deficiency
[Coagulation factor VII deficiency in 3 patients with trisomy 8]
coagulation factor viia deficiency
[Coagulation factor VII deficiency in a chronic carrier of the B virus]
coagulation factor viia deficiency
[Coagulation factor VII--new physiopathological and therapeutic aspects]
coagulation factor viia deficiency
[Concurrent obstetric disease and ischemic ictus in 2 cases with moderated factor VII deficiency]
coagulation factor viia deficiency
[Congenital factor VII deficiency (author's transl)]
coagulation factor viia deficiency
[Congenital factor VII deficiency and subarachnoidal haemorrhage due to intracranial aneurysm: a case report]
coagulation factor viia deficiency
[Congenital factor VII deficiency as a cause of obstetrical and gynecological hemorrhages]
coagulation factor viia deficiency
[Congenital factor VII deficiency associated with idiopathic osteopsathyrosis of Lobstein type.]
coagulation factor viia deficiency
[Congenital factor VII deficiency revealed by post-circumcision bleeding].
coagulation factor viia deficiency
[Congenital factor VII deficiency. Report of 4 cases]
coagulation factor viia deficiency
[Congenital factor VII deficiency: about two family cases].
coagulation factor viia deficiency
[Congenital factor VII deficiency; family investigation and physiological studies on factor VII.]
coagulation factor viia deficiency
[Congenital factor VII deficiency]
coagulation factor viia deficiency
[Congenital hypoproconvertinemia; case of congenital factor VII deficiency and brief review of literature.]
coagulation factor viia deficiency
[Contribution to the clinical picture of congenital factor VII deficiency]
coagulation factor viia deficiency
[Differential diagnosis of factor VII deficiency in the newborn.]
coagulation factor viia deficiency
[Double heterozygous mutations of non-canonical splice (IVS1a + 5g > a) and His348Gln caused inherited coagulation factor VII deficiency]
coagulation factor viia deficiency
[Efficacy of Recombinant Activated Factor VII for Intractable Bleeding after Cardiovascular Surgery].
coagulation factor viia deficiency
[Epistaxis due to coagulation disorder in factor VII deficiency.]
coagulation factor viia deficiency
[Factor VII deficiency and homocystinuria. Chance association or syndrome?]
coagulation factor viia deficiency
[Factor VII deficiency and surgery: infusion of fresh-frozen plasma in a case report]
coagulation factor viia deficiency
[Factor VII deficiency and surgery: is preoperative replacement necessary?]
coagulation factor viia deficiency
[Factor VII deficiency and surgery]
coagulation factor viia deficiency
[Factor VII deficiency revealed by intracranial hemorrhage.]
coagulation factor viia deficiency
[Factor VII deficiency--case report]
coagulation factor viia deficiency
[Factor VII deficiency. Preparation for surgical intervention]
coagulation factor viia deficiency
[Factor VII deficiency]
coagulation factor viia deficiency
[Gastrectomy for a patient with congenital factor VII deficiency--a case report]
coagulation factor viia deficiency
[Gastrectomy in congenital factor VII deficiency with substitution of factor VII concentrate]
coagulation factor viia deficiency
[Gene diagnosis of antithrombin deficiency and factor VII deficiency]
coagulation factor viia deficiency
[Genetic analysis of hereditary factor VII deficiency from a Chinese pedigree]
coagulation factor viia deficiency
[Genetic diagnosis of hereditary coagulation disorders]
coagulation factor viia deficiency
[Genotype and phenotype analysis of congenital coagulator factor VII deficiency in four Chinese pedigrees].
coagulation factor viia deficiency
[Haplotype Analysis of Coagulation Factor VII Gene in a Patient with Congenital Coagulation Factor VII Deficiency with Heterozygous p.Arg337Cys Mutation and o.Aro413Gin Polymorphism..]
coagulation factor viia deficiency
[Hemorrhage from the palatal tonsils in the course of angina in a child with factor VII deficiency]
coagulation factor viia deficiency
[Hemorrhagic diathesis due to factor VII deficiency (hypoproconvertinemia).]
coagulation factor viia deficiency
[Hemostasis anomalies and prognosis during severe infectious purpura in children. Retrospective study in 69 cases]
coagulation factor viia deficiency
[Hereditary coagulation factor VII deficiency in a case]
coagulation factor viia deficiency
[Hereditary heterozygote factor VII deficiency]
coagulation factor viia deficiency
[Hereditary heterozygous factor VII deficiency in patients undergoing surgery : Clinical relevance].
coagulation factor viia deficiency
[Homocystinuria and factor VII deficiency]
coagulation factor viia deficiency
[Homocystinuria. A type with vascular thrombosis and factor VII deficiency]
coagulation factor viia deficiency
[Inherited bleeding disorders common in Jews].
coagulation factor viia deficiency
[Inherited coagulation factor VII deficiency caused by double heterozygotic mutations Arg304Gln and Arg304Trp]
coagulation factor viia deficiency
[Inherited factor VII deficiency and pregnancy. Apropos of 1 case]
coagulation factor viia deficiency
[Intracranial hemorrhage in an infant with congenital factor VII deficiency]
coagulation factor viia deficiency
[Isolated acquired factor VII deficiency in patient with severe head trauma: use of factor VII (factor VII-LFB]
coagulation factor viia deficiency
[Liver cirrhosis with factor VII deficiency: a case report and literature review].
coagulation factor viia deficiency
[Molecular genetic analysis for a pedigree with severe hereditary coagulation factor VII deficiency]
coagulation factor viia deficiency
[Mutation analysis and prenatal diagnosis for a family affected with congenital factor VII deficiency].
coagulation factor viia deficiency
[Novel double heterozygous mutations on Met306Val and Thr181Asn related to a hereditary coagulation factor VII deficiency]
coagulation factor viia deficiency
[On a case of Christmas disease associated with factor VII deficiency.]
coagulation factor viia deficiency
[Panorama of congenital disorders of hemostasis diseases at University Hospital of Brazzaville, Congo]
coagulation factor viia deficiency
[Postpartum haemorrhage and factor VII deficiency].
coagulation factor viia deficiency
[Practical approaches for surgical procedures in congenital factor VII deficiency]
coagulation factor viia deficiency
[Pregnancy and delivery in a case with congenital factor VII deficiency]
coagulation factor viia deficiency
[Pregnancy and labor in severe hereditary factor VII deficiency]
coagulation factor viia deficiency
[Primary biliary cirrhosis combined with factor VII deficiency: a case report]
coagulation factor viia deficiency
[Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
coagulation factor viia deficiency
[Recombinant activated factor VII in paediatric practice. Universal hemostatic agent?]
coagulation factor viia deficiency
[Recurrent intracranial hemorrhage in a nursing infant with congenital factor VII deficiency. Survival and follow-up after neurosurgical intervention]
coagulation factor viia deficiency
[Serious congenital deficiency of FVII and acquired idiopathic thrombocytopenic purpura--the rare combination of two bleeding disorders]
coagulation factor viia deficiency
[Significant decrease in factor VII activity by tissue thromboplastin derived from rabbit brain in a patient with congenital factor VII deficiency (FVII Padua)].
coagulation factor viia deficiency
[Studies on inherited coagulation factor VII deficiency and tissue factor abnormality in a pedigree]
coagulation factor viia deficiency
[Study of prothrombin conversion in a case of congenital proconvertin deficiency (factor VII deficiency of serum prothrombin conversion accelerator deficiency.]
coagulation factor viia deficiency
[Subcutaneous hematomas, reduced Quick value. Factor VII deficiency]
coagulation factor viia deficiency
[Successful gastric resection in a male patient with factor VII deficiency and telangiectasia]
coagulation factor viia deficiency
[The change and significance of coagulation activity in bleomycin-induced lung fibrosis in rats]
coagulation factor viia deficiency
[The influence of factor VII deficiency on cardiac operations with extracorporeal circulation]
coagulation factor viia deficiency
[Two novel mutations in one pedigree with here-ditary Factor VII deficiency].
coagulation factor viia deficiency
[Variants of factor VII deficiency]
coagulation factor xa deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
coagulation factor xa deficiency
A NlaIII polymorphism within the human factor VII gene.
coagulation factor xa deficiency
A rare inherited coagulation disorder: combined homozygous factor VII and factor X deficiency.
coagulation factor xa deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
coagulation factor xa deficiency
Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Report of a new association and its possible relationship to endothelial cell injury.
coagulation factor xa deficiency
Clinical analysis of six cases of multiple myeloma first presenting with coagulopathy.
coagulation factor xa deficiency
Clinical audit of inherited bleeding disorders in a developing country.
coagulation factor xa deficiency
Congenital bleeding disorders of the vitamin K-dependent clotting factors.
coagulation factor xa deficiency
Diagnostic Error of a Patient with Combined Inherited Factor VII and Factor X Deficiency due to Accidental Ingestion of a Diphacinone Rodenticide.
coagulation factor xa deficiency
Factor VII and factor X deficiency in a child with a chromosome 13q duplication and deletion.
coagulation factor xa deficiency
Frequencies of mild factor V, VII and X deficiencies in a Japanese population.
coagulation factor xa deficiency
Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill.
coagulation factor xa deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
coagulation factor xa deficiency
Inherited bleeding disorders in the Eastern Province of Saudi Arabia.
coagulation factor xa deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
coagulation factor xa deficiency
Rare inherited coagulation disorders in India.
coagulation factor xa deficiency
Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency.
coagulation factor xa deficiency
Successful perioperative management of factor X deficiency associated with primary amyloidosis.
coagulation factor xa deficiency
Synergistic effect of factor VII gene polymorphisms causing mild factor VII deficiency in a case of severe factor X deficiency.
coagulation factor xa deficiency
The K-test (trypsin clotting time) in coumarin treated patients and in congenital deficiencies and abnormalities of the prothrombin complex.
coagulation factor xa deficiency
[A new case of homozygous congenital factor VII deficiency. Associated factor X deficiency in some members of the family]
coagulation factor xa deficiency
[Factors VII, VIII, IX, and X: molecular genetics and gene diagnosis]
coagulation factor xa deficiency
[Gene analysis of a combined inherited factor VII and factor X deficiency pedigree].
coagulation factor xa deficiency
[The change and significance of coagulation activity in bleomycin-induced lung fibrosis in rats]
coagulation factor xia deficiency
A novel congenital haemostatic defect: combined factor VII and factor XI deficiency.
coagulation factor xia deficiency
Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
coagulation factor xia deficiency
Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency.
coagulation factor xia deficiency
An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency.
coagulation factor xia deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
coagulation factor xia deficiency
Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.
coagulation factor xia deficiency
Changes in haemostasis and thrombosis associated with thyroid disease: Presentation of 2 cases.
coagulation factor xia deficiency
Characterization of combined factor VII and factor XI deficiencies.
coagulation factor xia deficiency
Clinical and laboratory features of 178 children with recurrent epistaxis.
coagulation factor xia deficiency
Descriptive epidemiology of hemophilia and other coagulation disorders in mansoura, egypt: retrospective analysis.
coagulation factor xia deficiency
Factor IX is activated in vivo by the tissue factor mechanism.
coagulation factor xia deficiency
Factor XII deficiency acquired by orthotopic liver transplantation: case report and review of the literature.
coagulation factor xia deficiency
Low endoscopy bleeding risk in patients with congenital bleeding disorders.
coagulation factor xia deficiency
Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors.
coagulation factor xia deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
coagulation factor xia deficiency
Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery.
coagulation factor xia deficiency
Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
coagulation factor xia deficiency
Obstetric analgesia and anaesthesia in women with inherited bleeding disorders.
coagulation factor xia deficiency
Perioperative use of modified thrombelastography in factor XI deficiency: a helpful method to assess drug effects.
coagulation factor xia deficiency
Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery.
coagulation factor xia deficiency
Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
coagulation factor xia deficiency
Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with congenital factor XI deficiency.
coagulation factor xia deficiency
Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency.
coagulation factor xia deficiency
The rare inherited coagulation disorders.
coagulation factor xia deficiency
The role of recombinant factor VIIa for obstetric block in women with severe factor XI deficiency.
coagulation factor xia deficiency
The use of recombinant factor VIIa (NovoSeven) in a patient with a factor XI deficiency and a circulating anticoagulant.
coagulation factor xia deficiency
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
coagulation factor xia deficiency
Use of recombinant factor VIIa for hip replacement surgery in a patient with severe factor XI deficiency and drug-induced platelet defect.
coagulation factor xia deficiency
[Inherited bleeding disorders common in Jews].
coagulation factor xia deficiency
[Use of recombinant, activated Factor VII in the treatment and prevention of bleeding complications in two female patients suffering from congenital XI factor deficiency during orthopedic and traumatology intervention. Case reports]
coagulation factor xiia deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
coagulation factor xiia deficiency
Resistance to activated protein C: evaluation of three functional assays.
Colic
Whole blood re-calcification time in equine colic.
Colitis
Rectal amputation sparing by haemostatic therapy with recombinant factor VIIa in a patient with cytomegalovirus-related colitis.
Colonic Neoplasms
A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.
Colonic Neoplasms
Factor VIIa regulates the expression of caspase-3, MMP-9, and CD44 in SW620 colon cancer cells involving PAR2/MAPKs/NF-?B signaling pathways.
Colonic Neoplasms
The FVIIa-tissue factor complex induces the expression of MMP7 in LOVO cells in vitro.
Colonic Neoplasms
Tissue factor-factor VIIa regulates interleukin-8, tissue factor and caspase-7 expression in SW620 cells through protease-activated receptor-2 activation.
Colonic Neoplasms
Tissue factor-targeted lidamycin inhibits growth and metastasis of colon carcinoma.
Colonic Neoplasms
Tissue factor/activated factor VIIa induces matrix metalloproteinase-7 expression through activation of c-Fos via ERK1/2 and p38 MAPK signaling pathways in human colon cancer cell.
Colonic Neoplasms
[Ectopic expression and clinical significance of tissue factor/coagulation factor VII complex in colorectal cancer.]
Colonic Neoplasms
[Investigation of the mechanisms of coagulation factor VIIa-induced colon cancer SW620 cell proliferation and migration]
Colonic Neoplasms
[Mechanism of cross talk between tissue factor/active coagulation factor VII and epidermal growth factor receptor signalings in colon cancer cells in culture].
Colonic Neoplasms
[Regulation of promatrilysin expression by tissue factor/actived coagulation factor VII complex in LoVo colon cancer cell line.]
Colorectal Neoplasms
A recombinant adenovirus vector encoding the light chain of human coagulation factor VII and IgG1 Fc fragment to targeting tissue factor for colorectal cancer immunotherapy in the mouse model.
Colorectal Neoplasms
Acquired factor VII deficiency following FOLFOX in a patient with colorectal cancer who was also DPD deficient.
Colorectal Neoplasms
Coagulation factor levels in non-metastatic colorectal cancer patients.
Colorectal Neoplasms
Crosstalk between TF/FVIIa and EGFR signaling in colorectal cancer cells.
Colorectal Neoplasms
Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
Colorectal Neoplasms
Inhibition of tissue factor-factor VIIa proteolytic activity blunts hepatic metastasis in colorectal cancer.
Colorectal Neoplasms
[Ectopic expression and clinical significance of tissue factor/coagulation factor VII complex in colorectal cancer.]
Coma
Factor VII levels as a guide to prognosis in fulminant hepatic failure.
Coma
Use of recombinant factor VIIa in US military casualties for a five-year period.
Common Variable Immunodeficiency
Severe menorrhagia due to factor VII deficiency successfully treated by thermal balloon endometrial ablation.
Communicable Diseases
Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion.
Compartment Syndromes
Early treatment with recombinant factor VIIa results in greater efficacy with less product.
Compartment Syndromes
Lower extremity compartment syndrome in the setting of iliofemoral deep vein thrombosis, phlegmasia cerulea dolens and factor VII deficiency.
Compartment Syndromes
Successful use of recombinant factor VIIa (NovoSeven) in children with compartment syndrome: two case reports.
Compartment Syndromes
Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
Compartment Syndromes
Thigh Compartment Syndrome in a Factor VII Deficient High School Football Player: 2322 June 2, 3: 55 PM - 4: 15 PM.
Compartment Syndromes
Use of Recombinant Factor VIIa for Bleeding Control in Treatment of Acute Extremity Compartment Syndrome Secondary to Primary Myelofibrosis: A Case Report.
Confusion
Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?
Congenital Abnormalities
Arthropathy and surgery in congenital factor VII deficiency.
Congenital Abnormalities
Defining the role of recombinant activated factor VII in pediatric cardiac surgery: where should we go from here?
Congenital Abnormalities
Effect of atorvastatin on hemorheologic-hemostatic parameters and serum fibrinogen levels in hyperlipidemic patients.
Congenital Abnormalities
Identification of a congenital defect of factor VII in a colony of beagle dogs: the clinical use of the plasma.
Congenital Abnormalities
The congenital factor VII abnormalities (dysproconvertinemias). The genetic plot thickens.
Congenital Abnormalities
Use of recombinant activated factor VII for reduction of perioperative blood loss during elective surgical correction of spine deformity in a Jehovah's Witness. Case repor.
Congenital Abnormalities
[DYSERGIC ANGIOPATHY (OF THE TYPE OF ANAPHYLACTOID VASCULAR PURPURA) ASSOCIATED WITH A CONGENITAL DEFECT OF FACTOR VII.]
Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
Contracture
Feasibility of using recombinant factor VIIa in continuous infusion.
Contracture
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
Corneal Opacity
Anterior segment dysgenesis in a child with factor VII deficiency.
Coronary Artery Disease
A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men.
Coronary Artery Disease
A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.
Coronary Artery Disease
A protective contribution of the Q allele of the R353Q polymorphism of the Factor VII gene in individuals with chronic stable angina?
Coronary Artery Disease
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Coronary Artery Disease
Activated factor VII levels in patients with angiographically confirmed coronary artery disease.
Coronary Artery Disease
Activation of coagulation factor VII during alimentary lipemia.
Coronary Artery Disease
Activity of factor VIIa and von Willebrand factor in non-insulin-dependent diabetic subjects with coronary artery disease.
Coronary Artery Disease
Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism.
Coronary Artery Disease
Aortic valve and coronary artery bypass surgery in a patient with factor VII deficiency.
Coronary Artery Disease
Association between R353Q polymorphism for coagulative factor VII and severity of coronary artery disease in Iranian population.
Coronary Artery Disease
Association of factor VII genotype with plasma factor VII activity and antigen levels in healthy Indian adults and interaction with triglycerides.
Coronary Artery Disease
Atherosclerosis and coronary bypass surgery in hereditary factor VII deficiency.
Coronary Artery Disease
Classical risk factors and emerging elements in the risk profile for coronary artery disease.
Coronary Artery Disease
Contribution of coagulation factor VII R353Q, -323P0/10 and HVR4 polymorphisms to coronary artery disease in Tunisians.
Coronary Artery Disease
Coronary artery disease and factor VII hyperactivity in elderly Japanese.
Coronary Artery Disease
Coronary artery plaque disruption as cause of acute myocardial infarction during cesarean section with spinal anesthesia.
Coronary Artery Disease
Dietary factor VII activation does not increase plasma concentrations of prothrombin fragment 1+2 in patients with stable angina pectoris and coronary atherosclerosis.
Coronary Artery Disease
Differences in postprandial lipaemic response between Northern and Southern Europeans.
Coronary Artery Disease
Effect of lipid-lowering treatment on factor VII profile in hyperlipidemic patients.
Coronary Artery Disease
Effects of coagulation Factor VII polymorphisms on the coronary artery disease in Japanese: Factor VII polymorphism and coronary disease.
Coronary Artery Disease
Effects of simvastatin or hormone replacement therapy, or both, on fibrinogen, factor VII, and plasminogen activator inhibitor levels in postmenopausal women with proven coronary artery disease.
Coronary Artery Disease
Elevation of factor VII activity and mass in coronary artery disease of varying severity.
Coronary Artery Disease
Evidence that factor VII levels correlate strongly with fibrinopeptide A release: evaluation by an ex vivo method.
Coronary Artery Disease
Factor VII activity state in coronary artery disease.
Coronary Artery Disease
Factor VII levels in patients undergoing coronary angiography: factor VII and coronary artery disease.
Coronary Artery Disease
Fibrinogen, factor VII clotting activity and coronary artery disease severity.
Coronary Artery Disease
Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
Coronary Artery Disease
Genetic contribution to circulating levels of hemostatic factors in healthy families with effects of known genetic polymorphisms on heritability.
Coronary Artery Disease
Genetic contribution to factor VII levels in families of patients undergoing coronary arteriography.
Coronary Artery Disease
Genetic determinants of plasma factor VII activity in the Japanese.
Coronary Artery Disease
Genotype associations of factor VII gene with plasma factor VII coagulant activity and antigen levels in healthy Chinese.
Coronary Artery Disease
Genotype-phenotype relationship of F7 R353Q polymorphism and plasma factor VII coagulant activity in Asian Indian families predisposed to coronary artery disease.
Coronary Artery Disease
Hemostatic risk factors of coronary artery disease in the Chinese.
Coronary Artery Disease
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis.
Coronary Artery Disease
Initiation of blood coagulation: the tissue factor/factor VIIa complex.
Coronary Artery Disease
Joint effect of G1691A factor V point mutation and factor VII Arg/Gln(353) gene polymorphism on the risk of premature coronary artery disease.
Coronary Artery Disease
Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
Coronary Artery Disease
Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction in patients undergoing coronary angiography.
Coronary Artery Disease
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease.
Coronary Artery Disease
Polymorphisms of factor V, factor VII, and fibrinogen genes. Relevance to severity of coronary artery disease.
Coronary Artery Disease
Promoter methylation in coagulation F7 gene influences plasma FVII concentrations and relates to coronary artery disease.
Coronary Artery Disease
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study.
Coronary Artery Disease
Racial variation of factor VII activity and antigen levels and their correlates in healthy Chinese and Indians at low and high risk for coronary artery disease.
Coronary Artery Disease
Recombinant nematode anticoagulant protein c2, an inhibitor of the tissue factor/factor VIIa complex, in patients undergoing elective coronary angioplasty.
Coronary Artery Disease
Relationships of insulin and intact and split proinsulin to haemostatic function in young men with and without coronary artery disease.
Coronary Artery Disease
Risk factors for cerebrovascular disease and the role of coagulation and fibrinolysis.
Coronary Artery Disease
Specific assays of hemostasis proteins: factor VII.
Coronary Artery Disease
Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation.
Coronary Artery Disease
The -323Ins10 polymorphism for factor VII is not associated with coronary atherosclerosis in symptomatic men. The REGRESS study group.
Coronary Artery Disease
The effects of three factor VII polymorphisms on factor VII coagulant levels in healthy Singaporean Chinese, Malay and Indian newborns.
Coronary Artery Disease
[Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease]
Coronary Artery Disease
[Myocardial infarction during pregnancy]
Coronary Artery Disease
[Role of the hemostatic system in pathogenesis of atherosclerosis as the main etiology of coronary ischemia] [corrected]
Coronary Disease
A functional haplotype in the 5' flanking region of the factor VII gene is associated with an increased risk of coronary heart disease.
Coronary Disease
A protective contribution of the Q allele of the R353Q polymorphism of the Factor VII gene in individuals with chronic stable angina?
Coronary Disease
A specific elevation in tissue plasminogen activator antigen in women with polycystic ovarian syndrome.
Coronary Disease
Activated protein C ratio, plasma tissue factor activity and activated factor VII in Chinese patients with coronary heart disease.
Coronary Disease
Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency.
Coronary Disease
Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism.
Coronary Disease
Antithrombotic therapy in the primary prevention of acute myocardial infarction.
Coronary Disease
Are risk factors for atherothrombotic disease associated with back pain sickness absence? The Whitehall II Study.
Coronary Disease
Association between polymorphisms in the coagulation factor VII gene and coronary heart disease risk in different ethnicities: a meta-analysis.
Coronary Disease
Association Between R353Q (rs6046) Polymorphism in Factor VII with Coronary Heart Disease.
Coronary Disease
Association between the factor VII haplotype containing the -402A allele and myocardial infarction in a population of elderly men at high risk for coronary heart disease.
Coronary Disease
Association of ACE and FACTOR VII gene variability with the risk of coronary heart disease in north Indian population.
Coronary Disease
Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.
Coronary Disease
Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.
Coronary Disease
Atorvastatin reduces plasma levels of factor VII activity and factor VII antigen in patients with hyperlipidemia.
Coronary Disease
Carotid artery measures are strongly associated with left ventricular mass in older adults (a report from the Cardiovascular Health Study).
Coronary Disease
Coagulation factor VII and inflammatory markers in patients with coronary heart disease.
Coronary Disease
Coagulation factor VII and the risk of coronary heart disease in healthy men.
Coronary Disease
Coagulation factor VII in middle-aged women with and without coronary heart disease.
Coronary Disease
Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
Coronary Disease
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
Coronary Disease
Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.
Coronary Disease
Constitutional, biochemical and lifestyle correlates of fibrinogen and factor VII activity in Polish urban and rural populations.
Coronary Disease
Correlates of blood pressure in community-dwelling older adults. The Cardiovascular Health Study. Cardiovascular Health Study (CHS) Collaborative Research Group.
Coronary Disease
Dietary fatty acids and blood coagulation.
Coronary Disease
Effect of meat replacement by tofu on CHD risk factors including copper induced LDL oxidation.
Coronary Disease
Effect of the Mediterranean Diet on Fasting Concentrations of Activated Factor VII in Healthy Persons.
Coronary Disease
Effects of coagulation Factor VII polymorphisms on the coronary artery disease in Japanese: Factor VII polymorphism and coronary disease.
Coronary Disease
Environmental influences on hemostasis and thrombosis. Diet and smoking.
Coronary Disease
Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men.
Coronary Disease
Factor VII and extrinsic pathway inhibitor in acute coronary disease.
Coronary Disease
Factor VII, antithrombin III, leukocyte and platelet counts in a sample of black and white Zimbabwean blood donors.
Coronary Disease
Factor VII, blood lipids and fat intake: gene-nutrient interaction and risk of coronary heart disease with the factor VII R353Q polymorphism.
Coronary Disease
Fat consumption and factor VII coagulant activity in middle-aged men. An association between a dietary and thrombogenic coronary risk factor.
Coronary Disease
FVII gene R353Q polymorphism and coronary heart disease: a meta-analysis including 3258 subjects.
Coronary Disease
Genetic and environmental determinants of factor VII coagulant activity in ethnic groups at differing risk of coronary heart disease.
Coronary Disease
Genetic polymorphisms of factor VII are not associated with arterial thrombosis.
Coronary Disease
Haplotype and genotype effects of the F7 gene on circulating factor VII, coagulation activation markers and incident coronary heart disease in UK men.
Coronary Disease
Hemostasis and cardiovascular risk. The British and European experience.
Coronary Disease
Hemostatic factors in the Coronary Artery Risk Development in Young Adults (CARDIA) Study.
Coronary Disease
Influence of factor VII gene polymorphisms and environmental factors on plasma coagulation factor VII concentrations in middle-aged women with and without manifest coronary heart disease.
Coronary Disease
Influences of lipid and non-lipid nutritional parameters on factor VII coagulant activity in normal subjects: the Nove study.
Coronary Disease
Interrelationships of factor VII activity and plasma leptin with insulin resistance in coronary heart disease.
Coronary Disease
Lipolysis of triglyceride-rich lipoproteins activates coagulant factor XII: a study in familial lipoprotein-lipase deficiency.
Coronary Disease
Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?
Coronary Disease
Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
Coronary Disease
Plasma fibrinogen explains much of the difference in risk of coronary heart disease between France and Northern Ireland. The PRIME study.
Coronary Disease
Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
Coronary Disease
Positive association between self-reported fatty food consumption and factor VII coagulant activity, a risk factor for coronary heart disease, in 4246 middle-aged men.
Coronary Disease
Postprandial lipaemia and haemostatic factors.
Coronary Disease
Prevalence in a Tunisian Arabic population of factor VII DNA variants and relation to factor VII plasma levels.
Coronary Disease
Prospective study of hemostatic factors and incidence of coronary heart disease: the Atherosclerosis Risk in Communities (ARIC) Study.
Coronary Disease
Relation of hemostatic risk factors to other risk factors for coronary heart disease and to sex hormones in men.
Coronary Disease
Relationship of tissue factor pathway inhibitor activity to plasma lipoproteins and myocardial infarction at a young age.
Coronary Disease
Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls.
Coronary Disease
The Northwick Park Heart Study: Evidence from the Laboratory.
Coronary Disease
Thrombin generation markers and coronary heart disease risk factors in a Polish population sample.
Coronary Disease
Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration.
Coronary Disease
Weight-loss induced changes in plasma factor VII coagulant activity and relation to the factor VII Arg/Gln353 polymorphism in moderately obese adults.
Coronary Disease
[Coagulant activity of factor VII (FVIIc) in the elderly with ischemic heart disease]
Coronary Disease
[Correlation between polymorphisms in the coagulation factor VII gene hypervariable region 4 site and the risk of coronary heart disease in population with different ethnic backgrounds: a Meta-analysis].
Coronary Disease
[Effect of the Mediterranean diet on fasting concentrations of activated factor VII in healthy persons]
Coronary Disease
[Factor VII and protein-C markers are no prognostic indicators in acute coronary heart disease]
Coronary Disease
[Study of the inhibitory effect of NF-kappaB decoy on tissue factor gene expression and FVII activation in cultured human umbilical vein endothelial cells]
Coronary Disease
[Study on plasma coagulation factor VII (FVII) levels and polymorphisms of FVII gene in patients with coronary heart disease]
Coronary Disease
[The influence of hormone replacement therapy containing transdermal 17-beta estradiol and oral medroxyprogesterone acetate on coagulation and fibrinolysis]
Coronary Disease
[The thrombophilic status and ischemic cardiopathy]
Coronary Stenosis
Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand?
Coronary Thrombosis
Influence of stearic acid on hemostatic risk factors in humans.
Coronary Thrombosis
Plasma fibrinogen and factor VII as risk factors for cardiovascular disease.
Coronary Thrombosis
Postprandial lipaemia and haemostatic factors.
Coronary Thrombosis
The effects of transdermal estradiol in combination with oral norethisterone on lipoproteins, coagulation, and endothelial markers in postmenopausal women with type 2 diabetes: a randomized, placebo-controlled study.
Craniocerebral Trauma
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma.
Craniocerebral Trauma
Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy.
Craniocerebral Trauma
Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage.
Craniocerebral Trauma
Intracranial bleeding following soccer-related head trauma in a young student with occult factor VII deficiency.
Craniocerebral Trauma
Medication-related complications in the trauma patient.
Craniocerebral Trauma
Recombinant activated coagulation factor VII and bleeding trauma patients.
Craniocerebral Trauma
Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII.
Craniocerebral Trauma
[Isolated acquired factor VII deficiency in patient with severe head trauma: use of factor VII (factor VII-LFB]
Craniocerebral Trauma
[The use of recombinant activated factor VII in traumatic intracranial haemorrhage]
Craniosynostoses
Elevated prothrombin time on routine preoperative laboratory results in a healthy infant undergoing craniosynostosis repair: Diagnosis and perioperative management of congenital factor VII deficiency.
Crigler-Najjar Syndrome
Hepatocyte transplantation for liver-based metabolic disorders.
Crigler-Najjar Syndrome
Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation.
Crigler-Najjar Syndrome
Liver after hepatocyte transplantation for liver-based metabolic disorders in children.
Crohn Disease
Recombinant factor VIIa for severe gastrointestinal hemorrhage associated with Crohn disease.
Crohn Disease
Successful treatment of severe gastrointestinal bleeding secondary to Crohn disease with recombinant factor VIIa.
Crohn Disease
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.
Cystic Fibrosis
Expanded carrier screening and preimplantation genetic diagnosis in a couple who delivered a baby affected with congenital factor VII deficiency.
Cystic Fibrosis
Recombinant activated factor VII for massive hemoptysis in patients with cystic fibrosis.
Cystinuria
Frequency of five disease-causing genetic mutations in a large mixed-breed dog population (2011-2012).
Cystitis
Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Cystitis
Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy.
Cystitis
Recombinant activated factor VII in treatment of bleeding complications following hematopoietic stem cell transplantation.
Cystitis
Recombinant activated factor VII to control life-threatening haemorrhagic radiation cystitis.
Cystitis
Recombinant factor VIIa to treat late radiation-induced hemorrhagic cystitis: a case report.
Cystitis
Successful treatment of cyclophosphamide induced intractable hemorrhagic cystitis with recombinant FVIIa (NovoSeven) after allogenic bone marrow transplantation.
Cysts
Prophylactic preparation and surgical extirpation of a very large abdominal blood cyst in a severe haemophilia A patient with inhibitors managed by rFVIIa.
Death, Sudden, Cardiac
[The advisability of modifying the current outline of blood coagulation]
Dementia, Vascular
Hemostasis abnormalities in patients with vascular dementia and Alzheimer's disease.
Dengue
Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study.
Dengue
Cost-utility analysis of an adjunctive recombinant activated factor VIIa for on-demand treatment of bleeding episodes in dengue haemorrhagic fever.
Dengue
Diagnostic laboratory for bleeding disorders ensures efficient management of haemorrhagic disorders.
Dengue
Effectiveness of Recombinant Activated Factor VII (rFVII a) for Controlling Intractable Postpartum Bleeding in a case of Dengue Hemorrhagic Fever.
Dengue
Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience.
Dengue
Successful use of N-acetyl cysteine and activated recombinant factor VII in fulminant hepatic failure and massive bleeding secondary to dengue hemorrhagic fever.
Dengue
The use of recombinant activated factor VII for controlling life-threatening bleeding in Dengue Shock Syndrome.
Dermatitis, Phototoxic
Selective and effective killing of angiogenic vascular endothelial cells and cancer cells by targeting tissue factor using a factor VII-targeted photodynamic therapy for breast cancer.
Diabetes Complications
Qualitative and quantitative studies of autoantibodies to phospholipids in diabetes mellitus.
Diabetes Insipidus, Nephrogenic
A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
Diabetes Mellitus
Analysis of the correlation between plasma coagulation factor VII, PAI-1, and uric acid with insulin resistance and macrovascular complications in elderly patients with type 2 diabetes.
Diabetes Mellitus
Blood glucose may condition factor VII levels in diabetic and normal subjects.
Diabetes Mellitus
Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction.
Diabetes Mellitus
Factor VII activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: results of an 11-year follow-up.
Diabetes Mellitus
Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.
Diabetes Mellitus
Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia.
Diabetes Mellitus
Fibrinogen and factor VII levels improve with glycemic control in patients with type 1 diabetes mellitus who have microvascular complications.
Diabetes Mellitus
Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
Diabetes Mellitus
Genetic influence of the R/Q353 genotype on factor VII activity is overwhelmed by environmental factors in Chinese patients with Type II (non-insulin-dependent) diabetes mellitus.
Diabetes Mellitus
Interrelationship between coagulation factor VII and obesity in diabetes mellitus (type 2).
Diabetes Mellitus
Metformin reduces circulating factor VII concentrations in patients with type 2 diabetes mellitus.
Diabetes Mellitus
Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.
Diabetes Mellitus
Tissue Factor, Tissue Factor Pathway Inhibitor and Factor VII Activity in Cardiovascular Complicated Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 1
Fibrinogen and factor VII levels improve with glycemic control in patients with type 1 diabetes mellitus who have microvascular complications.
Diabetes Mellitus, Type 1
PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria.
Diabetes Mellitus, Type 1
Risk factors for cardiovascular disease in IDDM. A study of identical twins.
Diabetes Mellitus, Type 1
Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes and Effects of Hyperglycemia and Hyperinsulinemia.
Diabetes Mellitus, Type 2
A chromogenic assay for coagulation factor VII: analytical performance characteristics and application in several diseases.
Diabetes Mellitus, Type 2
Activation of tissue factor-induced coagulation and endothelial cell dysfunction in non-insulin-dependent diabetic patients with microalbuminuria.
Diabetes Mellitus, Type 2
Activity of factor VIIa and von Willebrand factor in non-insulin-dependent diabetic subjects with coronary artery disease.
Diabetes Mellitus, Type 2
Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients.
Diabetes Mellitus, Type 2
Analysis of the correlation between plasma coagulation factor VII, PAI-1, and uric acid with insulin resistance and macrovascular complications in elderly patients with type 2 diabetes.
Diabetes Mellitus, Type 2
Blood coagulation and fibrinolysis in obese NIDDM patients.
Diabetes Mellitus, Type 2
Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.
Diabetes Mellitus, Type 2
Effects of Different Protein Sources on Plasminogen Inhibitor-1 and Factor VII Coagulant Activity Added to a Fat-Rich Meal in Type 2 Diabetes.
Diabetes Mellitus, Type 2
Effects of fish oil supplements in NIDDM subjects. Controlled study.
Diabetes Mellitus, Type 2
Effects of heparin treatment on hemostatic abnormalities in obese non-insulin-dependent diabetic patients.
Diabetes Mellitus, Type 2
Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Metformin reduces circulating factor VII concentrations in patients with type 2 diabetes mellitus.
Diabetes Mellitus, Type 2
Postmenopause hormone treatment in women with NIDDM or impaired glucose tolerance: the MEDIA randomized clinical trial.
Diabetes Mellitus, Type 2
Study of factor VII, tissue factor pathway inhibitor and monocyte tissue factor in noninsulin-dependent diabetes mellitus.
Diabetes Mellitus, Type 2
Thrombogenic factors are related to urinary albumin excretion rate in type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetic patients.
Diabetes Mellitus, Type 2
Tissue Factor, Tissue Factor Pathway Inhibitor and Factor VII Activity in Cardiovascular Complicated Type 2 Diabetes Mellitus.
Diabetes Mellitus, Type 2
Tissue factor/factor VIIa signalling promotes cytokine-induced beta cell death and impairs glucose-stimulated insulin secretion from human pancreatic islets.
Diabetes Mellitus, Type 2
Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes and Effects of Hyperglycemia and Hyperinsulinemia.
Diabetic Retinopathy
Successful use of recombinant activated factor VII in the treatment of vitreous haemorrhage: a report of seven cases.
Disseminated Intravascular Coagulation
A coagulation factor VII deficiency protects against acute inflammatory responses in mice.
Disseminated Intravascular Coagulation
A comparison of methods for the measurement of activated factor VII.
Disseminated Intravascular Coagulation
A method for the determination of activated factor VII using bovine and rabbit brain thromboplastins: demonstration of increased levels in disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Disseminated Intravascular Coagulation
Administration of recombinant activated factor VII (NovoSeven) in three cases of uncontrolled bleeding caused by disseminated intravascular coagulopathy.
Disseminated Intravascular Coagulation
Consumption of plasma factor VII in a rabbit model of non-overt disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Control of disseminated intravascular coagulation in Klippel-Trenaunay-Weber syndrome using enoxaparin and recombinant activated factor VIIa: a case report.
Disseminated Intravascular Coagulation
Desmopressin-induced Moschcowitz-like syndrome after treatment of uterine atonic bleeding in a 28-year-old pregnant woman: case report and overview of the literature.
Disseminated Intravascular Coagulation
Disseminated intravascular coagulation associated with low factor VII. Evidence for a new type of hemostatic disorder.
Disseminated Intravascular Coagulation
Effectiveness of recombinant activated factor VII in haemorragic cancer-related disseminated intravascular coagulation: a case report.
Disseminated Intravascular Coagulation
Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Disseminated Intravascular Coagulation
Experimental gram-negative septicemia: thromboplastin generation in mononuclear phagocytes from different anatomical sites.
Disseminated Intravascular Coagulation
Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Factor VIIa treatment of DIC as a clinical manifestation of amniotic fluid embolism in a patient with fetal demise.
Disseminated Intravascular Coagulation
Levels of activated factor VII in patients with disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Low plasma FVII:C and activated FVII as predictive markers for overt disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Management of factor VIII inhibitors: evolution and current status.
Disseminated Intravascular Coagulation
Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases.
Disseminated Intravascular Coagulation
Pediatric off-label use of recombinant factor VIIa.
Disseminated Intravascular Coagulation
Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Disseminated Intravascular Coagulation
Prevention of Bleeding Complications in Neonates With Liver Failure Undergoing Surgery Using Recombinant Factor VIIa.
Disseminated Intravascular Coagulation
Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Recombinant activated factor VII in hemophagocytic lymphohistiocytosis with disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism.
Disseminated Intravascular Coagulation
Recombinant factor VIIa: safety and efficacy.
Disseminated Intravascular Coagulation
Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy.
Disseminated Intravascular Coagulation
Safety profile of recombinant factor VIIa.
Disseminated Intravascular Coagulation
Septic miscarriage with toxic shock syndrome and disseminated intravascular coagulation (DIC): The role of surgery, recombinant activated factor VII and intravenous immunoglobulin (IVIG).
Disseminated Intravascular Coagulation
Splenic artery aneurysm presenting as a submucosal gastric lesion: A case report.
Disseminated Intravascular Coagulation
Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII.
Disseminated Intravascular Coagulation
Successful treatment with recombinant blood factor VIIa in severe postpartum hemorrhage-induced disseminated intravascular coagulation.
Disseminated Intravascular Coagulation
Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review.
Disseminated Intravascular Coagulation
Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model.
Disseminated Intravascular Coagulation
The use of recombinant factor VIIa (NovoSeven) for treatment of active or impending bleeding in brain injury: broadening the indications.
Disseminated Intravascular Coagulation
Timely 'off-label' use of recombinant activated factor VII (NovoSeven(®)) can help in avoiding hysterectomy in intractable obstetric bleeding complicated with disseminated intravascular coagulation: A case report and review of the literature.
Disseminated Intravascular Coagulation
Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
Disseminated Intravascular Coagulation
Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.
Disseminated Intravascular Coagulation
[Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group.]
Disseminated Intravascular Coagulation
[Hemostasis anomalies and prognosis during severe infectious purpura in children. Retrospective study in 69 cases]
Disseminated Intravascular Coagulation
[Plasma factor VII levels in disseminated intravascular coagulation]
Disseminated Intravascular Coagulation
[Successful application of recombinant activated factor VII in a patient with HELLP syndrome and disseminated intravascular coagulation]
Diverticular Diseases
Successful treatment of massive acute lower gastrointestinal bleeding in diverticular disease of colon, with activated recombinant factor VII (NovoSeven).
Down Syndrome
Homocysteine, factor VII and antithrombin III in subjects with different gene dosage for cystathionine beta-synthase.
Drug Resistant Epilepsy
Management of intracranial surgery for refractory epilepsy in severe factor VII deficiency: choosing the optimal dosing regimen.
Ductus Arteriosus, Patent
Recombinant Activated Factor VIIa (rFVIIa) Treatment in Very-Low-Birth-Weight (VLBW) Premature Infants with Acute Pulmonary Hemorrhage: A Single-Center, Retrospective Study.
Duodenal Ulcer
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.
Dyslipidemias
Characteristics of the insulin resistance syndrome in a Japanese population. The Jichi Medical School Cohort Study.
Dyslipidemias
Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
Dyslipidemias
Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.
Dyslipidemias
Interrelationships of factor VII activity and plasma leptin with insulin resistance in coronary heart disease.
Dyslipidemias
Relationship between plasma protein S levels and apolipoprotein C-II in Japanese middle-aged obese women and young nonobese women.
Dyslipidemias
[Fibrinogen and factor VII in women with dyslipidemia. The preliminary results of the Bellvitge-Costa de Ponent Study. The Bellvitge Study Group]
Dyspnea
Combined factor VII and protein C deficiency found in a patient with peripheral pulmonary artery stenosis accompanied by progressive pulmonary hypertension and hemoptysis.
Dyspnea
The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
Dyspnea
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
Ecchymosis
Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
Echinococcosis
Hydatid cyst surgery complicated by hemorrhage resistant to activated recombinant factor VII, in a hemophiliac A patient with an inhibitor.
Ehlers-Danlos Syndrome
The successful use of recombinant factor VIIa in a patient with vascular-type Ehlers-Danlos syndrome.
Ehlers-Danlos Syndrome
Whole-exome sequencing provides insights into monogenic disease prevalence in Northwest Russia.
Embolic Stroke
Individualized antithrombotic therapy.
Embolism
Amniotic fluid embolism.
Embolism
Complications of recombinant activated human coagulation factor VII.
Embolism
Factor VIIa treatment of DIC as a clinical manifestation of amniotic fluid embolism in a patient with fetal demise.
Embolism
Hematologic correlates of left atrial spontaneous echo contrast and thromboembolism in nonvalvular atrial fibrillation.
Embolism
Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
Embolism
Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism.
Embolism
Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism.
Embolism
Thromboembolic complications associated with factor VIIa administration.
Embolism
Use of Recombinant Factor VIIa in Patients with Amniotic Fluid Embolism.
Embolism
Use of Recombinant Factor VIIa in Patients with Amniotic Fluid Embolism: A Systematic Review of Case Reports.
Embolism, Amniotic Fluid
Amniotic fluid embolism.
Embolism, Amniotic Fluid
Factor VIIa treatment of DIC as a clinical manifestation of amniotic fluid embolism in a patient with fetal demise.
Embolism, Amniotic Fluid
Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
Embolism, Amniotic Fluid
Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism.
Embolism, Amniotic Fluid
Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism.
Embolism, Amniotic Fluid
Use of Recombinant Factor VIIa in Patients with Amniotic Fluid Embolism.
Embolism, Amniotic Fluid
Use of Recombinant Factor VIIa in Patients with Amniotic Fluid Embolism: A Systematic Review of Case Reports.
End Stage Liver Disease
Recombinant factor VIIa improves coagulopathy caused by liver failure.
Endometrial Hyperplasia
Recombinant activated factor VII administration in a patient with congenital lack of factor VII undergoing laparoscopic hysterectomy: A case report.
Endotoxemia
Enhanced lipid peroxidation in hepatic cirrhosis.
Endotoxemia
Recombinant nematode anticoagulant protein c2, an inhibitor of tissue factor/factor VIIa, attenuates coagulation and the interleukin-10 response in human endotoxemia.
Enterocolitis, Necrotizing
Spontaneous liver hemorrhage during laparotomy for necrotizing enterocolitis: a potential role for recombinant factor VIIa.
Enterocolitis, Necrotizing
Use of recombinant factor VIIa in infants with severe coagulopathy.
Eosinophilia
A severe deficiency of coagulation factor VIIa results in attenuation of the asthmatic response in mice.
Epidural Abscess
Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.
Epilepsy
Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature.
Epilepsy
Migraine and prothrombotic genetic risk factors.
Epistaxis
A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Epistaxis
A patient homozygous for a Gly354Cys mutation in factor VII that results in severely impaired secretion of the molecule, but not complete deficiency.
Epistaxis
A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa.
Epistaxis
Bilateral subdural hematomas, an unusual vaso-occlusive event and prolonged prothrombin time in a 58-year-old victim of an armed robbery.
Epistaxis
Color vision disturbances secondary to oral tranexamic acid.
Epistaxis
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.
Epistaxis
Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Epistaxis
Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding.
Epistaxis
Marked bleeding diathesis in patients with platelet dysfunction due to a novel mutation in RASGRP2, encoding CalDAG-GEFI (p.Gly305Asp).
Epistaxis
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®)).
Epistaxis
NovoSeven in warfarin-treated patients.
Epistaxis
Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors.
Epistaxis
Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa.
Epistaxis
Successful management of bleeding with recombinant factor VIIa (NovoSeven) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins.
Epistaxis
Successful treatment of hereditary factor VII deficiency presented for the first time with epistaxis in pregnancy: a case report.
Epistaxis
Treatment of a patient with Bernard-Soulier syndrome and recurrent nosebleeds with recombinant factor VIIa.
Epistaxis
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency.
Epistaxis
Use of recombinant activated factor VII to control bleeding in a young child with qualitative platelet disorder: a case report.
Epistaxis
[Epistaxis due to coagulation disorder in factor VII deficiency.]
Esophageal and Gastric Varices
A case of bleeding gastric varices treated with recombinant factor VII.
Esophageal and Gastric Varices
Laboratory evidence for hypercoagulability in cirrhotic patients with history of variceal bleeding.
Esophageal and Gastric Varices
Recombinant-activated factor VII as hemostatic therapy in eight cases of severe hemorrhage from esophageal varices.
Esophageal and Gastric Varices
[Recombinant factor VII in the treatment of acute hemorrhage due to esophageal varices.]
Esophageal Neoplasms
Plummer-Vinson Syndrome With Concomitant Factor VII Deficiency.
Essential Hypertension
Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria.
Essential Hypertension
Low order correlations of lipoprotein(a) with other blood lipids and with coagulation and fibrinolysis parameters in hypertensive and diabetic patients.
Exanthema
Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004.
Factor V Deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Factor V Deficiency
Abnormalities in liver function and coagulation profile following the Fontan procedure.
Factor V Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor V Deficiency
Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.
Factor V Deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
Factor V Deficiency
Clinical audit of inherited bleeding disorders in a developing country.
Factor V Deficiency
Descriptive epidemiology of hemophilia and other coagulation disorders in mansoura, egypt: retrospective analysis.
Factor V Deficiency
Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience.
Factor V Deficiency
Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study).
Factor V Deficiency
Frequencies of mild factor V, VII and X deficiencies in a Japanese population.
Factor V Deficiency
Frequency of specific coagulation inhibitors and antiphospholipid antibodies in Tunisian haemophiliacs.
Factor V Deficiency
Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level.
Factor V Deficiency
Rare inherited coagulation disorders in India.
Factor V Deficiency
Refractory Epistaxis due to Severe Factor V Deficiency with Inhibitor.
Factor V Deficiency
The use of activated recombinant coagulation factor VII during haemarthroses and synovectomy in a patient with congenital severe factor V deficiency.
Factor V Deficiency
Treatment of Massive Cecal Bleeding in a 28-Year-Old Patient with Homozygous Factor V Deficiency with Activated Factor VII.
Factor VII Deficiency
"Case report". A case of haemorrhagic diathesis due to factor VII deficiency.
Factor VII Deficiency
"Noninfective Endocarditis": A Case Report of Hereditary Coagulation Disorders in a 28-Year-Old Male.
Factor VII Deficiency
11p15 duplication and 13q34 deletion with Beckwith-Wiedemann syndrome and factor VII deficiency.
Factor VII Deficiency
3 ANESTHETIC MANAGEMENT OF LIVER TRANSPLANTATION FOR FACTOR VII DEFICIENCY IN A 6-MONTH-OLD CHILD-THROMBOELASTOGRAPHY-GUIDED INTRA-OPERATIVE REPLACEMENT OF RECOMBINANT FACTOR VIIa.
Factor VII Deficiency
A case of heterozygous factor VII deficiency in pregnancy.
Factor VII Deficiency
A case of intracranial hemorrhage in a neonate with congenital factor VII deficiency.
Factor VII Deficiency
A case presenting concurrence of Marfan syndrome, Basedow's disease and Arg353Gln polymorphism-related factor VII deficiency.
Factor VII Deficiency
A clinical evaluation of automated chromogenic tests as substitutes for conventional prothrombin time and activated partial thromboplastin time tests.
Factor VII Deficiency
A coagulation factor VII deficiency protects against acute inflammatory responses in mice.
Factor VII Deficiency
A Comparison Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Congenital Factor VII Deficiency.
Factor VII Deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Factor VII Deficiency
A Neonate with Acquired Factor VII Deficiency Successfully Managed with Immunomodulatory Therapy.
Factor VII Deficiency
A new mutation in the HNF4 binding region of the factor VII promoter in a patient with severe factor VII deficiency.
Factor VII Deficiency
A new perspective on perioperative coagulation management in a patient with congenital factor VII deficiency: A case report.
Factor VII Deficiency
A NlaIII polymorphism within the human factor VII gene.
Factor VII Deficiency
A novel gene insertion combined with a missense mutation causing factor VII deficiency in two unrelated Chinese families.
Factor VII Deficiency
A novel homozygous missense mutation in the factor VII gene of severe factor VII deficiency in a newborn baby.
Factor VII Deficiency
A novel homozygous missense mutation in the factor VII gene of severe factor VII deficiency in a pedigree: a description of two cases.
Factor VII Deficiency
A novel missense mutation close to the charge-stabilizing system in a patient with congenital factor VII deficiency.
Factor VII Deficiency
A novel missense mutation responsible for factor VII deficiency in research Beagle colonies.
Factor VII Deficiency
A Novel Presentation of Metaphyseal Chondrodysplasia, Schmid Type with Factor VII Deficiency.
Factor VII Deficiency
A rare case of Glanzmann's thrombasthenia and factor VII deficiency due to a combination of pathogenic and non-pathogenic gene variants.
Factor VII Deficiency
A Rare Case Report of Multiple Intracranial Aneurysms with Factor VII Deficiency.
Factor VII Deficiency
A rare combination: congenital factor VII deficiency with Chiari malformation.
Factor VII Deficiency
A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience.
Factor VII Deficiency
A self-controlled comparative clinical trial to explore the effectiveness of three topical hemostatic agents for stopping severe epistaxis in pediatrics with inherited coagulopathies.
Factor VII Deficiency
A syndrome of factor VII deficiency and abnormal platelet release reaction.
Factor VII Deficiency
A Thr359Met mutation in factor VII of a patient with a hereditary deficiency causes defective secretion of the molecule.
Factor VII Deficiency
Abnormalities in liver function and coagulation profile following the Fontan procedure.
Factor VII Deficiency
Acquired bleeding disorder in a patient with congenital factor VII deficiency.
Factor VII Deficiency
Acquired Factor VII deficiency - a rare but important consideration.
Factor VII Deficiency
Acquired factor VII deficiency associated with acute myeloid leukemia.
Factor VII Deficiency
Acquired factor VII deficiency associated with aplastic anaemia: correction with bone marrow transplantation.
Factor VII Deficiency
Acquired Factor VII Deficiency Associated with Bronchogenic Carcinoma: A Case Report.
Factor VII Deficiency
Acquired factor VII deficiency associated with pleural liposarcoma.
Factor VII Deficiency
Acquired factor VII deficiency associated with Wilms tumor.
Factor VII Deficiency
Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.
Factor VII Deficiency
Acquired factor VII deficiency following FOLFOX in a patient with colorectal cancer who was also DPD deficient.
Factor VII Deficiency
Acquired Factor VII Deficiency in Association with Pyelonephritis.
Factor VII Deficiency
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients.
Factor VII Deficiency
Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven).
Factor VII Deficiency
Acquired isolated factor VII deficiency during sepsis.
Factor VII Deficiency
Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
Factor VII Deficiency
Activated FVII levels in factor VII Padua (Arg304Gln) coagulation disorder and in true factor VII deficiency: a study in homozygotes and heterozygotes.
Factor VII Deficiency
Activation of Endoplasmic Reticulum Stress and Unfolded Protein Response in Congenital Factor VII Deficiency.
Factor VII Deficiency
Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency.
Factor VII Deficiency
Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations.
Factor VII Deficiency
Ala244Val is a common, probably ancient mutation causing factor VII deficiency in Moroccan and Iranian Jews.
Factor VII Deficiency
An immunological investigation of hemophilia B with a tentative classification of the disease into five variants.
Factor VII Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor VII Deficiency
An overview of inherited factor VII deficiency.
Factor VII Deficiency
An unusual complication of ice skating and the emergence of a previously undiagnosed bleeding disorder.
Factor VII Deficiency
Anaesthetic management of a parturient with factor VII deficiency and sepsis.
Factor VII Deficiency
Analysis of biological phenotypes from 42 patients with inherited factor VII deficiency: can biological tests predict the bleeding risk?
Factor VII Deficiency
Analysis of Phenotype and Genotypein an Inherited Coagulation Factor VII Deficiency Pedigree.
Factor VII Deficiency
Analysis of the genotypes and phenotypes of 37 unrelated patients with inherited factor VII deficiency.
Factor VII Deficiency
Anesthetic management of a patient with factor VII deficiency undergoing laparoscopic colectomy: a case report.
Factor VII Deficiency
Another patient with a congenital hemorrhagic disorder intermediate between factor X and factor VII deficiency.
Factor VII Deficiency
Anterior segment dysgenesis in a child with factor VII deficiency.
Factor VII Deficiency
Anti- and procoagulant activities in factor VII-deficient subjects.
Factor VII Deficiency
Anticoagulation of a patient with hypertrophic cardiomyopathy and factor VII deficiency.
Factor VII Deficiency
Anticoagulation Therapy Considerations in Factor VII Deficiency.
Factor VII Deficiency
Aortic valve and coronary artery bypass surgery in a patient with factor VII deficiency.
Factor VII Deficiency
Application of radioisotope synovectomy in the ankle joint in a child with congenital factor VII deficiency.
Factor VII Deficiency
Arthropathies in factor VII deficiency: a case report.
Factor VII Deficiency
Arthropathy and surgery in congenital factor VII deficiency.
Factor VII Deficiency
Asymptomatic factor VII deficiency in African Americans.
Factor VII Deficiency
Asymptomatic factor VII deficiency: gene analysis and structure-function relationships.
Factor VII Deficiency
Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
Factor VII Deficiency
Atherosclerosis and coronary bypass surgery in hereditary factor VII deficiency.
Factor VII Deficiency
Automated synthetic substrate assays for coagulopathies of dogs.
Factor VII Deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
Factor VII Deficiency
Avoiding Cardiovascular Collapse: Pediatric Cutaneous Mastocytosis and Anesthetic Challenges.
Factor VII Deficiency
Bilateral Subdural Hematomas in an Adult With Hereditary Factor VII Deficiency: A Complication of Sit-ups and Inversion?
Factor VII Deficiency
Bilateral subdural hematomas, an unusual vaso-occlusive event and prolonged prothrombin time in a 58-year-old victim of an armed robbery.
Factor VII Deficiency
Bleeding Gastric Heterotopic Polyp in the Duodenum of a Teenager with Severe Factor VII Deficiency.
Factor VII Deficiency
Bleeding Prophylaxis in a Child With Cleft Palate and Factor VII Deficiency: A Case Report.
Factor VII Deficiency
Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran.
Factor VII Deficiency
Bloody tears due to congenital factor VII deficiency.
Factor VII Deficiency
Canine factor VII deficiency: lessons learned in applying methods-based laboratory proficiency testing.
Factor VII Deficiency
Cardiac surgery with extracorporeal circulation in severe factor VII deficiency.
Factor VII Deficiency
Cardiac Surgery Without Blood Products in a Jehovah's Witness Child With Factor VII Deficiency.
Factor VII Deficiency
Carriers of factor VII deficiency are not always asymptomatic.
Factor VII Deficiency
Case report of factor VII deficiency.
Factor VII Deficiency
Case Report: A 70-Year-Old Man with Undiagnosed Factor VII Deficiency Presented with Acute Ischemic Stroke.
Factor VII Deficiency
Case Report: Factor VII deficiency in an obstetrical patient.
Factor VII Deficiency
Cerebral Venous Sinus Thrombosis in a Patient with Undiagnosed Factor VII Deficiency.
Factor VII Deficiency
Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
Factor VII Deficiency
Changes in haemostasis and thrombosis associated with thyroid disease: Presentation of 2 cases.
Factor VII Deficiency
Characterisation of a large complex intragenic re-arrangement in the FVII gene (F7) avoiding misdiagnosis in inherited factor VII deficiency.
Factor VII Deficiency
Characterization of a Cys329Gly mutation causing hereditary factor VII deficiency.
Factor VII Deficiency
Characterization of mild coagulation factor VII deficiency: activity and clearance of the Arg315Trp and Arg315Lys variants in the Cys310-Cys329 loop (c170s).
Factor VII Deficiency
Characterization of mutations causing factor VII deficiency in 61 unrelated Israeli patients.
Factor VII Deficiency
Characterization of two novel splice site mutations in human factor VII gene causing severe plasma factor VII deficiency and bleeding diathesis.
Factor VII Deficiency
Christmas disease associated with factor VII deficiency; case report with family survey.
Factor VII Deficiency
Clinical and laboratory features of 178 children with recurrent epistaxis.
Factor VII Deficiency
Clinical and Laboratory Findings in Jewish and Bedouin Patients in Southern Israel Who Were Diagnosed with Factor VII Deficiency.
Factor VII Deficiency
CLINICAL ASPECTS OF CONGENITAL FACTOR VII DEFICIENCY.
Factor VII Deficiency
Clinical audit of inherited bleeding disorders in a developing country.
Factor VII Deficiency
Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.
Factor VII Deficiency
Clinical management of thrombosis in inherited factor VII deficiency: a description of two cases.
Factor VII Deficiency
Clinical manifestations in 28 Italian and Iranian patients with severe factor VII deficiency.
Factor VII Deficiency
Clinical manifestations, management, and molecular genetics in congenital factor VII deficiency: the International Registry on Congenital Factor VII Deficiency (IRF7)
Factor VII Deficiency
Clinical phenotypes and factor VII genotype in congenital factor VII deficiency.
Factor VII Deficiency
Clinical picture and management of congenital factor VII deficiency.
Factor VII Deficiency
Clinical picture and treatment strategies in factor VII deficiency.
Factor VII Deficiency
Clinical pictures and prevalence of factor VII deficiency in Northeastern of Iran.
Factor VII Deficiency
Clinical problems and surgical interventions in inherited factor VII deficiency.
Factor VII Deficiency
Coagulation studies in patients with trisomy 8 syndrome.
Factor VII Deficiency
Coexistence of Factor VII Deficiency and Hereditary Spastic Paraplegia in Two Siblings.
Factor VII Deficiency
Color vision disturbances secondary to oral tranexamic acid.
Factor VII Deficiency
Combined congenital dysfibrinogenemia and factor VII deficiency from mutations in the FGB and F7 genes.
Factor VII Deficiency
Combined factor V and factor VII deficiency due to an independent segregation of the two defects.
Factor VII Deficiency
Combined factor V and factor VII deficiency. Report of a case with a record on combined defects and considerations on the relevance of partial deficiency of coagulation factors.
Factor VII Deficiency
Combined factor VII and factor VIII deficiency due to a casual association of heterozygosis for factor VII deficiency and hemophilia A.
Factor VII Deficiency
Combined mild PTC (plasma thromboplastin component) and factor VII deficiencies.
Factor VII Deficiency
Complexity of the genetic contribution to factor VII deficiency in two Spanish families: clinical and biological implications.
Factor VII Deficiency
Compound heterozygous mutations (p.Leu13Pro and p.Tyr294*) associated with factor VII deficiency cause impaired secretion through ineffective translocation and extensive intracellular degradation of factor VII.
Factor VII Deficiency
Compound heterozygous mutations in severe factor VII deficiency including a novel nonsense mutation.
Factor VII Deficiency
Compound Heterozygous Mutations in the F7 Gene in 2 Unrelated Families With Congenital Factor VII Deficiency.
Factor VII Deficiency
Congenital combined defects of factor VII: a critical review.
Factor VII Deficiency
Congenital deficiency of factor VII in subarachnoid hemorrhage.
Factor VII Deficiency
Congenital deficiency of factor VII.
Factor VII Deficiency
Congenital factor VII abnormality discovered in an infant at a routine checkup.
Factor VII Deficiency
Congenital factor VII deficiency and cerebrovascular stroke.
Factor VII Deficiency
Congenital factor VII deficiency complicated with hemoperitoneum and intracranial hemorrhage: report of a case.
Factor VII Deficiency
Congenital factor VII deficiency in a patient with an abdominal aortic aneurysm.
Factor VII Deficiency
Congenital Factor VII Deficiency in Association With Bicuspid Aortic Valve and Multicystic Dysplastic Kidney Disease in a Child.
Factor VII Deficiency
Congenital Factor VII Deficiency in Children at Tertiary Health Care Facility in Pakistan.
Factor VII Deficiency
Congenital factor VII deficiency in Iraqi children (Single Centre Experience).
Factor VII Deficiency
Congenital factor VII deficiency presenting as delayed bleeding following dental extraction. A review of the role of factor VII in coagulation.
Factor VII Deficiency
Congenital factor VII deficiency presenting as iron deficiency anaemia--Case report.
Factor VII Deficiency
Congenital factor VII deficiency presenting first time as isolated recurrent hematuria at late age.
Factor VII Deficiency
Congenital factor VII deficiency with cerebral haemorrhage treated with prothrombin concentrate.
Factor VII Deficiency
Congenital factor VII deficiency with normal Stuart activity: clinical, genetic and experimental observations.
Factor VII Deficiency
Congenital factor VII deficiency.
Factor VII Deficiency
Congenital factor VII deficiency. A case report.
Factor VII Deficiency
Congenital factor VII deficiency. A report of four new cases.
Factor VII Deficiency
Congenital factor VII deficiency. Clinical and laboratory characteristics of a newly discovered kindred.
Factor VII Deficiency
Congenital factor VII deficiency. Two cases in children of cousins.
Factor VII Deficiency
Congenital factor VII deficiency: a case report.
Factor VII Deficiency
Congenital factor VII deficiency: haematological and genetic aspects.
Factor VII Deficiency
Congenital factor VII deficiency: Multidisciplinary approach is the key to successful perioperative outcome.
Factor VII Deficiency
Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
Factor VII Deficiency
Congenital factor VII deficiency; a review with a report of a case in an Indian infant.
Factor VII Deficiency
Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observation.
Factor VII Deficiency
Constrictive pericarditis in a patient with inherited factor VII deficiency.
Factor VII Deficiency
Continuous infusion of human prothrombin complex in a patient with congenital factor VII deficiency undergoing laparoscopic cholecystectomy: A case report from China.
Factor VII Deficiency
Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency.
Factor VII Deficiency
Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.
Factor VII Deficiency
Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency.
Factor VII Deficiency
Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand?
Factor VII Deficiency
Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan.
Factor VII Deficiency
Decreasing the Need for Transfusion: Infant Cardiac Surgery Using Hemodilution and Recombinant Factor VIIa.
Factor VII Deficiency
Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency.
Factor VII Deficiency
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Factor VII Deficiency
Descriptive epidemiology of hemophilia and other coagulation disorders in mansoura, egypt: retrospective analysis.
Factor VII Deficiency
Detecting coagulopathy in pediatric patients with post-tonsillectomy hemorrhage.
Factor VII Deficiency
Detection of factor X activation in humans.
Factor VII Deficiency
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7).
Factor VII Deficiency
Determinants of coagulation activation in humans.
Factor VII Deficiency
Determinants of plasma factor VIIa levels in humans.
Factor VII Deficiency
Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deficient infant.
Factor VII Deficiency
Diagnosis and treatment discussion of congenital factor VII deficiency in pregnancy: A case report.
Factor VII Deficiency
Diagnosis and treatment of a patient with gallstone ileus.
Factor VII Deficiency
Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran.
Factor VII Deficiency
Differential functional readthrough over homozygous nonsense mutations contributes to the bleeding phenotype in coagulation factor VII deficiency.
Factor VII Deficiency
Direct oral anticoagulants for atrial fibrillation in patients with congenital factor VII deficiency.
Factor VII Deficiency
Direct oral anticoagulants in factor VII deficiency patient.
Factor VII Deficiency
Discrepancies in FVII:C levels depending on the thromboplastin: about a case.
Factor VII Deficiency
Disorders of menstruation and their effect on the quality of life in women with congenital factor VII deficiency.
Factor VII Deficiency
Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery.
Factor VII Deficiency
Double heterozygous mutations Gln100Leu and His348Gln of the F7 gene in a patient with factor VII deficiency.
Factor VII Deficiency
Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Factor VII Deficiency
Electroimmunoassay of factor VII antigen.
Factor VII Deficiency
Elevated prothrombin time on routine preoperative laboratory results in a healthy infant undergoing craniosynostosis repair: Diagnosis and perioperative management of congenital factor VII deficiency.
Factor VII Deficiency
Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience.
Factor VII Deficiency
Entering new areas in known fields: recombinant fusion protein linking recombinant factor VIIa with recombinant albumin (rVIIa-FP) - advancing the journey.
Factor VII Deficiency
Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
Factor VII Deficiency
Ethnic Differences in Coagulation Factor Abnormalities After the Fontan Procedure.
Factor VII Deficiency
Evaluation of a new chromogenic assay for factor VII and its application in patients on oral anticoagulant treatment.
Factor VII Deficiency
Evaluation of Bleeding Phenotype of Inherited Factor VII Deficiency in Children With a Bleeding Assessment Tool and Global Assays.
Factor VII Deficiency
Evidence for the presence of tissue factor activity on subendothelium.
Factor VII Deficiency
Evidence for tissue factor-dependent activation of the classic extrinsic coagulation mechanism in blood obtained from bleeding time wounds.
Factor VII Deficiency
Exclusion of the first EGF domain of factor VII by a splice site mutation causes lethal factor VII deficiency.
Factor VII Deficiency
Expanded carrier screening and preimplantation genetic diagnosis in a couple who delivered a baby affected with congenital factor VII deficiency.
Factor VII Deficiency
Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Factor VII Deficiency
F7 gene variants modulate protein levels in a large cohort of patients with factor VII deficiency. Results from a genotype-phenotype study.
Factor VII Deficiency
Factor IX is activated in vivo by the tissue factor mechanism.
Factor VII Deficiency
Factor IXa-factor VIIIa-cell surface complex does not contribute to the basal activation of the coagulation mechanism in vivo.
Factor VII Deficiency
Factor VII and haemostasis.
Factor VII Deficiency
Factor VII antibody-neutralizing material in hereditary and acquired factor VII deficiency.
Factor VII Deficiency
Factor VII central. A novel mutation in the catalytic domain that reduces tissue factor binding, impairs activation by factor Xa, and abolishes amidolytic and coagulant activity.
Factor VII Deficiency
Factor VII congenital deficiency. Clinical picture and classification of the variants.
Factor VII Deficiency
Factor VII deficiency - an enigma; clinicohematological profile in 12 cases.
Factor VII Deficiency
Factor VII deficiency and a copper metabolism disorder in a patient with Klippel-Trenaunay syndrome.
Factor VII Deficiency
Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature.
Factor VII Deficiency
Factor VII deficiency and its treatment in delivery with recombinant factor VII.
Factor VII Deficiency
Factor VII deficiency and pregnancy.
Factor VII Deficiency
Factor VII deficiency and pregnancy: a case report and review of literature.
Factor VII Deficiency
Factor VII deficiency and surgery. Is preoperative replacement therapy necessary?
Factor VII Deficiency
Factor VII deficiency and the FVII mutation database.
Factor VII Deficiency
Factor VII deficiency associated with nephrotic syndrome.
Factor VII Deficiency
Factor VII deficiency associated with valproate treatment.
Factor VII Deficiency
Factor VII deficiency caused by a structural variant N57D of the first epidermal growth factor domain.
Factor VII Deficiency
Factor VII deficiency detected in pregnancy: a case report.
Factor VII Deficiency
Factor VII deficiency diagnosed after minor genital trauma.
Factor VII Deficiency
Factor VII Deficiency due to Compound Heterozygosity for Leu-48Pro Mutation and a Novel Pro260Leu Mutation.
Factor VII Deficiency
Factor VII deficiency first observed at preoperative routine clotting test.
Factor VII Deficiency
Factor VII deficiency impairs cutaneous wound healing in mice.
Factor VII Deficiency
Factor VII deficiency in a mixed breed dog.
Factor VII Deficiency
Factor VII deficiency in a patient with retinal arteriolar tortuosity syndrome.
Factor VII Deficiency
Factor VII deficiency in an Alaskan malamute.
Factor VII Deficiency
Factor VII deficiency in an East Indian family.
Factor VII Deficiency
Factor VII deficiency in beagle dog plasma and its use in the assay of human factor VII.
Factor VII Deficiency
Factor VII deficiency in major artery occlusion stroke.
Factor VII Deficiency
Factor VII Deficiency in Patients Receiving Chronic Packed Cell Transfusions.
Factor VII Deficiency
Factor VII deficiency in pregnancy and delivery: a case report.
Factor VII Deficiency
Factor VII deficiency in pregnancy treated with recombinant factor VIIa.
Factor VII Deficiency
Factor VII deficiency presenting as a possible child abuse.
Factor VII Deficiency
Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit.
Factor VII Deficiency
Factor VII Deficiency Resulting in Acute Hemorrhage in Orthognathic Surgery: A Case Report.
Factor VII Deficiency
Factor VII deficiency with intracranial hemorrhage: a case report.
Factor VII Deficiency
Factor VII Deficiency, Masked by Warfarin Therapy, as a Cause of Bleeding After Cardiovascular Intervention.
Factor VII Deficiency
Factor VII deficiency.
Factor VII Deficiency
Factor VII Deficiency.
Factor VII Deficiency
Factor VII deficiency.
Factor VII Deficiency
Factor VII Deficiency.
Factor VII Deficiency
Factor VII deficiency: a double heterozygote of an Arg402Stop with a deletion of the C-terminal five amino acids and a Thr359Met.
Factor VII Deficiency
Factor VII deficiency: a novel missense variant and genotype-phenotype correlation in patients from Southern Italy.
Factor VII Deficiency
Factor VII Deficiency: A Rare Case Report.
Factor VII Deficiency
Factor VII Deficiency: A Single-Center Experience.
Factor VII Deficiency
Factor VII deficiency: clinical manifestation of 717 subjects from Europe and Latin America with mutations in the factor 7 gene.
Factor VII Deficiency
Factor VII Deficiency: Clinical Phenotype, Genotype and Therapy.
Factor VII Deficiency
Factor VII deficiency: defining the clinical picture and optimizing therapeutic options.
Factor VII Deficiency
Factor VII deficiency: do all need replacement for cardiac surgery?
Factor VII Deficiency
Factor VII deficiency: immunological characterization of genetic variants and detection of carriers.
Factor VII Deficiency
Factor VII deficiency: Unveiling the cellular and molecular mechanisms underlying three model alterations of the enzyme catalytic domain.
Factor VII Deficiency
Factor VII gene intronic mutation in a lethal factor VII deficiency: effects on splice-site selection.
Factor VII Deficiency
Factor VII half-life after transfusion of a steam-treated prothrombin complex concentrate in a patient with homozygous factor VII deficiency.
Factor VII Deficiency
Factor VII Mie: homozygous asymptomatic type I deficiency caused by an amino acid substitution of His (CAC) for Arg(247) (CGC) in the catalytic domain.
Factor VII Deficiency
Factor VII Morioka (FVII L-26P): a homozygous missense mutation in the signal sequence identified in a patient with factor VII deficiency.
Factor VII Deficiency
Factor VII Padua 2: another factor VII abnormality with defective ox brain thromboplastin activation and a complex hereditary pattern.
Factor VII Deficiency
Factor VII R110C: a novel missense mutation (Arg110Cys) in the second epidermal growth factor-like domain causing factor VII deficiency in members of a Japanese family.
Factor VII Deficiency
Factor VII Toyama (Thr 359 Met): a homozygous missense mutation causing severe type I deficiency.
Factor VII Deficiency
Factor VII verona coagulation disorder: double heterozygosis with an abnormal factor VII and heterozygous factor VII deficiency.
Factor VII Deficiency
Factor VIIa for correction of traumatic coagulopathy.
Factor VII Deficiency
Factor VIIa replacement therapy in factor VII deficiency.
Factor VII Deficiency
Factor VIIa-antithrombin complexes in patients with arterial and venous thrombosis.
Factor VII Deficiency
Familial factor VII deficiency with foetal and neonatal fatal cerebral haemorrhage associated with homozygosis to Gly180Arg mutation.
Factor VII Deficiency
Familial haemophilia and factor VII deficiency.
Factor VII Deficiency
Fatal intracranial hemorrhage in a newborn with factor VII deficiency.
Factor VII Deficiency
First living-related liver transplant to cure factor VII deficiency.
Factor VII Deficiency
First manifestation of a hereditary homozygous factor VII deficiency in a 3-year-old girl suspected as purpura fulminans.
Factor VII Deficiency
First molecular characterization of a patient with combined factor V and factor VII deficiency.
Factor VII Deficiency
Frequencies of mild factor V, VII and X deficiencies in a Japanese population.
Factor VII Deficiency
Frequency of five disease-causing genetic mutations in a large mixed-breed dog population (2011-2012).
Factor VII Deficiency
Functional and Molecular Characterization of C91S Mutation in the Second Epidermal Growth Factor-Like Domain of Factor VII.
Factor VII Deficiency
Gene Therapy for Inherited Bleeding Disorders.
Factor VII Deficiency
Generation of a human induced pluripotent stem cell line, YCMi002-A, from a Factor VII deficiency patient carrying F7 mutations.
Factor VII Deficiency
Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders.
Factor VII Deficiency
Genotype and phenotype correlation in intracranial hemorrhage in neonatal factor VII deficiency among Thai children.
Factor VII Deficiency
Genotype and phenotype relationships in 10 Pakistani unrelated patients with inherited factor VII deficiency.
Factor VII Deficiency
Genotypic heterogeneity may explain phenotypic variations in inherited factor VII deficiency.
Factor VII Deficiency
Glomerulitis and factor vii deficiency in Familial Mediterranean fever.
Factor VII Deficiency
Granulomatous Pneumocystis carinii pneumonia in a non-AIDS patient: an atypical presentation.
Factor VII Deficiency
HAART and Mycobacterium avium complex in an HIV infected patient with severe factor VII deficiency.
Factor VII Deficiency
Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill.
Factor VII Deficiency
Hematology of experimental acute Sarcocystis bovicanis infection in calves. II. Serum biochemistry and hemostasis studies.
Factor VII Deficiency
Hemipelvectomy after severe pelvic injury in Factor VII deficiency toddler.
Factor VII Deficiency
Hemophagocytic lymphohistiocytosis and congenital factor VII deficiency: a case report.
Factor VII Deficiency
Hemophilia A and concurrent factor VII deficiency. Studies of a patient with complicating cardiac tamponade.
Factor VII Deficiency
Hemophilia B with associated factor VII deficiency: a distinct variant of hemophilia B with low factor VII activity and normal factor VII antigen.
Factor VII Deficiency
Hemorrhagic diathesis due to factor VII deficiency.
Factor VII Deficiency
Hemorrhagic stroke in a child with protein S and factor VII deficiencies.
Factor VII Deficiency
Hepatocyte transplantation for inherited factor VII deficiency.
Factor VII Deficiency
Hepatocyte transplantation for liver-based metabolic disorders.
Factor VII Deficiency
Hereditary bleeding disorders in Riyadh, Saudi Arabia.
Factor VII Deficiency
Hereditary factor VII deficiency and increased contact activation time.
Factor VII Deficiency
Hereditary factor VII deficiency in a Chinese family.
Factor VII Deficiency
Hereditary Factor VII deficiency in newborns.
Factor VII Deficiency
Hereditary factor VII deficiency in pregnancy: peripartum treatment with factor VII concentrate.
Factor VII Deficiency
Hereditary factor VII deficiency in the Alaskan Klee Kai dog.
Factor VII Deficiency
HEREDITARY FACTOR VII DEFICIENCY IN THE ASIAN ELEPHANT (ELEPHAS MAXIMUS) CAUSED BY A F7 MISSENSE MUTATION.
Factor VII Deficiency
Hereditary factor VII deficiency in two siblings: two different clinical presentation.
Factor VII Deficiency
Hereditary factor VII deficiency: heterogeneity defined by combined functional and immunochemical analysis.
Factor VII Deficiency
Hereditary factor VII deficiency: report of a case of intracranial hemorrhage.
Factor VII Deficiency
Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.
Factor VII Deficiency
Heterozygous factor VII deficiency and severe hemophilia A in the same kindred.
Factor VII Deficiency
Hip surgery in a patient with severe factor VII deficiency.
Factor VII Deficiency
Hobby-induced factor VII deficiency.
Factor VII Deficiency
Home treatment for patients with congenital bleeding disorders in a developing country.
Factor VII Deficiency
Homozygous 2bp deletion in the human factor VII gene: a non-lethal mutation that is associated with a complete absence of circulating factor VII.
Factor VII Deficiency
Homozygous congenital factor VII deficiency with a novel mutation, associated with severe spontaneous intracranial bleeding in a neonate.
Factor VII Deficiency
Human factor VII deficiency caused by S339C mutation located adjacent to the specificity pocket of the catalytic domain.
Factor VII Deficiency
Identification of two novel mutations in three children with congenital factor VII deficiency.
Factor VII Deficiency
Impact of Telemedicine Tools on Record Keeping and Compliance in Haemophilia Care.
Factor VII Deficiency
In vivo studies of the role of factor VII in hemostasis.
Factor VII Deficiency
Inadvertent propagation of factor VII deficiency in a canine mucopolysaccharidosis type I research breeding colony.
Factor VII Deficiency
Incidence of hereditary bleeding disorders in Bradford, UK: variation with ethnic group.
Factor VII Deficiency
Increase in the risk of ST elevation myocardial infarction is associated with homocysteine level.
Factor VII Deficiency
Increased volume of distribution for recombinant activated factor VII and longer plasma-derived factor VII half-life may explain their long lasting prophylactic effect.
Factor VII Deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
Factor VII Deficiency
Inherited bleeding disorders in the Eastern Province of Saudi Arabia.
Factor VII Deficiency
Inherited factor VII deficiency and surgery: clinical data are the best criteria to predict the risk of bleeding.
Factor VII Deficiency
Inherited factor VII deficiency: genetics and molecular pathology.
Factor VII Deficiency
Inherited factor VII deficiency: identification of two novel mutations (A191V and T239P) in the catalytic domain.
Factor VII Deficiency
Inherited factor VII deficiency: molecular genetics and pathophysiology.
Factor VII Deficiency
Inhibitor development after liver transplantation in congenital factor VII deficiency.
Factor VII Deficiency
Inhibitor development in patients with congenital factor VII deficiency, a study on 50 Iranian patients.
Factor VII Deficiency
Inhibitor in Congenital Factor VII Deficiency; a Rare but Serious Therapeutic Challenge-A Systematic Literature Review.
Factor VII Deficiency
Inhibitor to factor VII in severe factor VII deficiency: detection and course of the inhibitory response.
Factor VII Deficiency
Inhibitors to factor VII in congenital factor VII deficiency.
Factor VII Deficiency
Intracranial bleeding following soccer-related head trauma in a young student with occult factor VII deficiency.
Factor VII Deficiency
Intracranial hemorrhage in congenital factor VII deficiency.
Factor VII Deficiency
Invasive EEG-electrodes in presurgical evaluation of epilepsies: Systematic analysis of implantation-, video-EEG-monitoring- and explantation-related complications, and review of literature.
Factor VII Deficiency
Invasive procedures and minor surgery in factor VII deficiency.
Factor VII Deficiency
Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous?
Factor VII Deficiency
Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency.
Factor VII Deficiency
Ischemic strokes in congenital bleeding disorders: comparison with myocardial infarction and other acute coronary syndromes.
Factor VII Deficiency
Isolated acquired factor VII deficiency: review of the literature.
Factor VII Deficiency
Isolated factor VII deficiency diagnosed after a life-threatening brain haemorrhage.
Factor VII Deficiency
Isolation of hepatocytes from livers from non-heart-beating donors for cell transplantation.
Factor VII Deficiency
Isotypic analysis of antibodies against activated Factor VII in patients with Factor VII deficiency using the x-MAP technology.
Factor VII Deficiency
Japanese family with congenital factor VII deficiency.
Factor VII Deficiency
Kidney Transplant in a Patient With Factor VII Deficiency: Case Report.
Factor VII Deficiency
Laboratory evaluation of hemorrhagic coagulopathies in small animal practice.
Factor VII Deficiency
Lack of bleeding in patients with severe factor VII deficiency.
Factor VII Deficiency
Lethal factor VII deficiency due to novel mutations in the F7 promoter: Functional analysis reveals disruption of HNF4 binding site.
Factor VII Deficiency
Life-threatening bleeding in a case of autoantibody-induced factor VII deficiency.
Factor VII Deficiency
Life-threatening bleeding in a patient with a lupus inhibitor and probable acquired factor VII deficiency.
Factor VII Deficiency
Life-threatening bleeding in factor VII deficiency: the role of prenatal diagnosis and primary prophylaxis.
Factor VII Deficiency
Life-threatening menorrhagia secondary to Factor VII deficiency and leiomyomata.
Factor VII Deficiency
Liver after hepatocyte transplantation for liver-based metabolic disorders in children.
Factor VII Deficiency
Liver cell transplantation.
Factor VII Deficiency
Liver transplant for congenital factor VII deficiency.
Factor VII Deficiency
Liver transplantation for factor VII deficiency.
Factor VII Deficiency
Liver transplantation for treatment of severe S-adenosylhomocysteine hydrolase deficiency.
Factor VII Deficiency
Long-term follow-up of prophylaxis with recombinant activated factor VII in patients with congenital factor VII deficiency.
Factor VII Deficiency
Long-term prophylaxis in severe factor VII deficiency.
Factor VII Deficiency
Long-term successful percutaneous coronary intervention in factor VII deficiency.
Factor VII Deficiency
Low endoscopy bleeding risk in patients with congenital bleeding disorders.
Factor VII Deficiency
Lower extremity compartment syndrome in the setting of iliofemoral deep vein thrombosis, phlegmasia cerulea dolens and factor VII deficiency.
Factor VII Deficiency
Lower extremity salvage complicated by recurrent microvascular thrombosis in a patient with congenital factor VII deficiency.
Factor VII Deficiency
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B.
Factor VII Deficiency
Management of a patient with atrial fibrillation and factor VII deficiency.
Factor VII Deficiency
Management of a patient with Factor VII deficiency.
Factor VII Deficiency
Management of concomitant factor VII deficiency and Factor V Leiden mutation.
Factor VII Deficiency
Management of intracranial haemorrhage in a newborn with inherited factor VII deficiency with the use of rFVIIa aliquots.
Factor VII Deficiency
Management of intracranial surgery for refractory epilepsy in severe factor VII deficiency: choosing the optimal dosing regimen.
Factor VII Deficiency
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report.
Factor VII Deficiency
Management of Labour and Delivery in a Patient With Acquired Factor VII Deficiency With Inhibitor: A Case Report.
Factor VII Deficiency
Management of Pregnancy in a Chilean Patient with Congenital Deficiency of Factor VII and Glanzmann's Thrombasthenia Variant.
Factor VII Deficiency
Management of pregnancy in women with factor VII deficiency: A case series.
Factor VII Deficiency
Management of Surgical Third Lower Molar Extraction and Postoperative Progress in Patients With Factor VII Deficiency: A Clinical Protocol and Focus on This Rare Pathologic Entity.
Factor VII Deficiency
Managing incidentally diagnosed isolated factor VII deficiency perioperatively: a brief expert consensus report.
Factor VII Deficiency
Mechanism underlying factor VII deficiency in Jewish populations with the Ala244Val mutation.
Factor VII Deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Factor VII Deficiency
Menorrhagia caused by severe hereditary factor VII deficiency. Case 1.
Factor VII Deficiency
Migraine, cortical blindness, multiple cerebral infarctions and hypocoagulopathy in celiac disease.
Factor VII Deficiency
Mild factor VII deficiency due to heterozygosis is not associated with a bleeding tendency.
Factor VII Deficiency
Mitral valve surgery in severe congenital factor VII deficiency.
Factor VII Deficiency
Molecular analysis in a patient with severe factor VII deficiency and an inhibitor: report of a novel mutation (S103G).
Factor VII Deficiency
Molecular analysis of factor VII deficiency in Italy: a frequent mutation (FVII Lazio) in a repeated intronic region.
Factor VII Deficiency
Molecular analysis of Polish patients with factor VII deficiency.
Factor VII Deficiency
Molecular analysis of the genotype-phenotype relationship in factor VII deficiency.
Factor VII Deficiency
Molecular and clinical aspects of factor VII deficiency.
Factor VII Deficiency
Molecular basis of hereditary factor VII deficiency in India: five novel mutations including a double missense mutation (Ala191Glu; Trp364Cys) in 11 unrelated patients.
Factor VII Deficiency
Molecular biology and clinical manifestation of hereditary factor VII deficiency.
Factor VII Deficiency
Molecular characterisation and three-dimensional structural analysis of mutations in 21 unrelated families with inherited factor VII deficiency.
Factor VII Deficiency
Molecular characterization of four novel mutations causing factor VII deficiency.
Factor VII Deficiency
Molecular Characterization of Iranian Patients with Inherited Coagulation Factor VII Deficiency.
Factor VII Deficiency
Molecular defects in CRM+ factor VII deficiencies: modelling of missense mutations in the catalytic domain of FVII.
Factor VII Deficiency
Molecular determination of the breakpoints of a 161 556 bp deletion at chromosome 13q34 that presented as severe factor VII deficiency in a neonate.
Factor VII Deficiency
Molecular mechanisms of FVII deficiency: expression of mutations clustered in the IVS7 donor splice site of factor VII gene.
Factor VII Deficiency
Molecular variant of factor VII.
Factor VII Deficiency
Monitoring of hemostatic status in four patients being treated with recombinant factor VIIa.
Factor VII Deficiency
Multiple cerebral aneurysms in factor VII deficiency.
Factor VII Deficiency
Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
Factor VII Deficiency
Multiple extractions in a patient with factor VII deficiency.
Factor VII Deficiency
Multiple intracranial hemorrhages at the time of a transiently prolonged activated partial thromboplastin time in an infant with congenital factor VII deficiency.
Factor VII Deficiency
Mutation in the factor VII hepatocyte nuclear factor 4?-binding site contributes to factor VII deficiency.
Factor VII Deficiency
Mutation pattern in clinically asymptomatic coagulation factor VII deficiency.
Factor VII Deficiency
National survey of patients with hemophilia and other congenital bleeding disorders in Thailand.
Factor VII Deficiency
Natural and engineered carboxy-terminal variants: decreased secretion and gain-of-function result in asymptomatic coagulation factor VII deficiency.
Factor VII Deficiency
Neonatal intracranial hemorrhage secondary to congenital factor VII deficiency: two case reports.
Factor VII Deficiency
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®)).
Factor VII Deficiency
Next-generation sequencing and recombinant expression characterized aberrant splicing mechanisms and provided correction strategies in factor VII deficiency.
Factor VII Deficiency
Novel factor VII gene mutations in six families with hereditary coagulation factor VII deficiency.
Factor VII Deficiency
Novel IVS7+1G>T mutation of life-threatening congenital factor VII deficiency in neonates: A retrospective study in China.
Factor VII Deficiency
Obstetric analgesia and anaesthesia in women with inherited bleeding disorders.
Factor VII Deficiency
Occult hemophilia as a cause of postoperative and postpartum hemorrhage. With special reference to factor VII deficiency.
Factor VII Deficiency
Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
Factor VII Deficiency
Occurrence of hereditary leaky red cell syndrome and partial coagulation factor VII deficiency in a Spanish family.
Factor VII Deficiency
Off-Label Recombinant Factor VIIa Use and Thrombosis in Children: A Multi-center Cohort Study.
Factor VII Deficiency
Off-label use of rFVIIa in children with excessive bleeding: A consecutive study of 153 off-label uses in 139 children.
Factor VII Deficiency
On a case of-Christmas disease associated with factor VII deficiency.
Factor VII Deficiency
One-step chromogenic equivalent of activated partial thromboplastin time evaluated for clinical application.
Factor VII Deficiency
Open heart surgery with factor VII deficiency.
Factor VII Deficiency
Open-heart surgery in an infant with heterozygous factor VII deficiency.
Factor VII Deficiency
Orbital Compartment Syndrome Following Post-Traumatic Subgaleal Hematoma.
Factor VII Deficiency
Orthopaedic surgery in severe bleeding disorders: a low-volume, high-cost procedure.
Factor VII Deficiency
Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency.
Factor VII Deficiency
Outcome of laparoscopic ovariohysterectomy or ovariectomy in dogs with von Willebrand disease or factor VII deficiency: 20 cases (2012-2014).
Factor VII Deficiency
Palliative open heart surgery in an infant with factor VII deficiency.
Factor VII Deficiency
Paracetamol poisoning unmasking factor VII deficiency.
Factor VII Deficiency
Pathogenetic role of Factor VII deficiency and thrombosis in cross-reactive material positive patients.
Factor VII Deficiency
Pediatric cardiac intervention in a case of congenital factor VII deficiency: a challenge to overcome.
Factor VII Deficiency
Pediatric cardiac surgery under cardiopulmonary bypass in factor VII deficiency.
Factor VII Deficiency
Percutaneous Nephrolithotomy in Rare Bleeding Disorders: A Case Report and Review of the Literature.
Factor VII Deficiency
Peri-operative replacement therapy with factor VII concentrate in a patient with severe factor VII deficiency.
Factor VII Deficiency
Perioperative pharmacokinetics of factor VII concentrate during liver surgery in a patient with congenital factor VII deficiency: an individual mathematical model.
Factor VII Deficiency
Persistent uterine and vaginal hemorrhage in a beagle with factor VII deficiency.
Factor VII Deficiency
Pharmacokinetic evaluation of recombinant, activated factor VII in patients with inherited factor VII deficiency.
Factor VII Deficiency
Pharmacology and clinical use of recombinant activated factor seven in neurosciences.
Factor VII Deficiency
Phenotypic and genotypic characterization of Factor VII deficiency patients from Western India.
Factor VII Deficiency
Phenotypic and genotypic characterization of four factor VII deficiency patients from central China.
Factor VII Deficiency
Plasma thromboplastin antecedent (Factor XI) deficiency in a black family.
Factor VII Deficiency
Plummer-Vinson Syndrome With Concomitant Factor VII Deficiency.
Factor VII Deficiency
Point-of-Care Thromboelastography for Intrathecal Drain Management in Patients With Coagulopathy and Thoracic Aorta Surgery: A Case Report.
Factor VII Deficiency
Possible homozygous factor VIIR disorder associated with fibrinolytic hyperactivity.
Factor VII Deficiency
Posterior reversible encephalopathy syndrome (PRES) in pregnancy: a diagnostic challenge to obstetricians.
Factor VII Deficiency
Postoperative bleeding with factor VII deficiency: case report.
Factor VII Deficiency
Pregnancy in women with congenital factor VII deficiency.
Factor VII Deficiency
Prenatal diagnosis of severe factor VII deficiency using mutation detection and linkage analysis.
Factor VII Deficiency
Prenatal exclusion of severe factor VII deficiency by DNA sequencing.
Factor VII Deficiency
Prenatal exclusion of severe factor VII deficiency.
Factor VII Deficiency
Preparation of factor VII concentrate using CNBr-activated Sepharose 4B immunoaffinity chromatography.
Factor VII Deficiency
Prevalence of factor VII deficiency and molecular characterization of the F7 gene in Brazilian patients.
Factor VII Deficiency
Prevalence of HIV infection in a cohort of patients with congenital coagulation defects of the prothrombin complex factors.
Factor VII Deficiency
Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
Factor VII Deficiency
Prevention of Bleeding Complications in Neonates With Liver Failure Undergoing Surgery Using Recombinant Factor VIIa.
Factor VII Deficiency
Primary factor VII deficiency.
Factor VII Deficiency
Primary prophylaxis for children with severe congenital factor VII deficiency - Clinical and laboratory assessment.
Factor VII Deficiency
Prolongation of prothrombin time in the presence of rivaroxaban: is this the only cause?
Factor VII Deficiency
Prophylactic effect of recombinant factor VIIa with congenital factor VII deficiency.
Factor VII Deficiency
Prophylactic therapy in a pregnant woman with severe factor VII deficiency.
Factor VII Deficiency
Prophylactic treatment of a small child with severe factor VII deficiency using repeat dosing from a single vial of recombinant activated factor VII.
Factor VII Deficiency
Prophylactic treatment of hereditary severe factor VII deficiency in pregnancy.
Factor VII Deficiency
Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports.
Factor VII Deficiency
Prophylaxis in congenital factor VII deficiency: indications, efficacy and safety. Results from the Seven Treatment Evaluation Registry (STER).
Factor VII Deficiency
Prophylaxis of peripartum haemorrhage using recombinant factor VIIa (rfVIIa) in pregnant women with congenital factor VII deficiency: A case report and literature review.
Factor VII Deficiency
Prophylaxis with recombinant-activated factor VII (rFVIIa) for minimally invasive surgery in a patient with congenital factor VII deficiency: a case report with a single-low dose of rFVIIa.
Factor VII Deficiency
Prophylaxis with rFVIIa before third molar extraction in a patient with factor VII deficiency.
Factor VII Deficiency
Prostate surgery in severe congenital factor VII deficiency: A case report.
Factor VII Deficiency
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
Factor VII Deficiency
Prothrombin complex concentrate for factor VII replacement in a patient undergoing left ventricular assist device implantation with factor VII deficiency.
Factor VII Deficiency
Psychosocial Impact and Disease Management in Patients with Congenital Factor VII Deficiency.
Factor VII Deficiency
Pulmonary embolism in a patient with mild factor VII deficiency after administration of recombinant activated factor VII during a urological procedure.
Factor VII Deficiency
Radiographic abnormalities in coagulation factor VII deficiency.
Factor VII Deficiency
Rare bleeding disorders: spectrum of disease and clinical manifestations in the Pakistani population.
Factor VII Deficiency
Rare factor VII variant inherited through genetic variant in proband's mother and another genetic variant in proband's father.
Factor VII Deficiency
Rare inherited coagulation disorders in India.
Factor VII Deficiency
Rational Use of Recombinant Factor VIIa in Clinical Practice.
Factor VII Deficiency
Recombinant activated factor VII (rFVIIa, NovoSeven).
Factor VII Deficiency
Recombinant activated factor VII for a patient with factor VII deficiency undergoing urgent intracerebral haematoma evacuation with underlying cavernous angioma.
Factor VII Deficiency
Recombinant activated factor VII in clinical practice: a 2014 update.
Factor VII Deficiency
Recombinant activated factor VII: mechanisms of action and current indications.
Factor VII Deficiency
Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.
Factor VII Deficiency
Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders.
Factor VII Deficiency
Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.
Factor VII Deficiency
Recombinant factor VIIa for long-term replacement therapy in patients with congenital factor VII deficiency.
Factor VII Deficiency
Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
Factor VII Deficiency
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Factor VII Deficiency
Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
Factor VII Deficiency
Recombinant factor VIIa for treatment of a child with severe factor VII deficiency and coarctation of the aorta.
Factor VII Deficiency
Recombinant factor VIIa prophylaxis in a patient with severe congenital factor VII deficiency.
Factor VII Deficiency
Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery.
Factor VII Deficiency
Recombinant factor VIIa: a universal hemostatic agent?
Factor VII Deficiency
Recombinant, activated factor VII for surgery in factor VII deficiency: a prospective evaluation - the surgical STER.
Factor VII Deficiency
Recurrent Bleedings in Newborn: A Factor VII Deficiency Case Report.
Factor VII Deficiency
Recurrent intracranial hemorrhage in an infant with congenital factor VII deficiency.
Factor VII Deficiency
Recurrent mutations and genotype-phenotype correlations in hereditary factor VII deficiency in Korea.
Factor VII Deficiency
Recurrent pre-retinal haemorrhages associated with coagulation factor VII deficiency.
Factor VII Deficiency
Regulatory polymorphisms underlying complex disease traits.
Factor VII Deficiency
Repair of abdominal aortic aneurysm in severe Factor VII deficiency.
Factor VII Deficiency
Repeated recombinant activated factor VII administration in a patient with congenital factor VII deficiency undergoing modified radical hysterectomy: a case report.
Factor VII Deficiency
Replacement therapy for bleeding episodes in factor VII deficiency. A prospective evaluation.
Factor VII Deficiency
Replacement therapy in inherited factor VII deficiency: occurrence of adverse events and relation with surgery.
Factor VII Deficiency
Residual factor VII activity and different hemorrhagic phenotypes in CRM(+) factor VII deficiencies (Gly331Ser and Gly283Ser).
Factor VII Deficiency
Resistance to activated protein C: evaluation of three functional assays.
Factor VII Deficiency
Response to treatment and adverse events associated with use of recombinant activated factor VII in children: a retrospective cohort study.
Factor VII Deficiency
Segmental liver transplantation from non-heart beating donors-an early experience with implications for the future.
Factor VII Deficiency
Selection of replacement therapy for patients with severe factor VII deficiency.
Factor VII Deficiency
Sensitivities of thromboplastins to factor VII deficiency.
Factor VII Deficiency
Sensitivity of different prothrombin time assays to factor VII deficiency in canine plasma.
Factor VII Deficiency
Sensitivity of different thromboplastin reagents to factor VII deficiency in the blood of beagle dogs.
Factor VII Deficiency
Serendipitous Discovery of Factor VII Deficiency and the Ensuing Dilemma.
Factor VII Deficiency
Severe arterial thrombosis in a congenitally factor VII deficient patient.
Factor VII Deficiency
Severe coagulation factor VII deficiency caused by a novel homozygous mutation (p. Trp284Gly) in loop 140s.
Factor VII Deficiency
Severe congenital Factor VII deficiency associated with the 13q deletion syndrome.
Factor VII Deficiency
Severe Congenital Factor VII Deficiency with Normal Perioperative Coagulation Profile Based on ROTEM Analysis in a Hepatectomy.
Factor VII Deficiency
Severe factor VII deficiency caused by a novel mutation His348 to Gln in the catalytic domain.
Factor VII Deficiency
Severe factor VII deficiency caused by a novel point mutation (Arg353Pro) combined with a rare Cys22Arg mutation.
Factor VII Deficiency
Severe factor VII deficiency caused by mutations abolishing the cleavage site for activation and altering binding to tissue factor.
Factor VII Deficiency
Severe factor VII deficiency due to a mutation disrupting a hepatocyte nuclear factor 4 binding site in the factor VII promoter.
Factor VII Deficiency
Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter.
Factor VII Deficiency
Severe factor VII deficiency with recurrent intracranial haemorrhages owing to double heterozygosity for a splice site mutation of an IVS4 and a novel nonsense mutation in exon 8 (Gln211-->Term).
Factor VII Deficiency
Severe menorrhagia due to factor VII deficiency successfully treated by thermal balloon endometrial ablation.
Factor VII Deficiency
Significance and causes of abnormal preoperative coagulation test results in children.
Factor VII Deficiency
Spectrum of factor X gene mutations in Iranian patients with congenital factor X deficiency.
Factor VII Deficiency
Spontaneous chronic subdural hematoma in young adult: the role of missing coagulation facto.
Factor VII Deficiency
Spontaneous hemorrhage after external ventricular drain placement in the setting of low factor VII secondary to liver cirrhosis.
Factor VII Deficiency
Spontaneous umbilical cord haematoma and congenital factor VII deficiency.
Factor VII Deficiency
Steps towards an effective treatment strategy in congenital factor VII deficiency.
Factor VII Deficiency
Studies on a family with the factor VII defect.
Factor VII Deficiency
Studies on immunological assay of vitamin K dependent factors. I. Measurement of factor VII antigen by radioimmunoassay.
Factor VII Deficiency
Study of different factor VII deficiency variants in nine families from Spain.
Factor VII Deficiency
Subdural Hematoma From an Acquired Factor VII Deficiency: Is It the Lupus or the Anticoagulant?
Factor VII Deficiency
Subgaleal hematoma with delayed proptosis and corneal ulceration.
Factor VII Deficiency
Substitution therapy of congenital factor VII deficiency at an extended operation with extracorporeal circulation.
Factor VII Deficiency
Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
Factor VII Deficiency
Successful coronary artery bypass graft surgery in severe congenital factor VII deficiency: Perioperative treatment with factor VII concentrate.
Factor VII Deficiency
Successful coronary artery bypass graft surgery in severe congenital factor VII deficiency: Perioperative treatment with pd-factor VII concentrate.
Factor VII Deficiency
Successful excision of hemorrhagic cavernous angioma in a patient with severe factor VII deficiency: perioperative treatment with factor VII concentrate.
Factor VII Deficiency
Successful management of maternal factor VII deficiency in a cesarean section.
Factor VII Deficiency
Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency.
Factor VII Deficiency
Successful prophylaxis of intracranial hemorrhage in infants with severe congenital factor VII deficiency.
Factor VII Deficiency
Successful short-term oral surgery prophylaxis with rFVIIa in severe congenital factor VII deficiency.
Factor VII Deficiency
Successful Splenectomy Management in a Patient With Moderate Factor VII Deficiency and Concomitant Severe Hereditary Spherocytosis.
Factor VII Deficiency
Successful treatment of hereditary factor VII deficiency presented for the first time with epistaxis in pregnancy: a case report.
Factor VII Deficiency
Successful treatment of mixed-type autoimmune hemolytic anemia with rituximab in a child following liver transplantation.
Factor VII Deficiency
Successful use of rFVIIa for major breast surgery prophylaxis in congenital factor VII deficiency.
Factor VII Deficiency
Successful use of rFVIIa for major breast surgery prophylaxis in congenital factor VII deficiency: a case report.
Factor VII Deficiency
Surgery for scoliosis in congenital factor VII deficiency.
Factor VII Deficiency
SURGERY IN PATIENTS WITH CONGENITAL FACTOR VII DEFICIENCY (CONGENITAL HYPOPROCONVERTINEMIA). EXPERIENCE WITH ONE CASE AND REVIEW OF THE LITERATURE.
Factor VII Deficiency
Surgery in patients with congenital factor VII deficiency - a single center study.
Factor VII Deficiency
Surgery in patients with congenital factor VII deficiency: A single center experience.
Factor VII Deficiency
Surgical Aortic Valve Replacement in an Adult Patient With Congenital Factor VII Deficiency: A Case Report of Perioperative Coagulation Management.
Factor VII Deficiency
Surgical interventions in childhood rare factor deficiencies: a single-center experience from Turkey.
Factor VII Deficiency
Synergistic effect of factor VII gene polymorphisms causing mild factor VII deficiency in a case of severe factor X deficiency.
Factor VII Deficiency
Synovectomy for haemophilic arthropathy: 6-21 years of follow-up in 16 patients.
Factor VII Deficiency
Synovectomy of the elbow in a patient with factor VII deficiency (hypoconvertinemia).
Factor VII Deficiency
Takayasu Arteritis Presenting as Renovascular Hypertension and Renal Failure in a Patient with Factor VII Deficiency.
Factor VII Deficiency
The clinical and laboratory significance of cases of congenital FX deficiency due to defects in the Gla-domain.
Factor VII Deficiency
The clotting action of Russell viper venom. 1954.
Factor VII Deficiency
The congenital factor VII abnormalities (dysproconvertinemias). The genetic plot thickens.
Factor VII Deficiency
The importance of tissue factor source in the management of Factor VII deficiency.
Factor VII Deficiency
The K-test (trypsin clotting time) in coumarin treated patients and in congenital deficiencies and abnormalities of the prothrombin complex.
Factor VII Deficiency
The paradoxical association between inherited factor VII deficiency and venous thrombosis.
Factor VII Deficiency
The role of tissue factor in the production of thrombin.
Factor VII Deficiency
The significance of published polymorphisms in 14 cases of mild factor VII deficiency.
Factor VII Deficiency
The spectrum of factor VII deficiencies and abnormalities.
Factor VII Deficiency
The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding.
Factor VII Deficiency
The use of recombinant activated factor VII in congenital and acquired factor VII deficiencies.
Factor VII Deficiency
The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
Factor VII Deficiency
The use of recombinant activated factor VII in three patients with central nervous system hemorrhages associated with factor VII deficiency.
Factor VII Deficiency
Thromboelastographic monitoring of the efficacy of recombinant factor VIIa administration in a parturient with factor VII deficiency.
Factor VII Deficiency
Thromboembolism in congenital factor VII deficiency.
Factor VII Deficiency
Thromboembolism in patients with hereditary deficiency of coagulation factors.
Factor VII Deficiency
Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency.
Factor VII Deficiency
Thrombosis in inherited factor VII deficiency.
Factor VII Deficiency
Thrombosis: a study of coagulation parameters and mechanisms during allograft rejection.
Factor VII Deficiency
Tissue factor pathway inhibitor activity in factor VII deficiency.
Factor VII Deficiency
Total hip arthroplasty in severe congenital factor VII deficiency: successful use of recombinant activated factor VII for hemostasis.
Factor VII Deficiency
Transmission of factor VII deficiency through liver transplantation.
Factor VII Deficiency
Treatment of congenital factor VII deficiency with a new concentrate.
Factor VII Deficiency
Treatment of factor VII deficiency with recombinant factor VIIa.
Factor VII Deficiency
Treatment of factor XI inhibitor using recombinant activated factor VIIa.
Factor VII Deficiency
Triple coronary artery bypass graft surgery in a patient with factor VII deficiency: a case report.
Factor VII Deficiency
Twenty two novel mutations of the factor VII gene in factor VII deficiency.
Factor VII Deficiency
Two novel cases of cerebral haemorrhages at the neonatal period associated with inherited factor VII deficiency, one of them revealing a new nonsense mutation (Ser52Stop).
Factor VII Deficiency
Two novel factor VII gene mutations in a Chinese family with factor VII deficiency.
Factor VII Deficiency
Two novel mutations in severe factor VII deficiency.
Factor VII Deficiency
Two typical hereditary charts of congenital factor VII deficiency.
Factor VII Deficiency
Two-incision laparoscopic appendectomy for a severe hemophilia A child patient with coagulation factor VII deficiency: Case report and review of literature.
Factor VII Deficiency
U1-snRNA-mediated rescue of mRNA processing in severe factor VII deficiency.
Factor VII Deficiency
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency.
Factor VII Deficiency
Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
Factor VII Deficiency
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
Factor VII Deficiency
Use of global assays to understand clinical phenotype in congenital factor VII deficiency.
Factor VII Deficiency
Use of recombinant factor VII for tooth extractions in a patient with severe congenital factor VII deficiency: a case report.
Factor VII Deficiency
Use of recombinant factor VIIa in hereditary bleeding disorders.
Factor VII Deficiency
Use of recombinant factor VIIa in surgery in factor-VII-deficient patients.
Factor VII Deficiency
Use of recombinant, activated factor VII in the treatment of congenital factor VII deficiencies.
Factor VII Deficiency
Using a minigene approach to characterize a novel splice site mutation in human F7 gene causing inherited factor VII deficiency in a Chinese pedigree.
Factor VII Deficiency
Vena porta thrombosis in patient with inherited factor VII deficiency.
Factor VII Deficiency
Visually Disabling Non-Traumatic Orbital Hemorrhage in an Anticoagulated Patient with Factor VII Deficiency.
Factor VII Deficiency
Warfarin-induced factor VII deficiency and the bleeding time.
Factor VII Deficiency
Whole-exome sequencing provides insights into monogenic disease prevalence in Northwest Russia.
Factor VII Deficiency
Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
Factor VII Deficiency
[A case of congenital factor VII deficiency (author's transl)]
Factor VII Deficiency
[A case of congenital hemorrhagic diathesis due to factor VII deficiency (hypoproconvertinemia)]
Factor VII Deficiency
[A family of congenital factor VII deficiency (author's transl)]
Factor VII Deficiency
[A new case of homozygous congenital factor VII deficiency. Associated factor X deficiency in some members of the family]
Factor VII Deficiency
[A Quebec family with factor VII deficiency]
Factor VII Deficiency
[Acquired and repeated factor VII deficiency during infections outbreaks: case-report]
Factor VII Deficiency
[Acquired factor VII deficiency]
Factor VII Deficiency
[Acquired isolated factor VII deficiency and bronchogenic carcinoma. A case report]
Factor VII Deficiency
[An acquired isolated transitory factor VII deficiency]
Factor VII Deficiency
[An inherited coagulation factor VII deficiency pedigree caused by homozygous mutation of His348Gln].
Factor VII Deficiency
[Anaesthetic management of a parturient with a severe factor VII deficiency: was activated factor VII really necessary?].
Factor VII Deficiency
[Analysis of a Chinese pedigree affected with hereditary factor VII deficiency caused by compound heterozygous variants of F7 gene].
Factor VII Deficiency
[Analysis of an inherited FVII deficiency pedigree caused by homozygosity of Thr359Met]
Factor VII Deficiency
[Anesthesia and coagulation factor VII deficiency]
Factor VII Deficiency
[Anesthesia and factor VII deficiency]
Factor VII Deficiency
[Anesthesia in a patient with hereditary factor VII deficiency]
Factor VII Deficiency
[Anesthesia in congenital factor VII deficiency]
Factor VII Deficiency
[Application of heat-treated factor VII concentrates in a patient with congenital factor VII deficiency during labor]
Factor VII Deficiency
[Assay of factor VII antigen by enzyme-linked immunosorbent assay (ELISA)]
Factor VII Deficiency
[Bleeding after cardiac surgery: the role of recombinant factor VIIa]
Factor VII Deficiency
[Blood transfusion as substitution therapy in factor V- and factor VII deficiency.]
Factor VII Deficiency
[Case of congenital factor VII deficiency]
Factor VII Deficiency
[Case of factor VII deficiency with systemic amyloidosis having a unique clinical course such as splenic rupture]
Factor VII Deficiency
[Classical factor VII deficiency: biological and genetic evaluation of 3 families]
Factor VII Deficiency
[Clinical and blood coagulation studies in patients with congenital factor VII deficiency]
Factor VII Deficiency
[Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group.]
Factor VII Deficiency
[Clinical studies of familial hereditary factor VII deficiency (author's transl)]
Factor VII Deficiency
[Coagulation factor VII deficiency in 3 patients with trisomy 8]
Factor VII Deficiency
[Coagulation factor VII deficiency in a chronic carrier of the B virus]
Factor VII Deficiency
[Concurrent obstetric disease and ischemic ictus in 2 cases with moderated factor VII deficiency]
Factor VII Deficiency
[Congenital factor VII deficiency (author's transl)]
Factor VII Deficiency
[Congenital factor VII deficiency and subarachnoidal haemorrhage due to intracranial aneurysm: a case report]
Factor VII Deficiency
[Congenital factor VII deficiency as a cause of obstetrical and gynecological hemorrhages]
Factor VII Deficiency
[Congenital factor VII deficiency associated with idiopathic osteopsathyrosis of Lobstein type.]
Factor VII Deficiency
[Congenital factor VII deficiency revealed by post-circumcision bleeding].
Factor VII Deficiency
[Congenital factor VII deficiency. Report of 4 cases]
Factor VII Deficiency
[Congenital factor VII deficiency: about two family cases].
Factor VII Deficiency
[Congenital factor VII deficiency; family investigation and physiological studies on factor VII.]
Factor VII Deficiency
[Congenital factor VII deficiency]
Factor VII Deficiency
[Congenital hypoproconvertinemia; case of congenital factor VII deficiency and brief review of literature.]
Factor VII Deficiency
[Contribution to the clinical picture of congenital factor VII deficiency]
Factor VII Deficiency
[Differential diagnosis of factor VII deficiency in the newborn.]
Factor VII Deficiency
[Double heterozygous mutations of non-canonical splice (IVS1a + 5g > a) and His348Gln caused inherited coagulation factor VII deficiency]
Factor VII Deficiency
[Efficacy of Recombinant Activated Factor VII for Intractable Bleeding after Cardiovascular Surgery].
Factor VII Deficiency
[Epistaxis due to coagulation disorder in factor VII deficiency.]
Factor VII Deficiency
[Factor VII deficiency and homocystinuria. Chance association or syndrome?]
Factor VII Deficiency
[Factor VII deficiency and surgery: infusion of fresh-frozen plasma in a case report]
Factor VII Deficiency
[Factor VII deficiency and surgery: is preoperative replacement necessary?]
Factor VII Deficiency
[Factor VII deficiency and surgery]
Factor VII Deficiency
[Factor VII deficiency revealed by intracranial hemorrhage.]
Factor VII Deficiency
[Factor VII deficiency--case report]
Factor VII Deficiency
[Factor VII deficiency. Preparation for surgical intervention]
Factor VII Deficiency
[Factor VII deficiency]
Factor VII Deficiency
[Gastrectomy for a patient with congenital factor VII deficiency--a case report]
Factor VII Deficiency
[Gastrectomy in congenital factor VII deficiency with substitution of factor VII concentrate]
Factor VII Deficiency
[Gene diagnosis of antithrombin deficiency and factor VII deficiency]
Factor VII Deficiency
[Genetic analysis of hereditary factor VII deficiency from a Chinese pedigree]
Factor VII Deficiency
[Genetic diagnosis of hereditary coagulation disorders]
Factor VII Deficiency
[Genotype and phenotype analysis of congenital coagulator factor VII deficiency in four Chinese pedigrees].
Factor VII Deficiency
[Haplotype Analysis of Coagulation Factor VII Gene in a Patient with Congenital Coagulation Factor VII Deficiency with Heterozygous p.Arg337Cys Mutation and o.Aro413Gin Polymorphism..]
Factor VII Deficiency
[Hemorrhage from the palatal tonsils in the course of angina in a child with factor VII deficiency]
Factor VII Deficiency
[Hemorrhagic diathesis due to factor VII deficiency (hypoproconvertinemia).]
Factor VII Deficiency
[Hemostasis anomalies and prognosis during severe infectious purpura in children. Retrospective study in 69 cases]
Factor VII Deficiency
[Hereditary coagulation factor VII deficiency in a case]
Factor VII Deficiency
[Hereditary heterozygote factor VII deficiency]
Factor VII Deficiency
[Hereditary heterozygous factor VII deficiency in patients undergoing surgery : Clinical relevance].
Factor VII Deficiency
[Homocystinuria and factor VII deficiency]
Factor VII Deficiency
[Homocystinuria. A type with vascular thrombosis and factor VII deficiency]
Factor VII Deficiency
[Inherited bleeding disorders common in Jews].
Factor VII Deficiency
[Inherited coagulation factor VII deficiency caused by double heterozygotic mutations Arg304Gln and Arg304Trp]
Factor VII Deficiency
[Inherited factor VII deficiency and pregnancy. Apropos of 1 case]
Factor VII Deficiency
[Intracranial hemorrhage in an infant with congenital factor VII deficiency]
Factor VII Deficiency
[Isolated acquired factor VII deficiency in patient with severe head trauma: use of factor VII (factor VII-LFB]
Factor VII Deficiency
[Liver cirrhosis with factor VII deficiency: a case report and literature review].
Factor VII Deficiency
[Molecular genetic analysis for a pedigree with severe hereditary coagulation factor VII deficiency]
Factor VII Deficiency
[Mutation analysis and prenatal diagnosis for a family affected with congenital factor VII deficiency].
Factor VII Deficiency
[Novel double heterozygous mutations on Met306Val and Thr181Asn related to a hereditary coagulation factor VII deficiency]
Factor VII Deficiency
[On a case of Christmas disease associated with factor VII deficiency.]
Factor VII Deficiency
[Panorama of congenital disorders of hemostasis diseases at University Hospital of Brazzaville, Congo]
Factor VII Deficiency
[Postpartum haemorrhage and factor VII deficiency].
Factor VII Deficiency
[Practical approaches for surgical procedures in congenital factor VII deficiency]
Factor VII Deficiency
[Pregnancy and delivery in a case with congenital factor VII deficiency]
Factor VII Deficiency
[Pregnancy and labor in severe hereditary factor VII deficiency]
Factor VII Deficiency
[Primary biliary cirrhosis combined with factor VII deficiency: a case report]
Factor VII Deficiency
[Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
Factor VII Deficiency
[Recombinant activated factor VII in paediatric practice. Universal hemostatic agent?]
Factor VII Deficiency
[Recurrent intracranial hemorrhage in a nursing infant with congenital factor VII deficiency. Survival and follow-up after neurosurgical intervention]
Factor VII Deficiency
[Significant decrease in factor VII activity by tissue thromboplastin derived from rabbit brain in a patient with congenital factor VII deficiency (FVII Padua)].
Factor VII Deficiency
[Studies on inherited coagulation factor VII deficiency and tissue factor abnormality in a pedigree]
Factor VII Deficiency
[Subcutaneous hematomas, reduced Quick value. Factor VII deficiency]
Factor VII Deficiency
[Successful gastric resection in a male patient with factor VII deficiency and telangiectasia]
Factor VII Deficiency
[The change and significance of coagulation activity in bleomycin-induced lung fibrosis in rats]
Factor VII Deficiency
[The influence of factor VII deficiency on cardiac operations with extracorporeal circulation]
Factor VII Deficiency
[Variants of factor VII deficiency]
Factor X Deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Factor X Deficiency
A NlaIII polymorphism within the human factor VII gene.
Factor X Deficiency
A rare inherited coagulation disorder: combined homozygous factor VII and factor X deficiency.
Factor X Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor X Deficiency
Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Report of a new association and its possible relationship to endothelial cell injury.
Factor X Deficiency
Clinical analysis of six cases of multiple myeloma first presenting with coagulopathy.
Factor X Deficiency
Clinical audit of inherited bleeding disorders in a developing country.
Factor X Deficiency
Congenital bleeding disorders of the vitamin K-dependent clotting factors.
Factor X Deficiency
Diagnostic Error of a Patient with Combined Inherited Factor VII and Factor X Deficiency due to Accidental Ingestion of a Diphacinone Rodenticide.
Factor X Deficiency
Factor VII and factor X deficiency in a child with a chromosome 13q duplication and deletion.
Factor X Deficiency
Frequencies of mild factor V, VII and X deficiencies in a Japanese population.
Factor X Deficiency
Haemoperitoneum associated with ovulation in women with bleeding disorders: the case for conservative management and the role of the contraceptive pill.
Factor X Deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
Factor X Deficiency
Inherited bleeding disorders in the Eastern Province of Saudi Arabia.
Factor X Deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Factor X Deficiency
Rare inherited coagulation disorders in India.
Factor X Deficiency
Recombinant human factor VIIa in the management of amyloid-associated factor X deficiency.
Factor X Deficiency
Successful perioperative management of factor X deficiency associated with primary amyloidosis.
Factor X Deficiency
Synergistic effect of factor VII gene polymorphisms causing mild factor VII deficiency in a case of severe factor X deficiency.
Factor X Deficiency
The K-test (trypsin clotting time) in coumarin treated patients and in congenital deficiencies and abnormalities of the prothrombin complex.
Factor X Deficiency
[A new case of homozygous congenital factor VII deficiency. Associated factor X deficiency in some members of the family]
Factor X Deficiency
[Factors VII, VIII, IX, and X: molecular genetics and gene diagnosis]
Factor X Deficiency
[Gene analysis of a combined inherited factor VII and factor X deficiency pedigree].
Factor X Deficiency
[The change and significance of coagulation activity in bleomycin-induced lung fibrosis in rats]
Factor XI Deficiency
A novel congenital haemostatic defect: combined factor VII and factor XI deficiency.
Factor XI Deficiency
Activated factor IX-antithrombin III complexes in human blood: quantification by an enzyme-linked differential antibody immunoassay and determination of the in vivo half-life.
Factor XI Deficiency
Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency.
Factor XI Deficiency
An illustrative case and a review on the dosing of recombinant factor VIIa in congenital factor XI deficiency.
Factor XI Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor XI Deficiency
Arterial and venous thrombosis in rare congenital bleeding disorders: a critical review.
Factor XI Deficiency
Changes in haemostasis and thrombosis associated with thyroid disease: Presentation of 2 cases.
Factor XI Deficiency
Characterization of combined factor VII and factor XI deficiencies.
Factor XI Deficiency
Clinical and laboratory features of 178 children with recurrent epistaxis.
Factor XI Deficiency
Descriptive epidemiology of hemophilia and other coagulation disorders in mansoura, egypt: retrospective analysis.
Factor XI Deficiency
Factor IX is activated in vivo by the tissue factor mechanism.
Factor XI Deficiency
Factor XII deficiency acquired by orthotopic liver transplantation: case report and review of the literature.
Factor XI Deficiency
Low endoscopy bleeding risk in patients with congenital bleeding disorders.
Factor XI Deficiency
Lower doses of rFVIIa therapy are safe and effective for surgical interventions in patients with severe FXI deficiency and inhibitors.
Factor XI Deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Factor XI Deficiency
Monitoring low dose recombinant factor VIIa therapy in patients with severe factor XI deficiency undergoing surgery.
Factor XI Deficiency
Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
Factor XI Deficiency
Obstetric analgesia and anaesthesia in women with inherited bleeding disorders.
Factor XI Deficiency
Perioperative use of modified thrombelastography in factor XI deficiency: a helpful method to assess drug effects.
Factor XI Deficiency
Recombinant factor VIIa for the prophylaxis of perioperative hemorrhage in a patient with congenital factor XI deficiency undergoing brain tumor neurosurgery.
Factor XI Deficiency
Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
Factor XI Deficiency
Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with congenital factor XI deficiency.
Factor XI Deficiency
Successful use of recombinant factor VIIa in a patient with inhibitor secondary to severe factor XI deficiency.
Factor XI Deficiency
The rare inherited coagulation disorders.
Factor XI Deficiency
The role of recombinant factor VIIa for obstetric block in women with severe factor XI deficiency.
Factor XI Deficiency
The use of recombinant factor VIIa (NovoSeven) in a patient with a factor XI deficiency and a circulating anticoagulant.
Factor XI Deficiency
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
Factor XI Deficiency
Use of recombinant factor VIIa for hip replacement surgery in a patient with severe factor XI deficiency and drug-induced platelet defect.
Factor XI Deficiency
[Inherited bleeding disorders common in Jews].
Factor XI Deficiency
[Use of recombinant, activated Factor VII in the treatment and prevention of bleeding complications in two female patients suffering from congenital XI factor deficiency during orthopedic and traumatology intervention. Case reports]
Factor XII Deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
Factor XII Deficiency
Resistance to activated protein C: evaluation of three functional assays.
Factor XIII Deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Factor XIII Deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Factor XIII Deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
Factor XIII Deficiency
Clinical audit of inherited bleeding disorders in a developing country.
Factor XIII Deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
Factor XIII Deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Factor XIII Deficiency
Rare inherited coagulation disorders in India.
Factor XIII Deficiency
Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
Familial Mediterranean Fever
Glomerulitis and factor vii deficiency in Familial Mediterranean fever.
Fatty Liver
Liver steatosis and its relation to plasma haemostatic factors in apparently healthy men--role of the metabolic syndrome.
Fatty Liver
Preliminary experience with use of recombinant activated factor VII to control postpartum hemorrhage in acute fatty liver of pregnancy and other pregnancy-related liver disorders.
Fatty Liver
Recombinant activated factor VII in the management of acute fatty liver of pregnancy: A case report.
Fatty Liver
Use of FloSeal hemostatic matrix in a patient with severe postpartum hemorrhage.
Fetal Death
Factor VIIa treatment of DIC as a clinical manifestation of amniotic fluid embolism in a patient with fetal demise.
Fibroma
Genetic deficiency of factor VII and hemorrhagic diathesis. A case report and literature review.
Fibrosarcoma
The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
Gallstones
Continuous infusion of human prothrombin complex in a patient with congenital factor VII deficiency undergoing laparoscopic cholecystectomy: A case report from China.
Gastrointestinal Hemorrhage
Novel IVS7+1G>T mutation of life-threatening congenital factor VII deficiency in neonates: A retrospective study in China.
Gastrointestinal Hemorrhage
Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Gastrointestinal Hemorrhage
Recombinant activated factor VIIa to treat refractory lower gastrointestinal hemorrhage in a patient with recently implanted mechanical valve: a case report.
Gastrointestinal Hemorrhage
Recombinant factor VIIa for severe gastrointestinal hemorrhage associated with Crohn disease.
Gastrointestinal Hemorrhage
Recombinant factor VIIa for treatment of gastrointestinal hemorrhage following rattlesnake envenomation.
Gastrointestinal Hemorrhage
Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven).
Gastrointestinal Hemorrhage
Transfusion Interventions in Critical Bleeding Requiring Massive Transfusion: A Systematic Review.
Genetic Diseases, Inborn
Diagnosis and treatment discussion of congenital factor VII deficiency in pregnancy: A case report.
Genetic Diseases, Inborn
[Congenital factor VII deficiency revealed by post-circumcision bleeding].
Genetic Diseases, Inborn
[Factor VII deficiency revealed by intracranial hemorrhage.]
Gingivitis
Total Extraction as a Treatment for Anaemia in a Patient of Glanzmann's Thrombasthenia with Chronic Gingival Bleed: Case Report.
Glioblastoma
Successful treatment of recurrent preoperative bleeding of glioblastoma with recombinant activated factor VII: pathophysiological hypothesis.
Glioblastoma
Transcriptional program induced by factor VIIa-tissue factor, PAR1 and PAR2 in MDA-MB-231 cells.
Glioma
EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma.
Glioma
Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.
Glioma
Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging.
Glioma
Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.
Glioma
VEGF Expression in Human Glioma Cells Treated with Tissue Factor and FVIIa.
Glioma
Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody.
Glucose Intolerance
Effects of dietary fat modification on fibrinogen, factor VII, and plasminogen activator inhibitor-1 activity in subjects with impaired glucose tolerance.
Glucose Intolerance
Hyperinsulinemia, hyperglycemia, and impaired hemostasis: the Framingham Offspring Study.
Glycogen Storage Disease
Hepatocyte transplantation for liver-based metabolic disorders.
Glycogen Storage Disease
Liver cell transplantation.
Graves Disease
A case presenting concurrence of Marfan syndrome, Basedow's disease and Arg353Gln polymorphism-related factor VII deficiency.
Heart Arrest
Case report: Intraoperative thrombosis cardiac arrest in extended right hepatectomy involving use of local haemostatic agent in intraoperative cell salvage (ICS) and administration of recombinant activated factor VII (rFVIIa).
Heart Arrest
Factor VIIa treatment of DIC as a clinical manifestation of amniotic fluid embolism in a patient with fetal demise.
Heart Arrest
Thrombogenic side-effects of recombinant factor VIIa after use in coronary artery bypass surgery.
Heart Defects, Congenital
An evaluation of eptacog alfa in nonhaemophiliac conditions.
Heart Defects, Congenital
Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy.
Heart Defects, Congenital
Factor VII for excessive bleeding following congenital heart disease surgery.
Heart Defects, Congenital
Recombinant factor VII for severe bleeding during extracorporeal membrane oxygenation following open heart surgery.
Heart Defects, Congenital
Recombinant factor VIIa (NovoSeven) as a hemostatic agent after surgery for congenital heart disease.
Heart Defects, Congenital
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Heart Defects, Congenital
rFVIIa in the treatment of persistent hemorrhage in pediatric patients on ECMO following surgery for congenital heart disease.
Heart Defects, Congenital
Severe deficiency of coagulation Factor VII results in spontaneous cardiac fibrosis in mice.
Heart Defects, Congenital
Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage.
Heart Defects, Congenital
Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with congenital factor XI deficiency.
Heart Defects, Congenital
Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
Heart Defects, Congenital
Use of Recombinant Activated Factor VII for Controlling Refractory Postoperative Bleeding in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass.
Heart Defects, Congenital
[New possibilities in the postoperative measures to prevent bleeding in cardiac surgery. Will the recombinant activated factor VII improve surgical results?]
Heart Diseases
Activity of factor VIIa and von Willebrand factor in non-insulin-dependent diabetic subjects with coronary artery disease.
Heart Diseases
Assay of factor VII activity by two techniques: evidence for increased conversion of VII to alpha VIIa in hyperlipidaemia, with possible implications for ischaemic heart disease.
Heart Diseases
Effects of changes in smoking and other characteristics on clotting factors and the risk of ischaemic heart disease.
Heart Diseases
Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN).
Heart Diseases
Factor VII and extrinsic pathway inhibitor in acute coronary disease.
Heart Diseases
Factor VII and ischaemic heart disease: epidemiological evidence.
Heart Diseases
Factor VII hyperactivity and ischaemic heart disease.
Heart Diseases
Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation.
Heart Diseases
Factor-VII activity and ischaemic heart disease: fatal and non-fatal events.
Heart Diseases
Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study.
Heart Diseases
Genes, coagulation and cardiovascular risk.
Heart Diseases
Haemostatic variables in Pacific Islanders apparently free from stroke and ischaemic heart disease--the Kitava Study.
Heart Diseases
Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.
Heart Diseases
Improvement of factor VII clotting activity following long-term NCPAP treatment in obstructive sleep apnoea syndrome.
Heart Diseases
Plasma factor VIIa: measurement and potential clinical significance.
Heart Diseases
Postprandial activation of coagulant factor VII by long-chain dietary fatty acids.
Heart Diseases
Reduction of factor VII coagulant activity (VIIC), a risk factor for ischaemic heart disease, by fixed dose warfarin: a double blind crossover study.
Heart Diseases
Regulatory polymorphisms underlying complex disease traits.
Heart Diseases
Role of coagulation factor VII in pathogenesis of ischemic heart disease.
Heart Diseases
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease.
Heart Diseases
Strenuous exercise, plasma fibrinogen, and factor VII activity.
Heart Diseases
The -323Ins10 polymorphism for factor VII is not associated with coronary atherosclerosis in symptomatic men. The REGRESS study group.
Heart Diseases
The protein concentration of blood coagulation factor VII can be measured equally well in plasma and serum.
Heart Diseases
Tissue factor interactions with factor VII: measurement and clinical significance of factor VIIa in plasma.
Heart Diseases
Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease.
Heart Diseases
[Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease]
Heart Diseases
[Evaluation of coagulation and fibrinolysis systems in women at peri- and postmenopausal age qualified for hormone replacement therapy]
Heart Diseases
[Factor VII detection and its association with lipid in ischaemic heart disease.]
Heart Failure
Factor VII and extrinsic pathway inhibitor in acute coronary disease.
Heart Failure
Hemostatic Markers in Congestive Heart Failure Dogs with Mitral Valve Disease.
Heart Failure
Levels of vitamin K-dependent procoagulant and anticoagulant proteins in over-anticoagulated patients.
Heart Failure
Low plasma concentrations of coagulation factors II, VII and XI indicate increased risk among elderly with symptoms of heart failure.
Heart Rupture
[Medical-surgical management of traumatic cardiac rupture: Relevance of recombinant activated factor VII]
Heart Septal Defects, Atrial
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
Heart Septal Defects, Atrial
Pediatric cardiac surgery under cardiopulmonary bypass in factor VII deficiency.
Heart Septal Defects, Atrial
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Heart Septal Defects, Atrial
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant.
Heart Septal Defects, Ventricular
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
Heart Septal Defects, Ventricular
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Heart Septal Defects, Ventricular
The Use of Activated Factor VII for Ventricular Septal Defect Closure in a Pediatric Patient With Hemophilia A and a High Titer of Inhibitor.
Heart Valve Diseases
Effect of the administration of recombinant activated factor VII (rFVIIa; NovoSeven) in the management of severe uncontrolled bleeding in patients undergoing heart valve replacement surgery.
HELLP Syndrome
A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome.
HELLP Syndrome
Liver rupture in a patient with HELLP syndrome successfully treated with extensive surgery combined with recombinant factor VIIa.
HELLP Syndrome
Successful use of recombinant factor VIIa for massive bleeding after caesarean section due to HELLP syndrome.
HELLP Syndrome
[Successful application of recombinant activated factor VII in a patient with HELLP syndrome and disseminated intravascular coagulation]
Hemangioma, Cavernous
Recombinant activated factor VII for a patient with factor VII deficiency undergoing urgent intracerebral haematoma evacuation with underlying cavernous angioma.
Hemangioma, Cavernous
Successful excision of hemorrhagic cavernous angioma in a patient with severe factor VII deficiency: perioperative treatment with factor VII concentrate.
Hemangiopericytoma
Application of recombinant activated factor VII during surgery for a giant skull base hemangiopericytoma to achieve safe hemostasis. Case report.
Hemangiosarcoma
Use of recombinant activated factor VII for bleeding following resection of mediastinal angiosarcoma.
Hemarthrosis
A prospective randomized trial of high and standard dosages of recombinant factor VIIa for treatment of hemarthroses in hemophiliacs with inhibitors.
Hemarthrosis
Acquired Factor VIII Inhibitors: Three Cases.
Hemarthrosis
Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII.
Hemarthrosis
Arthropathies in factor VII deficiency: a case report.
Hemarthrosis
Arthropathy and surgery in congenital factor VII deficiency.
Hemarthrosis
Congenital factor VII deficiency. A report of four new cases.
Hemarthrosis
Long-term prophylaxis in severe factor VII deficiency.
Hemarthrosis
Newly diagnosed congenital factor VII deficiency and utilization of recombinant activated factor VII (NovoSeven(®)).
Hemarthrosis
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic.
Hemarthrosis
Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors.
Hemarthrosis
Recombinant factor VIIa for the treatment of congenital factor VII deficiency.
Hemarthrosis
Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter.
Hemarthrosis
Single-dose recombinant activated factor VII for the treatment of joint bleeds in hemophilia patients with inhibitors.
Hemarthrosis
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency.
Hematemesis
Long-term FVII substitution in a preterm infant with severe gastrointestinal bleeding and FVII deficiency due to a homozygous donor splice mutation IVS4+1G-->A.
Hematologic Diseases
Acquired factor VII deficiency associated with acute myeloid leukemia.
Hematologic Neoplasms
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Hematologic Neoplasms
Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies.
Hematologic Neoplasms
Elevated extracellular trap formation and contact system activation in acute leukemia.
Hematologic Neoplasms
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies.
Hematologic Neoplasms
The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review.
Hematoma, Subdural
A forgotten or minimized head trauma, rather than a mild FVII deficiency, is the most likely cause of a subdural hematoma.
Hematoma, Subdural
Bilateral Subdural Hematomas in an Adult With Hereditary Factor VII Deficiency: A Complication of Sit-ups and Inversion?
Hematoma, Subdural
Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa.
Hematoma, Subdural
Subdural Hematoma From an Acquired Factor VII Deficiency: Is It the Lupus or the Anticoagulant?
Hematoma, Subdural
Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma.
Hematoma, Subdural, Acute
Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma.
Hematoma, Subdural, Intracranial
Bilateral Subdural Hematomas in an Adult With Hereditary Factor VII Deficiency: A Complication of Sit-ups and Inversion?
Hematuria
Acquired hemophilia A: A rare cause of gross hematuria.
Hematuria
Congenital factor VII deficiency presenting first time as isolated recurrent hematuria at late age.
Hematuria
Hematuria associated with continuous infusion of recombinant factor VIIa.
Hematuria
Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Hematuria
Refractory hematuria from amyloidosis successfully treated by splenectomy.
Hematuria
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency.
Hematuria
Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding.
Hematuria
[Acquired hemophilia complicated with hemorrhage induced acute renal failure]
Hemochromatosis
Genotyping on a thermal gradient DNA chip.
Hemochromatosis
Prediction of features of the course of chronic hepatitis C using Bayesian networks.
Hemoperitoneum
Congenital factor VII deficiency complicated with hemoperitoneum and intracranial hemorrhage: report of a case.
Hemoperitoneum
Recombinant activated factor VII for hemoperitoneum after transjugular intrahepatic portosystemic shunt.
Hemoperitoneum
Relationship between factor VII activity and clinical efficacy of recombinant factor VIIa given by continuous infusion to patients with factor VIII inhibitors.
Hemophilia A
"Primary prophylaxis" with rFVIIa in a patient with severe haemophilia a and inhibitor.
Hemophilia A
40K glycoPEGylated, recombinant FVIIa: 3-month, double-blind, randomized trial of safety, pharmacokinetics and preliminary efficacy in hemophilia patients with inhibitors.
Hemophilia A
A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand.
Hemophilia A
A case of acquired hemophilia caused by factor VIII inhibitor with rheumatoid arthritis, successfully treated with immunosuppressive treatment and recombinant activated factor VII.
Hemophilia A
A cell-based model of coagulation and the role of factor VIIa.
Hemophilia A
A Comparison of Efficacy Between Recombinant Activated Factor VII (Aryoseven) and Novoseven in Patients With Hereditary FVIII Deficiency With Inhibitor.
Hemophilia A
A comparison of FVII:C and FVIIa assays for the monitoring of recombinant factor VIIa treatment.
Hemophilia A
A comparison of methods for the measurement of activated factor VII.
Hemophilia A
A comprehensive review of rFVIIa use in a tertiary care pediatric center.
Hemophilia A
A cost evaluation of treatment alternatives for mild-to-moderate bleeding episodes in patients with haemophilia and inhibitors in Brazil.
Hemophilia A
A cost minimization model for the treatment of minor bleeding episodes in patients with haemophilia A and high-titre inhibitors.
Hemophilia A
A critical appraisal of the use of recombinant factor VIIa in acquired bleeding conditions.
Hemophilia A
A highly sensitive thrombin generation assay for assessment of recombinant activated factor VII therapy in haemophilia patients with an inhibitor.
Hemophilia A
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Hemophilia A
A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
Hemophilia A
A new approach to treatment of bleeding episodes in young hemophilia patients: a single bolus megadose of recombinant activated factor VII (NovoSeven).
Hemophilia A
A novel approach to improving recombinant factor VIIa activity with a preserved platelet preparation.
Hemophilia A
A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Hemophilia A
A novel protocol for accurate and reliable postoperative bolus administration of recombinant factor VIIa using an automated mini-pump system.
Hemophilia A
A novel supplemental approach to capturing post-marketing safety information on recombinant factor VIIa in acquired hemophilia: the Acquired Hemophilia Surveillance project.
Hemophilia A
A Phase II clinical trial of a mixture of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors: haemostatic efficacy, safety and pharmacokinetics/pharmacodynamics.
Hemophilia A
A phase III clinical trial of a mixture agent of plasma-derived factor VIIa and factor X (MC710) in haemophilia patients with inhibitors.
Hemophilia A
A prospective, observational, post-approval registry of inhibitor patients treated with multiple or single doses of recombinant activated factor VII.
Hemophilia A
A randomized comparison of bypassing agents in hemophilia complicated by an inhibitor: the FEIBA NovoSeven Comparative (FENOC) Study.
Hemophilia A
A randomized, double-blind comparison of two dosage levels of recombinant factor VIIa in the treatment of joint, muscle and mucocutaneous haemorrhages in persons with haemophilia A and B, with and without inhibitors. rFVIIa Study Group.
Hemophilia A
A randomized, double-blind trial demonstrating bioequivalence of the current recombinant activated factor VII formulation and a new robust 25 degrees C stable formulation.
Hemophilia A
A rare case of acquired hemophilia A associated with myelodysplastic syndrome.
Hemophilia A
A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience.
Hemophilia A
A review of the off-label use of recombinant activated factor VII in a developing country tertiary care center.
Hemophilia A
A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors.
Hemophilia A
A variant of recombinant factor VIIa with enhanced procoagulant and antifibrinolytic activities in an in vitro model of hemophilia.
Hemophilia A
A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia.
Hemophilia A
Acquired haemophilia A associated with autoimmune thyroiditis: a case report.
Hemophilia A
Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
Hemophilia A
Acquired haemophilia--a therapeutic challenge.
Hemophilia A
Acquired Hemophilia A: A Case Report.
Hemophilia A
Acquired Hemophilia A: Clinical Features, Surgery and Treatment of 34 Cases, and Experience of Using Recombinant Factor VIIa.
Hemophilia A
Acquired hemophilia in a 7-year-old girl successfully treated with recombinant FVIIA and steroids: A case report.
Hemophilia A
Activated prothrombin complex concentrate for acquired haemophilia when recombinant factor VIIa fails.
Hemophilia A
Activated recombinant factor VII (rFVIIa).
Hemophilia A
Activated recombinant human coagulation factor VII (rFVIIa) therapy for abdominal bleeding in patients with inhibitory antibodies to factor VIII.
Hemophilia A
Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program.
Hemophilia A
Activity of recombinant factor VIIa under different conditions in vitro: effect of temperature, pH, and haemodilution.
Hemophilia A
Acute hemarthroses: the benefits of early versus late treatment with recombinant activated factor VII.
Hemophilia A
Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor.
Hemophilia A
Administration of recombinant factor VIIa decreases blood loss after blunt trauma in noncoagulopathic pigs.
Hemophilia A
Administration of recombinant FVIIa (rFVIIa) to concizumab-dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits.
Hemophilia A
Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis.
Hemophilia A
Advances in gene therapy using factor VIIa in hemophilia.
Hemophilia A
Advances in the treatment of inherited coagulation disorders.
Hemophilia A
Altered factor VII activity in hemophilia.
Hemophilia A
American experience with home use of NovoSeven: recombinant factor VIIa in hemophiliacs with inhibitors.
Hemophilia A
An immunological investigation of hemophilia B with a tentative classification of the disease into five variants.
Hemophilia A
An in vitro evaluation of standard rotational thromboelastography in monitoring of effects of recombinant factor VIIa on coagulopathy induced by hydroxy ethyl starch.
Hemophilia A
An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.
Hemophilia A
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Hemophilia A
Analyses of recombinant activated factor VII treatments from clinical practice for rapid bleeding and acute pain control in haemophilia patients with inhibitors.
Hemophilia A
Animal models of FVIIa gene expression: their role in the future development of haemophilia treatment.
Hemophilia A
Anti-HCV agent, ribavirin, elevates the activity of clotting factor VII in patients with hemophilia: a possible mechanism of decreased events of bleeding in patients with hemophilia by ribavirin.
Hemophilia A
Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.
Hemophilia A
Antigenicity of activated recombinant factor VII followed through nine years of clinical experience.
Hemophilia A
aPCC vs. rFVIIa for the treatment of bleeding in patients with acquired haemophilia - a cost-effectiveness model.
Hemophilia A
Application of recombinant activated factor VII for treatment of impaired haemostasis during liver transplantation in recipients with Wilson's disease--a report of two cases.
Hemophilia A
Approaches towards successful home treatment in patients with inhibitors.
Hemophilia A
ARFI ultrasound monitoring of hemorrhage and hemostasis in vivo in canine von Willebrand disease and hemophilia.
Hemophilia A
Arthropathies in factor VII deficiency: a case report.
Hemophilia A
Aspects of current management: orthopaedic surgery in haemophilia.
Hemophilia A
Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors.
Hemophilia A
Assessment of individual dose utilization vs. physician prescribing recommendations for recombinant activated factor VII (rFVIIa) in paediatric and adult patients with congenital haemophilia and alloantibody inhibitors (CHwI): the Dosing Observational Study in Hemophilia (DOSE).
Hemophilia A
Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparin.
Hemophilia A
Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.
Hemophilia A
Associated risk of recombinant activated factor VIIa application.
Hemophilia A
Beyond stopping the bleed: short-term episodic prophylaxis with recombinant activated factor FVII in haemophilia patients with inhibitors.
Hemophilia A
Biochemical characterization of LR769, a new recombinant factor VIIa bypassing agent produced in the milk of transgenic rabbits.
Hemophilia A
Blockade of endothelial cell protein C receptor augments factor VIIa hemostatic effect in hemophilia treatment.
Hemophilia A
Bringing new therapy options to the hemophilia community.
Hemophilia A
Cardiac tamponade in a patient with moderate hemophilia A and factor VIII Inhibitors.
Hemophilia A
Case report on recombinant coagulation factor VIIa in the treatment of three haemophilia A patients with inhibitors in Singapore.
Hemophilia A
Catalytic domain modification and viral gene delivery of activated Factor VII confers hemostasis at reduced expression levels and vector doses in vivo.
Hemophilia A
Challenges in the laboratory analyses of bleeding disorders.
Hemophilia A
Challenges in the therapeutic use of a "so-called" universal hemostatic agent: recombinant factor VIIa.
Hemophilia A
Challenges of antithrombotic therapy in the management of cardiovascular disease in patients with inherited bleeding disorders: A single-centre experience.
Hemophilia A
Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
Hemophilia A
Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity.
Hemophilia A
Chondrocalcinosis and haemophilia.
Hemophilia A
Clinical and echographical control protocol of haemarthrosis in haemophilia patients with inhibitors: evaluation of the efficacy of recombinant factor VIIa in the evolution process (EFFISEVEN protocol).
Hemophilia A
Clinical and laboratory features of 178 children with recurrent epistaxis.
Hemophilia A
Clinical audit of inherited bleeding disorders in a developing country.
Hemophilia A
Clinical efficacy of prothrombin complex concentrates and recombinant factor VIIa in the treatment of bleeding episodes in patients with factor VII and IX inhibitors.
Hemophilia A
Clinical efficacy of recombinant activated factor VII (rFVIIa) during acute bleeding episode and surgery in a patient with acquired hemophilia A with high inhibitor titer.
Hemophilia A
Clinical experience with human plasma-derived factor VIIa in patients with hemophilia A and high titer inhibitors.
Hemophilia A
Clinical experience with recombinant factor VIIa.
Hemophilia A
Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.
Hemophilia A
Clinical pharmacological study of a plasma-derived factor VIIa and factor X mixture (MC710) in haemophilia patients with inhibitors - Phase I trial.
Hemophilia A
Clinical trial to investigate the pharmacokinetics, pharmacodynamics, safety, and efficacy of recombinant factor VIIa in Japanese patients with hemophilia with inhibitors.
Hemophilia A
Clinical use of recombinant FVIIa (rFVIIa).
Hemophilia A
Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients.
Hemophilia A
Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasma.
Hemophilia A
Combination of FVIII and low-dose rFVIIa improves haemostasis in acquired haemophilia A patients: a collaborative controlled study.
Hemophilia A
Combined administration of FVIII and rFVIIa improves haemostasis in haemophilia A patients with high-responding inhibitors - a thrombin generation-guided pilot study.
Hemophilia A
Combined factor VII and factor VIII deficiency due to a casual association of heterozygosis for factor VII deficiency and hemophilia A.
Hemophilia A
Combined treatment with APCC (FEIBA(®) ) and tranexamic acid in patients with haemophilia A with inhibitors and in patients with acquired haemophilia A - a two-centre experience.
Hemophilia A
Commentary on "Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms".
Hemophilia A
Commentary on Knight et al.: A systematic review of the cost-effectiveness of rFVIIa and APCC in the treatment of minor/moderate bleeding episodes for haemophilia patients with inhibitors.
Hemophilia A
Comparative Biochemical and Functional Studies on a Branded Human Recombinant Factor VIIa and a Biosimilar Equivalent Product.
Hemophilia A
Comparative incidence of thrombosis in reported cases of deficiencies of factors of the contact phase of blood coagulation.
Hemophilia A
Comparing The Cost-Effectiveness of Apcc Vs Rfviia In on-Demand Treatment of Bleeds In Hemophilia A Patients With Inhibitors: A Brazilian Public Health System Perspective.
Hemophilia A
Comparison of bypassing agents in bleeding reduction in treatment of bleeding episodes in patients with haemophilia and inhibitors.
Hemophilia A
Comparison of coagulant activity of factor VII and activated factor VII activity assays when used for determination of recombinant activated factor VII levels in plasma.
Hemophilia A
Comparison of kaolin and tissue factor activated thromboelastography in haemophilia.
Hemophilia A
Comparison of the effect of plasma-derived and recombinant human FVIIa in vitro and in a rabbit model.
Hemophilia A
Comparison of the factor VII:C clot analysis and a modified activated factor VII analysis for monitoring factor VII activity in patients treated with recombinant activated factor VII (NovoSeven).
Hemophilia A
Concomitant infusion of low doses of rFVIIa and FEIBA in haemophilia patients with inhibitors.
Hemophilia A
Concomitant Use of rFVIIa and Emicizumab in People with Hemophilia ?A with Inhibitors: Current Perspectives and Emerging Clinical Evidence.
Hemophilia A
Concurrent total hip and knee replacements in a patient with haemophilia with inhibitors using recombinant factor VIIa by continuous infusion.
Hemophilia A
Congenital combined factor VII and factor VIII deficiency.
Hemophilia A
Congenital Factor XI Deficiency: An Update.
Hemophilia A
Consecutive complex percutaneous coronary interventions using emicizumab and recombinant activated factor VII in a patient with severe haemophilia A and high-titre inhibitor.
Hemophilia A
Construction of a versatile expression library for all human single-pass transmembrane proteins for receptor pairings by high throughput screening.
Hemophilia A
Continuous infusion of recombinant activated factor VII: a review of data in congenital hemophilia with inhibitors and congenital factor VII deficiency.
Hemophilia A
Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and Belgium.
Hemophilia A
Controlling acute bleeding episodes with recombinant factor VIIa in haemophiliacs with inhibitor: continuous infusion and bolus injection.
Hemophilia A
Correction of bleeding in experimental severe hemophilia A by systemic delivery of factor VIII-encoding mRNA.
Hemophilia A
Correction to: Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia.
Hemophilia A
Cost analysis of prophylaxis with activated prothrombin complex concentrate vs. on-demand therapy with activated factor VII in severe haemophilia A patients with inhibitors, in Spain.
Hemophilia A
Cost and effectiveness of treatments for mild-to-moderate bleeding episodes in haemophilia patients with inhibitors in Korea.
Hemophilia A
Cost Minimization Analysis of Activated Prothrombin Complex Concentrate (Apcc) Compared To Recombinant Factor Viia (Rfviia) for Hemophilia Patients With Inhibitors.
Hemophilia A
Cost minimization analysis to compare activated prothrombin complex concentrate (APCC) and recombinant factor VIIa for haemophilia patients with inhibitors undergoing major orthopaedic surgeries.
Hemophilia A
Cost-Effectiveness Analysis of Biogeneric Recombinant Activated Factor VII (AryoSeven) and Activated Prothrombin Complex Concentrates (FEIBA) to Treat Hemophilia A Patients with Inhibitors in Iran.
Hemophilia A
Cost-effectiveness of recombinant activated factor VII vs. plasma-derived activated prothrombin complex concentrate in the treatment of mild-to-moderate bleeding episodes in patients with severe haemophilia A and inhibitors in Spain.
Hemophilia A
Cost-Effectiveness of rFVIIa versus pd-aPCC in the Management of Mild to Moderate Bleeds in Pediatric Patients with Hemophilia A with Inhibitors in Mexico.
Hemophilia A
Cost-utility analysis of immune tolerance induction therapy versus on-demand treatment with recombinant factor VII for hemophilia A with high titer inhibitors in Iran.
Hemophilia A
Critical appraisal of the role of recombinant activated factor VII in the treatment of hemophilia patients with inhibitors.
Hemophilia A
Crystal structure, epitope, and functional impact of an antibody against a superactive FVIIa provide insights into allosteric mechanism.
Hemophilia A
Current difficulties and recent advances in bypass therapy for the management of hemophilia with inhibitors: a new and practical formulation of recombinant factor VIIa.
Hemophilia A
Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan.
Hemophilia A
Current use of by-passing agents in Europe in the management of acute bleeds in patients with haemophilia and inhibitors.
Hemophilia A
Decline of factor VIII and factor IX inhibitors during long-term treatment with NovoSeven.
Hemophilia A
Decreasing the Need for Transfusion: Infant Cardiac Surgery Using Hemodilution and Recombinant Factor VIIa.
Hemophilia A
Design, synthesis and biological activity of novel peptidyl benzyl ketone FVIIa inhibitors.
Hemophilia A
Detection of factor X activation in humans.
Hemophilia A
Determinants of drug costs in hopitalised patients with haemophilia: impact of recombinant activated factor VII.
Hemophilia A
Determinants of plasma factor VIIa levels in humans.
Hemophilia A
Development and Validation of an Algorithm for Identifying Patients with Hemophilia A in an Administrative Claims Database.
Hemophilia A
Development of a flow cytometric assay for detection of coated platelets in dogs and evaluation of binding of coated platelets to recombinant human coagulation factor VIIa.
Hemophilia A
Development of a Transgenic Mouse Model with Immune Tolerance for Human Coagulation Factor VIIa.
Hemophilia A
Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitors.
Hemophilia A
Diffuse alveolar hemorrhage after allogeneic hematopoietic stem-cell transplantation: treatment with recombinant factor VIIa.
Hemophilia A
Disorders of menstruation and their effect on the quality of life in women with congenital factor VII deficiency.
Hemophilia A
Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion.
Hemophilia A
Distribution of the recombinant coagulation factor 125I-rFVIIa in rats.
Hemophilia A
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
Hemophilia A
Dose optimization of recombinant factor VIIa for control of mild to moderate bleeds in inhibitor patients: Improved efficacy with higher dosing.
Hemophilia A
Dose optimization of recombinant factor VIIa in the treatment of acute bleeding in haemophilia-associated inhibitors.
Hemophilia A
Dose titration of recombinant factor VIIa using thromboelastograph monitoring in a child with hemophilia and high titer inhibitors to factor VIII: a case report and brief review.
Hemophilia A
Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008).
Hemophilia A
Dosing and monitoring NovoSeven treatment.
Hemophilia A
Dosing factor VIIa (recombinant) in nonhemophiliac patients with bleeding after cardiac surgery.
Hemophilia A
Dosing with recombinant factor viia based on current evidence.
Hemophilia A
Early injection of high-dose recombinant factor VIIa decreases blood loss and prolongs time from injury to death in experimental liver injury.
Hemophilia A
Early treatment with recombinant factor VIIa results in greater efficacy with less product.
Hemophilia A
Early use of recombinant factor VIIa improves mean arterial pressure and may potentially decrease mortality in experimental hemorrhagic shock: a pilot study.
Hemophilia A
Economic analysis of recombinant activated factor VII versus plasma-derived activated prothrombin complex concentrate in mild to moderate bleeds: Haemophilia registry data from the Czech Republic.
Hemophilia A
Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
Hemophilia A
Economic evaluation of rFVIIa high initial dose compared to rFVIIa standard initial dose in patients with haemophilia with inhibitors using the Czech HemoRec registry.
Hemophilia A
Economic modelling of different treatment strategies for haemophilia A with high-responding inhibitors.
Hemophilia A
Economical comparison of APCC vs. rFVIIa for mild-to-moderate bleeding episodes in haemophilia patients with inhibitors.
Hemophilia A
Effect of activated recombinant human factor 7 (Niastase) on laboratory testing of inhibitors of factors VIII and IX.
Hemophilia A
Effect of glycoPEGylation on factor VIIa binding and internalization.
Hemophilia A
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.
Hemophilia A
Effect of recombinant factor VIIa variant (NN1731) on platelet function, clot structure and force onset time in whole blood from healthy volunteers and haemophilia patients.
Hemophilia A
Effect of rFVIIa dose and time to treatment on patients with haemophilia and inhibitors: analysis of HemoRec registry data from the Czech Republic.
Hemophilia A
Effective and safe use of recombinant factor VIIa (NovoSeven) in elderly mild haemophilia A patients with high-titre antibodies against factor VIII.
Hemophilia A
Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Hemophilia A
Effects of binding of ligand (FVIIa) to induced tissue factor in human endothelial cells.
Hemophilia A
Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma.
Hemophilia A
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: a systematic review.
Hemophilia A
Efficacy of different doses of recombinant activated factor VII in the treatment of haemophilia children with inhibitor.
Hemophilia A
Efficacy of NovoSeven during surgery on a haemophiliac with previous history of inhibitors.
Hemophilia A
Efficacy of recombinant activated Factor VII in patients with massive uncontrolled bleeding: a retrospective observational analysis.
Hemophilia A
Efficacy of recombinant activated factor VII vs. activated prothrombin complex concentrate for patients suffering from haemophilia complicated with inhibitors: a Bayesian meta-regression.
Hemophilia A
Efficacy of recombinant factor VIIa administered by continuous infusion to haemophilia patients with inhibitors.
Hemophilia A
Elective orthopaedic surgery for haemophilia patients with inhibitors: single centre experience of 40 procedures and review of the literature.
Hemophilia A
Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
Hemophilia A
Elevated function of blood clotting factor VIIa mutants that have enhanced affinity for membranes. Behavior in a diffusion-limited reaction.
Hemophilia A
Elimination of hepatitis C virus infection in patients with haemophilia in Belgium: A single-centre experience.
Hemophilia A
Engineering of a membrane-triggered activity switch in coagulation factor VIIa.
Hemophilia A
Enhanced in vitro procoagulant and antifibrinolytic potential of superactive variants of recombinant factor VIIa in severe hemophilia A.
Hemophilia A
Enhanced Pharmacokinetics of Factor VIIa as a Monomeric Fc Fusion.
Hemophilia A
Enhanced potency of recombinant factor VIIa with increased affinity to activated platelets.
Hemophilia A
Enhancement of factor VIIa haemostatic efficacy by formulation with PEGylated liposomes.
Hemophilia A
Entering new areas in known fields: recombinant fusion protein linking recombinant factor VIIa with recombinant albumin (rVIIa-FP) - advancing the journey.
Hemophilia A
Eptacog Alfa (Activated) Is Physically and Chemically Stable over 24 Hours when Administered as Bolus Injections in an Automated Infusion Pump.
Hemophilia A
Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
Hemophilia A
Eptacog beta: a novel recombinant human factor VIIa for the treatment of hemophilia A and B with inhibitors.
Hemophilia A
Ethics & Evidence in Medical Debates: The Case of Recombinant Activated Factor VII.
Hemophilia A
Evaluating and monitoring the efficacy of recombinant activated factor VIIa in patients with haemophilia and inhibitors.
Hemophilia A
Evaluation of Aryoseven Safety (Recombinant Activated Factor VII) in Patients with Bleeding Disorders (An Observational Post-Marketing Surveillance Study).
Hemophilia A
Evaluation of Coagulation Factors Activity in Different Types of Plasma Preparations.
Hemophilia A
Evaluation of off-label recombinant activated factor VII for multiple indications in children.
Hemophilia A
Evaluation of rFVIIa (NovoSeven) in Glanzmann patients with thromboelastogram.
Hemophilia A
Evaluation of thromboelastography for monitoring recombinant activated factor VII ex vivo in haemophilia A and B patients with inhibitors: a multicentre trial.
Hemophilia A
Evidence for the use of recombinant factor VIIa in the prevention and treatment of bleeding in patients without hemophilia.
Hemophilia A
Evidence-based use of recombinant FVIIa (NovoSeven((R)), NiaStase((R))) for the treatment of hemophilia with inhibitors in children and adolescents.
Hemophilia A
Excision of pseudotumour in a patient with haemophilia A and inhibitor managed with recombinant factor VIIa.
Hemophilia A
Experience of recombinant activated factor VII usage during surgery in patients with haemophilia with inhibitors.
Hemophilia A
Experience with a single dose of recombinant activated factor VII for the management of mild-to-moderate bleeds in haemophilia.
Hemophilia A
Experience with use of recombinant activated factor VII.
Hemophilia A
Experiences in the prevention of arthropathy in haemophila patients with inhibitors.
Hemophilia A
Experiences with continuous infusion of recombinant activated factor VII.
Hemophilia A
Experiences with recombinant human factor VIIa in patients with thrombocytopenia.
Hemophilia A
Exploratory in vitro evaluation of thrombin generation of eptacog beta (recombinant human fviia) and emicizumab in congenital haemophilia A plasma.
Hemophilia A
Exposure and safety of higher doses of recombinant factor VIIa ?250??g?kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008).
Hemophilia A
Expression of factor VII by muscle cells in vitro and in vivo following direct gene transfer: modelling gene therapy for haemophilia.
Hemophilia A
Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin.
Hemophilia A
Extensive Small-Angle X-ray Scattering Studies of Blood Coagulation Factor VIIa Reveal Interdomain Flexibility.
Hemophilia A
Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
Hemophilia A
Factor VII and haemostasis.
Hemophilia A
Factor VIIa analog has marked effects on platelet function and clot kinetics in blood from patients with hemophilia A.
Hemophilia A
Factor VIIa analogue (V158D/E296V/M298Q-FVIIa) normalises clot formation in whole blood from patients with severe haemophilia A.
Hemophilia A
Factor VIIa and its potential therapeutic use in bleeding-associated pathologies.
Hemophilia A
Factor VIIa bound to endothelial cell protein C receptor activates protease activated receptor-1 and mediates cell signaling and barrier protection.
Hemophilia A
Factor VIIa in the treatment of haemophilia.
Hemophilia A
Factor VIIa induces extracellular vesicles from the endothelium: a potential mechanism for its hemostatic effect.
Hemophilia A
Factor VIIa interaction with EPCR modulates the hemostatic effect of rFVIIa in hemophilia therapy: Mode of its action.
Hemophilia A
Factor VIIA levels in patients with hemophilia.
Hemophilia A
Factor XIII combined with recombinant factor VIIa: a new means of treating severe hemophilia A.
Hemophilia A
Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.
Hemophilia A
Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis.
Hemophilia A
Failure of recombinant FVIIa as treatment for abdominal bleeding in acquired hemophilia.
Hemophilia A
Familial haemophilia and factor VII deficiency.
Hemophilia A
Faster onset of effect and greater efficacy of NN1731 compared with rFVIIa, aPCC and FVIII in tail bleeding in hemophilic mice.
Hemophilia A
Fatal outcome of recombinant factor VIIa in heart transplantation with extracorporeal membrane oxygenation.
Hemophilia A
Fc-based half-life extension of human FVIIa - a new player for hemophilia treatment?
Hemophilia A
FEIBA versus NovoSeven in Hemophilia Patients with Inhibitors.
Hemophilia A
Fibrin gel structure obtained with a FVIIa analogue with enhanced FX-activating potential in haemophilia.
Hemophilia A
First 20 years with recombinant FVIIa (NovoSeven).
Hemophilia A
Formation of an inhibitor against factor VII as a postoperative complication in a severe case of hemophilia A.
Hemophilia A
Formulary management of recombinant factor VIIa at an academic medical center.
Hemophilia A
From theory to practice: applying current clinical knowledge and treatment strategies to the care of hemophilia a patients with inhibitors.
Hemophilia A
FVIIa as therapeutic agent in hemophilia and beyond.
Hemophilia A
FVIIa as used pharmacologically is not TF dependent in hemophilia B mice.
Hemophilia A
Gene Delivery of Activated Factor VII Using Alternative Adeno-Associated Virus Serotype Improves Hemostasis in Hemophiliac Mice with FVIII Inhibitors and Adeno-Associated Virus Neutralizing Antibodies.
Hemophilia A
Gene therapy in haemophilia--going for cure?
Hemophilia A
Gene-based continuous expression of FVIIa for the treatment of hemophilia.
Hemophilia A
Gene-based FVIIa prophylaxis modulates the spontaneous bleeding phenotype of hemophilia A rats.
Hemophilia A
General haemostatic agents--fact or fiction?
Hemophilia A
Genetic deficiency of factor VII and hemorrhagic diathesis. A case report and literature review.
Hemophilia A
Guidelines for the use of recombinant activated factor VII (rFVIIa) in uncontrolled bleeding: a report by the Israeli Multidisciplinary rFVIIa Task Force.
Hemophilia A
Haematuria in a young patient with severe haemophilia and inhibitor presence receiving prophylactic treatment with recombinant factor VIIa.
Hemophilia A
Haemophilia in Australia.
Hemophilia A
Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
Hemophilia A
Haemostatic efficacy and safety of bolus and continuous infusion of recombinant factor VIIa are comparable in haemophilia patients with inhibitors undergoing major surgery. Results from an open-label, randomized, multicenter trial.
Hemophilia A
Health economic review of recombinant activated factor VII for treatment of bleeding episodes in hemophilia patients with inhibitors.
Hemophilia A
Health economics of treating haemophilia A with inhibitors.
Hemophilia A
Hemophilia (AHG deficiency) and factor VII (stable factor) deficiency in the American Indian. Report of four cases.
Hemophilia A
Hemophilia A and concurrent factor VII deficiency. Studies of a patient with complicating cardiac tamponade.
Hemophilia A
Hemophilia home treatment. Economic analysis and implications for health policy.
Hemophilia A
Hemophilia in Iran.
Hemophilia A
Hemophilia. Treatment of patients with inhibitors: cost issues.
Hemophilia A
Hemostasis in liver resection surgery.
Hemophilia A
Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model.
Hemophilia A
Hemostatic effect of recombinant factor VIIa, NN1731 and recombinant factor VIII on needle-induced joint bleeding in hemophilia A mice.
Hemophilia A
Hemostatic properties of the FVIIa analog NN1731.
Hemophilia A
Hereditary bleeding disorders in Riyadh, Saudi Arabia.
Hemophilia A
Heterozygous factor VII deficiency and severe hemophilia A in the same kindred.
Hemophilia A
High-dose recombinant factor VIIa therapy in hemophilia patients with inhibitors.
Hemophilia A
High-level expression of functional recombinant human coagulation factor VII in insect cells.
Hemophilia A
History of rFVIIa therapy.
Hemophilia A
Home treatment for patients with congenital bleeding disorders in a developing country.
Hemophilia A
Home treatment of haemarthroses using a single dose regimen of recombinant activated factor VII in patients with haemophilia and inhibitors. A multi-centre, randomised, double-blind, cross-over trial.
Hemophilia A
Home treatment of haemarthrosis with recombinant activated factor VII in patients with haemophilia A or B and inhibitors: experience from developing countries.
Hemophilia A
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Hemophilia A
How factor VIIa works in hemophilia.
Hemophilia A
How we use recombinant activated Factor VII in patients with haemophilia A or B complicated by inhibitors.
Hemophilia A
Human coagulation factor FVIIa (recombinant) in the management of limb-threatening bleeds unresponsive to alternative therapies: results from the NovoSeven emergency-use programme in patients with severe haemophilia or with acquired inhibitors.
Hemophilia A
Human monocytes support factor X activation by factor VIIa, independent of tissue factor: implications for the therapeutic mechanism of high-dose factor VIIa in hemophilia.
Hemophilia A
Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity.
Hemophilia A
IL-1 beta, IL-6, KC and MCP-1 are elevated in synovial fluid from haemophilic mice with experimentally induced haemarthrosis.
Hemophilia A
Immune tolerance induction: a role for recombinant activated factor VII (rFVIIa)?
Hemophilia A
Immunogenicity of novel recombinant human activated factor VII analogues on factor VII neonatally-tolerized rats.
Hemophilia A
Immunological aspects of recombinant factor VIIa (rFVIIa) in clinical use.
Hemophilia A
Impact of Telemedicine Tools on Record Keeping and Compliance in Haemophilia Care.
Hemophilia A
Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa.
Hemophilia A
Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).
Hemophilia A
Improved hemostasis with superactive analogs of factor VIIa in a mouse model of hemophilia A.
Hemophilia A
In vitro characterization of MOD-5014, a novel long-acting carboxy-terminal peptide (CTP)-modified activated FVII.
Hemophilia A
In vitro evidence of a tissue factor-independent mode of action of recombinant factor VIIa in hemophilia.
Hemophilia A
In vitro stability of lyophilized and reconstituted recombinant activated factor VII formulated for storage at room temperature.
Hemophilia A
In vitro stability of two formulations of recombinant activated factor VIIa reconstituted in inappropriate solvents or at inappropriate volumes.
Hemophilia A
In vivo bypass of hemophilia A coagulation defect by factor XIIa implant.
Hemophilia A
In vivo clearance and metabolism of recombinant activated factor VII (rFVIIa) and its complexes with plasma protease inhibitors in the liver.
Hemophilia A
In vivo haemostatic effects of activated prothrombin complex concentrate and recombinant factor VIIa in a haemophilia A patient with inhibitors.
Hemophilia A
Induction of acquired factor IX inhibitors in cynomolgus monkey (Macaca fascicularis): a new primate model of hemophilia B.
Hemophilia A
Induction of tolerance after combined immunosuppression and -adsorption in two patients with acquired haemophilia after severe haemorrhages controlled by sequential administration of rFVIIa and FEIBA.
Hemophilia A
Influence of factor VIIa and phospholipids on coagulation in "acquired" hemophilia.
Hemophilia A
Inhibition of fibrinolysis by recombinant factor VIIa in plasma from patients with severe hemophilia A.
Hemophilia A
Inhibition of thrombin generation by the zymogen factor VII: implications for the treatment of hemophilia A by factor VIIa.
Hemophilia A
Inhibitors in hemophilia A: advances in elucidation of inhibitory mechanisms and in inhibitor management with bypassing agents.
Hemophilia A
Inhibitors in Patients with Congenital Bleeding Disorders Other Than Hemophilia.
Hemophilia A
International survey of attitudes towards secondary prophylaxis with recombinant factor VIIa in haemophilia A patients with inhibitors.
Hemophilia A
Intestinal surgery with activated recombinant factor VII prophylaxis in patients with haemophilia A and high responding inhibitors: a report of five cases.
Hemophilia A
Intra-patient variability of thromboelastographic parameters following in vivo and ex vivo administration of recombinant activated factor VII in haemophilia patients. A multi-centre, randomised trial.
Hemophilia A
Intracerebral hemorrhage: natural history and rationale of ultra-early hemostatic therapy.
Hemophilia A
Intraoperative use of recombinant activated factor VII (rFVIIa).
Hemophilia A
Intraoral hemostasis using a recombinant activated factor VII preparation in a hemophilia a patient with inhibitor.
Hemophilia A
Intravascular inhibition of factor VIIa and the analogue NN1731 by antithrombin.
Hemophilia A
Intravenous rFVIIa administered for hemorrhage control in hypothermic coagulopathic swine with grade V liver injuries.
Hemophilia A
Ischemic stroke after recombinant factor VIIa treatment in acquired hemophilia A patient.
Hemophilia A
Ischemic strokes in congenital bleeding disorders: comparison with myocardial infarction and other acute coronary syndromes.
Hemophilia A
Isotypic analysis of antibodies against activated Factor VII in patients with Factor VII deficiency using the x-MAP technology.
Hemophilia A
Kaolin, used to trigger coagulation in thrombin generation test, increases sensitivity of the method in hemophilia patients.
Hemophilia A
Kinetic analysis and binding studies of a new recombinant human factor VIIa for treatment of haemophilia.
Hemophilia A
Kinetic modeling sheds light on the mode of action of recombinant factor VIIa on thrombin generation.
Hemophilia A
Knee joint arthroplasty in a patient with haemophilia A and high inhibitor titre using recombinant factor VIIa (NovoSeven): a new case report and review of the literature.
Hemophilia A
Lessons from a systematic literature review of the effectiveness of recombinant factor VIIa in acquired haemophilia.
Hemophilia A
Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
Hemophilia A
Life-threatening bleeding in a patient with pemphigoid-induced acquired hemophilia A and successfully treated with rituximab and rFVIIa: A case report.
Hemophilia A
Life-threatening hemorrhage in neonates: management with recombinant activated factor VII.
Hemophilia A
Life-threatening mediastinal-retroperitoneal hemorrhage in a child with moderate hemophilia A and high inhibitor titer: successful management with recombinant activated factor VII.
Hemophilia A
Limited factor VIIa surface localization requirement of the factor VIIa-induced overall thrombin generation in platelet-rich hemophilia A plasma.
Hemophilia A
Liver transplantation in a patient with mild haemophilia A and low-titres of factor VIII inhibitors treated with recombinant factor VIIa. The first Argentinean case.
Hemophilia A
Long-term expression of canine FVIIa in hemophilic dogs.
Hemophilia A
Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality.
Hemophilia A
Long-term secondary prophylaxis with recombinant activated factor VII (rFVIIa) in haemophilia A with inhibitors: a case report.
Hemophilia A
Low endoscopy bleeding risk in patients with congenital bleeding disorders.
Hemophilia A
Major orthopaedic surgeries for haemophilia with inhibitors using rFVIIa.
Hemophilia A
Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision.
Hemophilia A
Major surgery in severe haemophilia A with inhibitors using a recombinant factor VIIa and activated prothrombin complex concentrate hybrid regimen.
Hemophilia A
Management and monitoring of recombinant activated factor VII.
Hemophilia A
Management of bleeding in acquired haemophilia A with recombinant activated factor VII: does one size fit all? A report of four cases.
Hemophilia A
Management of oral bleedings with recombinant factor VIIa in children with haemophilia A and inhibitor.
Hemophilia A
Managing acute bleeds in the patient with haemophilia and inhibitors: options, efficacy and safety.
Hemophilia A
Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia.
Hemophilia A
Measurement of basal levels of factor VIIa in hemophilia A and B patients.
Hemophilia A
Mechanism of action of factor VIIa in the treatment of coagulopathies.
Hemophilia A
Mechanism of action, development and clinical experience of recombinant FVIIa.
Hemophilia A
Mechanism of factor VIIa-dependent coagulation in hemophilia blood.
Hemophilia A
Mechanism of the immune response to human factor VIII in murine hemophilia A.
Hemophilia A
Mechanisms of action of recombinant activated factor VII in the context of tissue factor concentration and distribution.
Hemophilia A
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Hemophilia A
Methodologies for data collection in congenital haemophilia with inhibitors (CHwI): critical assessment of the literature and lessons learned from recombinant factor VIIa.
Hemophilia A
Mitigation of T-cell dependent immunogenicity by reengineering factor VIIa analogue.
Hemophilia A
Myelofibrosis and acquired hemophilia A: a case report.
Hemophilia A
Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII.
Hemophilia A
N-/O-glycosylation analysis of human FVIIa produced in the milk of transgenic rabbits.
Hemophilia A
National survey of patients with hemophilia and other congenital bleeding disorders in Thailand.
Hemophilia A
New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.
Hemophilia A
Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases.
Hemophilia A
Novel applications of recombinant factor VIIa for the management of pediatric coagulopathic diseases.
Hemophilia A
Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII.
Hemophilia A
NovoSeven (recombinant factor VIIa) in centeral nervous systems bleeds.
Hemophilia A
NovoSeven as a universal haemostatic agent.
Hemophilia A
NovoSeven in immune tolerance therapy.
Hemophilia A
NovoSeven: mode of action and use in acquired haemophilia.
Hemophilia A
Obstetric analgesia and anaesthesia in women with inherited bleeding disorders.
Hemophilia A
Occult hemophilia as a cause of postoperative and postpartum hemorrhage. With special reference to factor VII deficiency.
Hemophilia A
Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
Hemophilia A
Off-Label Recombinant Factor VIIa Use and Thrombosis in Children: A Multi-center Cohort Study.
Hemophilia A
Off-label use of recombinant activated factor VII in surgical and non-surgical patients at 16 Canadian hospitals from 2007 to 2010 (Canadian Registry Report).
Hemophilia A
Off-label use of recombinant factor VIIa in patients following bone marrow transplantation.
Hemophilia A
Off-label use of recombinant factor VIIa in U.S. hospitals: analysis of hospital records.
Hemophilia A
Off-label use of rFVIIa in children with excessive bleeding: A consecutive study of 153 off-label uses in 139 children.
Hemophilia A
On-demand treatment of bleeds in haemophilia patients with inhibitors: strategies for securing and maintaining predictable efficacy with recombinant activated factor VII.
Hemophilia A
On-label versus off-label use of recombinant activated factor VII: a comprehensive review of use in two Canadian centers.
Hemophilia A
One amino acid in mouse activated factor VII defines its endothelial protein C receptor (EPCR) binding and modulates its EPCR-dependent hemostatic activity in vivo.
Hemophilia A
Ongoing NovoSeven trials.
Hemophilia A
Optimizing on-demand treatment with NovoSeven room temperature stable.
Hemophilia A
Optimizing thrombelastography (TEG) assay conditions to monitor rFVIIa (NovoSeven) therapy in haemophilia A patients.
Hemophilia A
Orthopaedic surgery in haemophilic patients with inhibitors: an overview.
Hemophilia A
Orthopaedic surgery in severe bleeding disorders: a low-volume, high-cost procedure.
Hemophilia A
Overall experience with NovoSeven.
Hemophilia A
Overall haemostatic potential can be used for estimation of thrombin-activatable fibrinolysis inhibitor-dependent fibrinolysis in vivo and for possible follow-up of recombinant factor VIIa treatment in patients with inhibitors to factor VIII.
Hemophilia A
Overcoming delayed in-vitro response to rFVIIa: effects of rFVIIa and rFVIIa analogue (vatreptacog alfa) concentration escalation in whole blood assays.
Hemophilia A
Overview of the human pharmacokinetics of recombinant activated factor VII.
Hemophilia A
Parallel use of by-passing agents in haemophilia with inhibitors: a critical review.
Hemophilia A
Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE).
Hemophilia A
Patient/Caregiver-reported recombinant factor VIIa (rFVIIa) dosing: home treatment of acute bleeds in the Dosing Observational Study in Hemophilia (DOSE).
Hemophilia A
Perioperative use of recombinant activated factor VII in liver transplantation.
Hemophilia A
Pharmacoeconomic analysis of recombinant factor VIIa versus APCC in the treatment of minor-to-moderate bleeds in hemophilia patients with inhibitors.
Hemophilia A
Pharmacokinetic properties of two different recombinant activated factor VII formulations.
Hemophilia A
Pharmacokinetics and pharmacodynamics of recombinant factor VIIa.
Hemophilia A
Pharmacokinetics and pharmacodynamics of rFVIIa and new improved bypassing agents for the treatment of haemophilia.
Hemophilia A
Pharmacokinetics and safety of a 270?mcg?kg(-1) dose of room temperature stable recombinant activated factor VII in patients with haemophilia.
Hemophilia A
Pharmacokinetics of activated recombinant coagulation factor VII (NovoSeven) in children vs. adults with haemophilia A.
Hemophilia A
Pharmacokinetics of coagulation factors: clinical relevance for patients with haemophilia.
Hemophilia A
Pharmacokinetics of recombinant activated factor VII (rFVIIa).
Hemophilia A
Pharmacokinetics, distribution, and excretion of (125)I-labeled human plasma-derived-FVIIa and -FX with MC710 (FVIIa/FX mixture) in rats.
Hemophilia A
Pharmacokinetics, pharmacodynamics and safety of recombinant canine FVIIa in a study dosing one haemophilia A and one haemostatically normal dog.
Hemophilia A
Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP).
Hemophilia A
Pharmacological concentrations of recombinant factor VIIa restore hemostasis independent of tissue factor in antibody-induced hemophilia mice.
Hemophilia A
Pharmacological strategies to decrease transfusion requirements in patients undergoing surgery.
Hemophilia A
Pharmacology and clinical use of recombinant activated factor seven in neurosciences.
Hemophilia A
Phase 1, single-dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia.
Hemophilia A
Phase I, Randomized, Double-Blind, Placebo-Controlled, Single-Dose Escalation Study of the rFVIIa Variant BAY 86-6150 in Hemophilia.
Hemophilia A
Phenotypic correction of hemophilia A by ectopic expression of activated factor VII in platelets.
Hemophilia A
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic.
Hemophilia A
Plasma Exchange as an Initial Treatment for Severe Bleeding Induced by Acquired Factor V Deficiency: A Case Report and Mini Literature Review.
Hemophilia A
Platelet adhesiveness and aggregation in combined factor V and factor VIII deficiency and in combined factor VII and factor VIII deficiency.
Hemophilia A
Platelet binding and activity of a factor VIIa variant with enhanced tissue factor independent activity.
Hemophilia A
Platelet binding and activity of recombinant factor VIIa.
Hemophilia A
Platelet infusion supports recombinant factor VIIa in a patient with severe haemophilia A and inhibitor - Clinical outcome and laboratory observations.
Hemophilia A
Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa.
Hemophilia A
Poly-N-Acetylglucosamine Fibers Amplify the Effectiveness of Recombinant Factor VIIA on Clot Formation in Hemophilia B Canine Blood.
Hemophilia A
Polymorphism in factor VII gene modifies phenotype of severe haemophilia.
Hemophilia A
Polyphosphate as a general procoagulant agent.
Hemophilia A
Possible synergy between recombinant factor VIIa and prothrombin complex concentrate in hemophilia therapy.
Hemophilia A
Postsurgical coagulopathy in a hemophilia A patient with inhibitors: efficacy of recombinant factor VIIa.
Hemophilia A
Potential role of recombinant factor FVIIa in prophylaxis in severe hemophilia patients with inhibitors.
Hemophilia A
Potential role of recombinant factor VIIa as a hemostatic agent.
Hemophilia A
Prediction of human pharmacokinetics of activated recombinant factor VII and B-domain truncated factor VIII from animal population pharmacokinetic models of haemophilia.
Hemophilia A
Prediction of the haemostatic effects of bypassing therapy using comprehensive coagulation assays in emicizumab prophylaxis-treated haemophilia A patients with inhibitors.
Hemophilia A
Pregnancy in women with congenital factor VII deficiency.
Hemophilia A
Preparation of factor VII concentrate using CNBr-activated Sepharose 4B immunoaffinity chromatography.
Hemophilia A
Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI.
Hemophilia A
Prevention of arthropathy: may it be extrapolated from patients without inhibitors to patients with inhibitors?
Hemophilia A
PRO-PACT: Retrospective observational study on the prophylactic use of recombinant factor VIIa in hemophilia patients with inhibitors.
Hemophilia A
Production of coagulation factor VII in human cell lines Sk-Hep-1 and HKB-11.
Hemophilia A
Prohemostatic Activity of Factor X in Combination With Activated Factor VII in Dilutional Coagulopathy.
Hemophilia A
Prolonged half-life of glycoPEGylated rFVIIa variants compared to native rFVIIa.
Hemophilia A
Prolonged in-vivo half-life of factor VIIa by fusion to albumin.
Hemophilia A
Prophylactic and therapeutic use of recombinant activated factor VII in patients with cirrhosis and coagulation impairment.
Hemophilia A
Prophylactic preparation and surgical extirpation of a very large abdominal blood cyst in a severe haemophilia A patient with inhibitors managed by rFVIIa.
Hemophilia A
Prophylactic recombinant factor VIIa in haemophilia patients with inhibitors.
Hemophilia A
Prophylactic treatment of haemophilia patients with inhibitors: clinical experience with recombinant factor VIIa in European Haemophilia Centres.
Hemophilia A
Prophylaxis in congenital hemophilia with inhibitors: the role of recombinant activated factor VII.
Hemophilia A
Prophylaxis in haemophilia with inhibitors: update from international experience.
Hemophilia A
Prophylaxis therapy with bypassing agents in patients with haemophilia A and inhibitors undergoing surgery: A cost analysis in Spain.
Hemophilia A
Prophylaxis with recombinant factor VIIa for the management of bleeding episodes during immune tolerance treatment in a boy with severe haemophilia A and high-response inhibitors.
Hemophilia A
Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.
Hemophilia A
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
Hemophilia A
Quality of haemophilia treatment in Serbia: National Haemophilia Registry Report.
Hemophilia A
Randomized, prospective clinical trial of recombinant factor VIIa for secondary prophylaxis in hemophilia patients with inhibitors.
Hemophilia A
Rapid rFVIIa enhanced on-demand dosing in haemophilia inhibitor patients.
Hemophilia A
Rational Use of Recombinant Factor VIIa in Clinical Practice.
Hemophilia A
Real-World Early Treatment with Room Temperature-Stable Recombinant Factor VIIa in Hemophilia A/B and Inhibitors: SMART-7 Post Hoc Analyses.
Hemophilia A
Real-world outcomes with recombinant factor VIIa treatment of acute bleeds in haemophilia patients with inhibitors: results from the international ONE registry.
Hemophilia A
Recombinant activated clotting factor VII (rFVIIa) in the treatment of surgical and spontaneous bleeding episodes in hemophilic patients.
Hemophilia A
Recombinant activated factor VII (NovoSeven) treatment of platelet-related bleeding disorders. International Registry on Recombinant Factor VIIa and Congenital Platelet Disorders Group.
Hemophilia A
Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors.
Hemophilia A
Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Hemophilia A
Recombinant activated factor VII (rFVIIa): characterization, manufacturing, and clinical development.
Hemophilia A
Recombinant activated factor VII (rFVIIa, NovoSeven).
Hemophilia A
Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
Hemophilia A
Recombinant activated factor VII as a general haemostatic agent: evidence-based efficacy and safety.
Hemophilia A
Recombinant activated factor VII as a universal haemostatic agent.
Hemophilia A
Recombinant activated factor VII controls chemotherapy-related hemorrhage in patients with solid intra-abdominal tumors: a report of three pediatric cases.
Hemophilia A
Recombinant activated factor VII for a warfarinised Jehovah's Witness with an acute subdural haematoma.
Hemophilia A
Recombinant activated factor VII for acute intracerebral hemorrhage.
Hemophilia A
Recombinant activated factor VII for adjunctive hemorrhage control in trauma.
Hemophilia A
Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis.
Hemophilia A
Recombinant activated factor VII for haemophilia patients with inhibitors undergoing orthopaedic surgery: a review of the literature.
Hemophilia A
Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
Hemophilia A
Recombinant activated factor VII for massive hemoptysis in patients with cystic fibrosis.
Hemophilia A
Recombinant activated factor VII for treatment of intramuscular haemorrhages: a comparison of early versus late treatment.
Hemophilia A
Recombinant activated factor VII in cardiac surgery: experience from the Australian and New Zealand Haemostasis Registry.
Hemophilia A
Recombinant activated factor VII in clinical practice: a 2014 update.
Hemophilia A
Recombinant activated factor VII in patients at high risk of bleeding.
Hemophilia A
Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders.
Hemophilia A
Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors.
Hemophilia A
Recombinant Activated Factor VII Is Reabsorbed in Renal Proximal Tubules and Is a Ligand to Megalin and Cubilin.
Hemophilia A
Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008).
Hemophilia A
Recombinant activated factor VII therapy in acquired hemophilia of the elderly.
Hemophilia A
Recombinant activated factor VII use in the emergency department.
Hemophilia A
Recombinant activated factor VII: 30 years of research and innovation.
Hemophilia A
Recombinant Activated Factor VII: Current Perspectives and Epworth Experience.
Hemophilia A
Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
Hemophilia A
Recombinant activated factor VII: mechanisms of action and current indications.
Hemophilia A
Recombinant blood components: clinical administration today and tomorrow.
Hemophilia A
Recombinant coagulation factor VIIa: from the concept to clinical application in hemophilia treatment in 2000.
Hemophilia A
Recombinant factor IX.
Hemophilia A
Recombinant factor VIIa (eptacog alfa): a pharmacoeconomic review of its use in haemophilia in patients with inhibitors to clotting factors VIII or IX.
Hemophilia A
Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders.
Hemophilia A
Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.
Hemophilia A
Recombinant factor VIIa (Novoseven) and the safety of treatment.
Hemophilia A
Recombinant factor VIIa (Novoseven) as a hemostatic agent.
Hemophilia A
Recombinant factor VIIa (NovoSeven) as a hemostatic agent.
Hemophilia A
Recombinant factor VIIa (NovoSeven) in the treatment of internal bleeding in patients with factor VIII and IX inhibitors.
Hemophilia A
Recombinant factor VIIa (r-FVIIa) in haemophilia management.
Hemophilia A
Recombinant factor VIIa (rFVIIa) and its use in severe bleeding in surgery and trauma: a review.
Hemophilia A
Recombinant factor VIIa (rFVIIa): its potential role as a hemostatic agent.
Hemophilia A
Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: a randomized controlled trial.
Hemophilia A
Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa.
Hemophilia A
Recombinant factor VIIa analog NN1731 (V158D/E296V/M298Q-FVIIa) enhances fibrin formation, structure and stability in lipidated hemophilic plasma.
Hemophilia A
Recombinant factor VIIa and factor VIII treatment for acquired factor VIII deficiency: a case of repeated thrombotic endotracheal occlusion in a mechanically ventilated patient.
Hemophilia A
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with Haemophilia A and inhibitors.
Hemophilia A
Recombinant Factor VIIa concentrate versus plasma derived concentrates for the treatment of acute bleeding episodes in people with haemophilia and inhibitors.
Hemophilia A
Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors.
Hemophilia A
Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
Hemophilia A
Recombinant factor VIIa for intracranial haemorrhage in a Jehovah's Witness with severe haemophilia A and factor VIII inhibitors.
Hemophilia A
Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
Hemophilia A
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia.
Hemophilia A
Recombinant factor VIIa for the treatment of severe postoperative and traumatic hemorrhage.
Hemophilia A
Recombinant factor VIIa in an infant with haemophilia A and inhibitors.
Hemophilia A
Recombinant factor VIIa in continuous infusion during central line insertion in a child with factor VIII high-titre inhibitor.
Hemophilia A
Recombinant factor VIIa in joint and muscle bleeding episodes.
Hemophilia A
Recombinant factor VIIa in paediatric bleeding disorders--a 2006 review.
Hemophilia A
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.
Hemophilia A
Recombinant factor VIIa in the management of a pseudotumour in acquired haemophilia.
Hemophilia A
Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high responding inhibitors.
Hemophilia A
Recombinant factor VIIa in the management of surgery and acute bleeding episodes in children with haemophilia and high-responding inhibitors.
Hemophilia A
Recombinant factor VIIa in the treatment of bleeding.
Hemophilia A
Recombinant Factor VIIa Reduces Bleeding after Blunt Liver Injury in a Pig Model of Dilutional Coagulopathy under Severe Hypothermia.
Hemophilia A
Recombinant factor VIIa reduces rebleed hemorrhage volume in a swine aortotomy model: a randomized double-blinded study.
Hemophilia A
Recombinant factor VIIa treatment for asymptomatic factor VII deficient patients going through major surgery.
Hemophilia A
Recombinant factor VIIa treatment for life-threatening haemoptysis.
Hemophilia A
Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent.
Hemophilia A
Recombinant Factor VIIa-Mediated Activation of Prothrombin Complex Concentrates: Studies on the Comparison of NovoSeven With a Biosimilar Product.
Hemophilia A
Recombinant factor VIIa.
Hemophilia A
Recombinant Factor VIIa.
Hemophilia A
Recombinant factor VIIa: a universal hemostatic agent?
Hemophilia A
Recombinant factor VIIa: an assessment of evidence regarding its efficacy and safety in the off-label setting.
Hemophilia A
Recombinant Factor VIIa: clinical applications for an intravenous hemostatic agent with broad-spectrum potential.
Hemophilia A
Recombinant Factor VIIa: Hemostatic Adjunct in the Coagulopathic Burn Patient.
Hemophilia A
Recombinant factor VIIa: its background, development and clinical use.
Hemophilia A
Recombinant factor VIIa: review of current "off license" indications and implications for practice.
Hemophilia A
Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors.
Hemophilia A
Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome.
Hemophilia A
Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases.
Hemophilia A
Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias.
Hemophilia A
Recombinant FVIIa in elective non-orthopaedic surgery of adults with haemophilia and inhibitors: A systematic literature review.
Hemophilia A
Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment.
Hemophilia A
Recombinant FVIIa in the management of uncontrolled hemorrhage.
Hemophilia A
Recombinant FVIIa in the treatment of bleeding in acquired hemophilia.
Hemophilia A
Recombinant human coagulation factor VIIa in Jehovah's Witness patients undergoing liver transplantation.
Hemophilia A
Recombinant human factor VIIa (rFVIIa) cleared principally by antithrombin following intravenous administration in hemophilia patients.
Hemophilia A
Recombinant human factor VIIa (rFVIIa) in hemophilia: mode of action and evidence to date.
Hemophilia A
Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis.
Hemophilia A
Recombinant-activated coagulation factor VIIa (NovoSeven): current development.
Hemophilia A
Recombinant-activated factor VII for control and prevention of hemorrhage in nonhemophilic pediatric patients.
Hemophilia A
Redistribution and hemostatic action of recombinant activated factor VII associated with platelets.
Hemophilia A
Registry of Hemophilia and other bleeding disorders in Syria.
Hemophilia A
Relevance of a single dose of 270microg/kg recombinant factor VIIa for the treatment of patients with haemophilia and inhibitors.
Hemophilia A
Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors.
Hemophilia A
Response of factor VIII and IX-deficient blood to wild type and high membrane affinity mutant factor VIIa in an in vitro whole blood clotting assay: possible correlation to clinical outcome.
Hemophilia A
Response to treatment and adverse events associated with use of recombinant activated factor VII in children: a retrospective cohort study.
Hemophilia A
Results of clot waveform analysis and thrombin generation test for a plasma-derived factor VIIa and X mixture (MC710) in haemophilia patients with inhibitors-phase I trial: 2nd report.
Hemophilia A
Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.
Hemophilia A
Retroviral-mediated transfer and amplification of a functional human factor VIII gene.
Hemophilia A
Reversal of clopidogrel-induced bleeding with rFVIIa in healthy subjects: a randomized, placebo-controlled, double-blind, exploratory study.
Hemophilia A
Review: Recombinant factor VIIa does not differ from placebo for prevention or treatment of bleeding in patients without hemophilia.
Hemophilia A
Ribavirin-induced intracellular GTP depletion activates transcription elongation in coagulation factor VII gene expression.
Hemophilia A
Risk-sharing approach for managing factor VIIa reimbursement in haemophilia patients with inhibitors.
Hemophilia A
Robustness of factor assays following cordocentesis in the prenatal diagnosis of haemophilia and other bleeding disorders.
Hemophilia A
Role of prothrombin complex concentrate in perioperative coagulation therapy.
Hemophilia A
Room-temperature-stable recombinant activated coagulation factor VII recombinant: chemical and microbiologic stability over 24 hours during continuous in vitroinfusion.
Hemophilia A
Rotational thromboelastometry can predict the probability of bleeding events in a translational rat model of haemophilia A following gene-based FVIIa prophylaxis.
Hemophilia A
Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical program.
Hemophilia A
Safety and dose-dependency of eptacog beta (activated) in a dose escalation study of non-bleeding congenital haemophilia A or B patients, with or without inhibitors.
Hemophilia A
Safety and effectiveness of room temperature stable recombinant factor VIIa in patients with haemophilia A or B and inhibitors: Results of a multinational, prospective, observational study.
Hemophilia A
Safety and efficacy of recombinant activated coagulation factor VII in congenital hemophilia with inhibitors in the home treatment setting: A review of clinical studies and registries.
Hemophilia A
Safety and efficacy of recombinant activated factor VII for long-term secondary prophylaxis in a haemophilia boy with high-titre inhibitors.
Hemophilia A
Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label.
Hemophilia A
Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study.
Hemophilia A
Safety and pharmacokinetics of subcutaneously administered recombinant activated factor VII (rFVIIa).
Hemophilia A
Safety of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors: overall rFVIIa exposure and intervals following high (>240 ?g kg?¹) rFVIIa doses across clinical trials and registries.
Hemophilia A
Safety profile of recombinant factor VIIa.
Hemophilia A
Safety update on recombinant factor VIIa in the treatment of congenital and acquired hemophilia.
Hemophilia A
Safety update on the use of recombinant activated factor VII in approved indications.
Hemophilia A
Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors.
Hemophilia A
Safety, efficacy and cost-effectiveness of home therapy with recombinant activated factor VII in a patient with severe haemophilia A and an anti-factor VIII inhibitor.
Hemophilia A
Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII--an open label, exploratory, cross-over, phase I/II study.
Hemophilia A
Secondary prophylaxis with recombinant activated factor VII improves health-related quality of life of haemophilia patients with inhibitors.
Hemophilia A
Secondary prophylaxis with rFVIIa in hemophilia and inhibitors: recommendations from an experts committee from Argentina.
Hemophilia A
Sequential therapy with activated prothrombin complex concentrate (FEIBA) and recombinant factor VIIa in a patient with severe haemophilia A, inhibitor presence and refractory bleeding.
Hemophilia A
Sequential therapy with activated prothrombin complex concentrate and recombinant factor VIIa in patients with severe haemophilia and inhibitors.
Hemophilia A
Sequential therapy with activated prothrombin complex concentrates and recombinant activated factor VII to treat unresponsive bleeding in patients with hemophilia and inhibitors: a single center experience.
Hemophilia A
Sequential therapy with activated prothrombin complex concentrates and recombinant FVIIa in patients with severe haemophilia and inhibitors: update of our previous experience.
Hemophilia A
Sequential treatment with bolus and continuous infusion of recombinant factor VIIa for hip arthroplasty in a patient with haemophilia A and inhibitor.
Hemophilia A
Severe acquired hemophilia A successfully treated with activated recombinant human factor VII.
Hemophilia A
Severe aquired haemophilia A treated with recombinant factor VIIa.
Hemophilia A
Short-course use of recombinant factor VIIa in a haemophilia patient with inhibitor undergoing cataract surgeries.
Hemophilia A
Single 270 microg kg(-1)-dose rFVIIa vs. standard 90 microg kg(-1)-dose rFVIIa and APCC for home treatment of joint bleeds in haemophilia patients with inhibitors: a randomized comparison.
Hemophilia A
Single higher dose of recombinant activated factor VII in the treatment of hemorrhages in patients with hemophilia complicated by inhibitors.
Hemophilia A
Single-dose (270 microg kg(-1)) recombinant activated factor VII for the treatment and prevention of bleeds in haemophilia A patients with inhibitors: experience from seven European haemophilia centres.
Hemophilia A
Single-dose recombinant activated factor VII for the treatment of joint bleeds in hemophilia patients with inhibitors.
Hemophilia A
Single-dose recombinant activated factor VII therapy in hemophilia patients with inhibitors.
Hemophilia A
Small dose of recombinant factor VIIa (rFVIIa) to perform percutaneous liver biopsies in cirrhotic patients.
Hemophilia A
Some recent developments regarding arthropathy and inhibitors in haemophilia.
Hemophilia A
Spectrum of mutations in CRM-positive and CRM-reduced hemophilia A.
Hemophilia A
Spinal epidural haematoma in haemophilia A with inhibitors--efficacy of recombinant factor VIIa concentrate.
Hemophilia A
ST-Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII.
Hemophilia A
Standardization and evaluation of the performance of the thrombin generation test under hypo- and hypercoagulability conditions.
Hemophilia A
Standardization of factor VII/activated factor VII measurement in plasma of patients treated with recombinant factor activated VII.
Hemophilia A
Studies of factor IX concentrate therapy in hemophilia.
Hemophilia A
Subcutaneous engineered factor VIIa marzeptacog alfa (activated) in hemophilia with inhibitors: Phase 2 trial of pharmacokinetics, pharmacodynamics, efficacy, and safety.
Hemophilia A
Successful concurrent triple surgery in an adolescent patient with haemophilia A and inhibitors treated with recombinant factor VIIa.
Hemophilia A
Successful hemostasis during a major orthopedic operation by using recombinant activated factor VII in a patient with severe hemophilia A and a potent inhibitor.
Hemophilia A
Successful management of Mallory-Weiss syndrome in a haemophilia A patient with inhibitor by recombinant activated factor VII.
Hemophilia A
Successful management of massive intraperitoneal bleeding in a hemophilia A patient with inhibitor by surgical debridement of the incomplete hematoma and administration of recombinant factor VIII and activated factor VII.
Hemophilia A
Successful total hip replacement in a patient with severe haemophilia A with inhibitors using recombinant factor VIIa.
Hemophilia A
Successful treatment of a patient with acquired haemophilia A with a combination of a low-dose rituximab and recombinant human FVIIa.
Hemophilia A
Successful treatment of acquired factor VIII deficiency in a child using activated factor VII concentrates: case report and review of the literature.
Hemophilia A
Successful treatment of canine hemophilia by continuous expression of canine FVIIa.
Hemophilia A
Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature.
Hemophilia A
Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation.
Hemophilia A
Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII.
Hemophilia A
Successful urgent neurosugery management with rFVIIa mega doses in a child with haemophilia a and high titre inhibitor.
Hemophilia A
Successful use of recombinant factor VII in massive hemoptysis due to community-acquired pneumonia.
Hemophilia A
Successful use of recombinant factor VIIa for emergency fasciotomy in a patient with hemophilia A and high-titer inhibitor unresponsive to factor VIII inhibitor bypassing activity.
Hemophilia A
Successful use of recombinant factor VIIa in patient with severe haemophilia A during synovectomy.
Hemophilia A
Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
Hemophilia A
Surgery in patients with haemophilia and high responding inhibitors: Izmir experience.
Hemophilia A
Surgical Experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
Hemophilia A
Surgical interventions in a cohort of patients with haemophilia A and inhibitors: an experiential retrospective chart review.
Hemophilia A
Sustained pro-haemostatic activity of rFVIIa in non-bleeding pigs may explain efficacy of once-daily prophylaxis in humans.
Hemophilia A
Synovectomy for haemophilic arthropathy: 6-21 years of follow-up in 16 patients.
Hemophilia A
Synthesis and characterization of recombinant factor VIIa-conjugated magnetic iron oxide nanoparticles for hemophilia treatment.
Hemophilia A
Systematic literature review of economics analysis on treatment of mild-to-moderate bleeds with aPCC versus rFVIIa.
Hemophilia A
Systematic review of efficacy of rFVIIa and aPCC treatment for hemophilia patients with inhibitors.
Hemophilia A
Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications.
Hemophilia A
Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery.
Hemophilia A
Tailoring haemostatic treatment to patient requirements - an update on monitoring haemostatic response using thrombelastography.
Hemophilia A
Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan.
Hemophilia A
The action of high-dose factor VIIa (FVIIa) in a cell-based model of hemostasis.
Hemophilia A
The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.
Hemophilia A
The concept of recombinant factor VIIa megadose for treating bleeding episodes in high-titer inhibitor patients with hemophilia: toward an expanding indication?
Hemophilia A
The danger of using a sledgehammer to crack a nut: ROTEM-guided administration of recombinant activated factor VII in a patient with refractory bleeding post-ventricular assist device implantation.
Hemophilia A
The effect of factor X level on thrombin generation and the procoagulant effect of activated factor VII in a cell-based model of coagulation.
Hemophilia A
The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.
Hemophilia A
The effect of recombinant factor VIIa (NovoSeven(R)) on peri-operative bleeding during total knee replacement in a non-hemophiliac patient.
Hemophilia A
The effect of recombinant factor VIIa on coagulopathic pigs with grade V liver injuries.
Hemophilia A
The effect of recombinant factor VIIa on noncoagulopathic pigs with grade V liver injuries.
Hemophilia A
The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents.
Hemophilia A
The efficacy of bypassing agents in surgery of hemophilia patients with inhibitors.
Hemophilia A
The emerging role of recombinant activated Factor VII (rFVIIa) in the treatment of blunt traumatic haemorrhage.
Hemophilia A
The endothelial protein C receptor enhances hemostasis of FVIIa administration in hemophilic mice in vivo.
Hemophilia A
The evidence for the use of recombinant factor VIIa in massive bleeding: development of a transfusion policy framework.
Hemophilia A
The evolution of factor VIIa in the treatment of bleeding in haemophilia with inhibitors.
Hemophilia A
The function of factor VIIa in hemophilia A: an hypothesis.
Hemophilia A
The intractable intra-abdominal hemorrhage with unknown etiology in a patient with severe hemophilia A.
Hemophilia A
The intraoperative use of recombinant FVIIa in child with hemophilia A with antibodies.
Hemophilia A
The Judicious Use of Recombinant Factor VIIa.
Hemophilia A
The pharmacokinetics and pharmacodynamics of single-dose and multiple-dose recombinant activated factor VII in patients with haemophilia A or B.
Hemophilia A
The pharmacokinetics of clotting factor therapy.
Hemophilia A
The potential correlation between patient-reported symptoms and the use of additional haemostatic medication for joint bleeding in haemophilia patients with inhibitors: a post hoc exploratory analysis of recombinant activated factor VII data from the ADEPT2 trial.
Hemophilia A
The potential role of recombinant activated FVII in the management of critical hemato-oncological bleeding: a systematic review.
Hemophilia A
The regulation of the factor VII-dependent coagulation pathway: rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders.
Hemophilia A
The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa.
Hemophilia A
The role of factor VII in haemostasis: infusion studies of factor VIIa in a canine model of factor VIII deficiency.
Hemophilia A
The role of recombinant activated factor VII in neurosurgery: hope or hype?
Hemophilia A
The role of recombinant activated factor VII in the haematological management of elective orthopaedic surgery in haemophilia A patients with inhibitors.
Hemophilia A
The role of tissue factor and factor VIIa in hemostasis.
Hemophilia A
The safety and efficacy of the administration of recombinant activated factor VII in major surgery and trauma patients.
Hemophilia A
The treatment of bleeding in acquired haemophilia with recombinant factor VIIa: a multicentre study.
Hemophilia A
The Use of Activated Factor VII for Ventricular Septal Defect Closure in a Pediatric Patient With Hemophilia A and a High Titer of Inhibitor.
Hemophilia A
The use of combination FEIBA and rFVIIa bypassing therapy, with TEG profiling, in uncontrollable bleeding associated with acquired haemophilia A.
Hemophilia A
The use of PEGylated liposomes in the development of drug delivery applications for the treatment of hemophilia.
Hemophilia A
The use of recombinant activated coagulation factor VII for spine surgery.
Hemophilia A
The use of recombinant activated factor VII in congenital and acquired von Willebrand disease.
Hemophilia A
The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage.
Hemophilia A
The use of recombinant activated factor VII in patients with acquired haemophilia.
Hemophilia A
The use of recombinant activated factor VII to control bleeding during repair of a suprarenal abdominal aortic aneurysm.
Hemophilia A
The use of recombinant coagulation factor VIIa in patients undergoing surgical correction of scoliosis with the C-D method.
Hemophilia A
The use of recombinant factor VIIa for bleeding in paediatric practice.
Hemophilia A
The use of recombinant factor VIIa for severe intractable bleeding during spine surgery.
Hemophilia A
The use of recombinant factor VIIa in a patient with acquired haemophilia A undergoing surgery.
Hemophilia A
The use of recombinant factor VIIa in controlling surgical bleeding in non-haemophiliac patients.
Hemophilia A
The use of rFVIIa in non-haemophilia bleeding conditions in paediatrics. A systematic review.
Hemophilia A
Therapeutic challenges in acquired factor VIII deficiency.
Hemophilia A
Therapeutic doses of recombinant factor VIIa in hemophilia generates thrombin in platelet-dependent and -independent mechanisms.
Hemophilia A
Thrombelastgram as a hemostatic monitor during recombinant factor VIIa treatment in hemophilia A patients with inhibitor to factor VIII.
Hemophilia A
Thrombelastographic monitoring of recombinant factor VIIa in acquired haemophilia.
Hemophilia A
Thrombelastography-guided factor VIIa therapy in a surgical patient with severe hemophilia and factor VIII inhibitor.
Hemophilia A
Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
Hemophilia A
Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
Hemophilia A
Thrombin generation in clinical conditions.
Hemophilia A
Thrombin generation in haemophilia A patients with factor VIII inhibitors after infusion of recombinant factor VIIa.
Hemophilia A
Thrombin generation in plasma of patients with haemophilia A and B with inhibitors: Effects of bypassing agents and antithrombin reduction.
Hemophilia A
Thromboelastography and recombinant factor VIIa-hemophilia and beyond.
Hemophilia A
Thromboembolic adverse events after use of recombinant human coagulation factor VIIa.
Hemophilia A
Thrombosis: a study of coagulation parameters and mechanisms during allograft rejection.
Hemophilia A
Thrombotic events in neonates receiving recombinant factor VIIa or fresh frozen plasma.
Hemophilia A
Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC).
Hemophilia A
Tissue factor and factor VIIa as therapeutic targets in disorders of hemostasis.
Hemophilia A
To general haemostasis--the evidence-based route.
Hemophilia A
Total joint replacement in haemophilia A patients with high titre of inhibitor using a new brand recombinant factor VIIa (Aryoseven(®) ).
Hemophilia A
Toward optimal therapy for inhibitors in hemophilia.
Hemophilia A
Tranexamic acid as adjunct therapy to bypassing agents in haemophilia A patients with inhibitors.
Hemophilia A
Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study.
Hemophilia A
Transfusion medicine service policies for recombinant factor VIIa administration.
Hemophilia A
Transplacental hemophilia A and prophylactic treatment with intravenous immunoglobulin and recombinant factor VIIa in the newborn period: a case report.
Hemophilia A
Treatment and prevention of bleeding in congenital hemophilia A patients with inhibitors.
Hemophilia A
Treatment for preventing bleeding in people with haemophilia or other congenital bleeding disorders undergoing surgery.
Hemophilia A
Treatment of acquired factor VIII inhibitor with recombinant activated factor VIIa: data from the Italian registry of acquired hemophilia.
Hemophilia A
Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal.
Hemophilia A
Treatment of acute bleeding in acquired haemophilia A with recombinant activated factor VII: analysis of 10-year Japanese postmarketing surveillance data.
Hemophilia A
Treatment of bleeding after kidney biopsy with recombinant activated factor VII.
Hemophilia A
Treatment of bleeding episodes in patients with hemophilia and an inhibitor: comparison of two treatment protocols with recombinant activated factor VII.
Hemophilia A
Treatment of bleeding in acquired hemophilia A with the proper administration of recombinant activated factor VII: single-center study of 7 cases.
Hemophilia A
Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa.
Hemophilia A
Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.
Hemophilia A
Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
Hemophilia A
Treatment Regimens with Bypassing Agents in Patients with Hemophilia A and Inhibitors: A Survey from the Italian Association of Hemophilia Centers (AICE).
Hemophilia A
Treatment with recombinant activated factor VII in a patient with hemophilia A and an inhibitor: advantages of administration by continuous infusion over bolus intermittent injections.
Hemophilia A
TRUST trial: BAY 86-6150 use in haemophilia with inhibitors and assessment for immunogenicity.
Hemophilia A
Turnover of prothrombin, factor VII and factor IX in a patient with hemophilia A.
Hemophilia A
Two-incision laparoscopic appendectomy for a severe hemophilia A child patient with coagulation factor VII deficiency: Case report and review of literature.
Hemophilia A
U.S. survey of surgical capabilities and experience with surgical procedures in patients with congenital haemophilia with inhibitors.
Hemophilia A
Ulcerative Colitis in Hemophilia A Patient: Case Report.
Hemophilia A
Ultra-early hemostatic therapy for acute intracerebral hemorrhage.
Hemophilia A
Ultra-early hemostatic therapy for primary intracerebral hemorrhage: a review.
Hemophilia A
Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries.
Hemophilia A
Uncontrolled bleeding in surgical patients: the role of recombinant activated factor VIIa.
Hemophilia A
Understanding the hemostatic effects of recombinant factor VIIa by clot wave form analysis.
Hemophilia A
Understanding the therapeutic action of recombinant factor VIIa in platelet disorders.
Hemophilia A
Unifying the mechanism of recombinant FVIIa action: dose dependence is regulated differently by tissue factor and phospholipids.
Hemophilia A
Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
Hemophilia A
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
Hemophilia A
Update on Novo Nordisk's clinical trial programme on NovoSeven.
Hemophilia A
Updates in the management of severe coagulopathy in trauma patients.
Hemophilia A
US experience with recombinant factor VIIa for surgery and other invasive procedures in acquired haemophilia: analysis from the Hemostasis and Thrombosis Research Society Registry.
Hemophilia A
Use of albumin fusion technology to prolong the half-life of recombinant factor VIIa.
Hemophilia A
Use of high dose factor VIIa in hemophilia patients.
Hemophilia A
Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
Hemophilia A
Use of Low-Dose Recombinant Factor ?a for Uncontrolled Perioperative Bleeding.
Hemophilia A
Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study.
Hemophilia A
Use of Recombinant Activated Factor VII for Intractable Bleeding in Patients Without Hemophilia: A Developing Country Tertiary Care Center's Experience.
Hemophilia A
Use of recombinant activated factor VII for the treatment of perioperative bleeding in noncardiac surgery patients without hemophilia: A systematic review and meta-analysis of randomized controlled trials.
Hemophilia A
Use of recombinant activated factor VII in patients without hemophilia: a meta-analysis of randomized control trials.
Hemophilia A
Use of recombinant activated factor VII to treat the acquired coagulopathy of trauma.
Hemophilia A
Use of Recombinant Factor VII in Cardiac Surgery.
Hemophilia A
Use of recombinant factor VIIa (NovoSeven) in a haemophilia A patient with inhibitor in Kuwait.
Hemophilia A
Use of recombinant factor VIIa during excision of vascular anomalies.
Hemophilia A
Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.
Hemophilia A
Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis.
Hemophilia A
Use of recombinant factor VIIa in the management of severe bleeding episodes in patients with Bernard-Soulier syndrome.
Hemophilia A
Use of recombinant factor VIIa in the perioperative period.
Hemophilia A
Use of recombinant factor VIIa, Novo Seven, in the management of acute haemorrhage.
Hemophilia A
Use of the UKHCDO Database for a postmarketing surveillance study of different doses of recombinant factor VIIa in haemophilia.
Hemophilia A
Uses of recombinant factor VIIa in trauma.
Hemophilia A
Utilization of recombinant activated factor VII in southern Ontario in 85 patients with and without haemophilia.
Hemophilia A
Variability of thromboelastographic responses following the administration of rFVIIa to haemophilia A dogs supports the individualization of therapy with a global test of haemostasis.
Hemophilia A
Views on methods for monitoring recombinant factor VIIa in inhibitor patients.
Hemophilia A
Visual evaluation of blood coagulation during mural thrombogenesis under high shear blood flow.
Hemophilia A
Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
Hemophilia A
[A Jehovah's Witness child with hemophilia B and factor IX inhibitors undergoing scoliosis surgery]
Hemophilia A
[Acquired hemophilia A requiring plasma exchange and mechanical ventilation].
Hemophilia A
[Acquired hemophilia complicated with hemorrhage induced acute renal failure]
Hemophilia A
[Acquired inhibitory body hemophilia]
Hemophilia A
[Activated prothrombin complex preparations for the treatment of anticoagulant hemophilia. Preparation--method of operation--supply possibility]
Hemophilia A
[Acute treatment with recombinant factor VII is probably indicated for intracerebral haematoma]
Hemophilia A
[Aortic root replacement in Marfan syndrome with hemophilia A]
Hemophilia A
[Application of recombinant activated factor VII in treatment of intracranial haemorrhage in haemophilic patient with inhibitor]
Hemophilia A
[Comparison of modified Bethesda assay and Nijmegen assay in detecting FVII inhibitor in patients with hemophilia A]
Hemophilia A
[Continuous infusion of recombinant activated factor VII during and after elbow arthroplasty in a hemophilia A patient with inhibitors]
Hemophilia A
[Current status and trends in blood biologicals].
Hemophilia A
[Efficacy of Recombinant Activated Factor VII for Intractable Bleeding after Cardiovascular Surgery].
Hemophilia A
[Factor VII deficiency and surgery]
Hemophilia A
[Factors VII, VIII, IX, and X: molecular genetics and gene diagnosis]
Hemophilia A
[Health economics of inhibitor bypassing agents in haemophilia A-activated prothrombin complex concentrate (aPCC) and recombinant activated factor VIIa (rFVIIa)].
Hemophilia A
[Hemophilia and other inherited blood coagulation disorders in Poland]
Hemophilia A
[Hemophilia--present and past]
Hemophilia A
[Infective morbidity of replacement therapy in congenital coagulation deficiencies and its effects on demand of coagulation factors]
Hemophilia A
[Intraoperative use of plasma-derived activated factor VII (F VII a) in a hemophilia A patient with inhibitors]
Hemophilia A
[Lessons about recombinant activated factor VII. Ten years since its registration for use in hemophilia with inhibitor.]
Hemophilia A
[Long-term prophylaxis in congenital haemophilia with inhibitors - experiences with rFVIIa]
Hemophilia A
[New possibilities in the management of hemorrhagic diathesis caused by factor deficiency and thrombocytopenia: recombinant active factor VII concentrate]
Hemophilia A
[Our experince with the use of recombinant activated factor VII in postpartum haemorrhage]
Hemophilia A
[Panorama of congenital disorders of hemostasis diseases at University Hospital of Brazzaville, Congo]
Hemophilia A
[Perioperative use of recombinant activated factor VII (rF VIIa) in a patient with hemophilia A having inhibitors]
Hemophilia A
[Problems of conductor demonstration in haemophilia A: error possibilities in the determination of factor-VIII-associated antigen]
Hemophilia A
[Recombinant activated Factor VII (Novoseven Novo Nordisk) for hemostasis in acquired Factor VIII-inhibitor hemophilia]
Hemophilia A
[Recombinant activated factor VII for perioperative bleeding]
Hemophilia A
[Recombinant activated factor VII in paediatric practice. Universal hemostatic agent?]
Hemophilia A
[Recombinant activated factor VII: a new treatment for hemophilia]
Hemophilia A
[Recombinant factor VIIa (NovoSeven). A review of current and possible future indications]
Hemophilia A
[Recombinant factor VIIa. A new alternative for patients with hemophilia]
Hemophilia A
[Recombinant plasma proteins for therapeutic use--status and developmental trends]
Hemophilia A
[Rehabilitation in haemophilic children with inhibitors using recombinant activated factor VII]
Hemophilia A
[Serological markers of hepatitis B virus and cytomegalovirus in patients with hemophilia]
Hemophilia A
[Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII]
Hemophilia A
[Successful treatment of hemothorax with recombinant factor VIIa in a hemophilic child with inhibitor]
Hemophilia A
[The use of activated recombinant factor VII in the treatment of nasopharyngeal hemorrhage in a patient with extensive fronto-basal injuries. Case report]
Hemophilia A
[Thrombocyte aggregation and the secretion reaction in hemophilia patients]
Hemophilia A
[Treatment and prevention of haemorrhage with recombinant activated factor VII, not only in hemophilia]
Hemophilia A
[Treatment of psoas haematoma in a patient with haemophilia and inhibitors]
Hemophilia A
[Use of recombinant activated factor VII]
Hemophilia A
[Use of recombinant, activated Factor VII in the treatment and prevention of bleeding complications in two female patients suffering from congenital XI factor deficiency during orthopedic and traumatology intervention. Case reports]
Hemophilia A
[Which urologic treatment alternatives are there for the hemophiliac patient?]
Hemophilia B
A Candidate Activation Pathway for Coagulation Factor VII.
Hemophilia B
A Factor VIIa Variant with Enhanced Tissue Factor Independent Activity Speeds Wound Healing in a Mouse Hemophilia B Model.
Hemophilia B
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
Hemophilia B
A novel therapeutic approach combining human plasma-derived Factors VIIa and X for haemophiliacs with inhibitors: evidence of a higher thrombin generation rate in vitro and more sustained haemostatic activity in vivo than obtained with Factor VIIa alone.
Hemophilia B
Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency.
Hemophilia B
Advances in gene therapy using factor VIIa in hemophilia.
Hemophilia B
An immunological investigation of hemophilia B with a tentative classification of the disease into five variants.
Hemophilia B
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
Hemophilia B
Antibodies to factor VIIa in patients with haemophilia and high-responding inhibitors.
Hemophilia B
Antigenicity of activated recombinant factor VII followed through nine years of clinical experience.
Hemophilia B
Arthroscopic synovectomy of the elbow covered with rFVIIa in a haemophilia B juvenile with inhibitor.
Hemophilia B
Characterization of heterogeneity of haemophilia B for the detection of carriers.
Hemophilia B
Christmas disease associated with factor VII deficiency; case report with family survey.
Hemophilia B
Clinical and laboratory features of 178 children with recurrent epistaxis.
Hemophilia B
Clinical audit of inherited bleeding disorders in a developing country.
Hemophilia B
Comparison of the effect of plasma-derived and recombinant human FVIIa in vitro and in a rabbit model.
Hemophilia B
Current status of hemophilia patients and recombinant coagulation factor concentrates in Japan.
Hemophilia B
Determinants of coagulation activation in humans.
Hemophilia B
Determinants of plasma factor VIIa levels in humans.
Hemophilia B
Development of novel treatment options for patients with haemophilia.
Hemophilia B
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.
Hemophilia B
Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma.
Hemophilia B
Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin.
Hemophilia B
Factor IX variants of hemophilia B. The effect of activated factor XI and the reaction product of factor VII and tissue factor on the abnormal factor IX molecules.
Hemophilia B
Factor VII activity and antigen in haemophilia B variants.
Hemophilia B
Factor VIIa in the treatment of haemophilia.
Hemophilia B
Factor VIIa levels are decreased in patients with hemophilia B.
Hemophilia B
FVIIa as used pharmacologically is not TF dependent in hemophilia B mice.
Hemophilia B
Hemophilia B associated with a decreased factor VII activity.
Hemophilia B
Hemophilia B associated with decreased factor VII activity.
Hemophilia B
Hemophilia B with associated factor VII deficiency: a distinct variant of hemophilia B with low factor VII activity and normal factor VII antigen.
Hemophilia B
High dose factor VIIa improves clot structure and stability in a model of haemophilia B.
Hemophilia B
How factor VIIa works in hemophilia.
Hemophilia B
Improved coagulation in bleeding disorders by Non-Anticoagulant Sulfated Polysaccharides (NASP).
Hemophilia B
Influence of factor VIIa and phospholipids on coagulation in "acquired" hemophilia.
Hemophilia B
Iron studies in hemophilia.
Hemophilia B
Long-term expression of murine activated factor VII is safe, but elevated levels cause premature mortality.
Hemophilia B
Low endoscopy bleeding risk in patients with congenital bleeding disorders.
Hemophilia B
Major differences in bleeding symptoms between factor VII deficiency and hemophilia B.
Hemophilia B
Mechanism of factor VIIa-dependent coagulation in hemophilia blood.
Hemophilia B
Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements.
Hemophilia B
Multiple congenital coagulopathies co-expressed with Von Willebrand's disease: the experience of Hemophilia Region III Treatment Centers over 25 years and review of the literature.
Hemophilia B
Non-catheter associated venous thrombosis in hemophilia A and B. A critical review of all reported cases.
Hemophilia B
Novel products for haemostasis.
Hemophilia B
Novel therapeutic approach for hemophilia using gene delivery of an engineered secreted activated Factor VII.
Hemophilia B
NovoSeven in immune tolerance therapy.
Hemophilia B
Orthopaedic surgery in severe bleeding disorders: a low-volume, high-cost procedure.
Hemophilia B
Over-expression of factor VIIa in vivo.
Hemophilia B
Pharmacokinetics and pharmacodynamics of recombinant factor VIIa.
Hemophilia B
Poly-N-Acetylglucosamine Fibers Amplify the Effectiveness of Recombinant Factor VIIA on Clot Formation in Hemophilia B Canine Blood.
Hemophilia B
Pregnancy and oral contraceptives in congenital bleeding disorders of the vitamin K-dependent coagulation factors.
Hemophilia B
Prevalence of HIV infection in a cohort of patients with congenital coagulation defects of the prothrombin complex factors.
Hemophilia B
Prophylaxis Using a Mixture of Plasma-Derived Activated Factor VII and Factor X (pdFVIIa/FX) in a Patient with Hemophilia B Complicated by Inhibitors and Allergy to Factor IX Concentrates: A Case Report.
Hemophilia B
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
Hemophilia B
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
Hemophilia B
Recombinant activated factor VII in the treatment of bleeding episodes in patients with inherited and acquired bleeding disorders.
Hemophilia B
Recombinant factor IX.
Hemophilia B
Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders.
Hemophilia B
Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.
Hemophilia B
Recombinant factor VIIa (NovoSeven) in the treatment of internal bleeding in patients with factor VIII and IX inhibitors.
Hemophilia B
Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors.
Hemophilia B
Registry of Hemophilia and other bleeding disorders in Syria.
Hemophilia B
Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors.
Hemophilia B
Replacing the first epidermal growth factor-like domain of factor IX with that of factor VII enhances activity in vitro and in canine hemophilia B.
Hemophilia B
Rituximab in the treatment of alloimmune factor VIII and IX antibodies in two children with severe haemophilia.
Hemophilia B
Robustness of factor assays following cordocentesis in the prenatal diagnosis of haemophilia and other bleeding disorders.
Hemophilia B
Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a phase I study.
Hemophilia B
The clotting system - a major player in wound healing.
Hemophilia B
Thrombin generation and platelet activation induced by rFVIIa (NovoSeven) and NN1731 in a reconstituted cell-based model mimicking haemophilia conditions.
Hemophilia B
Very low activated factor VII and reduced factor VII antigen in familial abetalipoproteinaemia.
Hemophilia B
Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
Hemophilia B
[Acquired haemophilia B: a case report and literature review].
Hemophilia B
[Infective morbidity of replacement therapy in congenital coagulation deficiencies and its effects on demand of coagulation factors]
Hemophilia B
[On a case of Christmas disease associated with factor VII deficiency.]
Hemophilia B
[Successful completion of left total hip arthroplasty by inhibitor neutralization therapy in a hemophilia B patient with high responding inhibitor].
Hemophilia B
[Thrombocyte aggregation and the secretion reaction in hemophilia patients]
Hemoptysis
A case of massive airway clotting after use of activated factor VII for massive hemoptysis: management with flexible bronchoscopy and cryoadhesion.
Hemoptysis
Combined factor VII and protein C deficiency found in a patient with peripheral pulmonary artery stenosis accompanied by progressive pulmonary hypertension and hemoptysis.
Hemoptysis
Recombinant activated factor VII for massive hemoptysis in patients with cystic fibrosis.
Hemoptysis
Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis.
Hemoptysis
Successful treatment of massive hemoptysis in acute leukemia with recombinant factor VIIa.
Hemoptysis
Successful use of recombinant activated coagulation factor VII in a patient with massive hemoptysis from a penetrating thoracic injury.
Hemoptysis
Successful use of recombinant factor VII in massive hemoptysis due to community-acquired pneumonia.
Hemoptysis
Traumatic hemoptysis treated with recombinant human factor VIIa.
Hemorrhagic Disorders
Another patient with a congenital hemorrhagic disorder intermediate between factor X and factor VII deficiency.
Hemorrhagic Disorders
Functional and Molecular Characterization of C91S Mutation in the Second Epidermal Growth Factor-Like Domain of Factor VII.
Hemorrhagic Disorders
Genetic deficiency of factor VII and hemorrhagic diathesis. A case report and literature review.
Hemorrhagic Disorders
Genotypic heterogeneity may explain phenotypic variations in inherited factor VII deficiency.
Hemorrhagic Disorders
Hemorrhagic diathesis due to factor VII deficiency.
Hemorrhagic Disorders
Phenotypic and genotypic characterization of four factor VII deficiency patients from central China.
Hemorrhagic Disorders
Prevention of bleeding and hemorrhagic complications in surgical patients with inherited factor VII deficiency.
Hemorrhagic Disorders
Recombinant Factor VIIa Use for Endoscopic Retrograde Cholangiopancreatography With Sphincterotomy in a Patient With Choledocholithiasis and Unusual Coagulopathy.
Hemorrhagic Disorders
Recurrent intracranial haemorrhages in a patient with factor seven deficiency: a case report.
Hemorrhagic Disorders
Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
Hemorrhagic Disorders
Surgery in patients with congenital factor VII deficiency - a single center study.
Hemorrhagic Disorders
Surgery in patients with congenital factor VII deficiency: A single center experience.
Hemorrhagic Disorders
The use of recombinant activated factor VII in the circumcision operation in the case of a congenital factor VII deficiency.
Hemorrhagic Disorders
Tissue factor-independent effects of recombinant factor VIIa on hemostasis.
Hemorrhagic Disorders
Total hip arthroplasty in severe congenital factor VII deficiency: successful use of recombinant activated factor VII for hemostasis.
Hemorrhagic Disorders
[A case of congenital hemorrhagic diathesis due to factor VII deficiency (hypoproconvertinemia)]
Hemorrhagic Disorders
[APROPOS OF HEMORRHAGIC DIATHESIS CAUSED BY A DEFICIT OF FACTOR VII.]
Hemorrhagic Disorders
[Clinical studies of familial hereditary factor VII deficiency (author's transl)]
Hemorrhagic Disorders
[Congenital factor VII (SPCA) deficiency as the cause of hemophilic-type hemorrhagic diathesis.]
Hemorrhagic Disorders
[Hemorrhagic diathesis caused by factor VII (proconvertin) deficiency.]
Hemorrhagic Disorders
[Hemorrhagic diathesis due to factor VII deficiency (hypoproconvertinemia).]
Hemorrhagic Disorders
[New possibilities in the management of hemorrhagic diathesis caused by factor deficiency and thrombocytopenia: recombinant active factor VII concentrate]
Hemorrhagic Disorders
[Prophylactic use of a recombinant activated factor VII in delivery haemorrhage by caesarean in a woman with major factor VII deficiency: a case report].
Hemorrhagic Fever, Ebola
Multiple roles of the coagulation protease cascade during virus infection.
Hemorrhagic Stroke
Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?
Hemorrhagic Stroke
Hemorrhagic stroke in a child with protein S and factor VII deficiencies.
Hemorrhagic Stroke
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.
Hemorrhagic Stroke
Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system.
Hemorrhagic Stroke
The role of recombinant-activated factor VII in bleeding trauma patients.
Hemorrhagic Stroke
Thromboembolic events with recombinant activated factor VII in spontaneous intracerebral hemorrhage: results from the Factor Seven for Acute Hemorrhagic Stroke (FAST) trial.
Hemorrhagic Stroke
[Management and predictors in patients with spontaneous intracerebral hemorrhage.]
Hemostatic Disorders
Disseminated intravascular coagulation associated with low factor VII. Evidence for a new type of hemostatic disorder.
Hemostatic Disorders
Inadvertent propagation of factor VII deficiency in a canine mucopolysaccharidosis type I research breeding colony.
Hemostatic Disorders
Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
Hemostatic Disorders
[Use of recombinant activated factor VII]
Hemothorax
Cardiac tamponade in a patient with moderate hemophilia A and factor VIII Inhibitors.
Hemothorax
Successful Treatment of Intractable Hemothorax with Recombinant Factor VIIa in a Nonhemophilic Patient.
Hemothorax
[Successful treatment of hemothorax with recombinant factor VIIa in a hemophilic child with inhibitor]
Hepatic Encephalopathy
Treatment of fulminant hepatic failure with intravenous prostaglandin E1.
Hepatic Insufficiency
1-year survey of patients with advanced liver cirrhosis. Prognostic value of clinical and laboratory indexes identified by the Cox regression model.
Hepatic Insufficiency
Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosis.
Hepatic Insufficiency
Prekallikrein and factor VII as prognostic indexes of liver failure.
Hepatic Veno-Occlusive Disease
[Hemostasis tests as markers of hepatic and endothelial toxicity in chemotherapy]
Hepatitis
Factor VII deficiency in pregnancy treated with recombinant factor VIIa.
Hepatitis
Non-A/non-B hepatitis in experimentally infected chimpanzees: cross-challenge and electron microscopic studies.
Hepatitis
Prekallikrein and factor VII as prognostic indexes of liver failure.
Hepatitis
Segmental liver transplantation from non-heart beating donors-an early experience with implications for the future.
Hepatitis
The predictive value factor VII in acute hepatitis and coagulapathy. Is it really predictive?
Hepatitis
The predictive value of admission and follow up factor V and VII levels in patients with acute hepatitis and coagulopathy.
Hepatitis
Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate.
Hepatitis A
Transmission of symptomatic parvovirus B19 infection by clotting factor concentrate.
Hepatitis B
Heterozygous factor VII deficiency and severe hemophilia A in the same kindred.
Hepatitis B
Treatment of inherited platelet disorders.
Hepatitis B
[Serological markers of hepatitis B virus and cytomegalovirus in patients with hemophilia]
Hepatitis C
Congenital factor VII deficiency in Iraqi children (Single Centre Experience).
Hepatitis C
Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis.
Hepatitis C
Ribavirin-induced intracellular GTP depletion activates transcription elongation in coagulation factor VII gene expression.
Hepatitis C
Small dose of recombinant factor VIIa (rFVIIa) to perform percutaneous liver biopsies in cirrhotic patients.
Hepatitis C, Chronic
Small dose of recombinant factor VIIa (rFVIIa) to perform percutaneous liver biopsies in cirrhotic patients.
Hepatitis C, Chronic
[Mathematic Model for Prediction of Liver Fibrosis Progression Rate in Patients with Chronic Hepatitis C Based on Combination of Genomic Markers].
Hepatitis, Chronic
Factor VII deficiency and its treatment in delivery with recombinant factor VII.
Hepatitis, Chronic
Prekallikrein and factor VII as prognostic indexes of liver failure.
Hepatitis, Chronic
Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms.
Hepatoblastoma
Recombinant factor VIIa for intraoperative bleeding in a child with hepatoblastoma and review of recombinant activated factor VIIa use in children undergoing surgery.
Hepatoblastoma
Segmental liver transplantation from non-heart beating donors-an early experience with implications for the future.
Hepatoblastoma
Two common functional polymorphisms in the promoter region of the coagulation factor VII gene determining plasma factor VII activity and mass concentration.
Hepatolenticular Degeneration
Application of recombinant activated factor VII for treatment of impaired haemostasis during liver transplantation in recipients with Wilson's disease--a report of two cases.
Hepatolenticular Degeneration
Preemptive administration of recombinant factor VII (rVIIa) in patients transplanted due to fulminant Wilson's disease.
Hepatolenticular Degeneration
Whole-exome sequencing provides insights into monogenic disease prevalence in Northwest Russia.
Hermanski-Pudlak Syndrome
Successful thyroidectomy in a patient with Hermansky-Pudlak syndrome treated with recombinant activated factor VII and platelet concentrates.
Herpes Simplex
Coagulation factor VIIa binds to herpes simplex virus 1-encoded glycoprotein C forming a factor X-enhanced tenase complex oriented on membranes.
Herpes Simplex
Herpes simplex virus type 1-encoded glycoprotein C enhances coagulation factor VIIa activity on the virus.
Herpes Simplex
Novel Agents in the Management of Pancreatic Adenocarcinoma: Phase I Studies. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Hodgkin Disease
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Homocystinuria
Superior sagittal sinus thrombosis with homocystinuria and deficiency of antithrombin III and factor VII: case report.
Homocystinuria
Tissue factor pathway inhibitor levels in patients with homocystinuria.
Homocystinuria
[Factor VII deficiency and homocystinuria. Chance association or syndrome?]
Homocystinuria
[Homocystinuria and factor VII deficiency]
Hydrocephalus
A rare combination: congenital factor VII deficiency with Chiari malformation.
Hydrocephalus
Familial factor VII deficiency with foetal and neonatal fatal cerebral haemorrhage associated with homozygosis to Gly180Arg mutation.
Hydrocephalus
In silico method for identification of novel copper and iron metabolism proteins in various neurodegenerative disorders.
Hydrocephalus
Unexpected posthemorrhagic hydrocephalus in patients treated with rFVIIa.
Hydronephrosis
A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
Hydronephrosis
rFVIIa and obstructive hydronephrosis.
Hypercholesterolemia
Effect of monthly atorvastatin treatment on hemostasis.
Hypercholesterolemia
Hemostatic effects of simvastatin in subjects with impaired glucose tolerance.
Hypercholesterolemia
Increasing plasma fibrinogen, but unchanged levels of intraplatelet cyclic nucleotides, plasma endothelin-1, factor VII, and neopterin during cholesterol lowering with fluvastatin.
Hypercholesterolemia
Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia.
Hypercholesterolemia
[Lipids/hemostasis interactions. A new approach to cardiovascular risk factors]
Hyperglycemia
Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia.
Hyperglycemia
Hemostasis and glycemic control in the cardiac surgical patient.
Hyperglycemia
Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes and Effects of Hyperglycemia and Hyperinsulinemia.
Hyperhomocysteinemia
Analysis of polymorphisms Leiden Factor V G1691A and prothrombin G20210A as risk factors for acute myocardial infarction.
Hyperhomocysteinemia
Assessment of hemostatic risk factors in predicting arterial thrombotic events.
Hyperinsulinism
Cardiovascular risk factors: interactive effects of lipids, coagulation and fibrinolysis.
Hyperinsulinism
Characteristics of the insulin resistance syndrome in a Japanese population. The Jichi Medical School Cohort Study.
Hyperinsulinism
Hemostasis and glycemic control in the cardiac surgical patient.
Hyperinsulinism
Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients.
Hyperinsulinism
Whole-Blood Tissue Factor Procoagulant Activity Is Elevated in Type 1 Diabetes and Effects of Hyperglycemia and Hyperinsulinemia.
Hyperinsulinism
[Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome]
Hyperlipidemias
Activation of coagulation factor VII during alimentary lipemia.
Hyperlipidemias
Activation of factor VII during alimentary lipemia occurs in healthy adults and patients with congenital factor XII or factor XI deficiency, but not in patients with factor IX deficiency.
Hyperlipidemias
Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia.
Hyperlipidemias
Atorvastatin reduces plasma levels of factor VII activity and factor VII antigen in patients with hyperlipidemia.
Hyperlipidemias
Dietary fat and postprandial lipids.
Hyperlipidemias
Dietary fatty acids, hemostasis, and cardiovascular disease risk.
Hyperlipidemias
Do oxidized fatty acids activate coagulation factor VII during post-prandial lipemia in women?
Hyperlipidemias
Effect of individual dietary fatty acids on postprandial activation of blood coagulation factor VII and fibrinolysis in healthy young men.
Hyperlipidemias
Effect of interesterification of palmitic acid-rich triacylglycerol on postprandial lipid and factor VII response.
Hyperlipidemias
Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipemia in patients with combined hyperlipemia.
Hyperlipidemias
Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
Hyperlipidemias
Hemostasis and cardiovascular risk. The British and European experience.
Hyperlipidemias
In vivo demonstration in humans that large postprandial triglyceride-rich lipoproteins activate coagulation factor VII through the intrinsic coagulation pathway.
Hyperlipidemias
Increased activity of factor VII and factor VII-phospholipid complex measured using a Normotest system in subjects with hyperlipidemia.
Hyperlipidemias
Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial triglyceridemia in patients with ischemic heart disease confirmed by angiography.
Hyperlipidemias
Influence of a stearic acid-rich structured triacylglycerol on postprandial lipemia, factor VII concentrations, and fibrinolytic activity in healthy subjects.
Hyperlipidemias
Influence of fatty acid chain length and cis/trans isomerization on postprandial lipemia and factor VII in healthy subjects (postprandial lipids and factor VII).
Hyperlipidemias
Influence of stearic acid on hemostatic risk factors in humans.
Hyperlipidemias
Influence of stearic acid on postprandial lipemia and hemostatic function.
Hyperlipidemias
Influence of triacylglycerol structure on the postprandial response of factor VII to stearic acid-rich fats.
Hyperlipidemias
Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Hyperlipidemias
Long-chain n-3 polyunsaturated fatty acids and triacylglycerol metabolism in the postprandial state.
Hyperlipidemias
Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
Hyperlipidemias
Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
Hyperlipidemias
Relationship between apolipoprotein E polymorphism, postprandial hyperlipemia and hemostatic variables in patients with combined hyperlipemia.
Hyperlipidemias
Relationship between thyroid hormones and plasma D-dimer levels.
Hyperlipidemias
Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients.
Hyperlipidemias
The impact of postprandial lipemia in accelerating atherothrombosis.
Hyperlipidemias
The solid fat content of stearic acid-rich fats determines their postprandial effects.
Hyperlipidemias
Treatment with cerivastatin in primary mixed hyperlipidemia induces changes in platelet aggregation and coagulation system components.
Hyperlipidemias
[Hemostasis profiles in thrombotic disease]
Hyperlipoproteinemia Type II
R353Q polymorphism in the factor VII gene and cardiovascular risk in Heterozygous Familial Hypercholesterolemia: a case-control study.
Hyperlipoproteinemia Type II
[The relationships between the lipoprotein profile and rheological-coagulation parameters in patients with hyperlipoproteinemia type II]
Hyperlipoproteinemias
Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons.
Hyperlipoproteinemias
Increased activity of factor VII and factor VII-phospholipid complex measured using a Normotest system in subjects with hyperlipidemia.
Hyperlipoproteinemias
Relationship between triglycerides and factor VIIc and plasminogen activator inhibitor type-1: lack of threshold value.
Hyperlipoproteinemias
[Changes in the level of certain hemostatic factors during treatment with lovastatin in patients with primary hyperlipoproteinemia and phenotype IIa and IIb]
Hyperlipoproteinemias
[The relationships between the lipoprotein profile and rheological-coagulation parameters in patients with hyperlipoproteinemia type II]
Hyperoxaluria, Primary
Segmental liver transplantation from non-heart beating donors-an early experience with implications for the future.
Hyperparathyroidism, Primary
Blood coagulation, fibrinolysis and lipid profile in patients with primary hyperparathyroidism: increased plasma factor VII and X activities and D-Dimer levels.
Hypersensitivity
Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
Hypersensitivity
Prophylaxis Using a Mixture of Plasma-Derived Activated Factor VII and Factor X (pdFVIIa/FX) in a Patient with Hemophilia B Complicated by Inhibitors and Allergy to Factor IX Concentrates: A Case Report.
Hypersensitivity
Thrombelastography monitoring of platelet substitution therapy and rFVIIa administration in haemato-oncological patients with severe thrombocytopenia.
Hypersensitivity, Immediate
Avoiding Cardiovascular Collapse: Pediatric Cutaneous Mastocytosis and Anesthetic Challenges.
Hypertension
Are risk factors for atherothrombotic disease associated with back pain sickness absence? The Whitehall II Study.
Hypertension
Association between factor VII polymorphisms and blood pressure: the Stanislas Cohort.
Hypertension
Characteristics of the insulin resistance syndrome in a Japanese population. The Jichi Medical School Cohort Study.
Hypertension
Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.
Hypertension
Effects of lipids and lipid-lowering therapy on hemostatic factors in patients with myocardial infarction.
Hypertension
Exercise training in mild hypertension: effects on blood pressure, left ventricular mass and coagulation factor VII and fibrinogen.
Hypertension
Factor VII activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: results of an 11-year follow-up.
Hypertension
Factor VII hyperactivity and endothelial cell damage are found in elderly hypertensives only when concomitant with microalbuminuria.
Hypertension
Factor VII levels, R353Q and -323P0/10 Factor VII variants, and the risk of acute coronary syndrome among Arab-African Tunisians.
Hypertension
Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
Hypertension
Haemostatic and other cardiovascular risk factors, and socioeconomic status among middle-aged Finnish men and women.
Hypertension
Haemostatic markers are associated with measures of vascular disease in adults with hypertension.
Hypertension
High factor VIII, von Willebrand factor, and fibrinogen levels and risk of venous thromboembolism in blacks and whites.
Hypertension
Hyperlipidemia, hypercoagulability, and accelerated thrombosis: studies in congenitally hyperlipidemic rats and in rats and monkeys with induced hyperlipidemia.
Hypertension
Microalbuminuria and endothelial dysfunction in essential hypertension.
Hypertension
Procoagulant stress reactivity and recovery in apparently healthy men with systolic and diastolic hypertension.
Hypertension
Prothrombin fragment 1.2 in both treated and untreated hypertensive patients.
Hypertension
Reducing the burden of diabetes: managing cardiovascular disease.
Hypertension
Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension.
Hypertension
Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism.
Hypertension
Takayasu Arteritis Presenting as Renovascular Hypertension and Renal Failure in a Patient with Factor VII Deficiency.
Hypertension
[Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease]
Hypertension
[Polymorphism (353)R>Q of Gene of Blood Clotting Factor FVII and Plasma Hemostasis].
Hypertension, Portal
Splenectomy Improves Hemostatic and Liver Functions in Hepatosplenic Schistosomiasis Mansoni.
Hypertension, Portal
Splenic embolization in a Jehovah's Witness: role of recombinant human factor VIIa.
Hypertension, Portal
[Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures]
Hypertension, Pulmonary
Combined factor VII and protein C deficiency found in a patient with peripheral pulmonary artery stenosis accompanied by progressive pulmonary hypertension and hemoptysis.
Hypertension, Pulmonary
Recombinant factor VIIa to treat bleeding after cardiac surgery in an infant.
Hypertension, Renovascular
Takayasu Arteritis Presenting as Renovascular Hypertension and Renal Failure in a Patient with Factor VII Deficiency.
Hyperthyroidism
Contact system activation and high thrombin generation in hyperthyroidism.
Hyperthyroidism
Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study.
Hypertriglyceridemia
Atorvastatin and omega-3 fatty acids protect against activation of the coagulation system in patients with combined hyperlipemia.
Hypertriglyceridemia
Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
Hypertriglyceridemia
Effects of fish oil supplements in NIDDM subjects. Controlled study.
Hypertriglyceridemia
Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons.
Hypertriglyceridemia
Hypercoagulability and factor VII in hypertriglyceridemia.
Hypertriglyceridemia
Phospholipase C sensitive FVII activity and FVII antigen in hypertriglyceridemia.
Hypertrophy, Left Ventricular
Canonical correlation analysis for gene-based pleiotropy discovery.
Hypertrophy, Left Ventricular
[The indices of the fibrinolysis, blood coagulation and lipid transport systems in hypertension patients]
Hypocalcemia
Resuscitation and transfusion principles for traumatic hemorrhagic shock.
Hypoglycemia
Rabbit hemorrhagic viral disease: characterization of a new animal model of fulminant liver failure.
Hypoprothrombinemias
Comparison between the one-stage prothrombin time and factor VII and X complex determination in bishydroxycoumarin-induced hypoprothrombinemia countered by phytonadione.
Hypoprothrombinemias
Diagnosis, clinical manifestations and management of rare bleeding disorders in Iran.
Hypoprothrombinemias
[Effects of vitamin K1 on factor VII and prothrombin deficiency in newborn.]
Hypoprothrombinemias
[Idiopathic hemorrhagic disease due to factor VII and prothrombin deficiency.]
Hypotension
Acute hypotension associated with intraoperative cell salvage using a leukocyte depletion filter during management of obstetric hemorrhage due to amniotic fluid embolism.
Hypotension
Damage control resuscitation: a sensible approach to the exsanguinating surgical patient.
Hypotension
Recombinant tissue factor pathway inhibitor prevents lipopolysaccharide-induced systemic hypotension in rats by inhibiting excessive production of nitric oxide.
Hypotension
Reducing perioperative blood loss and allogeneic blood transfusion in patients undergoing major spine surgery.
Hypotension
[Trauma-induced coagulopathy--mechanisms and state of the art treatment].
Hypothyroidism
Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine.
Hypothyroidism
Effects of Thyroid Function on Hemostasis, Coagulation, and Fibrinolysis: A Mendelian Randomization Study.
Hypothyroidism
Hemostasis in Hypothyroidism and Autoimmune Thyroid Disorders.
Hypothyroidism
Increased thrombin-activatable fibrinolysis inhibitor and decreased tissue factor pathway inhibitor in patients with hypothyroidism.
Ichthyosis
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Idiopathic Pulmonary Fibrosis
Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease.
Idiopathic Pulmonary Fibrosis
Role of Protease-Activated Receptor-2 in Idiopathic Pulmonary Fibrosis.
IgA Vasculitis
Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
Immunoglobulin Light-chain Amyloidosis
Acquired factor VII deficiency causing severe bleeding disorder secondary to AL amyloidosis of the liver.
Immunoglobulin Light-chain Amyloidosis
Successful perioperative management of factor X deficiency associated with primary amyloidosis.
Infarction, Middle Cerebral Artery
[Acute stroke therapy : Current developments.]
Infections
A new scoring system to determine thromboembolic risk after heart valve replacement.
Infections
Acquired factor VII deficiency associated with acute myeloid leukemia.
Infections
Avoiding Cardiovascular Collapse: Pediatric Cutaneous Mastocytosis and Anesthetic Challenges.
Infections
Bmal1 Regulates Coagulation Factor Biosynthesis in Mouse Liver in Streptococcus oralis Infection.
Infections
Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion.
Infections
Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
Infections
Endogenous Heparinoids May Cause Bleeding in Mucor Infection and can be Detected by Nonactivated Thromboelastometry and Treated by Recombinant Activated Factor VII: A Case Report.
Infections
Factor VII deficiency and pregnancy: a case report and review of literature.
Infections
Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation. A link between infection and acute myocardial infarction?
Infections
Influence of coagulation factor zymogens on the infectivity of adenoviruses pseudotyped with fibers from subgroup D.
Infections
Inhibition of the extrinsic or intrinsic coagulation pathway during pneumonia derived sepsis.
Infections
Isolated acquired factor VII deficiency: review of the literature.
Infections
Plasma levels of activated FVII in various diseases.
Infections
Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections.
Infections
Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies.
Infections
Recombinant Human Factor VIIa for Alveolar Hemorrhage Following Allogeneic Stem Cell Transplantation.
Infections
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease.
Infections
Septic miscarriage with toxic shock syndrome and disseminated intravascular coagulation (DIC): The role of surgery, recombinant activated factor VII and intravenous immunoglobulin (IVIG).
Infections
Successful induction of immune tolerance with FIX recombinant in a patient with haemophilia B with inhibitor.
Infections
The procoagulant envelope virus surface: contribution to enhanced infection.
Infections
Tissue factor and glycoprotein C on herpes simplex virus type 1 are protease activated receptor 2 cofactors that enhance infection.
Infections
[Acquired and repeated factor VII deficiency during infections outbreaks: case-report]
Insulin Resistance
Albuminuria is directly associated with increased plasma PAI-1 and factor VII levels in NIDDM patients.
Insulin Resistance
Analysis of the correlation between plasma coagulation factor VII, PAI-1, and uric acid with insulin resistance and macrovascular complications in elderly patients with type 2 diabetes.
Insulin Resistance
Association of inflammation markers with impaired insulin sensitivity and coagulative activation in obese healthy women.
Insulin Resistance
Circulating levels of factor VII, fibrinogen, and von Willebrand factor and features of insulin resistance in first-degree relatives of patients with NIDDM.
Insulin Resistance
Coagulation factor VII activity, Arg/Gln353 polymorphism and features of insulin resistance in first-degree-relatives of South Asian patients with stroke.
Insulin Resistance
Dietary treatment of thrombogenic disorders related to the metabolic syndrome.
Insulin Resistance
Estrogen replacement therapy and cardiovascular protection: lipid mechanisms are the tip of an iceberg.
Insulin Resistance
Factor VII gene polymorphisms, factor VII:C levels and features of insulin resistance in non-insulin-dependent diabetes mellitus.
Insulin Resistance
Inhibition of thrombin action ameliorates insulin resistance in type 2 diabetic db/db mice.
Insulin Resistance
Interrelationship between coagulation factor VII and obesity in diabetes mellitus (type 2).
Insulin Resistance
Interrelationships of factor VII activity and plasma leptin with insulin resistance in coronary heart disease.
Insulin Resistance
Is there a menopausal metabolic syndrome?
Insulin Resistance
Moderate red wine consumption and cardiovascular disease risk: beyond the "French paradox".
Insulin Resistance
Obesity, haemostasis and the fibrinolytic system.
Insulin Resistance
Polymorphisms of coagulation/fibrinolysis genes: gene environment interactions and vascular risk.
Insulin Resistance
The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Insulin Resistance
Thrombogenic and fibrinolytic factors and cardiovascular risk in non-insulin-dependent diabetes mellitus.
Insulin Resistance
[Atheroma and antithrombotic agents]
Insulin Resistance
[Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome]
Insulin Resistance
[Relationship between parameters of hemostasis and manifestations of the metabolic syndrome in men with mild and moderate hypertension]
Intellectual Disability
Congenital combined defects of factor VII: a critical review.
Intellectual Disability
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
Intestinal Atresia
Inherited thrombophilia: a possible cause of in utero vascular thrombosis in children with intestinal atresia.
Intra-Abdominal Hypertension
A novel use of recombinant factor VIIa in HELLP syndrome associated with spontaneous hepatic rupture and abdominal compartment syndrome.
Intracranial Aneurysm
A Rare Case Report of Multiple Intracranial Aneurysms with Factor VII Deficiency.
Intracranial Aneurysm
Multiple cerebral aneurysms in factor VII deficiency.
Intracranial Aneurysm
[Congenital factor VII deficiency and subarachnoidal haemorrhage due to intracranial aneurysm: a case report]
Intracranial Arteriosclerosis
The influence of the degree of cerebral atherosclerosis on the changes in hemostatic system in patients with ischemic brain disease and atherosclerotic encephalopathy.
Intracranial Arteriovenous Malformations
Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis.
Intracranial Embolism
Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method.
Intracranial Hemorrhage, Traumatic
The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage.
Intracranial Hemorrhages
A case of intracranial hemorrhage in a neonate with congenital factor VII deficiency.
Intracranial Hemorrhages
A Neonate with Acquired Factor VII Deficiency Successfully Managed with Immunomodulatory Therapy.
Intracranial Hemorrhages
A novel homozygous missense mutation in the factor VII gene of severe factor VII deficiency in a newborn baby.
Intracranial Hemorrhages
Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program.
Intracranial Hemorrhages
Acute intracranial hemorrhage in a cirrhotic controlled with recombinant factor VIIa.
Intracranial Hemorrhages
Asymptomatic intracranial hemorrhage in a newborn with congenital factor VII deficiency and successful treatment with recombinant activated factor VII.
Intracranial Hemorrhages
Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.
Intracranial Hemorrhages
Coagulation factor VIIa (recombinant) for warfarin-induced intracranial hemorrhage.
Intracranial Hemorrhages
Comparison of a Low, Fixed Dose and a High, Weight-Based Dose of Recombinant Factor VIIa in the Treatment of Warfarin-Associated Intracranial Hemorrhage.
Intracranial Hemorrhages
Congenital factor VII deficiency complicated with hemoperitoneum and intracranial hemorrhage: report of a case.
Intracranial Hemorrhages
Congenital factor VII deficiency.
Intracranial Hemorrhages
Dabigatran etexilate: management in acute ischemic stroke.
Intracranial Hemorrhages
Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage.
Intracranial Hemorrhages
Effects of recombinant factor VIIa on thrombin generation and thromboelastography in a patient with dabigatran-associated intracranial hemorrhage.
Intracranial Hemorrhages
Factor VII deficiency with intracranial hemorrhage: a case report.
Intracranial Hemorrhages
Fatal intracranial hemorrhage in a newborn with factor VII deficiency.
Intracranial Hemorrhages
Genotype and phenotype correlation in intracranial hemorrhage in neonatal factor VII deficiency among Thai children.
Intracranial Hemorrhages
Hereditary factor VII deficiency: report of a case of intracranial hemorrhage.
Intracranial Hemorrhages
Heterozygous congenital Factor VII deficiency with the 9729del4 mutation, associated with severe spontaneous intracranial bleeding in an adolescent male.
Intracranial Hemorrhages
Intracellular readthrough of nonsense mutations by aminoglycosides in coagulation factor VII.
Intracranial Hemorrhages
Intracranial hemorrhage in congenital factor VII deficiency.
Intracranial Hemorrhages
Management of Life-Threatening Hemorrhages and Unsafe Interventions in Nonhemophiliac Children by Recombinant Factor VIIa.
Intracranial Hemorrhages
Mortality and Factors Associated With Hemorrhage During Pediatric Extracorporeal Membrane Oxygenation.
Intracranial Hemorrhages
Multiple intracranial hemorrhages at the time of a transiently prolonged activated partial thromboplastin time in an infant with congenital factor VII deficiency.
Intracranial Hemorrhages
Neonatal intracranial hemorrhage secondary to congenital factor VII deficiency: two case reports.
Intracranial Hemorrhages
Novel IVS7+1G>T mutation of life-threatening congenital factor VII deficiency in neonates: A retrospective study in China.
Intracranial Hemorrhages
Outcome of intracranial hemorrhage in infants with congenital factor VII deficiency.
Intracranial Hemorrhages
Pharmacology and clinical use of recombinant activated factor seven in neurosciences.
Intracranial Hemorrhages
Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Intracranial Hemorrhages
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic.
Intracranial Hemorrhages
Polymorphisms of clotting factors modify the risk for primary intracranial hemorrhage.
Intracranial Hemorrhages
Prenatal exclusion of severe factor VII deficiency.
Intracranial Hemorrhages
Prophylaxis Using a Mixture of Plasma-Derived Activated Factor VII and Factor X (pdFVIIa/FX) in a Patient with Hemophilia B Complicated by Inhibitors and Allergy to Factor IX Concentrates: A Case Report.
Intracranial Hemorrhages
Rapid Warfarin Reversal in the Setting of Intracranial Hemorrhage: A Comparison of Plasma, Recombinant Activated Factor VII, and Prothrombin Complex Concentrate.
Intracranial Hemorrhages
RBC Exposure in Pediatric Extracorporeal Membrane Oxygenation: Epidemiology and Factors Associated With Large Blood Transfusion Volume.
Intracranial Hemorrhages
Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors.
Intracranial Hemorrhages
Recombinant activated factor VII (rFVIIa) treatment in infants with hemorrhage.
Intracranial Hemorrhages
Recombinant Activated Factor VII Use in Critically Ill Patients: Clinical Outcomes and Thromboembolic Events (April).
Intracranial Hemorrhages
Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma.
Intracranial Hemorrhages
Recombinant factor VIIa for rapid reversal of anticoagulant effect in patients with intracranial hemorrhage: the Israeli experience and review of the literature.
Intracranial Hemorrhages
Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage.
Intracranial Hemorrhages
Recombinant factor VIIa for warfarin-associated intracranial bleeding.
Intracranial Hemorrhages
Recombinant factor VIIa use in patients presenting with intracranial hemorrhage.
Intracranial Hemorrhages
Recurrent intracranial hemorrhage in an infant with congenital factor VII deficiency.
Intracranial Hemorrhages
rFVII for pediatric acute intracranial hemorrhage.
Intracranial Hemorrhages
Successful prophylaxis against intracranial hemorrhage using weekly administration of activated recombinant factor VII in a newborn with severe factor VII deficiency.
Intracranial Hemorrhages
Successful prophylaxis of intracranial hemorrhage in infants with severe congenital factor VII deficiency.
Intracranial Hemorrhages
Successful treatment of acute lymphoblastic leukemia with L-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child.
Intracranial Hemorrhages
Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature.
Intracranial Hemorrhages
The Judicious Use of Recombinant Factor VIIa.
Intracranial Hemorrhages
Thromboelastography to direct the administration of recombinant activated factor VII in a child with traumatic injury requiring massive transfusion.
Intracranial Hemorrhages
Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study.
Intracranial Hemorrhages
Treatment of warfarin-related intracranial hemorrhage: a comparison of prothrombin complex concentrate and recombinant activated factor VII.
Intracranial Hemorrhages
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency.
Intracranial Hemorrhages
Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
Intracranial Hemorrhages
Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.
Intracranial Hemorrhages
Use of three procoagulants in improving bleeding outcomes in the warfarin patient with intracranial hemorrhage.
Intracranial Hemorrhages
[Factor VII deficiency revealed by intracranial hemorrhage.]
Intracranial Hemorrhages
[Intracranial hemorrhage in an infant with congenital factor VII deficiency]
Intracranial Hemorrhages
[Recurrent intracranial hemorrhage in a nursing infant with congenital factor VII deficiency. Survival and follow-up after neurosurgical intervention]
Intracranial Thrombosis
Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method.
Invasive Pulmonary Aspergillosis
Successful Off-Label Use of Recombinant Factor VIIa and Coil Embolization in an Adolescent with Massive Hemoptysis Due to Invasive Pulmonary Aspergillosis.
Iron Deficiencies
Congenital factor VII deficiency presenting as iron deficiency anaemia--Case report.
Iron Deficiencies
Treatment of inherited platelet disorders.
Ischemic Stroke
A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.
Ischemic Stroke
Antiphospholipid syndrome with catastrophic bleeding and recurrent ischemic strokes as initial presentation of systemic lupus erythematosus.
Ischemic Stroke
Assessing Circulating Factor VIIa-Antithrombin Complexes in Acute Ischemic Stroke: A Pilot Study.
Ischemic Stroke
Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.
Ischemic Stroke
Association of genetic variants with coronary artery disease and ischemic stroke in a longitudinal population-based genetic epidemiological study.
Ischemic Stroke
Associations of activated coagulation factor VII and factor VIIa-antithrombin levels with genome-wide polymorphisms and cardiovascular disease risk.
Ischemic Stroke
Blood coagulation and fibrinolysis in acute ischaemic and haemorrhagic (intracerebral and subarachnoid haemorrhage) stroke: does decreased plasmin inhibitor indicate increased fibrinolysis in subarachnoid haemorrhage compared to other types of stroke?
Ischemic Stroke
Case Report: A 70-Year-Old Man with Undiagnosed Factor VII Deficiency Presented with Acute Ischemic Stroke.
Ischemic Stroke
Complications of recombinant activated human coagulation factor VII.
Ischemic Stroke
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Ischemic Stroke
Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular disease.
Ischemic Stroke
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk.
Ischemic Stroke
Factor VII antigen levels are differentially associated to etiological subtypes of ischaemic stroke.
Ischemic Stroke
Factor VII gene haplotypes and risk of ischemic stroke.
Ischemic Stroke
Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia.
Ischemic Stroke
Hemostatic factors as predictors of stroke and cardiovascular diseases: the FINRISK '92 Hemostasis Study.
Ischemic Stroke
Hemostatic risk factors in ischemic stroke.
Ischemic Stroke
Intracerebral hemorrhage: outcomes and eligibility for factor VIIa treatment in a National Stroke Registry.
Ischemic Stroke
Ischemic stroke after recombinant factor VIIa treatment in acquired hemophilia A patient.
Ischemic Stroke
Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency.
Ischemic Stroke
Meta-Analysis of Factor V, Factor VII, Factor XII, and Factor XIII-A Gene Polymorphisms and Ischemic Stroke.
Ischemic Stroke
Multiple ischemic strokes associated with use of recombinant activated factor VII.
Ischemic Stroke
Polymorphisms in platelet glycoprotein 1balpha and factor VII and risk of ischemic stroke: a meta-analysis.
Ischemic Stroke
Polymorphisms in the factor VII gene and ischemic stroke in young adults.
Ischemic Stroke
Polymorphisms of Genes Encoding Coagulation Factors II, V, VII, and XIII in Relation to Pediatric Ischemic Stroke: Family-based and Case-Control Study.
Ischemic Stroke
Protein Z in ischaemic stroke.
Ischemic Stroke
Recombinant activated factor VII for acute intracerebral hemorrhage.
Ischemic Stroke
Repeat measurement of case-control data: corrections for measurement error in a study of ischaemic stroke and haemostatic factors.
Ischemic Stroke
Risk factors of diffuse alveolar hemorrhage after acute ischemic stroke treated with tissue-type plasminogen activator. The effectiveness of activated recombinant factor VII treatment.
Ischemic Stroke
Safety of Anticoagulation Reversal in Patients Supported with Continuous-flow Left-ventricular Assist Devices.
Ischemic Stroke
The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial.
Ischemic Stroke
The tissue factor pathway in ischemic stroke.
Ischemic Stroke
Von Willebrand factor and risk of ischemic stroke.
Ischemic Stroke
[Acute treatment with recombinant factor VII is probably indicated for intracerebral haematoma]
Jaundice, Chronic Idiopathic
Active and inactive factor VII in Dubin-Johnson syndrome with factor-VII deficiency, hereditary factor-VII deficiency and on coumadin administration.
Jaundice, Chronic Idiopathic
Age estimates of ancestral mutations causing factor VII deficiency and Dubin-Johnson syndrome in Iranian and Moroccan Jews are consistent with ancient Jewish migrations.
Jaundice, Chronic Idiopathic
Hereditary deficiency of blood clotting factor VII and Dubin-Johnson syndrome in an Israeli family.
Joint Diseases
A syndrome of factor VII deficiency and abnormal platelet release reaction.
Joint Diseases
Arthropathies in factor VII deficiency: a case report.
Joint Diseases
Arthropathy and surgery in congenital factor VII deficiency.
Joint Diseases
Arthropathy in factor VII coagulation deficiency. Description of a clinical case.
Joint Diseases
Economic evaluation of major knee surgery with recombinant activated factor VII in hemophilia patients with high titer inhibitors and advanced knee arthropathy: exploratory results via literature-based modeling.
Joint Diseases
EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.
Joint Diseases
Long-term prophylaxis in severe factor VII deficiency.
Joint Diseases
Prevention of arthropathy: may it be extrapolated from patients without inhibitors to patients with inhibitors?
Joint Diseases
Prevention of haemarthrosis in a murine model of acute joint bleeding.
Joint Diseases
Rationale for the use of high dose rFVIIa in a high-titre inhibitor patient with haemophilia B during major orthopaedic procedures.
Joint Diseases
Severe factor VII deficiency due to a mutation disrupting an Sp1 binding site in the factor VII promoter.
Joint Diseases
The use of rituximab as an adjuvant for immune tolerance therapy in a hemophilia B boy with inhibitor and anaphylaxis to factor IX concentrate.
Kasabach-Merritt Syndrome
The use of recombinant activated factor VII during major surgery in a child with Kasabach-Merritt syndrome.
Kidney Calculi
Percutaneous Nephrolithotomy in Rare Bleeding Disorders: A Case Report and Review of the Literature.
Kidney Diseases
Congenital Factor VII Deficiency in Association With Bicuspid Aortic Valve and Multicystic Dysplastic Kidney Disease in a Child.
Kidney Failure, Chronic
Blood coagulation, fibrinolytic, and inhibitory proteins in end-stage renal disease: effect of hemodialysis.
Kidney Failure, Chronic
Kidney Transplant in a Patient With Factor VII Deficiency: Case Report.
Kidney Failure, Chronic
Management of Kidney Transplantation in a Factor VII-Deficient Patient: Case Report.
Kidney Failure, Chronic
Protracted bleeding after hirudin anticoagulation for cardiac surgery in a patient with HIT II and chronic renal failure.
Kidney Failure, Chronic
Recombinant factor VIIa reduces bleeding risk in patients on platelet aggregation inhibitors immediately prior to renal transplantation--a retrospective analysis.
Kidney Failure, Chronic
Successful use of recombinant factor VIIa (NovoSeven) in children with compartment syndrome: two case reports.
Kidney Failure, Chronic
Use of recombinant factor VIIa in patients with warfarin-associated intracranial hemorrhage.
Kidney Failure, Chronic
[Coagulation factor VII levels in uremic patients and theirs influence factors]
Klippel-Trenaunay-Weber Syndrome
Control of disseminated intravascular coagulation in Klippel-Trenaunay-Weber syndrome using enoxaparin and recombinant activated factor VIIa: a case report.
Klippel-Trenaunay-Weber Syndrome
Factor VII deficiency and a copper metabolism disorder in a patient with Klippel-Trenaunay syndrome.
Leiomyosarcoma
[Factor VII deficiency and surgery]
Leishmaniasis, Visceral
[Transitory deficiency of factor VII in a case of kala-azar]
Leptospirosis
Parenteral use of recombinant activated factor VII during diffuse alveolar hemorrhage secondary to leptospirosis.
Lethargy
Congenital factor VII deficiency.
Leukemia
Cerebral hemorrhage treated with NovoSeven in acute promyelocytic leukemia.
Leukemia
Elevated extracellular trap formation and contact system activation in acute leukemia.
Leukemia
IV. Anticoagulant activity of compound 48/80: inhibition of factor VII activation in leukemia THP-1 monocytes.
Leukemia
Management of Life-Threatening Hemorrhages and Unsafe Interventions in Nonhemophiliac Children by Recombinant Factor VIIa.
Leukemia
Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia.
Leukemia
Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia.
Leukemia
Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience.
Leukemia
Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven).
Leukemia
Successful treatment of massive hemoptysis in acute leukemia with recombinant factor VIIa.
Leukemia
Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : Report on one case and review of other uses in acute leukemias.
Leukemia
Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia.
Leukemia
[Hemostasis tests as markers of hepatic and endothelial toxicity in chemotherapy]
Leukemia
[Recombinant factor VIIa for the treatment of acute promyelocytic leukemia with severe bleeding: 8 cases report and literature review].
Leukemia, Biphenotypic, Acute
Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven).
Leukemia, Erythroblastic, Acute
Interference of activated factor VII in apoptosis of erytholeukemic K562 cells.
Leukemia, Lymphocytic, Chronic, B-Cell
Massive oral bleeding after full-mouth extraction in a patient with B-cell lymphocytic leukemia/small lymphocytic lymphoma reversed with recombinant activated factor VII.
Leukemia, Megakaryoblastic, Acute
Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia.
Leukemia, Myeloid, Acute
Acquired factor VII deficiency associated with acute myeloid leukemia.
Leukemia, Myeloid, Acute
Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency.
Leukemia, Myeloid, Acute
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Leukemia, Myeloid, Acute
Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.
Leukemia, Myeloid, Acute
Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia.
Leukemia, Myeloid, Acute
Successful Treatment of Intracranial Hemorrhage with Recombinant Activated Factor VII in a Patient with Newly Diagnosed Acute Myeloid Leukemia: A Case Report and Review of the Literature.
Leukemia, Myeloid, Acute
Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : Report on one case and review of other uses in acute leukemias.
Leukemia, Myeloid, Acute
Successful use of recombinant activated factor VII in controlling upper gastrointestinal bleeding in a patient with relapsed acute myeloid leukemia.
Leukemia, Myeloid, Acute
Treatment of diffuse alveolar hemorrhage after allogeneic bone marrow transplant with recombinant factor VIIa.
Leukemia, Promyelocytic, Acute
Cerebral hemorrhage treated with NovoSeven in acute promyelocytic leukemia.
Leukemia, Promyelocytic, Acute
[Recombinant factor VIIa for the treatment of acute promyelocytic leukemia with severe bleeding: 8 cases report and literature review].
Liposarcoma
Acquired factor VII deficiency associated with pleural liposarcoma.
Livedo Reticularis
Cerebral ischemia and livedo reticularis in a patient with impairment of coagulation factor VII and free protein S.
Liver Cirrhosis
Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
Liver Cirrhosis
Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis.
Liver Cirrhosis
Effect of Recombinant Activated Factor VII in Critical Bleeding : Clinical Experience of a Single Center.
Liver Cirrhosis
Effectiveness of the recombinant factor VIIa in patients with the coagulopathy of advanced child's B and C cirrhosis.
Liver Cirrhosis
Enhanced lipid peroxidation in hepatic cirrhosis.
Liver Cirrhosis
Enzyme-linked immunosorbent assay of human factor VII based upon a monoclonal antibody that recognizes the native conformation of the protein.
Liver Cirrhosis
Expression of factor VII in the liver of patients with liver disease: correlations with the disease severity and impairment in the hemostasis.
Liver Cirrhosis
Factor VII in liver cirrhosis.
Liver Cirrhosis
Haemostasis unbalance in Pugh-scored liver cirrhosis: characteristic changes of plasma levels of protein C versus protein S.
Liver Cirrhosis
Interrelation between factor VII, prekallikrein, and hyperfibrinolysis in advanced cirrhosis.
Liver Cirrhosis
Measurement of the procoagulant activity of factor VII in patients with liver cirrhosis and normal prothrombin activity: evaluation of the bleeding risk.
Liver Cirrhosis
Prekallikrein and factor VII as prognostic indexes of liver failure.
Liver Cirrhosis
Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms.
Liver Cirrhosis
Recombinant factor VIIa for variceal bleeding in liver cirrhosis: still only a hope.
Liver Cirrhosis
Spontaneous hemorrhage after external ventricular drain placement in the setting of low factor VII secondary to liver cirrhosis.
Liver Cirrhosis
The Marburg I polymorphism of factor VII activating protease is associated with low proteolytic and low pro-coagulant activity.
Liver Cirrhosis
Validation and functional analysis of the critical proteins in combination with taurine, epigallocatechin gallate and genistein against liver fibrosis in rats.
Liver Cirrhosis
[Mathematic Model for Prediction of Liver Fibrosis Progression Rate in Patients with Chronic Hepatitis C Based on Combination of Genomic Markers].
Liver Cirrhosis
[Plasma factor VII levels in disseminated intravascular coagulation]
Liver Cirrhosis
[The value of coagulation factors in severity categorization of hepatitis B-related liver cirrhosis]
Liver Cirrhosis, Alcoholic
Pericardiocentesis and pancreatic aspiration needle biopsy in coagulopathic and thrombocytopenic cirrhotic patient.
Liver Cirrhosis, Alcoholic
Small dose of recombinant factor VIIa (rFVIIa) to perform percutaneous liver biopsies in cirrhotic patients.
Liver Cirrhosis, Biliary
[Primary biliary cirrhosis combined with factor VII deficiency: a case report]
Liver Diseases
Acquired Factor VII Deficiency in Association with Pyelonephritis.
Liver Diseases
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients.
Liver Diseases
Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven).
Liver Diseases
Blood loss in orthotopic liver transplantation: a retrospective analysis of transfusion requirements and the effects of autotransfusion of cell saver blood in 164 consecutive patients.
Liver Diseases
Characterization of the coagulation profile in children with liver disease and extrahepatic portal vein obstruction or shunt.
Liver Diseases
Clinical experiences and current evidence for therapeutic recombinant factor VIIa treatment in nontrauma settings.
Liver Diseases
Clinical use of recombinant FVIIa (rFVIIa).
Liver Diseases
Coagulation abnormalities in 22 cats with naturally occurring liver disease.
Liver Diseases
Coagulation Profile and its Correlation with Severity of Liver Dysfunction and Gastrointestinal Bleed in Alcoholic Liver Disease Patients.
Liver Diseases
Combined fresh frozen plasma with recombinant factor VIIa in restoring hemostasis for invasive procedures in children with liver diseases.
Liver Diseases
Comparison of Fresh Frozen Plasma, Four-Factor Prothrombin Complex Concentrates, and Recombinant Factor VIIa to Facilitate Procedures in Critically Ill Patients with Coagulopathy from Liver Disease: A Retrospective Cohort Study.
Liver Diseases
Coupled amidolytic assay for factor VII: its use with a clotting assay to determine the activity state of factor VII.
Liver Diseases
Critical issues in hematology: anemia, thrombocytopenia, coagulopathy, and blood product transfusions in critically ill patients.
Liver Diseases
Effect of activated recombinant human factor 7 (Niastase) on laboratory testing of inhibitors of factors VIII and IX.
Liver Diseases
Evaluation of solvent/detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders.
Liver Diseases
Experiences with recombinant factor VIIa for the prevention of bleeding in patients with chronic liver disease undergoing percutaneous liver biopsies and endoscopic retrograde cholangiopancreatography (ERCP).
Liver Diseases
Expression of factor VII in the liver of patients with liver disease: correlations with the disease severity and impairment in the hemostasis.
Liver Diseases
Factor VII as a marker of hepatocellular synthetic function in liver disease.
Liver Diseases
Factor VII deficiency - an enigma; clinicohematological profile in 12 cases.
Liver Diseases
FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases.
Liver Diseases
Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function.
Liver Diseases
Hemostatic effect of activated recombinant factor VII (rFVIIa) in liver disease: studies in an in vitro model.
Liver Diseases
Hepatocyte transplantation for liver-based metabolic disorders.
Liver Diseases
Heterozygous factor VII deficiency and severe hemophilia A in the same kindred.
Liver Diseases
Human recombinant activated factor VII for upper gastrointestinal bleeding in patients with liver diseases.
Liver Diseases
Liver-enriched transcription factor expression relates to chronic hepatic failure in humans.
Liver Diseases
Monoclonal antibodies to human factor VII: a one step immunoradiometric assay for VII:Ag.
Liver Diseases
Monoclonal antibodies to human factor VII: production of immunodepleted plasma for VII:C assays.
Liver Diseases
NovoSeven as a universal haemostatic agent.
Liver Diseases
Ongoing NovoSeven trials.
Liver Diseases
Prolonged prothrombin time, Factor VII and activated FVII levels in chronic liver disease are partly dependent on Factor VII gene polymorphisms.
Liver Diseases
Recombinant activated factor VII (rFVIIa) as a hemostatic agent in liver disease: a break from convention in need of controlled trials.
Liver Diseases
Recombinant activated factor VII as a universal haemostatic agent.
Liver Diseases
Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Liver Diseases
Recombinant activated factor VII in chronic liver diseases: Should we be afraid of thromboembolic events?
Liver Diseases
Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand.
Liver Diseases
Recombinant activated factor VII in patients at high risk of bleeding.
Liver Diseases
Recombinant factor VIIa as haemostatic therapy in advanced liver disease.
Liver Diseases
Recombinant factor VIIa for treatment of massive liver fracture in a premature infant.
Liver Diseases
Recombinant factor VIIa in the treatment of non-hemophiliac bleeding.
Liver Diseases
Recombinant factor VIIa reduces transfusion requirements in liver transplant patients with high MELD scores.
Liver Diseases
Recombinant factor VIIa to treat severe bleeding in patients with liver disease: pitfalls and possibilities.
Liver Diseases
Recombinant factor VIIa.
Liver Diseases
Recombinant factor VIIa: a universal hemostatic agent?
Liver Diseases
Recombinant factor VIIa: unregulated continuous use in patients with bleeding and coagulopathy does not alter mortality and outcome.
Liver Diseases
Recombinant FVIIa in children with liver disease.
Liver Diseases
Recombinant human factor VIIa-induced alterations in tissue factor and thrombomodulin in patients with advanced liver cirrhosis.
Liver Diseases
Safety and efficacy of a single bolus administration of recombinant factor VIIa in liver transplantation due to chronic liver disease.
Liver Diseases
Safety and efficacy of recombinant factor VIIa in patients with liver disease undergoing laparoscopic liver biopsy.
Liver Diseases
Small dose of recombinant factor VIIa (rFVIIa) to perform percutaneous liver biopsies in cirrhotic patients.
Liver Diseases
Successful outcome of a cirrhotic patient with postoperative haematuria treated with a single high dose of recombinant factor VIIa.
Liver Diseases
Synthetic factor VIIa concentrate to treat coagulopathy and gastrointestinal bleeding in an infant with end-stage liver disease.
Liver Diseases
The coagulopathy of liver disease: does vitamin K help?
Liver Diseases
The role of anti-fibrinolytics, rFVIIa and other pro-coagulants: prophylactic versus rescue?
Liver Diseases
The use of recombinant factor VIIa in liver diseases.
Liver Diseases
Treating coagulopathy in liver disease with plasma transfusions or recombinant factor VIIa: an evidence-based review.
Liver Diseases
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency.
Liver Diseases
Use of factor-VII-rich prothrombin complex concentrate in liver disease.
Liver Diseases
Use of recombinant factor VII in hepatology.
Liver Diseases
Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy.
Liver Diseases
Use of recombinant factor VIIa to correct the coagulation status of individuals with advanced liver disease prior to a percutaneous liver biopsy.
Liver Diseases
Vitamin K-dependent blood clotting changes in female rats treated with oestrogens.
Liver Diseases
Which coagulation factors interfere with the one-stage prothrombin time?
Liver Diseases
[Assay of factor VII antigen by enzyme-linked immunosorbent assay (ELISA)]
Liver Diseases
[Clinical studies on blood coagulation factors, prothrombin, factor V and factor VII liver diseases and their response to vitamin K1 and synka-vit.]
Liver Diseases
[Influence of massive doses if vitamin K1 on the coagulation factors prothrombin, factor V and factor VII in liver diseases.]
Liver Diseases
[Recombinant factor VIIa (NovoSeven). A review of current and possible future indications]
Liver Diseases, Alcoholic
Successful management of intra-abdominal hemorrhage in the presence of severe alcoholic liver disease with activated recombinant factor VII (rFVIIa; NovoSeven): a case report and review of the literature on approved and off-label use of rFVIIa.
Liver Failure
Clinical usefulness of recombinant activated factor VII in patients with liver failure undergoing invasive procedures.
Liver Failure
Medical management of variceal bleeding in patients with cirrhosis.
Liver Failure
Overall experience with NovoSeven.
Liver Failure
Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Liver Failure
Prekallikrein and factor VII as prognostic indexes of liver failure.
Liver Failure
Prevention of Bleeding Complications in Neonates With Liver Failure Undergoing Surgery Using Recombinant Factor VIIa.
Liver Failure
Recombinant activated factor VII in children with acute bleeding resulting from liver failure and disseminated intravascular coagulation.
Liver Failure
Recombinant Activated Factor VII Significantly Reduces Transfusion Requirements in Cardiothoracic Surgery.
Liver Failure
Recombinant factor VIIa improves coagulopathy caused by liver failure.
Liver Failure
Successful outcome of using recombinant activated factor VII (rFVIIa) in liver biopsy in a patient with liver failure.
Liver Failure
Successful treatment of massive acute upper gastrointestinal bleeding in liver failure with activated recombinant factor VII (NovoSeven): a case report.
Liver Failure
Successful use of recombinant factor VIIa (NovoSeven) in children with compartment syndrome: two case reports.
Liver Failure
Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
Liver Failure
Use of recombinant factor VIIa in pediatric patients with liver failure and severe coagulopathy.
Liver Failure, Acute
Acute coagulopathy after reperfusion of the liver graft in children correction with recombinant activated factor VII.
Liver Failure, Acute
Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver Failure.
Liver Failure, Acute
Erratum: Recombinant activated factor VIIa in case of pregnancy with acute hepatic failure and massive blood loss.
Liver Failure, Acute
Factor VII levels as a guide to prognosis in fulminant hepatic failure.
Liver Failure, Acute
FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases.
Liver Failure, Acute
Glycine conjugation of para-aminobenzoic acid (PABA): a quantitative test of liver function.
Liver Failure, Acute
Insertion of intracranial pressure monitors in fulminant hepatic failure patients: early experience using recombinant factor VII.
Liver Failure, Acute
Preliminary experience with use of recombinant activated factor VII to control postpartum hemorrhage in acute fatty liver of pregnancy and other pregnancy-related liver disorders.
Liver Failure, Acute
Quick correction of hemostasis in two patients with fulminant liver failure undergoing liver transplantation by recombinant activated factor VII.
Liver Failure, Acute
Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Liver Failure, Acute
Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1A: a single tertiary academic centre experience.
Liver Failure, Acute
Recombinant activated factor VIIa in a case of pregnancy with acute hepatic failure and massive blood loss.
Liver Failure, Acute
Recombinant activated factor VIIa in case of pregnancy with acute hepatic failure and massive blood loss.
Liver Failure, Acute
Recombinant activated factor VIIa in case of pregnancy with acute hepatic failure and massive blood loss: Reply.
Liver Failure, Acute
Successful use of N-acetyl cysteine and activated recombinant factor VII in fulminant hepatic failure and massive bleeding secondary to dengue hemorrhagic fever.
Liver Failure, Acute
The use of activated recombinant factor VII in a patient with fulminant hepatic failure requiring placement of an intracranial pressure monitor.
Liver Failure, Acute
Total hepatectomy, recombinant activated factor VII and rescue liver transplantation.
Liver Neoplasms
Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis.
Liver Neoplasms
Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.
Lung Diseases
Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease.
Lung Diseases
Recombinant activated factor VII for massive hemoptysis in patients with cystic fibrosis.
Lung Diseases, Interstitial
Fibrinopeptide A reactive peptides and procoagulant activity in bronchoalveolar lavage: relationship to rheumatoid interstitial lung disease.
Lung Diseases, Interstitial
Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease.
Lung Injury
Blockade of tissue factor: treatment for organ injury in established sepsis.
Lung Injury
Current view on alveolar coagulation and fibrinolysis in acute inflammatory and chronic interstitial lung diseases.
Lung Injury
Nebulised recombinant activated factor VII (rFVIIa) does not attenuate the haemorrhagic effects of blast lung injury.
Lung Neoplasms
Circulating levels of coagulation and inflammation markers and cancer risks: individual participant analysis of data from three long-term cohorts.
Lung Neoplasms
Continuous infusion of recombinant activated factor VII for bleeding control after lobectomy in a patient with inherited factor VII deficiency.
Lung Neoplasms
Prognostic significance of blood coagulation tests in lung cancer.
Lung Neoplasms
Tissue factor is the only activator of coagulation in cultured human lung cancer cells.
Lupus Erythematosus, Systemic
Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays.
Lupus Erythematosus, Systemic
Increased factor VIIa levels in systemic lupus erythematosus patients with lupus anticoagulant.
Lupus Erythematosus, Systemic
Plasma levels of activated FVII in various diseases.
Lupus Erythematosus, Systemic
Treatment of diffuse alveolar hemorrhage in systemic lupus erythematosus patient with local pulmonary administration of factor VIIa (rFVIIa): a case report.
Lupus Erythematosus, Systemic
Treatment of diffuse alveolar hemorrhage secondary to lupus erythematosus with recombinant activated factor VII administered with a jet nebulizer.
Lymphatic Metastasis
[Ectopic expression and clinical significance of tissue factor/coagulation factor VII complex in colorectal cancer.]
Lymphohistiocytosis, Hemophagocytic
Control of bleeding associated with hemophagocytic syndrome in children: an audit of the clinical use of recombinant activated factor VII.
Lymphohistiocytosis, Hemophagocytic
Hemophagocytic lymphohistiocytosis and congenital factor VII deficiency: a case report.
Lymphohistiocytosis, Hemophagocytic
Recombinant activated factor VII in hemophagocytic lymphohistiocytosis with disseminated intravascular coagulation.
Lymphoma
A Rare Case of Factor VII Inhibitor in a Patient Presenting with Primary Splenic Marginal Zone Lymphoma.
Lymphoma, B-Cell
Effects of recombinant activated coagulation factor VII on apoptosis and expressions of Bcl-2 and Bax in rats with intracerebral hemorrhage.
Lymphoma, Non-Hodgkin
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Lymphoma, Non-Hodgkin
Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis.
Lymphoma, T-Cell
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Malaria
A new method for factor VII deficient substrate preparation and coagulation studies in malaria.
Mallory-Weiss Syndrome
Mallory-Weiss tear: use of recombinant factor VIIa for exsanguinating bleed.
Mallory-Weiss Syndrome
Successful management of Mallory-Weiss syndrome in a haemophilia A patient with inhibitor by recombinant activated factor VII.
Malnutrition
Fluorogenic assay of activated factor VII. Plasma factor VIIa levels in relation to arterial cardiovascular diseases in Japanese.
Malnutrition
Plasma fibrinogen and factor VII concentrations in adults after prenatal exposure to famine.
Marfan Syndrome
A case presenting concurrence of Marfan syndrome, Basedow's disease and Arg353Gln polymorphism-related factor VII deficiency.
Marfan Syndrome
Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.
Massive Hepatic Necrosis
[Successful treatment of an infant with fulminant hepatitis by factor VII concentrate]
Mastocytosis, Cutaneous
Avoiding Cardiovascular Collapse: Pediatric Cutaneous Mastocytosis and Anesthetic Challenges.
Measles
Measles virus induction of human endothelial cell tissue factor procoagulant activity in vitro.
Meconium Aspiration Syndrome
Successful use of recombinant activated FVII and aminocaproic acid in four neonates with life-threatening hemorrhage.
Mediastinitis
Recombinant factor VIIa in intractable bleeding due to severe mediastinitis.
Medulloblastoma
Tissue Factor Regulation by miR-520g in Primitive Neuronal Brain Tumor Cells: A Possible Link between Oncomirs and the Vascular Tumor Microenvironment.
Melanoma
Interaction of human tumor cells with human platelets and the coagulation system.
Melanoma
Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
Melanoma
MDA-9/Syntenin Is Essential for Factor VIIa-induced Signaling, Migration, and Metastasis in Melanoma Cells.
Melanoma
Proteolytic activation of tissue plasminogen activator by plasma and tissue enzymes.
Melanoma, Experimental
Cytochalasin D promotes pulmonary metastasis of B16 melanoma through expression of tissue factor.
Meningioma
Surgical resection of a sphenoid wing meningioma in a patient with Glanzmann thrombasthenia.
Menorrhagia
Disorders of menstruation and their effect on the quality of life in women with congenital factor VII deficiency.
Menorrhagia
Experience with recombinant-activated factor VII in 30 patients with congenital factor VII deficiency.
Menorrhagia
Factor VII deficiency and pregnancy: a case report and review of literature.
Menorrhagia
Life-threatening menorrhagia secondary to Factor VII deficiency and leiomyomata.
Menorrhagia
Management of surgery, menorrhagia and child-birth for patients with unclassified bleeding disorders: a systematic review of cohort studies.
Menorrhagia
Menorrhagia caused by severe hereditary factor VII deficiency. Case 1.
Menorrhagia
Peculiar Congenital Factor VII Defect with the Proposita and Her Mother Showing the Same Compound Heterozygosity for Thr384Met and Arg413Gln.
Menorrhagia
Prophylactic treatment of hereditary severe factor VII deficiency in pregnancy.
Menorrhagia
Recombinant FVIIa therapy for heavy menstrual bleeding in patients with severe FV deficiency.
Menorrhagia
Severe menorrhagia due to factor VII deficiency successfully treated by thermal balloon endometrial ablation.
Menorrhagia
Successful treatment of severe menorrhagia at menarche with recombinant factor VIIa in an adolescent girl with type III von Willebrand's disease.
Menorrhagia
Successful use of recombinant factor VIIa for management of severe menorrhagia in an adolescent with an acquired inhibitor of human thrombin.
Menorrhagia
Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency.
Menorrhagia
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency.
Menorrhagia
Women and inherited bleeding disorders: menstrual issues.
Menorrhagia
Women with congenital factor VII deficiency: clinical phenotype and treatment options from two international studies.
Mesenteric Ischemia
Complications of recombinant activated human coagulation factor VII.
Mesenteric Ischemia
Thromboembolic complications associated with factor VIIa administration.
Metabolic Diseases
Liver cell transplantation.
Metabolic Syndrome
Investigation of potential biomarkers for thrombosis related diseases in Turkish Cypriot population.
Metabolic Syndrome
Pleiotropic effects of atorvastatin and fenofibrate in metabolic syndrome and different types of pre-diabetes.
Metabolic Syndrome
Prediction of incident type 2 diabetes mellitus based on a twenty-year follow-up of the Ventimiglia heart study.
Metabolic Syndrome
[Fibrate influence on lipids and insulin resistance in patients with metabolic syndrome]
Metrorrhagia
Administration of recombinant FVIIa (rFVIIa) to concizumab-dosed monkeys is safe, and concizumab does not affect the potency of rFVIIa in hemophilic rabbits.
Metrorrhagia
Comparison of bypassing agents in patients on emicizumab using global hemostasis assays.
Metrorrhagia
Practical considerations for nonfactor-replacement therapies in the treatment of haemophilia with inhibitors.
Metrorrhagia
Thrombin generation in plasma of patients with haemophilia A and B with inhibitors: Effects of bypassing agents and antithrombin reduction.
Microcephaly
Congenital combined defects of factor VII: a critical review.
Microcephaly
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
Microcephaly
Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature.
Microcephaly
Liver transplantation for treatment of severe S-adenosylhomocysteine hydrolase deficiency.
Microscopic Polyangiitis
Factor viia for alveolar hemorrhage in microscopic polyangiitis.
Microscopic Polyangiitis
Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis.
Migraine Disorders
Migraine and prothrombotic genetic risk factors.
Migraine Disorders
Migraine, cortical blindness, multiple cerebral infarctions and hypocoagulopathy in celiac disease.
Migraine Disorders
Prothrombotic genetic risk factors in patients with coexisting migraine and ischemic cerebrovascular disease.
Mitral Valve Prolapse
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
Mucopolysaccharidoses
Inadvertent propagation of factor VII deficiency in a canine mucopolysaccharidosis type I research breeding colony.
Mucopolysaccharidosis I
Inadvertent propagation of factor VII deficiency in a canine mucopolysaccharidosis type I research breeding colony.
Mucormycosis
Endogenous Heparinoids May Cause Bleeding in Mucor Infection and can be Detected by Nonactivated Thromboelastometry and Treated by Recombinant Activated Factor VII: A Case Report.
Multicystic Dysplastic Kidney
Congenital Factor VII Deficiency in Association With Bicuspid Aortic Valve and Multicystic Dysplastic Kidney Disease in a Child.
Multiple Myeloma
Elevated extracellular trap formation and contact system activation in acute leukemia.
Multiple Myeloma
[Combined deficiency of factor VII and X in a patient with multiple myeloma and amyloidosis]
Muscle Hypotonia
[Use of recombinant factor VIIa for the control of massive bleeding caused by uterine hypotonia in post-placental period]
Muscular Diseases
Liver transplantation for treatment of severe S-adenosylhomocysteine hydrolase deficiency.
Myelodysplastic Syndromes
Elevated extracellular trap formation and contact system activation in acute leukemia.
Myelodysplastic Syndromes
Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
Myeloproliferative Disorders
Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
Myocardial Infarction
A functional haplotype in the 5' flanking region of the factor VII gene is associated with an increased risk of coronary heart disease.
Myocardial Infarction
A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men.
Myocardial Infarction
A novel polymorphism in intron 1a of the human factor VII gene (G73A): study of a healthy Italian population and of 190 young survivors of myocardial infarction.
Myocardial Infarction
Activated and total coagulation factor VII, and fibrinogen in coronary artery disease.
Myocardial Infarction
Activation of coagulation factor VII during alimentary lipemia.
Myocardial Infarction
Acute myocardial infarction following administration of recombinant activated factor VII (Novo Seven) in a patient with haemophilia A and inhibitor.
Myocardial Infarction
Acute myocardial infarction with decreased factor VII.
Myocardial Infarction
Angiotensin-converting enzyme insertion/deletion genotype is associated with the activities of plasma coagulation factor VII and X independent of triglyceride metabolism.
Myocardial Infarction
Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.
Myocardial Infarction
Association between the factor VII haplotype containing the -402A allele and myocardial infarction in a population of elderly men at high risk for coronary heart disease.
Myocardial Infarction
Association of coagulation factor VII with the risk of myocardial infarction in the Chinese.
Myocardial Infarction
Associations of fibrinogen, factor VII and PAI-1 with baseline findings among 10,500 male participants in a prospective study of myocardial infarction--the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Myocardial Infarction
Augmented Hageman factor and prolactin titers, enhanced cold activation of factor VII, and spontaneous shortening of prothrombin time in survivors of myocardial infarction.
Myocardial Infarction
Behavior of coagulation factors and normal inhibitors of coagulation during the acute phase of myocardial infarction.
Myocardial Infarction
Blood coagulation factor VII activity and the risk of myocardial infarction: the novel identification of a genetic protection that can be mimicked by an old drug.
Myocardial Infarction
Changes in levels of factor VII and protein S after acute myocardial infarction: effects of low-dose warfarin.
Myocardial Infarction
Cigarette smoking doubles the risk of myocardial infarction in carriers of a protective polymorphism in the blood coagulation factor VII gene.
Myocardial Infarction
Coagulation factor VII and inflammatory markers in patients with coronary heart disease.
Myocardial Infarction
Coagulation factor VII and the risk of coronary heart disease in healthy men.
Myocardial Infarction
Coagulation factor VII mass and activity in young men with myocardial infarction at a young age. Role of plasma lipoproteins and factor VII genotype.
Myocardial Infarction
Coagulation factor VII, R353Q polymorphism, and serum choline-containing phospholipids in males at high risk for coronary heart disease.
Myocardial Infarction
Coagulation gene polymorphisms as risk factors for myocardial infarction in young Indian Asians.
Myocardial Infarction
Common polymorphisms and cardiovascular factors in patients with myocardial infarction of Costa Rica.
Myocardial Infarction
Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity.
Myocardial Infarction
Comparison of novel hemostatic factors and conventional risk factors for prediction of coronary heart disease.
Myocardial Infarction
Complications of recombinant activated human coagulation factor VII.
Myocardial Infarction
Concurrent administration of sustained-release bezafibrate may counteract the increased thrombotic risk associated with oral estrogen therapy.
Myocardial Infarction
Congenital protein C deficiency and myocardial infarction:concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis.
Myocardial Infarction
Dietary effects on coagulation factor VII vary across genotypes of the R/Q353 polymorphism in elderly people.
Myocardial Infarction
Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction.
Myocardial Infarction
Elevation of factor VII activity and mass in coronary artery disease of varying severity.
Myocardial Infarction
Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology.
Myocardial Infarction
Factor VII and extrinsic pathway inhibitor in acute coronary disease.
Myocardial Infarction
Factor VII and incidence of myocardial infarction in a Japanese population: The Jichi Medical School Cohort Study.
Myocardial Infarction
Factor VII Arg/Gln353 polymorphism determines factor VII coagulant activity in patients with myocardial infarction (MI) and control subjects in Belfast and in France but is not a strong indicator of MI risk in the ECTIM study.
Myocardial Infarction
Factor VII gene polymorphisms are not associated with myocardial infarction in young women.
Myocardial Infarction
Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation.
Myocardial Infarction
Factor VII polymorphisms and myocardial infarction: what is special in Italians? REGRESS study group. Regression Growth Evaluation Statin Study.
Myocardial Infarction
Factor VII Tokushima: the first case of factor VII Cys22Gly with the development of myocardial infarction in the proband receiving recombinant factor VIIa replacement therapy.
Myocardial Infarction
Factor VIIa as a predictor of cardiac events following myocardial infarction in women.
Myocardial Infarction
Factor-VII activity and ischaemic heart disease: fatal and non-fatal events.
Myocardial Infarction
Failure of thrombolytic therapy in patients with myocardial infarction is associated with high plasma levels of factor VII antigen.
Myocardial Infarction
Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons.
Myocardial Infarction
Genes, coagulation and cardiovascular risk.
Myocardial Infarction
Genetic polymorphisms, Biochemical Factors, and Conventional Risk Factors in Young and Elderly North Indian Patients With Acute Myocardial Infarction.
Myocardial Infarction
Genotype-specific increase in plasma concentrations of activated coagulation factor VII in response to experimental inflammation. A link between infection and acute myocardial infarction?
Myocardial Infarction
Hageman factor and risk of myocardial infarction in middle-aged men.
Myocardial Infarction
Heightened thrombin formation but normal plasma levels of activated factor VII in patients with acute coronary syndromes.
Myocardial Infarction
Hemostatic risk factors of coronary artery disease in the Chinese.
Myocardial Infarction
Hypercoagulability and reduced fibrinolysis in hyperlipidemia: relationship to the metabolic cardiovascular syndrome.
Myocardial Infarction
Imbalance of plasminogen activator inhibitor-I/ tissue plasminogen activator and tissue factor/tissue factor pathway inhibitor in young Japanese men with myocardial infarction.
Myocardial Infarction
Increased level of von Willebrand factor is significantly and independently associated with diabetes in postinfarction patients. THROMBO Investigators.
Myocardial Infarction
Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis.
Myocardial Infarction
Lack of association between polymorphisms of the coagulation factor VII and myocardial infarction in middle-aged Spanish men.
Myocardial Infarction
Myocardial infarction and other arterial occlusions in hemophilia a patients. A cardiological evaluation of all 42 cases reported in the literature.
Myocardial Infarction
Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease.
Myocardial Infarction
Myocardial infarction occurring in a case of acquired haemophilia during the treatment course with recombinant activated factor VII.
Myocardial Infarction
Myocardial infarctions and other acute coronary syndromes in rare congenital bleeding disorders: a critical analysis of all reported cases.
Myocardial Infarction
No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age.
Myocardial Infarction
Plasma level of triglyceride-rich lipoprotein remnants is closely associated with the activation of coagulation factor VII in patients with myocardial infarction.
Myocardial Infarction
Plasma Levels and Distribution of Gene Polymorphisms of Factor VII in Turkish Population.
Myocardial Infarction
Plasma thrombomodulin activity, tissue factor activity and high levels of circulating procoagulant phospholipid as prognostic factors for acute myocardial infarction.
Myocardial Infarction
Polymorphism of R353Q (rs6046) in factor VII and the risk of myocardial infarction: A systematic review and meta-analysis.
Myocardial Infarction
Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction in patients undergoing coronary angiography.
Myocardial Infarction
Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction.
Myocardial Infarction
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease.
Myocardial Infarction
Polymorphisms in the factor VII gene and the risk of myocardial infarction.
Myocardial Infarction
Polymorphisms in the genes for coagulation factor II, V, VII in patients undergoing coronary angiography.
Myocardial Infarction
Postprandial triglycerides and blood coagulation.
Myocardial Infarction
Prothrombotic gene polymorphisms and plasma factors in young north Indian survivors of acute myocardial infarction.
Myocardial Infarction
Prothrombotic genetic risk factors in young survivors of myocardial infarction.
Myocardial Infarction
R353Q polymorphism, activated factor VII, and risk of premature myocardial infarction in Japanese men.
Myocardial Infarction
Recombinant Activated Factor VII Safety in Trauma Patients: Results From the CONTROL Trial.
Myocardial Infarction
Relationships of insulin and intact and split proinsulin to haemostatic function in young men with and without coronary artery disease.
Myocardial Infarction
Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men.
Myocardial Infarction
Sex hormones and hemostatic risk factors for coronary heart disease in men with hypertension.
Myocardial Infarction
Soluble fibrin, C-reactive protein, fibrinogen, factor VII, antithrombin, proteins C and S, tissue factor, D-dimer, and prothrombin fragment 1 + 2 in men with acute myocardial infarction
Myocardial Infarction
ST-Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII.
Myocardial Infarction
Temporal and genotype-driven variation of factor VII levels in patients with acute myocardial infarction.
Myocardial Infarction
The decanucleotide insertion/deletion polymorphism in the promoter region of the coagulation factor VII gene and the risk of familial myocardial infarction.
Myocardial Infarction
The effects of genotype and infant weight on adult plasma levels of fibrinogen, factor VII, and LDL cholesterol are additive.
Myocardial Infarction
The PLAT Study: a multidisciplinary study of hemostatic function and conventional risk factors in vascular disease patients.
Myocardial Infarction
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
Myocardial Infarction
The safety of recombinant factor VIIa in cardiac surgery.
Myocardial Infarction
Thrombogenic side-effects of recombinant factor VIIa after use in coronary artery bypass surgery.
Myocardial Infarction
Tissue factor and coagulation factor VII levels during acute myocardial infarction: association with genotype and adverse events.
Myocardial Infarction
Two polymorphisms of the FVII gene and their impact on the risk of myocardial infarction in poles under 45 years of age.
Myocardial Infarction
Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004.
Myocardial Infarction
Variation of the factor VII gene and ischemic heart disease in Japanese subjects.
Myocardial Infarction
[Acute treatment with recombinant factor VII is probably indicated for intracerebral haematoma]
Myocardial Infarction
[Association between gene polymorphisms and myocardial infarction in Han Chinese of Yunnan province].
Myocardial Infarction
[Association of coagulation factor V, VII gene polymorphisms with coronary heart disease]
Myocardial Infarction
[Distributions of polymorphisms of genes of some components of hemostasis in patients with ischemic heart disease]
Myocardial Infarction
[Increased fibrinogen and factor VII activity levels in patients after myocardial infarction]
Myocardial Infarction
[Study of the polymorphism R353Q in the coagulation factor VII gene and the N700S in the thrombospondin-1 gene in young patients with acute myocardial infarction].
Myocardial Infarction
[Study on plasma coagulation factor VII (FVII) levels and polymorphisms of FVII gene in patients with coronary heart disease]
Myocardial Infarction
[The coagulation factor VII gene polymorphisms in patients with myocardial infarction in Ningxia Hui and Han populations]
Myocardial Infarction
[Value of plasma tissue factor, tissue factor pathway inhibitor and factor VII assessments in patients with acute myocardial and cerebral infarction]
Myocardial Ischemia
Association of beta-fibrinogen and factor VII polymorphism with plasma fibrinogen and factor VII levels, and no association of PAI-1 polymorphism with plasma PAI-1 levels in hemodialysis patients.
Myocardial Ischemia
Correlation of factor VII activity and antigen with cholesterol and triglycerides in healthy young adults.
Myocardial Ischemia
Correlation of vitamin K-dependent clotting factors with cholesterol and triglycerides in healthy young adults.
Myocardial Ischemia
Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism.
Myocardial Ischemia
Effect of treatment with low-dose warfarin-aspirin on activated factor VII.
Myocardial Ischemia
Effect of varying the ratio of n-6 to n-3 fatty acids by increasing the dietary intake of alpha-linolenic acid, eicosapentaenoic and docosahexaenoic acid, or both on fibrinogen and clotting factors VII and XII in persons aged 45-70 y: the OPTILIP study.
Myocardial Ischemia
Effects of diet composition on coagulation pathways.
Myocardial Ischemia
Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids.
Myocardial Ischemia
Elevation of factor VII activity and mass in young adults at risk of ischemic heart disease.
Myocardial Ischemia
Factor VII and haemostasis.
Myocardial Ischemia
Factor VII clotting assay: influence of different thromboplastins and factor VII-deficient plasmas. CISMEL Study Group.
Myocardial Ischemia
Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration.
Myocardial Ischemia
Factor VII polymorphisms in populations with different risks of cardiovascular disease.
Myocardial Ischemia
Fibrinogen, factor VII, antithrombin III, cholesterol and triglycerides in young men with myocardial infarction and in their sons.
Myocardial Ischemia
Increased levels of factor VII, fibrinogen and activity of plasminogen activator inhibitor during postprandial triglyceridemia in patients with ischemic heart disease confirmed by angiography.
Myocardial Ischemia
Nutrition and thrombogenic factors.
Myocardial Ischemia
Polymorphisms of the coagulation factor VII gene and its plasma levels in relation to acute cerebral infarction differences in allelic frequencies between Chinese Han and European populations.
Myocardial Ischemia
Postprandial effects of an oleic acid-rich oil compared with butter on clotting factor VII and fibrinolysis in healthy men.
Myocardial Ischemia
Postprandial elevation of activated factor VII in young adults.
Myocardial Ischemia
Predictive value of coagulation tests in arterial thrombosis.
Myocardial Ischemia
Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation.
Myocardial Ischemia
Risks and mechanisms of cardiovascular events in users of oral contraceptives.
Myocardial Ischemia
Role of coagulation factor VII in pathogenesis of ischemic heart disease.
Myocardial Ischemia
The association of dietary fat and fiber with coagulation factor VII in the elderly: the Rotterdam Study.
Myocardial Ischemia
The impact of cardiac ischemia and reperfusion on markers of activated haemostasis and fibrinolysis during cardiopulmonary bypass: comparison of plasma levels in arterial and coronary venous blood.
Myocardial Ischemia
Thromboembolic complications associated with factor VIIa administration.
Myocardial Ischemia
Variation of the factor VII gene and ischemic heart disease in Japanese subjects.
Myocardial Ischemia
Vitamin K-dependent clotting factors are elevated in young adults who have close relatives with ischemic heart disease.
Myocardial Ischemia
[Coagulant activity of factor VII (FVIIc) in the elderly with ischemic heart disease]
Myocardial Ischemia
[Should hemostatic factors be considered in the prevention of cardiovascular disease?]
Myotonia Congenita
Frequency of five disease-causing genetic mutations in a large mixed-breed dog population (2011-2012).
Myxoma
Imaging and intervention of paraneoplastic effect of a right atrial myxoma on factor VII activity levels.
Myxoma
Open heart surgery with factor VII deficiency.
Neoplasm Metastasis
Activation of factor VII in patients with carcinoma of the prostate. A preliminary report.
Neoplasm Metastasis
Antiapoptotic effect of coagulation factor VIIa.
Neoplasm Metastasis
Cellular consequences upon factor VIIa binding to tissue factor.
Neoplasm Metastasis
Coagulation factors VIIa and Xa inhibit apoptosis and anoikis.
Neoplasm Metastasis
Cytochalasin D promotes pulmonary metastasis of B16 melanoma through expression of tissue factor.
Neoplasm Metastasis
Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
Neoplasm Metastasis
Generation of a polyclonal rabbit anti-mouse tissue factor antibody by nucleic acid immunisation.
Neoplasm Metastasis
High factor VIIa levels do not promote tumor metastasis.
Neoplasm Metastasis
Immunological and functional analyses of the extracellular domain of human tissue factor.
Neoplasm Metastasis
Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.
Neoplasm Metastasis
Inhibition of tissue factor-factor VIIa proteolytic activity blunts hepatic metastasis in colorectal cancer.
Neoplasm Metastasis
Requirement for binding of catalytically active factor VIIa in tissue factor-dependent experimental metastasis.
Neoplasm Metastasis
Role of tissue factor in metastasis: functions of the cytoplasmic and extracellular domains of the molecule.
Neoplasm Metastasis
Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
Neoplasm Metastasis
Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
Neoplasm Metastasis
The FVIIa-tissue factor complex induces the expression of MMP7 in LOVO cells in vitro.
Neoplasm Metastasis
The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody.
Neoplasm Metastasis
Tissue factor as a novel target for treatment of breast cancer.
Neoplasm Metastasis
Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
Neoplasm Metastasis
Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells.
Neoplasm Metastasis
Tissue factor-factor VIIa complex induces epithelial ovarian cancer cell invasion and metastasis through a monocytes-dependent mechanism.
Neoplasm Metastasis
Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.
Neoplasm Metastasis
Tumor cell adhesion and migration supported by interaction of a receptor-protease complex with its inhibitor.
Neoplasm Metastasis
[Ectopic expression and clinical significance of tissue factor/coagulation factor VII complex in colorectal cancer.]
Neoplasm Metastasis
[The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer.]
Neoplasms
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.
Neoplasms
Acquired factor VII deficiency associated with pleural liposarcoma.
Neoplasms
Acquired Isolated FVII Deficiency: An Underestimated and Potentially Important Laboratory Finding.
Neoplasms
Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Neoplasms
Activation of human factor VII by factors IXa and Xa on human bladder carcinoma cells.
Neoplasms
Active site inhibited factor VIIa (DEGR VIIa) attenuates the coagulant and interleukin-6 and -8, but not tumor necrosis factor, responses of the baboon to LD100 Escherichia coli.
Neoplasms
Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency.
Neoplasms
Allosteric disulfide bonds in thrombosis and thrombolysis.
Neoplasms
Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.
Neoplasms
An antibody-drug conjugate that targets tissue factor exhibits potent therapeutic activity against a broad range of solid tumors.
Neoplasms
Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
Neoplasms
Antiapoptotic effect of coagulation factor VIIa.
Neoplasms
Apixaban Suppresses the Release of TF-Positive Microvesicles and Restrains Cancer Cell Proliferation through Directly Inhibiting TF-fVIIa Activity.
Neoplasms
Association between enhanced soluble CD40 ligand and proinflammatory and prothrombotic states in major depressive disorder: pilot observations on the effects of selective serotonin reuptake inhibitor therapy.
Neoplasms
Bleeding from endometrial and vaginal malignant tumors treated with activated recombinant factor VII.
Neoplasms
Breast cancer phenotypes regulated by tissue factor-factor VII pathway: Possible therapeutic targets.
Neoplasms
Case Report: Massive epistaxis from juvenile angiofibroma in an adolescent with severe haemophilia A.
Neoplasms
Cellular consequences upon factor VIIa binding to tissue factor.
Neoplasms
Changes of the coagulation and fibrinolysis system in malignancy: their possible impact on future diagnostic and therapeutic procedures.
Neoplasms
Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles.
Neoplasms
Chronological expression of PAR isoforms in acute liver injury and its amelioration by PAR2 blockade in a rat model of sepsis.
Neoplasms
Circulating levels of coagulation and inflammation markers and cancer risks: individual participant analysis of data from three long-term cohorts.
Neoplasms
Coagulant and fibrinolytic activities of a metastasising and non-metastasising tumour line.
Neoplasms
Coagulation and oxidative stress plasmatic levels in a type 2 diabetes population.
Neoplasms
Coagulation factors VIIa and Xa inhibit apoptosis and anoikis.
Neoplasms
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).
Neoplasms
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
Neoplasms
Correction of both prothrombin time and primary haemostasis by recombinant factor VII during therapeutic alcohol injection of hepatocellular cancer in liver cirrhosis.
Neoplasms
Cortactin activation by FVIIa/tissue factor and PAR2 promotes endothelial cell migration.
Neoplasms
Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer.
Neoplasms
Different expression of procoagulant activity in human cancer cells cultured "in vitro" or in cells isolated from human tumor tissues.
Neoplasms
Effect of all-trans-retinoic acid on the hypercoagulable state of patients with breast cancer.
Neoplasms
Effects of tumor-expressed coagulation factors on cancer progression and venous thrombosis: is there a key factor?
Neoplasms
Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
Neoplasms
Elevated extracellular trap formation and contact system activation in acute leukemia.
Neoplasms
Enhanced Antitumor Activity of EGFP-EGF1-Conjugated Nanoparticles by a Multitargeting Strategy.
Neoplasms
Enhanced expression of urokinase receptor induced through the tissue factor-factor VIIa pathway in human pancreatic cancer.
Neoplasms
Extrahepatic synthesis of coagulation factor VII by colorectal cancer cells promotes tumor invasion and metastasis.
Neoplasms
Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor.
Neoplasms
Factor VII light chain-targeted lidamycin targets tissue factor-overexpressing tumor cells for cancer therapy.
Neoplasms
Factor VII promotes hepatocellular carcinoma progression through ERK-TSC signaling.
Neoplasms
Factor VII, blood lipids and fat intake: gene-nutrient interaction and risk of coronary heart disease with the factor VII R353Q polymorphism.
Neoplasms
Factor VIIa induces anti-inflammatory signaling via EPCR and PAR1.
Neoplasms
Factor X-activating activity in normal and malignant colorectal tissue.
Neoplasms
Fibrinogen deposition without thrombin generation in primary human breast cancer tissue.
Neoplasms
Formation of tissue factor-factor VIIa-factor Xa complex promotes cellular signaling and migration of human breast cancer cells.
Neoplasms
FVIIa Neutralization by a FXa Inhibitor: How It Could Dampen Tumorigenic Cancer Cell Phenotypes.
Neoplasms
Gene expression profile of FVII and AR in primary prostate cancer.
Neoplasms
Generation of a polyclonal rabbit anti-mouse tissue factor antibody by nucleic acid immunisation.
Neoplasms
Genetics of intracerebral hemorrhage: Insights from candidate gene approaches.
Neoplasms
Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation.
Neoplasms
Hemostatic response to postprandial lipemia before and after exercise training.
Neoplasms
Hepatocyte nuclear factor-4-independent synthesis of coagulation factor VII in breast cancer cells and its inhibition by targeting selective histone acetyltransferases.
Neoplasms
High factor VIIa levels do not promote tumor metastasis.
Neoplasms
High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors.
Neoplasms
Identification of the integrin-binding site on coagulation factor VIIa required for proangiogenic PAR2 signaling.
Neoplasms
Immunohistochemical identification of tissue factor in solid tumors.
Neoplasms
In situ characterization of antigenic and functional tissue factor expression in human tumors utilizing monoclonal antibodies and recombinant factor VIIa as probes.
Neoplasms
Inducible expression of tissue factor in small-cell lung cancer: impact on morphology and matrix metalloproteinase secretion.
Neoplasms
Inhibition of tissue factor by ixolaris reduces primary tumor growth and experimental metastasis in a murine model of melanoma.
Neoplasms
Interconnections between autophagy and the coagulation cascade in hepatocellular carcinoma.
Neoplasms
Intramuscular Expression of Plasmid-Encoded FVII-Fc Immunoconjugate for Tumor Immunotherapy by Targeting Tumoral Blood Vessels and Cells.
Neoplasms
Intratumoral injection of adenoviral vectors encoding tumor-targeted immunoconjugates for cancer immunotherapy.
Neoplasms
Intrinsic versus extrinsic coagulation. Kinetic considerations.
Neoplasms
Isolated acquired factor VII deficiency: review of the literature.
Neoplasms
Isolation and characterization of cancer procoagulant: a cysteine proteinase from malignant tissue.
Neoplasms
Localization of tissue factor in actin-filament-rich membrane areas of epithelial cells.
Neoplasms
Longitudinal association of hemostatic factors with risk for cancers of the breast, colorectum, and lung among postmenopausal women.
Neoplasms
Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ.
Neoplasms
Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
Neoplasms
Modular degradable dendrimers enable small RNAs to extend survival in an aggressive liver cancer model.
Neoplasms
Natural killer cells are crucial for the efficacy of Icon (factor VII/human IgG1 Fc) immunotherapy in human tongue cancer.
Neoplasms
No significant association between the promoter region polymorphisms of factor VII gene and risk of venous thrombosis in cancer patients.
Neoplasms
Occurrence of blood coagulation factors in situ in small cell carcinoma of the lung.
Neoplasms
Periodontal disease and biomarkers related to cardiovascular disease.
Neoplasms
Plasma levels of activated FVII in various diseases.
Neoplasms
Platelets, Constant and Cooperative Companions of Sessile and Disseminating Tumor Cells, Crucially Contribute to the Tumor Microenvironment.
Neoplasms
PO-58 - Cardiovascular risk profile in survivors of adult cancer - results from the general population study.
Neoplasms
Potential blood biomarkers in chronic spontaneous urticaria.
Neoplasms
Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Neoplasms
Preliminary study to identify cancer patients at high risk of venous thrombosis following major surgery.
Neoplasms
Procoagulant activity associated with plasma membrane vesicles shed by cultured tumor cells.
Neoplasms
Procoagulant activity in cancer cells is dependent on tissue factor expression.
Neoplasms
Properties of proteins in cancer procoagulant preparations that are detected by anti-tissue factor antibodies.
Neoplasms
Protease-activated receptor 2 (PAR2) blocking peptide counteracts endotoxin-induced inflammation and coagulation and ameliorates renal fibrin deposition in a rat model of acute renal failure.
Neoplasms
Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Neoplasms
Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies.
Neoplasms
Recombinant activated factor VII controls chemotherapy-related hemorrhage in patients with solid intra-abdominal tumors: a report of three pediatric cases.
Neoplasms
Recombinant activated factor VII in patients with cancer and hemorrhagic disseminated intravascular coagulation.
Neoplasms
Role of phosphoinositide 3-kinase in adhesion of platelets to fibrinogen stimulated by cancer procoagulant.
Neoplasms
Role of the coagulation system in tumor-cell-induced platelet aggregation and metastasis.
Neoplasms
Roles of factor Xa beyond coagulation.
Neoplasms
Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
Neoplasms
Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Neoplasms
Sequential 5-Aza 2'-deoxycytidine/depsipeptide FK228 treatment induces tissue factor pathway inhibitor 2 (TFPI-2) expression in cancer cells.
Neoplasms
Several murine metastasizing tumors possess a cysteine proteinase with cancer procoagulant characteristics.
Neoplasms
Signal transduction via the mitogen-activated protein kinase pathway induced by binding of coagulation factor VIIa to tissue factor.
Neoplasms
Successful control of massive coumarol-induced acute upper gastrointestinal bleeding and correction of prothrombin time by recombinant active factor VII (Eptacog-alpha, NovoSeven) in a patient with a prosthetic aortic valve and two malignancies (chronic lymphoid leukaemia and lung cancer).
Neoplasms
Synergistic Inhibitory Effect of Traditional Chinese Medicine Astragaloside IV and Curcumin on Tumor Growth and Angiogenesis in an Orthotopic Nude-Mouse Model of Human Hepatocellular Carcinoma.
Neoplasms
Systemic thrombin generation in cancer patients is correlated with extrinsic pathway activation.
Neoplasms
Targeting tissue factor on tumour cells and angiogenic vascular endothelial cells by factor VII-targeted verteporfin photodynamic therapy for breast cancer in vitro and in vivo in mice.
Neoplasms
Targeting tissue factor-expressing tumor angiogenesis and tumors with EF24 conjugated to factor VIIa.
Neoplasms
Targeting tumor vasculature endothelial cells and tumor cells for immunotherapy of human melanoma in a mouse xenograft model.
Neoplasms
The effect of short-term cold exposure on risk factors for cardiovascular disease.
Neoplasms
The effect of Warfarin and factor VII on tissue procoagulant activity and pulmonary seeding.
Neoplasms
The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Neoplasms
The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-? or isoproterenol.
Neoplasms
The relationship between tissue factor and cancer progression: insights from bench and bedside.
Neoplasms
The tick-derived inhibitor Ixolaris prevents tissue factor signaling on tumor cells.
Neoplasms
The use of recombinant factor VIIa in a patient with acquired haemophilia A undergoing surgery.
Neoplasms
Thrombin-activatable fibrinolysis inhibitor levels in patients with non-small-cell lung cancer.
Neoplasms
Tissue factor as a novel target for treatment of breast cancer.
Neoplasms
Tissue factor cytoplasmic domain stimulates migration by activation of the GTPase Rac1 and the mitogen-activated protein kinase p38.
Neoplasms
Tissue factor in cancer angiogenesis and metastasis.
Neoplasms
Tissue factor isoforms in cancer and coagulation: may the best isoform win.
Neoplasms
Tissue factor proangiogenic signaling in cancer progression.
Neoplasms
Tissue factor regulation by epidermal growth factor receptor and epithelial-to-mesenchymal transitions: effect on tumor initiation and angiogenesis.
Neoplasms
Tissue Factor-Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells.
Neoplasms
Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration.
Neoplasms
Tissue factor-like activity of the human monocytic tumor cell line U937.
Neoplasms
Tissue Factor/ FVIIa prevents the extrinsic pathway of apoptosis by regulation of the tumor suppressor Death-Associated Protein Kinase 1 (DAPK1).
Neoplasms
Tissue factor/factor VIIa induces cell survival and gene transcription by transactivation of the insulin-like growth factor 1 receptor.
Neoplasms
Tissue factor/factor VIIa inhibitors block angiogenesis and tumor growth through a nonhemostatic mechanism.
Neoplasms
Transdermal Progesterone: Effects on Menopausal Symptoms and on Thrombotic, Anticoagulant, and Inflammatory Factors in Postmenopausal Women.
Neoplasms
Tri(n-butyl) phosphate/detergent treatment of licensed therapeutic and experimental blood derivatives.
Neoplasms
Tumor cells expressing tissue factor influence the migration of smooth muscle cells in a catalytic activity-dependent way.
Neoplasms
Tumor cells induce platelet aggregation and intraplatelet calcium ion movements.
Neoplasms
Tumor microenvironment mediated by suppression of autophagic flux drives liver malignancy.
Neoplasms
Uncomplicated neurosurgical resection of a malignant glioneuronal tumour under haemostatic cover of rFVIIa in a severe haemophilia patient with a high-titre inhibitor: a case report and literature review of rFVIIa use in major surgeries.
Neoplasms
Unlabeled uses of factor VIIa (recombinant) in pediatric patients.
Neoplasms
VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation.
Neoplasms
Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody.
Neoplasms
Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome.
Neoplasms
[Acquired isolated factor VII deficiency and bronchogenic carcinoma. A case report]
Neoplasms
[Anti-tumor effects of mouse factor VII-staphylococcus enterotoxin A (mfVII) chimeric protein in mice]
Neoplasms
[Ectopic expression and clinical significance of tissue factor/coagulation factor VII complex in colorectal cancer.]
Neoplasms
[Investigation of the mechanisms of coagulation factor VIIa-induced colon cancer SW620 cell proliferation and migration]
Neoplasms
[Recombinant activated factor VII in the treatment of intractable non-surgical bleeding following major vascular procedures]
Neoplasms
[Successful Anesthetic Management of a Patient with Critical Bleeding during Hepatectomy Using Recombinant Activated Factor VII and Intraoperative Blood Salvage].
Neoplasms
[The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer.]
Neoplasms
[Use of recombinant factor VIIa to reduce transfusional load in hemorrhaging patients after surgery for malignant tumors].
Nephrotic Syndrome
Changes of coagulation factors IX, VIII, VII, X, and V in nephrotic syndrome.
Nephrotic Syndrome
Factor VII deficiency associated with nephrotic syndrome.
Neuroblastoma
Successful outcome of DIC and life-threatening bleeding in a toddler with neuroblastoma treated with recombinant activated factor VII.
Neuroblastoma
Tissue factor/FVIIa activates Bcl-2 and prevents doxorubicin-induced apoptosis in neuroblastoma cells.
Neurofibroma
Utilization of recombinant activated factor VII in a case of spontaneous massive haemothorax in a patient with Von Recklinghausen's disease.
Neurofibromatosis 1
Utilization of recombinant activated factor VII in a case of spontaneous massive haemothorax in a patient with Von Recklinghausen's disease.
Neurologic Manifestations
Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study.
Nevus
Hypercoagulability and hyperfibrinolysis in patients with melanoma.
Non-alcoholic Fatty Liver Disease
Vascular Disease in Patients with Nonalcoholic Fatty Liver Disease.
Noonan Syndrome
The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.
Obesity
Adipokines and Thrombosis.
Obesity
Association of fibrinogen and coagulation factors VII and VIII with cardiovascular risk factors in the elderly: the Cardiovascular Health Study. Cardiovascular Health Study Investigators.
Obesity
Cardiovascular risk factors: interactive effects of lipids, coagulation and fibrinolysis.
Obesity
Dietary treatment of thrombogenic disorders related to the metabolic syndrome.
Obesity
Factor VII activity is an independent predictor of cardiovascular mortality in elderly women of a Sicilian population: results of an 11-year follow-up.
Obesity
Factor VII and ischaemic heart disease: epidemiological evidence.
Obesity
Factor VII deficiency - an enigma; clinicohematological profile in 12 cases.
Obesity
Factor VII, tissue factor pathway inhibitor, and monocyte tissue factor in diabetes mellitus: influence of type of diabetes, obesity index, and age.
Obesity
Genetic determination of coagulation factor VIIc levels among healthy middle-aged women.
Obesity
Haemostatic and other cardiovascular risk factors, and socioeconomic status among middle-aged Finnish men and women.
Obesity
Inflammatory and prothrombotic parameters in normotensive non-diabetic obese women: effect of weight loss obtained by gastric banding.
Obesity
Interrelationship between coagulation factor VII and obesity in diabetes mellitus (type 2).
Obesity
Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
Obesity
Population correlates of coagulation factor VII. Importance of age, sex, and menopausal status as determinants of activated factor VII.
Obesity
Skinfold thickness, body mass index, and fatal coronary heart disease: 30 year follow up of the Northwick Park heart study.
Obesity
The production of coagulation factor VII by adipocytes is enhanced by tumor necrosis factor-? or isoproterenol.
Obesity
[Factor VII and cardiovascular risk in obese subjects]
Obesity
[Hemostasis profiles in thrombotic disease]
Obesity, Abdominal
Coagulation, fibrinolysis and haemorheology in premenopausal obese women with different body fat distribution.
Obesity, Abdominal
Effect of the factor VII R353Q missense mutation on plasma apolipoprotein B levels: impact of visceral obesity.
Obesity, Abdominal
Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.
Obesity, Abdominal
Lower androgenicity is associated with higher plasma levels of prothrombotic factors irrespective of age, obesity, body fat distribution, and related metabolic parameters in men.
Obesity, Abdominal
Obesity, haemostasis and the fibrinolytic system.
Obesity, Morbid
Postprandial factor VII activation does not increase plasma concentrations of prothrombin fragment 1 + 2 in patients with morbid obesity.
Obesity, Morbid
Reduction in factor VII, fibrinogen and plasminogen activator inhibitor-1 activity after surgical treatment of morbid obesity.
Osteoarthritis
Total hip arthroplasty in severe congenital factor VII deficiency: successful use of recombinant activated factor VII for hemostasis.
Osteogenesis Imperfecta
Recombinant factor VIIa after aortic valve replacement in a patient with osteogenesis imperfecta.
Ovarian Neoplasms
Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Ovarian Neoplasms
Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles.
Ovarian Neoplasms
Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Ovarian Neoplasms
Tissue Factor-Factor VII Complex As a Key Regulator of Ovarian Cancer Phenotypes.
Ovarian Neoplasms
[Study of the effect of TF/FVIIa complex on the expression of u-PAR mRNA in human ovarian cancer]
Ovarian Neoplasms
[The effects of tissue factor/activated factor VII complex on the invasion and metastasis of human ovarian cancer.]
Overweight
Impact of smoking, physical training and weight reduction on FVII, PAI-1 and hemostatic markers in sedentary men.
Overweight
Impact of weight loss on plasminogen activator inhibitor (PAI-1), factor VII, and other hemostatic factors in moderately overweight adults.
Overweight
Moderate weight reduction improves red cell aggregation and factor VII activity in overweight subjects.
Overweight
[Prothrombotic and prethrombotic markers in obese diabetic and non-diabetic subjects]
Pancreatic Neoplasms
A Phase 2 Study of PCI-27483, a Factor VIIa Inhibitor in Combination with Gemcitabine for Advanced Pancreatic Cancer.
Pancreatic Neoplasms
Differing mechanisms of thrombin generation in live haematological and solid cancer cells determined by calibrated automated thrombography.
Pancreatic Neoplasms
Novel Agents in the Management of Pancreatic Adenocarcinoma: Phase I Studies. Highlights from the "2011 ASCO Gastrointestinal Cancers Symposium". San Francisco, CA, USA. January 20-22, 2011.
Pancreatic Neoplasms
PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-labeled Active Site Inhibited Factor VII.
Pancreatic Neoplasms
The inhibition of pancreatic cancer invasion-metastasis cascade in both cellular signal and blood coagulation cascade of tissue factor by its neutralisation antibody.
Pancreatic Neoplasms
Visualizing cancer and response to therapy in vivo using Cy5.5-labeled factor VIIa and anti-tissue factor antibody.
Pancreatitis
A double-blind, randomized, controlled study to explore the efficacy of rFVIIa on intraoperative blood loss and mortality in patients with severe acute pancreatitis.
Pancreatitis
Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa.
Pancreatitis
Treatment of bleeding in severe necrotizing pancreatitis with recombinant factor VIIa.
Pancreatitis
Treatment with anti-factor VIIa in acute pancreatitis in rats: blocking both coagulation and inflammation?
Pancreatitis
Use of recombinant activated factor VII for bleeding in pancreatitis: a case series.
Pancreatitis
Use of recombinant activated factor VII for the treatment of perioperative bleeding in noncardiac surgery patients without hemophilia: A systematic review and meta-analysis of randomized controlled trials.
Pancreatitis
Use of recombinant factor VIIa for life-threatening bleeding in a patient with severe necrotizing pancreatitis.
Pancreatitis
Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis.
Pancreatitis, Acute Hemorrhagic
Treatment of bleeding in severe hemorrhagic pancreatitis with recombinant factor VIIa.
Pancreatitis, Chronic
Use of recombinant activated factor VII for bleeding in pancreatitis: a case series.
Pancytopenia
Observations on serum prothrombin conversion accelerator in radiation-induced pancytopenia.
Pancytopenia
Successful treatment of gastrointestinal bleeding with recombinant factor VIIa after kidney transplantation in patients with pancytopenia.
Paraneoplastic Syndromes
[Recombinant activated factor VII in haemostasis after radical nephrectomy]
Paraplegia
Contribution of D-Dimer determination in the exclusion of deep venous thrombosis in spinal cord injury patients.
Pediatric Obesity
Elevated circulating tissue factor procoagulant activity, factor VII, and plasminogen activator inhibitor-1 in childhood obesity: evidence of a procoagulant state.
Pemphigus
Coexistence of pemphigus foliaceus and acquired hemophilia A: A case report.
Pericardial Effusion
Intra-Pericardial Use of Recombinant Factor VIIa in a Patient With Acute Hemorrhagic Pericardial Effusion Following Transcutaneous Aortic Valve Replacement-A Case Report.
Pericardial Effusion
Treatment of hemopericardium caused by mitral balloon valvuloplasty with activated factor VII: a case report.
Pericarditis, Constrictive
Constrictive pericarditis in a patient with inherited factor VII deficiency.
Periodontal Diseases
Periodontal disease and biomarkers related to cardiovascular disease.
Peripheral Arterial Disease
A two adenine insertion polymorphism in the 3' untranslated region of factor VII gene is associated with peripheral arterial disease but not with venous thrombosis. Results of case-control studies.
Peripheral Arterial Disease
Ankle-brachial index and hemostatic markers in the Atherosclerosis Risk in Communities (ARIC) study cohort.
Peripheral Arterial Disease
Relation between hemostatic variables and increase of common carotid intima-media thickness in patients with peripheral arterial disease.
Peripheral Vascular Diseases
The PLAT Study: hemostatic function in relation to atherothrombotic ischemic events in vascular disease patients. Principal results. PLAT Study Group. Progetto Lombardo Atero-Trombosi (PLAT) Study Group.
Phenylketonurias
Whole-exome sequencing provides insights into monogenic disease prevalence in Northwest Russia.
Pilonidal Sinus
Bleeding characteristics and management of minor surgeries in rare bleeding disorders: report from a Turkish Pediatric Hematology Center.
Pituitary Neoplasms
Prophylaxis and therapy with factor VII concentrate (human) immuno, vapor heated in patients with congenital factor VII deficiency: a summary of case reports.
Placenta Accreta
Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage.
Placenta Accreta
Successful treatment of severe retro-peritoneal bleeding with recombinant factor VIIa in women with placenta percreta invading into the left broad ligament: unusual repeated ante-partum intra-abdominal bleeding.
Placenta Accreta
Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
Placenta Previa
Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa.
Placenta Previa
Topical application of recombinant activated factor VII during cesarean delivery for placenta previa.
Placenta Previa
Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
Platelet Storage Pool Deficiency
Management of platelet storage pool disease during pregnancy with recombinant factor VIIa.
Plummer-Vinson Syndrome
Plummer-Vinson Syndrome With Concomitant Factor VII Deficiency.
Pneumonia
Granulomatous Pneumocystis carinii pneumonia in a non-AIDS patient: an atypical presentation.
Pneumonia
Inhibition of the extrinsic or intrinsic coagulation pathway during pneumonia derived sepsis.
Pneumonia
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Pneumonia
Protease-Activated Receptor 2 Facilitates Bacterial Dissemination in Pneumococcal Pneumonia.
Pneumonia
Successful use of recombinant factor VII in massive hemoptysis due to community-acquired pneumonia.
Pneumonia
Two elderly patients with difficult-to-treat acquired hemophilia A.
Pneumonia
Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
Pneumonia, Pneumococcal
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Pneumonia, Pneumocystis
Granulomatous Pneumocystis carinii pneumonia in a non-AIDS patient: an atypical presentation.
Pneumothorax
Elevated Interleukin-6 Concentration and Alterations of the Coagulation System Are Associated with the Development of Intraventricular Hemorrhage in Extremely Preterm Infants.
Pneumothorax
Reversal of thrombocytopenia and bleeding tendency in a preterm neonate with recombinant activated factor VII: case report.
Polycythemia Vera
[Factor V and factor VII content in polycythemia vera.]
Polyuria
[Complications during epilepsy surgery. Experience after 102 interventions between 1997 and 2001]
Posterior Leukoencephalopathy Syndrome
Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis.
Postpartum Hemorrhage
A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
Postpartum Hemorrhage
Diagnosis and treatment discussion of congenital factor VII deficiency in pregnancy: A case report.
Postpartum Hemorrhage
Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Postpartum Hemorrhage
Factor VII deficiency detected in pregnancy: a case report.
Postpartum Hemorrhage
Failure of recombinant factor VIIa to correct the coagulopathy in a case of severe postpartum hemorrhage.
Postpartum Hemorrhage
Low-dose recombinant activated factor VII temporally stopped bleeding from small artery in severe postpartum hemorrhage: a case report.
Postpartum Hemorrhage
Massive postpartum hemorrhage: recombinant factor VIIa use is safe but not effective.
Postpartum Hemorrhage
Occult hemophilia as a cause of postoperative and postpartum hemorrhage. With special reference to factor VII deficiency.
Postpartum Hemorrhage
Postpartum hemorrhage in a Jehovah's Witness patient controlled with Tisseel, tranexamic acid, and recombinant factor VIIa.
Postpartum Hemorrhage
Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Postpartum Hemorrhage
Preliminary experience with use of recombinant activated factor VII to control postpartum hemorrhage in acute fatty liver of pregnancy and other pregnancy-related liver disorders.
Postpartum Hemorrhage
Real efficacy of factor VIIa in the treatment of the postpartum hemorrhage.
Postpartum Hemorrhage
Recombinant activated factor VII as a promising adjuvant therapy for postpartum hemorrhage in the practice of obstetric anesthesia: Experience from a university hospital in Taiwan.
Postpartum Hemorrhage
Recombinant Activated Factor VII as a Second Line Treatment for Postpartum Hemorrhage.
Postpartum Hemorrhage
Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry.
Postpartum Hemorrhage
Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy.
Postpartum Hemorrhage
Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
Postpartum Hemorrhage
Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study.
Postpartum Hemorrhage
Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial.
Postpartum Hemorrhage
Successful management of maternal factor VII deficiency in a cesarean section.
Postpartum Hemorrhage
Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII.
Postpartum Hemorrhage
Successful use of recombinant factor VIIa for treatment of severe postpartum hemorrhage.
Postpartum Hemorrhage
The role of recombinant activated factor VII in obstetric hemorrhage.
Postpartum Hemorrhage
The use of recombinant activated FVII in postpartum hemorrhage.
Postpartum Hemorrhage
The use of recombinant factor VIIa in severe postpartum hemorrhage.
Postpartum Hemorrhage
Use of Activated Recombinant Factor VII in Severe Bleeding - Evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac Surgery, and Gastrointestinal Bleeding.
Postpartum Hemorrhage
Use of recombinant activated factor VII for massive postpartum hemorrhage.
Postpartum Hemorrhage
Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004.
Postpartum Hemorrhage
Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
Postpartum Hemorrhage
[Discussion of the article: Successful treatment of severe postpartum hemorrhage after cesarean section with recombinant activated factor VII]
Postpartum Hemorrhage
[Efficiency and safety of recombinant activated factor VII in a case of severe postpartum hemorrhage].
Postpartum Hemorrhage
[Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use]
Postpartum Hemorrhage
[Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia]
Postpartum Hemorrhage
[Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony].
Pre-Eclampsia
Fetal corticotrophin-releasing hormone mRNA, but not phosphatidylserine-exposing microparticles, in maternal plasma are associated with factor VII activity in pre-eclampsia.
Pre-Eclampsia
Fibrinogen and factor VII promoter polymorphisms in women with preeclampsia.
Pre-Eclampsia
Hemostatic abnormalities may predict chronic hypertension after preeclampsia.
Pre-Eclampsia
Plasma factor VII: a potential marker of pre-eclampsia.
Pre-Eclampsia
Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Intrapulmonary rFVIIa for life threatening pulmonary hemorrhage in a case of relapsing acute lymphoblastic leukemia and platelet refractoriness.
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Successful treatment of acute lymphoblastic leukemia with L-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child.
Priapism
Progression of the Prothrombotic State in Aging Bmal1-Deficient Mice.
Primary Myelofibrosis
Use of Recombinant Factor VIIa for Bleeding Control in Treatment of Acute Extremity Compartment Syndrome Secondary to Primary Myelofibrosis: A Case Report.
Prolactinoma
BLOOD COAGULATION, FIBRINOLYSIS AND LIPID PROFILE IN PATIENTS WITH PROLACTINOMA.
Prostatic Neoplasms
Activation of factor VII in patients with carcinoma of the prostate. A preliminary report.
Prostatic Neoplasms
Activators and inhibitors of coagulation and fibrinolysis in patients with prostatic cancer treated with oestrogen or orchidectomy.
Prostatic Neoplasms
Effects of oestrogen therapy and orchidectomy on coagulation and prostanoid synthesis in patients with prostatic cancer.
Prostatic Neoplasms
Gene expression profile of FVII and AR in primary prostate cancer.
Prostatic Neoplasms
Targeting tissue factor on tumor vascular endothelial cells and tumor cells for immunotherapy in mouse models of prostatic cancer.
Prostatic Neoplasms
Use of recombinant activated factor VII for the treatment of perioperative bleeding in noncardiac surgery patients without hemophilia: A systematic review and meta-analysis of randomized controlled trials.
Protein C Deficiency
Autologous bone marrow transplantation and factor XII, factor VII, and protein C deficiencies. Report of a new association and its possible relationship to endothelial cell injury.
Protein C Deficiency
Combined factor VII and protein C deficiency found in a patient with peripheral pulmonary artery stenosis accompanied by progressive pulmonary hypertension and hemoptysis.
Protein C Deficiency
Congenital protein C deficiency and myocardial infarction:concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis.
Protein C Deficiency
Detection of protein C deficiency during oral anticoagulant therapy--use of the protein C:factor VII ratio.
Protein C Deficiency
Factor XII deficiency acquired by orthotopic liver transplantation: case report and review of the literature.
Protein C Deficiency
Recurrent restenosis after percutaneous transluminal coronary angioplasty in a patient with congenital protein C deficiency and high activated factor VII level.
Protein C Deficiency
Suppression of plasma-activated factor VII levels by warfarin therapy.
Protein C Deficiency
[Levels of antithrombin III and proteins C in the newborn infant]
protein-glutamine gamma-glutamyltransferase deficiency
A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
protein-glutamine gamma-glutamyltransferase deficiency
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
protein-glutamine gamma-glutamyltransferase deficiency
Autosomal recessive inherited bleeding disorders in Pakistan: a cross-sectional study from selected regions.
protein-glutamine gamma-glutamyltransferase deficiency
Clinical audit of inherited bleeding disorders in a developing country.
protein-glutamine gamma-glutamyltransferase deficiency
Inherited bleeding disorders in Indian women with menorrhagia.
protein-glutamine gamma-glutamyltransferase deficiency
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
protein-glutamine gamma-glutamyltransferase deficiency
Rare inherited coagulation disorders in India.
protein-glutamine gamma-glutamyltransferase deficiency
Successful use of recombinant factor VIIa in a child with Schoenlein-Henoch purpura presenting with compartment syndrome and severe factor XIII deficiency.
Proteinuria
Haemostatic variables associated with diabetes and its complications.
Proteinuria
Hemostatic function tests associated with diabetic microangiopathy.
Pulmonary Arterial Hypertension
Successful placement of a right ventricular assist device for treatment of a presumed amniotic fluid embolism.
Pulmonary Atresia
Palliative open heart surgery in an infant with factor VII deficiency.
Pulmonary Disease, Chronic Obstructive
Circulating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary disease.
Pulmonary Disease, Chronic Obstructive
Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales.
Pulmonary Disease, Chronic Obstructive
Thrombin generation in chronic obstructive pulmonary disease: Dependence on plasma factor composition.
Pulmonary Edema
Use of recombinant factor VIIa to correct the coagulation status of individuals with advanced liver disease prior to a percutaneous liver biopsy.
Pulmonary Embolism
Congenital FVII Deficiency and Pulmonary Embolism : A Critical Appraisal of All Reported Cases.
Pulmonary Embolism
Congenital FVII deficiency and thrombotic events after replacement therapy.
Pulmonary Embolism
Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency.
Pulmonary Embolism
Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology.
Pulmonary Embolism
Lack of bleeding in patients with severe factor VII deficiency.
Pulmonary Embolism
Management of massive pulmonary embolism using recombinant activated Factor VII.
Pulmonary Embolism
Massive pulmonary embolism after treatment with rFVIIa in a thrombocytopenic patient with acute myelogenous leukemia and intractable bleeding.
Pulmonary Embolism
Medication-related complications in the trauma patient.
Pulmonary Embolism
Postoperative pulmonary thromboembolism possibly associated with recombinant activated factor VII infusion for the treatment of uncontrolled hemorrhage during vertebral instrumentation.
Pulmonary Embolism
Pulmonary embolism after administration of recombinant activated Factor VII for major obstetric hemorrhage.
Pulmonary Embolism
Pulmonary embolism after sequential use of recombinant factor VIIa and activated prothrombin complex concentrate in a factor VIII inhibitor patient.
Pulmonary Embolism
Pulmonary embolism in a patient with mild factor VII deficiency after administration of recombinant activated factor VII during a urological procedure.
Pulmonary Embolism
Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity.
Pulmonary Embolism
ST-Segment Elevation Myocardial Infarction (STEMI) and Pulmonary Embolism in a Hemophilia A Patient Receiving Emicizumab and recombinant Activated Factor VII.
Pulmonary Embolism
Therapeutic plasma exchange as part of multimodal treatment of acquired hemophilia in a patient with concurrent acute intracerebral bleed and pulmonary embolism.
Pulmonary Embolism
Thromboembolism in patients with hereditary deficiency of coagulation factors.
Pulmonary Embolism
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
Purpura
[Hemostasis anomalies and prognosis during severe infectious purpura in children. Retrospective study in 69 cases]
Purpura Fulminans
First manifestation of a hereditary homozygous factor VII deficiency in a 3-year-old girl suspected as purpura fulminans.
Purpura, Thrombocytopenic, Idiopathic
Combination of recombinant factor VIIa and fibrinogen corrects clot formation in primary immune thrombocytopenia at very low platelet counts.
Purpura, Thrombocytopenic, Idiopathic
Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura.
Purpura, Thrombocytopenic, Idiopathic
Experiences with recombinant FVIIa in the emergency treatment of patients with autoimmune thrombocytopenia: a review of the literature.
Purpura, Thrombocytopenic, Idiopathic
Heparin-induced thrombocytopenia and other immune thrombocytopenias: lessons from mouse models.
Purpura, Thrombocytopenic, Idiopathic
Plasma levels of activated FVII in various diseases.
Purpura, Thrombocytopenic, Idiopathic
Recombinant factor VIIa for refractive haemorrhage in autoimmune idiopathic thrombocytopenic purpura.
Purpura, Thrombocytopenic, Idiopathic
Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment.
Purpura, Thrombocytopenic, Idiopathic
Screening bleeding disorders in adolescents and young women with menorrhagia.
Purpura, Thrombocytopenic, Idiopathic
Severe gastrointestinal haemorrhage responding to recombinant factor VIIa in a Jehovah's Witness with refractory immune thrombocytopenia.
Purpura, Thrombocytopenic, Idiopathic
Successful control of severe postoperative bleeding with recombinant factor VIIa in a case of refractory idiopathic thrombocytopenic purpura.
Purpura, Thrombocytopenic, Idiopathic
Use of Recombinant Factor VIIa in a Pediatric Patient With Initial Presentation of Refractory Acute Immune Thrombocytopenic Purpura and Severe Bleeding.
Purpura, Thrombocytopenic, Idiopathic
[Serious congenital deficiency of FVII and acquired idiopathic thrombocytopenic purpura--the rare combination of two bleeding disorders]
Purpura, Thrombocytopenic, Idiopathic
[Use of recombinant activated factor VII (NovoSeven) in the treatment of a patient with idiopathic thrombocytopenic purpura complicated with subarachnoid and parenchimatous hemorrhage]
Pyelonephritis
Acquired Factor VII Deficiency in Association with Pyelonephritis.
Pyelonephritis
Avoiding Cardiovascular Collapse: Pediatric Cutaneous Mastocytosis and Anesthetic Challenges.
Quadriplegia
Contribution of D-Dimer determination in the exclusion of deep venous thrombosis in spinal cord injury patients.
Rectal Neoplasms
Anesthetic management of a patient with factor VII deficiency undergoing laparoscopic colectomy: a case report.
Refsum Disease
Liver cell transplantation.
Refsum Disease, Infantile
Hepatocyte transplantation for liver-based metabolic disorders.
Renal Insufficiency
A role for very low-dose recombinant activated factor VII in refractory bleeding after cardiac surgery: Lessons from an observational study.
Renal Insufficiency
Impact of Early, Low-Dose Factor VIIa on Subsequent Transfusions and Length of Stay in Cardiac Surgery.
Renal Insufficiency
Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery.
Renal Insufficiency
Recombinant activated factor VII treatment of retroperitoneal hematoma in a patient with renal failure receiving enoxaparin and clopidogrel.
Renal Insufficiency
Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
Renal Insufficiency
Successful control of postsurgical bleeding by recombinant factor VIIa in a renal failure patient given low molecular weight heparin and aspirin.
Renal Insufficiency
Takayasu Arteritis Presenting as Renovascular Hypertension and Renal Failure in a Patient with Factor VII Deficiency.
Renal Insufficiency
Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
Renal Insufficiency
[Activated factor VII as a new cardiovascular risk factor of atherothrombotic disease]
Renal Insufficiency
[Pathophysiological and therapeutic aspects of amniotic fluid embolism (anaphylactoid syndrome of pregnancy): case report with lethal outcome and overview]
Renal Insufficiency, Chronic
Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype.
Respiratory Distress Syndrome
A multicenter, randomized, double-blind, placebo-controlled, dose-escalation trial assessing safety and efficacy of active site inactivated recombinant factor VIIa in subjects with acute lung injury or acute respiratory distress syndrome*
Respiratory Distress Syndrome
Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII.
Respiratory Distress Syndrome
Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
Respiratory Distress Syndrome
Recombinant Activated Factor VII Safety in Trauma Patients: Results From the CONTROL Trial.
Respiratory Distress Syndrome
The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage.
Respiratory Insufficiency
Recombinant activated factor VII for exsanguinating haemorrhage post bilateral lung transplantation for extra-corporeal lung support-dependent respiratory failure.
Respiratory Insufficiency
[Primary myelofibrosis complicated by acquired hemophilia A and subsequent development of acute myeloid leukemia].
Respiratory Tract Infections
Prothrombotic changes in hemostatic parameters and C-reactive protein in the elderly with winter acute respiratory tract infections.
Retinal Vein Occlusion
Is activated factor VII associated with retinal vein occlusion?
Rhabdomyosarcoma
Recombinant activated factor VII controls chemotherapy-related hemorrhage in patients with solid intra-abdominal tumors: a report of three pediatric cases.
Rheumatic Diseases
Anti-factor Xa antibodies in patients with antiphospholipid syndrome and their effects upon coagulation assays.
Sagittal Sinus Thrombosis
Superior sagittal sinus thrombosis with homocystinuria and deficiency of antithrombin III and factor VII: case report.
Sarcoidosis
Human alveolar macrophages synthesize factor VII in vitro. Possible role in interstitial lung disease.
Sarcoma
Role of factor VII in correcting dilutional coagulopathy and reducing re-operations for bleeding following non-traumatic major gastrointestinal and abdominal surgery.
Sarcoma
Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
Schistosomiasis
Splenectomy Improves Hemostatic and Liver Functions in Hepatosplenic Schistosomiasis Mansoni.
Scleroderma, Systemic
Low levels of activated factor VII in systemic sclerosis.
Scoliosis
Bleeding and coagulation changes during spinal fusion surgery: a comparison of neuromuscular and idiopathic scoliosis patients.
Scoliosis
Recombinant coagulation factor VIIa--a novel haemostatic agent in scoliosis surgery?
Scoliosis
Surgery for scoliosis in congenital factor VII deficiency.
Scoliosis
The use of recombinant coagulation factor VIIa in patients undergoing surgical correction of scoliosis with the C-D method.
Scoliosis
[A Jehovah's Witness child with hemophilia B and factor IX inhibitors undergoing scoliosis surgery]
Seizures
Congenital factor VII deficiency.
Seizures
High-dose tranexamic acid is related to increased risk of generalized seizures after aortic valve replacement.
Seizures
Medication-related complications in the trauma patient.
Seizures
Multiple intracranial hemorrhages at the time of a transiently prolonged activated partial thromboplastin time in an infant with congenital factor VII deficiency.
Seizures
Novel IVS7+1G>T mutation of life-threatening congenital factor VII deficiency in neonates: A retrospective study in China.
Seizures
Successful control of central nervous system bleeding in two newborns with severe factor VII deficiency using rFVIIa administered via Port-a-Cath.
Sepsis
Acquired isolated factor VII deficiency during sepsis.
Sepsis
Acquired Isolated FVII Deficiency: An Underestimated and Potentially Important Laboratory Finding.
Sepsis
Acute Myelogenous Leukemia With Trisomy 8 and Concomitant Acquired Factor VII Deficiency.
Sepsis
Anaesthetic management of a parturient with factor VII deficiency and sepsis.
Sepsis
Blockade of tissue factor: treatment for organ injury in established sepsis.
Sepsis
Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
Sepsis
Expression of tissue factor in experimental bovine pneumonic pasteurellosis and endotoxemia.
Sepsis
Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.
Sepsis
Failure of recombinant factor VIIa in a patient with severe polymicrobial sepsis and postoperative uncontrolled intraabdominal bleeding.
Sepsis
Hepatocyte transplantation for inherited factor VII deficiency.
Sepsis
Human leukocyte elastase and cathepsin G inactivate factor VII by limited proteolysis.
Sepsis
Increased mortality in systemic inflammatory response syndrome patients with high levels of coagulation factor VIIa.
Sepsis
Induction of human endothelial tissue factor expression by Neisseria meningitidis: the influence of bacterial killing and adherence to the endothelium.
Sepsis
Inhibition of the extrinsic or intrinsic coagulation pathway during pneumonia derived sepsis.
Sepsis
Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice.
Sepsis
Initiation of blood coagulation: the tissue factor/factor VIIa complex.
Sepsis
Local activation of the tissue factor-factor VIIa pathway in patients with pneumonia and the effect of inhibition of this pathway in murine pneumococcal pneumonia.
Sepsis
Low plasma FVII:C and activated FVII as predictive markers for overt disseminated intravascular coagulation.
Sepsis
Management of Life-Threatening Hemorrhages and Unsafe Interventions in Nonhemophiliac Children by Recombinant Factor VIIa.
Sepsis
Potential role of recombinant activated factor VII for the treatment of severe bleeding associated with disseminated intravascular coagulation: a systematic review.
Sepsis
Recombinant Activated Factor VII Use in Critically Ill Patients: Clinical Outcomes and Thromboembolic Events (April).
Sepsis
Recombinant factor VII (activated) for haemorrhagic complications of severe sepsis treated with recombinant protein C (activated).
Sepsis
Review of cellular and molecular pathways linking thrombosis and innate immune system during sepsis.
Sepsis
Safety profile of recombinant factor VIIa.
Sepsis
Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
Sepsis
Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site.
Sepsis
The development of hypoprothrombinaemia following antibiotic therapy in malnourished patients with low serum vitamin K1 levels.
Sepsis
Tissue factor as an evolutionary conserved cytokine receptor: Implications for inflammation and signal transduction.
Sepsis
Tissue factor in experimental acute lung injury.
Sepsis
Use of recombinant factor VIIa in the treatment of massive retroperitoneal bleeding due to severe necrotizing pancreatitis.
Sepsis
VIIa/tissue factor interaction results in a tissue factor cytoplasmic domain-independent activation of protein synthesis, p70, and p90 S6 kinase phosphorylation.
Sepsis
[Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use]
Sepsis
[Studies on low protein C-expression in severe sepsis]
Severe Dengue
Control of bleeding in children with Dengue hemorrhagic fever using recombinant activated factor VII: a randomized, double-blind, placebo-controlled study.
Severe Dengue
Effectiveness of Recombinant Activated Factor VII (rFVII a) for Controlling Intractable Postpartum Bleeding in a case of Dengue Hemorrhagic Fever.
Severe Dengue
Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience.
Severe Dengue
Successful use of N-acetyl cysteine and activated recombinant factor VII in fulminant hepatic failure and massive bleeding secondary to dengue hemorrhagic fever.
Severe Dengue
The use of recombinant activated factor VII for controlling life-threatening bleeding in Dengue Shock Syndrome.
Severe Dengue
[Treatment of hemorrhagic dengue in the pediatric population: a systematic review].
Shock, Cardiogenic
Activated recombinant factor VII for control of diffuse bleeding after implantation of ventricular assist device.
Shock, Septic
Can Coagulation System Disorders and Cytokine and Inflammatory Marker Levels Predict the Temporary Clinical Deterioration or Improvement of Septic Patients on ICU Admission?
Shock, Septic
Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients.
Shock, Septic
Septic miscarriage with toxic shock syndrome and disseminated intravascular coagulation (DIC): The role of surgery, recombinant activated factor VII and intravenous immunoglobulin (IVIG).
Shock, Septic
Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock.
Shock, Septic
[Bleeding associated with septic shock treated successfully with recombinant activated factor VII: a case report]
Sinus Thrombosis, Intracranial
Cerebral sinus thrombosis in a trauma patient after recombinant activated factor VII infusion.
Sinus Thrombosis, Intracranial
Cerebral Venous Sinus Thrombosis in a Patient with Undiagnosed Factor VII Deficiency.
Sleep Apnea Syndromes
Factor VII deficiency and developmental abnormalities in a patient with partial monosomy of 13q and trisomy of 16p: case report and review of the literature.
Sleep Deprivation
Chronic sleep deprivation markedly reduces coagulation factor VII expression.
Spastic Paraplegia, Hereditary
Coexistence of Factor VII Deficiency and Hereditary Spastic Paraplegia in Two Siblings.
Spinal Cord Diseases
Description of breed ancestry and genetic health traits in arctic sled dog breeds.
Splenic Rupture
[Case of factor VII deficiency with systemic amyloidosis having a unique clinical course such as splenic rupture]
Starvation
Anti-apoptotic genes are synergistically activated in OVSAYO cells cultured under conditions of serum starvation and hypoxia.
Starvation
Cholesterol Starvation and Hypoxia Activate the FVII Gene via the SREBP1-GILZ Pathway in Ovarian Cancer Cells to Produce Procoagulant Microvesicles.
Stenosis, Pulmonary Artery
Combined factor VII and protein C deficiency found in a patient with peripheral pulmonary artery stenosis accompanied by progressive pulmonary hypertension and hemoptysis.
Stomach Neoplasms
Major surgery for a gastric cancer in a haemophilic with high inhibitor titre successfully performed by the use of recombinant FVIIa.
Stomach Neoplasms
[Gastrectomy for a patient with congenital factor VII deficiency--a case report]
Stroke
A meta-analysis of the efficacy and safety of recombinant activated factor VII for patients with acute intracerebral hemorrhage without hemophilia.
Stroke
ACE gene polymorphisms influence t-PA-induced brain vessel reopening following ischemic stroke.
Stroke
Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
Stroke
Anticoagulation Therapy Considerations in Factor VII Deficiency.
Stroke
Association of coagulation-related and inflammation-related genes and factor VIIc levels with stroke: the Cardiovascular Health Study.
Stroke
Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.
Stroke
Blood coagulation and fibrinolysis in acute ischaemic and haemorrhagic (intracerebral and subarachnoid haemorrhage) stroke: does decreased plasmin inhibitor indicate increased fibrinolysis in subarachnoid haemorrhage compared to other types of stroke?
Stroke
Clinical Strategies Against Early Hematoma Expansion Following Intracerebral Hemorrhage.
Stroke
Coagulation factor VII activity, Arg/Gln353 polymorphism and features of insulin resistance in first-degree-relatives of South Asian patients with stroke.
Stroke
Concurrent administration of sustained-release bezafibrate may counteract the increased thrombotic risk associated with oral estrogen therapy.
Stroke
Congenital factor VII deficiency and cerebrovascular stroke.
Stroke
Decreased fibrinolytic potential in South Asian women with ischaemic cerebrovascular disease.
Stroke
Effect of Recombinant Activated Coagulation Factor VII on Hemorrhage Expansion Among Patients With Spot Sign-Positive Acute Intracerebral Hemorrhage: The SPOTLIGHT and STOP-IT Randomized Clinical Trials.
Stroke
Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage.
Stroke
Ethnic differences in cardiovascular risk factor burden among middle-aged women: Study of Women's Health Across the Nation (SWAN).
Stroke
Factor VII -323 decanucleotide D/I polymorphism in atrial fibrillation: implications for the prothrombotic state and stroke risk.
Stroke
Factor VII deficiency in major artery occlusion stroke.
Stroke
Factor VII gene haplotypes and risk of ischemic stroke.
Stroke
Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls.
Stroke
Factor VIIa and tissue factor procoagulant activity in diabetes mellitus after acute ischemic stroke: impact of hyperglycemia.
Stroke
Haemostatic variables in Pacific Islanders apparently free from stroke and ischaemic heart disease--the Kitava Study.
Stroke
Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study.
Stroke
Hypercoagulability in acute ischemic stroke: analysis of the extrinsic coagulation reactions in plasma by a highly sensitive automated method.
Stroke
Intracerebral hemorrhage: outcomes and eligibility for factor VIIa treatment in a National Stroke Registry.
Stroke
Lp(a), homocysteine and a family history of early ischemic cerebral stroke.
Stroke
Metabolic, inflammatory and haemostatic effects of a low-dose continuous combined HRT in women with type 2 diabetes: potentially safer with respect to vascular risk?
Stroke
Novel anticoagulant therapy: principle and practice.
Stroke
Polymorphisms of the factor VII gene and circulating FVII:C levels in relation to acute cerebrovascular disease and poststroke mortality.
Stroke
Recent bacterial and viral infection is a risk factor for cerebrovascular ischemia: clinical and biochemical studies.
Stroke
Recombinant activated factor VII in cardiac surgery: a meta-analysis.
Stroke
Recombinant Activated Factor VII Increases Stroke in Cardiac Surgery: A Meta-analysis.
Stroke
Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery.
Stroke
Recombinant factor VIIa for hemorrhagic stroke treatment at earliest possible time (FASTEST): Protocol for a phase III, double-blind, randomized, placebo-controlled trial.
Stroke
Recombinant factor VIIa in a case of pontine hemorrhage.
Stroke
Recombinant factor VIIa use in acute type A aortic dissection repair: A multicenter propensity-score-matched report from the Nordic Consortium for Acute Type A Aortic Dissection.
Stroke
Recombinant factor VIIa use in patients presenting with intracranial hemorrhage.
Stroke
Reversal of warfarin-induced anticoagulation with factor VIIa prior to rt-PA in acute stroke.
Stroke
Safety and efficacy of recombinant activated factor VII: a randomized placebo-controlled trial in the setting of bleeding after cardiac surgery.
Stroke
Seasonal variations of plasma fibrinogen and factor VII activity in the elderly: winter infections and death from cardiovascular disease.
Stroke
The safety of recombinant factor VIIa in cardiac surgery.
Stroke
The tissue factor pathway in ischemic stroke.
Stroke
Tissue factor/factor VIIa pathway mediates coagulation activation in induced-heat stroke in the baboon.
Stroke
[Acute stroke therapy : Current developments.]
Stroke
[Intracerebral haemorrhage, what's new?]
Stroke, Lacunar
Factor VII R353Q polymorphism and lacunar stroke in Japanese hypertensive patients and normotensive controls.
Subarachnoid Hemorrhage
Congenital deficiency of factor VII in subarachnoid hemorrhage.
Subarachnoid Hemorrhage
Invasive EEG-electrodes in presurgical evaluation of epilepsies: Systematic analysis of implantation-, video-EEG-monitoring- and explantation-related complications, and review of literature.
Subarachnoid Hemorrhage
Perioperative Use of Recombinant Factor VII to Prevent Intraoperative Aneurysm Rupture in High Risk Patients: A Preliminary Safety Evaluation.
Subarachnoid Hemorrhage
Recombinant factor VIIa as an adjunct in nonoperative management of solid organ injuries in children.
Synovitis
EPCR deficiency or function-blocking antibody protects against joint bleeding-induced pathology in hemophilia mice.
Synovitis
Hemophilic synovitis: factor VII and the potential role of extravascular factor VIIa.
Synovitis
Prevention of haemarthrosis in a murine model of acute joint bleeding.
Takayasu Arteritis
Takayasu Arteritis Presenting as Renovascular Hypertension and Renal Failure in a Patient with Factor VII Deficiency.
Telangiectasis
[Successful gastric resection in a male patient with factor VII deficiency and telangiectasia]
Teratoma
Recombinant factor VIIa for treatment of massive liver fracture in a premature infant.
Teratoma
Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa.
Tetralogy of Fallot
Recombinant factor VIIa to control excessive bleeding following surgery for congenital heart disease in pediatric patients.
Thrombasthenia
A case of Glanzmann's thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug.
Thrombasthenia
A patient with Glanzmann thrombasthenia and epistaxis successfully treated with recombinant factor VIIa.
Thrombasthenia
A patient with Glanzmann's thrombasthenia for emergent abdominal surgery.
Thrombasthenia
A rare case of Glanzmann's thrombasthenia and factor VII deficiency due to a combination of pathogenic and non-pathogenic gene variants.
Thrombasthenia
Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
Thrombasthenia
Buccal mucosa bleeding time is prolonged in canine models of primary hemostatic disorders.
Thrombasthenia
Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
Thrombasthenia
Clinical use of recombinant human activated factor VII (rFVIIa) in the prevention and treatment of bleeding episodes in patients with Glanzmann's thrombasthenia.
Thrombasthenia
Confirmation of high dose recombinant factor VIIa in treating patients with Glanzmann thrombasthenia.
Thrombasthenia
Control of severe bleeding episode in case of Glanzmann's thrombasthenia refractory to platelet transfusion therapy by administering recombinant factor VIIa.
Thrombasthenia
Eptacog alfa activated: a recombinant product to treat rare congenital bleeding disorders.
Thrombasthenia
Gene Therapy for Inherited Bleeding Disorders.
Thrombasthenia
Glanzmann thrombasthenia successfully operated for nasal deformation with recombinant factor VIIA.
Thrombasthenia
Glanzmann's thrombasthenia treatment: a prospective observational registry on the use of recombinant human activated factor VII and other hemostatic agents.
Thrombasthenia
Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.
Thrombasthenia
Independent Adjudicator Assessments of Platelet Refractoriness and rFVIIa Efficacy in Bleeding Episodes and Surgeries from the Multinational Glanzmann's Thrombasthenia Registry.
Thrombasthenia
Inherited bleeding disorders in the Eastern Province of Saudi Arabia.
Thrombasthenia
Inherited Bleeding Disorders in the Obstetric Patient.
Thrombasthenia
Intensive Menstrual Bleeding Successfully Treated With Recombinant Factor VIIa in Glanzmann Thrombasthenia.
Thrombasthenia
Low Concentrations of Recombinant Factor VIIa May Improve the Impaired Thrombin Generation of Glanzmann Thrombasthenia Patients.
Thrombasthenia
Management of Pregnancy in a Chilean Patient with Congenital Deficiency of Factor VII and Glanzmann's Thrombasthenia Variant.
Thrombasthenia
Menorrhagia and reproductive health in rare bleeding disorders: a study from the Indian subcontinent.
Thrombasthenia
New Insights Into the Treatment of Glanzmann Thrombasthenia.
Thrombasthenia
NovoSeven (recombinant factor VIIa) for the treatment of bleeding episodes and perioperative management in patients with Glanzmann's thrombasthenia.
Thrombasthenia
NovoSeven as a universal haemostatic agent.
Thrombasthenia
Pharmacokinetic properties of two different recombinant activated factor VII formulations.
Thrombasthenia
Pharmacology and clinical use of recombinant activated factor seven in neurosciences.
Thrombasthenia
Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
Thrombasthenia
Pyelolithotomy in a patient with Glanzmann thrombasthenia and antiglycoprotein IIb/IIIa antibodies: the shortest possible duration of treatment with recombinant activated factor VII and platelet transfusions.
Thrombasthenia
Rational Use of Recombinant Factor VIIa in Clinical Practice.
Thrombasthenia
Recognition and management of platelet-refractory bleeding in patients with Glanzmann's thrombasthenia and other severe platelet function disorders.
Thrombasthenia
Recombinant Activated Factor VII (Eptacog Alfa Activated, NovoSeven®) in Patients with Rare Congenital Bleeding Disorders. A Systematic Review on its Use in Surgical Procedures.
Thrombasthenia
Recombinant activated factor VII (rFVIIa, NovoSeven).
Thrombasthenia
Recombinant activated factor VII and epsilon aminocaproic acid treatment of a patient with Glanzmann's thrombasthenia for nasal polipectomy.
Thrombasthenia
Recombinant activated factor VII and the anaesthetist.
Thrombasthenia
Recombinant activated factor VII as a universal haemostatic agent.
Thrombasthenia
Recombinant Activated Factor VII Combined with Desmopressin in Preventing Bleeding from Dental Extraction in a Patient with Glanzmann's Thrombasthenia.
Thrombasthenia
Recombinant activated factor VII combined with local measures in preventing bleeding from invasive dental procedures in patients with Glanzmann thrombasthenia.
Thrombasthenia
Recombinant activated factor VII in clinical practice: a 2014 update.
Thrombasthenia
Recombinant activated factor VII in patients at high risk of bleeding.
Thrombasthenia
Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience.
Thrombasthenia
Recombinant activated factor VII: 30 years of research and innovation.
Thrombasthenia
Recombinant activated factor VII: mechanisms of action and current indications.
Thrombasthenia
Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders.
Thrombasthenia
Recombinant factor VIIa (Eptacog Alfa): a review of its use in congenital or acquired haemophilia and other congenital bleeding disorders.
Thrombasthenia
Recombinant factor VIIa enhances deposition of platelets with congenital or acquired alpha IIb beta 3 deficiency to endothelial cell matrix and collagen under conditions of flow via tissue factor-independent thrombin generation.
Thrombasthenia
Recombinant factor VIIa in a patient with Glanzmann's thrombasthenia undergoing gynecological surgery: open issues in light of successful treatment.
Thrombasthenia
Recombinant factor VIIa is effective for bleeding and surgery in patients with Glanzmann thrombasthenia.
Thrombasthenia
Recombinant factor VIIa restores aggregation of alphaIIbbeta3-deficient platelets via tissue factor-independent fibrin generation.
Thrombasthenia
Recombinant factor VIIa: a universal hemostatic agent?
Thrombasthenia
Results of the WIRK prospective, non-interventional observational study of recombinant activated factor VII (rFVIIa) in patients with congenital haemophilia with inhibitors and other bleeding disorders.
Thrombasthenia
Safety update on the use of recombinant activated factor VII in approved indications.
Thrombasthenia
Screening bleeding disorders in adolescents and young women with menorrhagia.
Thrombasthenia
Study of the Relationship between HPA-1 and HPA-5 Gene Polymorphisms and Refractory to Platelet Therapy and Recombinant Factor VII in Glanzmann Thrombasthenia Patients in Southeast of Iran.
Thrombasthenia
Successful epistaxis control in a patient with Glanzmann thrombasthenia by increased bolus injection dose of recombinant factor VIIa.
Thrombasthenia
Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombasthenia.
Thrombasthenia
Successful use of recombinant factor VIIa (NovoSeven) during cardiac surgery in a pediatric patient with Glanzmann thrombasthenia.
Thrombasthenia
Successful use of recombinant factor VIIa in a patient with acquired Glanzmann thrombasthenia.
Thrombasthenia
Surgical procedures in patients with Glanzmann's thrombasthenia: case series and literature review.
Thrombasthenia
Surgical resection of a sphenoid wing meningioma in a patient with Glanzmann thrombasthenia.
Thrombasthenia
The danger of using a sledgehammer to crack a nut: ROTEM-guided administration of recombinant activated factor VII in a patient with refractory bleeding post-ventricular assist device implantation.
Thrombasthenia
The effect of platelets on fibrin gel structure formed in the presence of recombinant factor VIIa in hemophilia plasma and in plasma from a patient with Glanzmann thrombasthenia.
Thrombasthenia
The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia.
Thrombasthenia
The international, prospective Glanzmann Thrombasthenia Registry: treatment and outcomes in surgical intervention.
Thrombasthenia
The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia.
Thrombasthenia
The Judicious Use of Recombinant Factor VIIa.
Thrombasthenia
The Use of Recombinant Activated Factor VII in Patients with Glanzmann's Thrombasthenia.
Thrombasthenia
The use of recombinant factor VIIa in a patient with severe Glanzmann's thrombasthenia to facilitate insertion of a Port-a-Cath.
Thrombasthenia
The use of recombinant FVIIa in a patient with Glanzmann thrombasthenia with uncontrolled bleeding after tonsillectomy.
Thrombasthenia
Thromboelastographic evaluation of recombinant factor VIIa in a child with Glanzmann's thrombasthenia.
Thrombasthenia
Thrombotic events with recombinant activated factor VII (rFVIIa) in approved indications are rare and associated with older age, cardiovascular disease, and concomitant use of activated prothrombin complex concentrates (aPCC).
Thrombasthenia
Tissue factor-independent effects of recombinant factor VIIa on hemostasis.
Thrombasthenia
To general haemostasis--the evidence-based route.
Thrombasthenia
Total Extraction as a Treatment for Anaemia in a Patient of Glanzmann's Thrombasthenia with Chronic Gingival Bleed: Case Report.
Thrombasthenia
Treatment of bleeding after kidney biopsy with recombinant activated factor VII.
Thrombasthenia
Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
Thrombasthenia
Understanding the therapeutic action of recombinant factor VIIa in platelet disorders.
Thrombasthenia
Use of recombinant activated factor VII in patients with Glanzmann's thrombasthenia: a review of the literature.
Thrombasthenia
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia.
Thrombasthenia
Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.
Thrombasthenia
Use of recombinant factor VIIa for post-operative haemorrhage in a patient with Glanzmann's thrombasthenia and human leucocyte antigen antibodies.
Thrombasthenia
Use of recombinant factor VIIa in 3 patients with inherited type I Glanzmann's thrombasthenia undergoing invasive procedures.
Thrombasthenia
Use of rFVIIa in 4 children with Glanzmann thrombasthenia.
Thrombasthenia
Use of rFVIIa in Preventing Recurrent Intra-articular Hemorrhages in a 15-Year-Old Patient With Glanzmann Thrombasthenia.
Thrombasthenia
Weekly low-dose recombinant factor VIIa prophylaxis in Glanzmann thrombasthenia.
Thrombasthenia
[Activated Factor VII - 31 years experience on clinical grounds].
Thrombasthenia
[Application of rFVIIa for controlling acute bleeding in the obstetric and gynecologic practice]
Thrombasthenia
[Bleeding after cardiac surgery: the role of recombinant factor VIIa]
Thrombasthenia
[Efficacy of Recombinant Activated Factor VII for Intractable Bleeding after Cardiovascular Surgery].
Thrombasthenia
[Inherited bleeding disorders common in Jews].
Thrombasthenia
[Panorama of congenital disorders of hemostasis diseases at University Hospital of Brazzaville, Congo]
Thrombasthenia
[Postpartum hemorrhage successfully treated with recombinant factor VIIa in Glanzmann thromboasthenia]
Thrombasthenia
[Recombinant activated factor VII in paediatric practice. Universal hemostatic agent?]
Thrombasthenia
[Recombinant factor VIIa in patients with platelet function disorders or thrombocytopenia]
Thrombasthenia
[Therapy of inherited diseases of platelet function. Interdisciplinary S2K guideline of the Permanent Paediatric Committee of the Society of Thrombosis and Haemostasis Research (GTH e.?V.)].
Thrombasthenia
[Thrombasthenia of Glanzmann. Vaginal hysterectomy treated with recombinant factor VIIa]
Thrombasthenia
[Use of recombinant factor VII in Glanzmann thrombasthenia: a case report].
Thrombocytopenia
A novel hemostatic agent: the potential role of recombinant activated factor VII (rFVIIa) in anesthetic practice.
Thrombocytopenia
Activated factor VII activates factors IX and X on the surface of activated platelets: thoughts on the mechanism of action of high-dose activated factor VII.
Thrombocytopenia
Acute left atrial thrombus after recombinant factor VIIa administration during left ventricular assist device implantation in a patient with heparin-induced thrombocytopenia.
Thrombocytopenia
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
Thrombocytopenia
Alternative agents versus prophylactic platelet transfusion for preventing bleeding in patients with thrombocytopenia due to chronic bone marrow failure: a network meta-analysis and systematic review.
Thrombocytopenia
Clinical and laboratory features of 178 children with recurrent epistaxis.
Thrombocytopenia
Clinical experience with recombinant factor VIIa in patients with thrombocytopenia.
Thrombocytopenia
Coagulopathy of Liver Disease.
Thrombocytopenia
Combination therapy with rFVIIa and platelets for hemorrhage in patients with severe thrombocytopenia and alloimmunization.
Thrombocytopenia
Congenital FX deficiency combined with other clotting defects or with other abnormalities: a critical evaluation of the literature.
Thrombocytopenia
Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated factor VII.
Thrombocytopenia
Diminished response to recombinant factor VIIa in a patient with idiopathic thrombocytopenic purpura.
Thrombocytopenia
Effect of a factor VIII concentrate on type IIB von Willebrand's disease-associated thrombocytopenia presenting during pregnancy in identical twin mothers.
Thrombocytopenia
Effect of recombinant factor VIIa (Novoseven) on thrombocytopenia-like conditions in vitro.
Thrombocytopenia
Effective hemostasis with rFVIIa treatment in two patients with severe thrombocytopenia and life-threatening hemorrhage.
Thrombocytopenia
Experiences with recombinant activated factor VII in the treatment of severe refractory thrombocytopenia.
Thrombocytopenia
Experiences with recombinant human factor VIIa in patients with thrombocytopenia.
Thrombocytopenia
Haemorrhagic complications of thrombocytopenia and oral anticoagulation: is there a role for recombinant activated factor VII?
Thrombocytopenia
Hemostatic consequences of a non-fresh or reconstituted whole blood small volume cardiopulmonary bypass prime in neonates and infants.
Thrombocytopenia
Heparin-induced thrombocytopenia and cardiopulmonary bypass: anticoagulation with unfractionated heparin and the GPIIb/IIIa inhibitor tirofiban and successful use of rFVIIa for post-protamine bleeding due to persistent platelet blockade.
Thrombocytopenia
High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system.
Thrombocytopenia
Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders.
Thrombocytopenia
Levels of prothrombin activation peptide F1+2 in patients with a bleeding tendency.
Thrombocytopenia
Management of bleeding complications of hematologic malignancies.
Thrombocytopenia
Management of bleeding in a multi-transfused patient with positive HLA class I alloantibodies and thrombocytopenia associated with platelet dysfunction refractory to transfusion of cross-matched platelets.
Thrombocytopenia
Management of thrombocytopenic bleeding: is there a role for recombinant coagulation factor VIIa?
Thrombocytopenia
Mechanism of action of factor VIIa in the treatment of coagulopathies.
Thrombocytopenia
Neonatal thrombocytopenia: Thrombin generation in presence of reduced platelet counts and effects of rFVIIa in cord blood.
Thrombocytopenia
New insights into the coagulation system and implications for new therapeutic options with recombinant factor VIIa.
Thrombocytopenia
On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation.
Thrombocytopenia
Ongoing NovoSeven trials.
Thrombocytopenia
Overall experience with NovoSeven.
Thrombocytopenia
Platelet membrane fragments enhance the procoagulant effect of recombinant factor VIIa in studies with circulating human blood under conditions of experimental thrombocytopenia.
Thrombocytopenia
Point-of-Care Thromboelastography for Intrathecal Drain Management in Patients With Coagulopathy and Thoracic Aorta Surgery: A Case Report.
Thrombocytopenia
Potential role of recombinant factor VIIa as a hemostatic agent.
Thrombocytopenia
Prophylactic recombinant factor VIIa administration to an infant with congenital systemic juvenile xanthogranuloma.
Thrombocytopenia
Recombinant activated coagulation factor VII and bleeding trauma patients.
Thrombocytopenia
Recombinant activated Factor VII as a hemostatic agent in very low birth weight preterms with gastrointestinal hemorrhage and disseminated intravascular coagulation.
Thrombocytopenia
Recombinant activated factor VII as a universal haemostatic agent.
Thrombocytopenia
Recombinant activated factor VII as an additional agent in the management of bleeding in patients with chemotherapy-induced thrombocytopenia.
Thrombocytopenia
Recombinant activated factor VII for hemostatic cover of orthopedic interventions in a girl with thrombocytopenia with absent radii syndrome.
Thrombocytopenia
Recombinant activated factor VII in liver patients: a retrospective cohort study from Australia and New Zealand.
Thrombocytopenia
Recombinant activated factor VII in patients at high risk of bleeding.
Thrombocytopenia
Recombinant activated factor VII: its mechanism of action and role in the control of hemorrhage.
Thrombocytopenia
Recombinant factor VIIa enhances platelet adhesion and activation under flow conditions at normal and reduced platelet count.
Thrombocytopenia
Recombinant factor VIIa for bleeding in refractory thrombocytopenia.
Thrombocytopenia
Recombinant factor VIIa for treatment of massive liver fracture in a premature infant.
Thrombocytopenia
Recombinant factor VIIa is an effective therapy for abdominal surgery and severe thrombocytopenia: a case report.
Thrombocytopenia
Recombinant factor VIIa reduces bleeding in severely thrombocytopenic rabbits.
Thrombocytopenia
Recombinant factor VIIa: a universal hemostatic agent?
Thrombocytopenia
Recombinant FVIIa in the management of intracerebral haemorrhage in severe thrombocytopenia unresponsive to platelet-enhancing treatment.
Thrombocytopenia
Reversal of thrombocytopenia and bleeding tendency in a preterm neonate with recombinant activated factor VII: case report.
Thrombocytopenia
Successful treatment of massive gastrointestinal hemorrhage in acute biphenotypic leukemia with recombinant factor VIIa (NovoSeven).
Thrombocytopenia
Successful treatment of severe bleeding with recombinant factor VIIa after kidney transplantation.
Thrombocytopenia
Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII : Report on one case and review of other uses in acute leukemias.
Thrombocytopenia
The evidence for the use of recombinant human activated factor VII in the treatment of bleeding patients with quantitative and qualitative platelet disorders.
Thrombocytopenia
The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation.
Thrombocytopenia
The use of recombinant activated coagulation factor VII for spine surgery.
Thrombocytopenia
The use of recombinant factor viia in a jehovah's witness with auto-immune thrombocytopenia and post-splenectomy haemorrhage.
Thrombocytopenia
Thrombelastography monitoring of platelet substitution therapy and rFVIIa administration in haemato-oncological patients with severe thrombocytopenia.
Thrombocytopenia
Thromboelastography-guided recombinant factor VIIa administration in a patient with refractory autoimmune idiopathic thrombocytopenia.
Thrombocytopenia
To general haemostasis--the evidence-based route.
Thrombocytopenia
Transfusion medicine service policies for recombinant factor VIIa administration.
Thrombocytopenia
Treatment of bleeding in patients with platelet disorders: is there a place for recombinant factor VIIa?
Thrombocytopenia
Understanding the therapeutic action of recombinant factor VIIa in platelet disorders.
Thrombocytopenia
Use of low dose of rFVIIa (recombinant Factor VII activated) to control late bleeding after percutaneous dilational tracheostomy.
Thrombocytopenia
Use of recombinant activated factor VII in a patient with severe thrombocytopenia due to myelodysplastic syndrome with uncontrolled gastrointestinal bleeding.
Thrombocytopenia
Use of Recombinant Factor VII in Cardiac Surgery.
Thrombocytopenia
Use of recombinant factor VIIa (NovoSeven) to reduce postoperative bleeding after total hip arthroplasty in a patient with cirrhosis and thrombocytopenia.
Thrombocytopenia
Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia.
Thrombocytopenia
Whole blood coagulation in children with thrombocytopenia and the response to platelet replacement, recombinant factor VIIa, and a potent factor VIIa analogue.
Thrombocytopenia
[Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group.]
Thrombocytopenia
[Coagulation factor VII--new physiopathological and therapeutic aspects]
Thrombocytopenia
[Hemostasis anomalies and prognosis during severe infectious purpura in children. Retrospective study in 69 cases]
Thrombocytopenia
[New possibilities in the management of hemorrhagic diathesis caused by factor deficiency and thrombocytopenia: recombinant active factor VII concentrate]
Thrombocytopenia
[Pharmacological alternatives to blood transfusion: what is new about?]
Thrombocytopenia
[Recombinant activated factor VII use for the bleeding implications prevention during central venous catheterization in pediatric patients with acute leucosis and thrombocytopenia].
Thrombocytopenia
[Recombinant factor VIIa in patients with platelet function disorders or thrombocytopenia]
Thrombocytopenia
[Use of recombinant activated factor VII (NovoSeven) in the treatment of a patient with idiopathic thrombocytopenic purpura complicated with subarachnoid and parenchimatous hemorrhage]
Thrombocytopenia
[Use of recombinant activated factor VII]
Thrombocytopenia, Neonatal Alloimmune
Neonatal thrombocytopenia: Thrombin generation in presence of reduced platelet counts and effects of rFVIIa in cord blood.
Thromboembolism
An evaluation of eptacog alfa in nonhaemophiliac conditions.
Thromboembolism
Analysis of Outcomes Using Low-Dose and Early Administration of Recombinant Activated Factor VII in Cardiac Surgery.
Thromboembolism
Case report: Intraoperative thrombosis cardiac arrest in extended right hepatectomy involving use of local haemostatic agent in intraoperative cell salvage (ICS) and administration of recombinant activated factor VII (rFVIIa).
Thromboembolism
Change of coagulation after NovoSeven® use for bleeding during cardiac surgery.
Thromboembolism
Coagulation factor abnormalities after the Fontan procedure and its modifications.
Thromboembolism
Complications of recombinant activated human coagulation factor VII.
Thromboembolism
Efficacy of recombinant factor VIIa for severe bleeding complicated by platelet transfusion refractoriness in patients with hematologic malignancies.
Thromboembolism
Factor VII in subjects at risk for thromboembolism: activation or increased synthesis?
Thromboembolism
Haemostatic drug therapies for acute primary intracerebral haemorrhage.
Thromboembolism
Individualized antithrombotic therapy.
Thromboembolism
Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease.
Thromboembolism
Parallel use of by-passing agents in haemophilia with inhibitors: a critical review.
Thromboembolism
Recombinant activated factor VII (rFVIIa) in refractory haemorrhage for non-haemophiliacs: an eleven-year single-centre experience.
Thromboembolism
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data.
Thromboembolism
Recombinant factor VIIa reduces bleeding after blunt liver injury in coagulopathic, hypofibrinogenaemic pigs.
Thromboembolism
Renal thromboembolism during treatment with recombinant activated factor VII (rFVIIa) in a child with hemophilia B with factor IX inhibitors.
Thromboembolism
The incidence of thromboembolism formation following the use of recombinant factor VIIa in patients suffering blunt force compared to penetrating trauma: a systematic review protocol.
Thromboembolism
The incidence of thromboembolism formation following the use of recombinant factor VIIa in patients suffering from blunt force trauma compared with penetrating trauma: a systematic review.
Thromboembolism
Thromboembolic complications associated with factor VIIa administration.
Thromboembolism
Thromboembolic risks of recombinant factor VIIa Use in warfarin-associated intracranial hemorrhage: a case-control study.
Thromboembolism
Thromboembolism and Factor VII defect.
Thromboembolism
Thromboembolism in congenital factor VII deficiency.
Thromboembolism
Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency.
Thromboembolism
Unopposed estrogen increases total plasma factor VII, but not active factor VII--a short-term placebo-controlled study in healthy postmenopausal women.
Thromboembolism
Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004.
Thrombophilia
Absence of hypercoagulability in acute Kawasaki disease.
Thrombophilia
Antithrombin III infusion suppresses the hypercoagulable state in adult acute lymphoblastic leukaemia patients treated with a low dose of Escherichia coli L-asparaginase. A GIMEMA study.
Thrombophilia
Assessment of hemostatic risk factors in predicting arterial thrombotic events.
Thrombophilia
Clotting factors after emergency contraception.
Thrombophilia
Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
Thrombophilia
Contribution of D-Dimer determination in the exclusion of deep venous thrombosis in spinal cord injury patients.
Thrombophilia
Degree of hypercoagulability and hyperfibrinolysis is related to organ failure and prognosis after burn trauma.
Thrombophilia
Does recombinant factor VIIa, apart from overall hemostasis, regulate TAFI dependent fibrinolysis? In vitro analysis using overall hemostasis potential (OHP) assay.
Thrombophilia
Effects of total fat content and fatty acid composition in diet on factor VII coagulant activity and blood lipids.
Thrombophilia
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).
Thrombophilia
Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype.
Thrombophilia
Factor Xa generation by computational modeling: an additional discriminator to thrombin generation evaluation.
Thrombophilia
Genetic markers for inherited thrombophilia are associated with fetal growth retardation in the population of Central Russia.
Thrombophilia
Hypercoagulability and factor VII in hypertriglyceridemia.
Thrombophilia
Hypercoagulability in venous and arterial thrombosis.
Thrombophilia
Is activated factor VII associated with retinal vein occlusion?
Thrombophilia
Is veno-occlusive disease a specific syndrome or the exacerbation of physiopathologic hemostatic changes in hematopoietic stem cell transplantation (HSCT)?
Thrombophilia
Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Thrombophilia
Lipoproteins and the haemostatic system in atherothrombotic disorders.
Thrombophilia
Morning hypercoagulability and hypofibrinolysis. Diurnal variations in circulating activated factor VII, prothrombin fragment F1+2, and plasmin-plasmin inhibitor complex.
Thrombophilia
Plasma levels of activated FVII in various diseases.
Thrombophilia
Plasma markers of hypercoagulability in patients with serious infections and risk of septic shock.
Thrombophilia
Polycations selectively blocking tissue factor-dependent FVII activation: collective in vitro anticoagulation studies.
Thrombophilia
Pro-thrombotic states and their diagnosis.
Thrombophilia
Recombinant factor VIIa does not induce hypercoagulability in vitro.
Thrombophilia
Recombinant factor VIIa: safety and efficacy.
Thrombophilia
Role of adipose tissue in haemostasis, coagulation and fibrinolysis.
Thrombophilia
Simultaneous genotyping of four single nucleotide polymorphisms associated with risk factors of hemostasis disorders.
Thrombophilia
Standardization and evaluation of the performance of the thrombin generation test under hypo- and hypercoagulability conditions.
Thrombophilia
Systematic review on the effect of glucocorticoid use on procoagulant, anticoagulant and fibrinolytic factors.
Thrombophilia
The Northwick Park Heart Study: Evidence from the Laboratory.
Thrombophilia
Warfarin withdrawal. Pharmacokinetic-pharmacodynamic considerations.
Thrombophilia
Warfarin-induced venous limb ischemia/gangrene complicating cancer: a novel and clinically distinct syndrome.
Thrombophilia
[Diagnosis and treatment of coagulation disorders]
Thrombophilia
[Myocardial infarction and thromboembolism during pregnancy]
Thrombophlebitis
Postoperative use of rFVIIa by continuous infusion in a haemophilic boy.
Thrombophlebitis
Recombinant factor VIIa for patients with inhibitors to factor VIII or IX or factor VII deficiency.
Thrombophlebitis
Recombinant FVIIa (NovoSeven) continuous infusion and total hip replacement in patients with haemophilia and high titre of inhibitors to FVIII: experience of two cases.
Thrombophlebitis
Ten-year experience of recombinant activated factor VII use in surgical patients with congenital haemophilia with inhibitors or acquired haemophilia in Japan.
Thrombosis
8(th) Symposium on Hemostasis: Translational and Basic Science Discoveries.
Thrombosis
A Budget Impact Model of Hemophilia Bypassing Agent Prophylaxis Relative to Recombinant Factor VIIa On-Demand.
Thrombosis
A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
Thrombosis
A direct thrombin inhibitor studied by dynamic whole blood clot formation. Haemostatic response to ex-vivo addition of recombinant factor VIIa or activated prothrombin complex concentrate.
Thrombosis
A high-fat meal does not activate blood coagulation factor VII in minipigs.
Thrombosis
A multiscale model of venous thrombus formation with surface-mediated control of blood coagulation cascade.
Thrombosis
A novel immunoassay for the quantification of human tissue factor binding to activated factor VII.
Thrombosis
A Retrospective Analysis of Clinical and Laboratory Data of Patients with Factor VII Deficiency: A Single Centre Experience.
Thrombosis
A selective, slow binding inhibitor of factor VIIa binds to a nonstandard active site conformation and attenuates thrombus formation in vivo.
Thrombosis
A two adenine insertion polymorphism in the 3' untranslated region of factor VII gene is associated with peripheral arterial disease but not with venous thrombosis. Results of case-control studies.
Thrombosis
Acquired Antibodies to ?IIb?3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond.
Thrombosis
Activation of coagulation factor VII during alimentary lipemia.
Thrombosis
Active site-blocked factors VIIa and IXa differentially inhibit fibrin formation in a human ex vivo thrombosis model.
Thrombosis
Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury.
Thrombosis
Active-site inactivated FVIIa decreases thrombosis and necrosis in a random skin flap model of acute ischemia.
Thrombosis
Acute Aortic Valve Thrombosis Secondary to Recombinant Factor VIIa.
Thrombosis
Acute left atrial thrombus after recombinant factor VIIa administration during left ventricular assist device implantation in a patient with heparin-induced thrombocytopenia.
Thrombosis
Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time.
Thrombosis
Advances in Clinical and Basic Science of Coagulation: Illustrated abstracts of the 9th Chapel Hill Symposium on Hemostasis.
Thrombosis
Aeruginosin analogs and other compounds with rigid bicyclic structure as potential antithrombotic agents.
Thrombosis
Age-related changes in factor VII proteolysis in vivo.
Thrombosis
An economic analysis of different treatments for bleeding in patients with acquired haemophilia.
Thrombosis
An in-vitro assessment of tranexamic acid as an adjunct to rFVIII or rFVIIa treatment in haemophilia A.
Thrombosis
Analysis of the substrate specificity of Factor VII activating protease (FSAP) and design of specific and sensitive peptide substrates.
Thrombosis
Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
Thrombosis
Antithrombotic and antilesion benefits without hemorrhagic risks by inhibiting tissue factor pathway.
Thrombosis
Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.
Thrombosis
Antithrombotic efficacy of inactivated active site recombinant factor VIIa is shear dependent in human blood.
Thrombosis
Aortic valve thrombosis after treatment with recombinant factor VIIa: letter 2.
Thrombosis
aPCC vs. rFVIIa for the treatment of bleeding in patients with acquired haemophilia - a cost-effectiveness model.
Thrombosis
Arg 304 Gln (FVII Padua) and Ala 294 Val mutations are equally present in patients with FVII deficiency and thrombosis.
Thrombosis
Arterial thrombosis is accelerated in histidine-rich glycoprotein deficient mice.
Thrombosis
Assessment of acquired hemophilia patient demographics in the United States: the Hemostasis and Thrombosis Research Society Registry.
Thrombosis
Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.
Thrombosis
Association of coagulation-related and inflammation-related genes and factor VIIc levels with stroke: the Cardiovascular Health Study.
Thrombosis
Associations of plasma fibrinogen and factor VII clotting activity with coronary heart disease and stroke: prospective cohort study from the screening phase of the Thrombosis Prevention Trial.
Thrombosis
Atherosclerosis and coronary bypass surgery in hereditary factor VII deficiency.
Thrombosis
Biochemical, molecular and clinical aspects of coagulation factor VII and its role in hemostasis and thrombosis.
Thrombosis
Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
Thrombosis
Blood coagulation-dependent inflammation. Coagulation-dependent inflammation and inflammation-dependent thrombosis.
Thrombosis
Blood viscosity, coagulation, and activated protein C resistance in central retinal vein occlusion: a population controlled study.
Thrombosis
Case 6--2007: massive intraoperative thrombosis and death after recombinant activated factor VII administration.
Thrombosis
Case report: Intraoperative thrombosis cardiac arrest in extended right hepatectomy involving use of local haemostatic agent in intraoperative cell salvage (ICS) and administration of recombinant activated factor VII (rFVIIa).
Thrombosis
Cerebral Venous Sinus Thrombosis in a Patient with Undiagnosed Factor VII Deficiency.
Thrombosis
Characterization of a tissue factor/factor VIIa-dependent model of thrombosis in hypercholesterolemic rabbits.
Thrombosis
Characterization of the coagulation profile in children with liver disease and extrahepatic portal vein obstruction or shunt.
Thrombosis
Circulating markers of arterial thrombosis and late-stage age-related macular degeneration: a case-control study.
Thrombosis
Clinical management of thrombosis in inherited factor VII deficiency: a description of two cases.
Thrombosis
Clinical study of recovery and half-life of vapor-heated factor VII concentrate.
Thrombosis
Coagulation activation in young survivors of myocardial infarction (MI)--a population-based case-control study.
Thrombosis
Coagulation factor VII and plasma triglycerides. Decreased catabolism as a possible mechanism of factor VII hyperactivity.
Thrombosis
Coagulation factor VII and the risk of coronary heart disease in healthy men.
Thrombosis
Comparative thrombotic event incidence after infusion of recombinant factor VIIa versus factor VIII inhibitor bypass activity.
Thrombosis
Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
Thrombosis
Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observation.
Thrombosis
Congenital FVII deficiency and thrombotic events after replacement therapy.
Thrombosis
Congenital protein C deficiency and myocardial infarction:concomitant factor VII hyperactivity may play a role in the onset of arterial thrombosis.
Thrombosis
Continuous infusion of monoclonal antibody-purified factor VIII: rational approach to serious hemorrhage in patients with allo-/autoantibodies to factor VIII.
Thrombosis
Coronary artery stenosis treatment in aging patients with inherited Factor VII deficiency: Where do we stand?
Thrombosis
Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver Failure.
Thrombosis
Crystal structures of uninhibited factor VIIa link its cofactor and substrate-assisted activation to specific interactions.
Thrombosis
Darexaban: anticoagulant effects in mice and human plasma in vitro, antithrombotic effects in thrombosis and bleeding models in mice and effects of anti-inhibitor coagulant complex and recombinant factor VIIa.
Thrombosis
Decreased plasma levels of activated factor VII in patients with deep vein thrombosis.
Thrombosis
Deep vein thrombosis after recombinant factor VIIa infusion to control severe recurrent postoperative bleeding.
Thrombosis
Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency.
Thrombosis
Design, parallel synthesis, and crystal structures of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
Thrombosis
Determinants of plasma factor VIIa levels in humans.
Thrombosis
Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deficient infant.
Thrombosis
Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales.
Thrombosis
Dietary fatty acids and the haemostatic system.
Thrombosis
Discovery of Phenylglycine Lactams as Potent Neutral Factor VIIa Inhibitors.
Thrombosis
Dissociation of antithrombotic effect and bleeding time prolongation in rabbits by inhibiting tissue factor function.
Thrombosis
Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion.
Thrombosis
Does ovarian stimulation for in-vitro fertilization induce a hypercoagulable state?
Thrombosis
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
Thrombosis
Dosing and effectiveness of recombinant activated factor VII (rFVIIA) in congenital haemophilia with inhibitors by bleed type and location: the experience of the Haemophilia and Thrombosis Research Society (HTRS) Registry (2004-2008).
Thrombosis
Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: The experience of the Hemostasis and Thrombosis Research Society (HTRS) Registry (2004-2008).
Thrombosis
Effect of activated prothrombin complex concentrate or recombinant factor VIIa on the bleeding time and thrombus formation during anticoagulation with a direct thrombin inhibitor.
Thrombosis
Effect of chitosan and coagulation factors on the wound repair phenotype of bioengineered blood clots.
Thrombosis
Effect of extra virgin olive oil on experimental thrombosis and primary hemostasis in rats.
Thrombosis
Effect of lipid-lowering treatment on factor VII profile in hyperlipidemic patients.
Thrombosis
Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis.
Thrombosis
Effect of selective factor Xa inhibition on arterial thrombus formation triggered by tissue factor/factor VIIa or collagen in an ex vivo model of shear-dependent human thrombogenesis.
Thrombosis
Effect of transdermal hormone therapy on platelet haemostasis in menopausal women.
Thrombosis
Effects of recombinant active site-blocked activated factor VII in rabbit models of carotid stenosis and myocardial infarction.
Thrombosis
Efficacy and safety of continuous infusion of factor VII concentrate in a factor VII-deficient patient at high risk for arterial thrombosis.
Thrombosis
Emicizumab Augments Thrombus Formation in Whole Blood from Patients with Hemophilia A under High Shear Flow Conditions.
Thrombosis
Encryption and decryption of tissue factor.
Thrombosis
Endothelial cell protein C receptor-mediated redistribution and tissue-level accumulation of factor VIIa.
Thrombosis
Endotoxin-induced activation of the coagulation cascade in humans: effect of acetylsalicylic acid and acetaminophen.
Thrombosis
Evaluation of prothrombin complex concentrate and recombinant activated factor VII to reverse rivaroxaban in a rabbit model.
Thrombosis
Evaluation of recombinant activated factor VII, prothrombin complex concentrate, and fibrinogen concentrate to reverse apixaban in a rabbit model of bleeding and thrombosis.
Thrombosis
Evaluation of the Antihemostatic and Antithrombotic Effects of Lowering Coagulation Factor VII Levels in a Non-human Primate.
Thrombosis
Evidence for Activation of Tissue Factor by an Allosteric Disulfide Bond.
Thrombosis
Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology.
Thrombosis
Exposure and safety of higher doses of recombinant factor VIIa ?250??g?kg(-1) in individuals with congenital haemophilia complicated by alloantibody inhibitors: the Haemophilia and Thrombosis Research Society Registry experience (2004-2008).
Thrombosis
Expression and purification of recombinant rabbit factor VII.
Thrombosis
Extracellular protein disulfide isomerase regulates coagulation on endothelial cells through modulation of phosphatidylserine exposure.
Thrombosis
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).
Thrombosis
Factor VII and haemostasis.
Thrombosis
Factor VII and heparin in thrombosis.
Thrombosis
Factor VII deficiency and pregnancy: a case report and review of literature.
Thrombosis
Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation.
Thrombosis
Factor VII in subjects at risk for thromboembolism: activation or increased synthesis?
Thrombosis
Factor VIIa and other haemostatic variables following bone marrow transplantation.
Thrombosis
Factor VIIa inhibitors: Chemical optimization, preclinical pharmacokinetics, pharmacodynamics, and efficacy in an arterial baboon thrombosis model.
Thrombosis
Factor VIIa stimulates endothelin-1 synthesis in TNF-primed endothelial cells by activation of protease-activated receptor 2.
Thrombosis
Factor VIIa-tissue factor: functional importance of protein-membrane interactions.
Thrombosis
Failure of an Abiomed left ventricular assist device in association with factor VIIa administration.
Thrombosis
Fatal outcome of recombinant factor VIIa in heart transplantation with extracorporeal membrane oxygenation.
Thrombosis
Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII.
Thrombosis
Fatal Thrombosis After Factor VII Administration During Extracorporeal Membrane Oxygenation.
Thrombosis
Fatal thrombosis with activated factor VII in a paediatric patient on extracorporeal membrane oxygenation.
Thrombosis
FVIIa corrects the coagulopathy of fulminant hepatic failure but may be associated with thrombosis: a report of four cases.
Thrombosis
Genetic polymorphisms modify the response of factor VII to oral contraceptive use: an example of gene-environment interaction.
Thrombosis
Genetic polymorphisms of factor VII are not associated with arterial thrombosis.
Thrombosis
Genetic Polymorphisms of Hemostatic Factors and Thrombotic Risk in Non BCR-ABL Myeloproliferative Neoplasms: A Pilot Study.
Thrombosis
Haemostatic function and arterial disease.
Thrombosis
Hemostasis: old system, new players, new directions.
Thrombosis
Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primates.
Thrombosis
Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives.
Thrombosis
Hemostatic system activation in patients with lupus anticoagulant and essential thrombocythemia.
Thrombosis
Heparin blunts endotoxin-induced coagulation activation.
Thrombosis
Hip surgery in a patient with severe factor VII deficiency.
Thrombosis
Hypercoagulation following brain death cannot be reversed by the neutralization of systemic tissue factor.
Thrombosis
Incidence and risk factors for venous thromboembolism in critically ill children after trauma.
Thrombosis
Incorporation of an active site inhibitor in factor VIIa alters the affinity for tissue factor.
Thrombosis
Increased factor VIIa levels in systemic lupus erythematosus patients with lupus anticoagulant.
Thrombosis
Inherited thrombophilia: a possible cause of in utero vascular thrombosis in children with intestinal atresia.
Thrombosis
Inhibition of acute vascular thrombosis in chimpanzees by an anti-human tissue factor antibody targeting the factor X binding site.
Thrombosis
Inhibition of arterial thrombosis by a soluble tissue factor mutant and active site-blocked factors IXa and Xa in the guinea pig.
Thrombosis
Inhibitors of Factor VIIa/tissue factor.
Thrombosis
Inhibitors of the initiation of coagulation.
Thrombosis
Interaction of activated factor VII and active site-inhibited activated factor VII with tissue factor.
Thrombosis
Interrelationship of plasma triglyceride and coagulant factor VII levels in normotriglyceridemic hypercholesterolemia.
Thrombosis
Intracerebral hemorrhage associated with oral anticoagulant therapy: current practices and unresolved questions.
Thrombosis
Investigation of potential biomarkers for thrombosis related diseases in Turkish Cypriot population.
Thrombosis
Is recombinant activated factor VII effective in the treatment of excessive bleeding after paediatric cardiac surgery?
Thrombosis
Is recombinant activated factor VII useful for intractable bleeding after cardiac surgery?
Thrombosis
Is the coexistence of thromboembolic events and Factor VII deficiency fortuitous?
Thrombosis
Is there a high thrombosis rate associated with recombinant factor VIIa use in intractable hemorrhage in Australia?
Thrombosis
Ischemic stroke in a patient with moderate to severe inherited factor VII deficiency.
Thrombosis
Lack of association between potential prothrombotic genetic risk factors and arterial and venous thrombosis.
Thrombosis
Levels of factor VIIc associated with decreased tissue factor pathway inhibitor and increased plasminogen activator inhibitor-1 in dyslipidemias.
Thrombosis
Local application of FFR-rFVIIa reduces thrombus formation at arterial anastomosis in rats.
Thrombosis
Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model.
Thrombosis
Long-lasting antithrombotic effects of a single dose of human recombinant, active site-blocked factor VII: insights into possible mechanism(s) of action.
Thrombosis
Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group.
Thrombosis
Lower extremity compartment syndrome in the setting of iliofemoral deep vein thrombosis, phlegmasia cerulea dolens and factor VII deficiency.
Thrombosis
Lower extremity salvage complicated by recurrent microvascular thrombosis in a patient with congenital factor VII deficiency.
Thrombosis
Management of recurrent thrombosis in liver transplant recipients: a case report.
Thrombosis
Mechanisms of hydroxyethyl starch induced dilutional coagulopathy.
Thrombosis
Medication-related complications in the trauma patient.
Thrombosis
Middle Cerebral Arterial Thrombosis in a Patient with Hypofibrinogenemia, 5 Days After rFVIIa and FFP Infusion.
Thrombosis
Modulators of the coagulation cascade: focus and recent advances in inhibitors of tissue factor, factor VIIa and their complex.
Thrombosis
Molecular dynamics simulations of the binary complex of human tissue factor (TF(1-242) ) and factor VIIa (TF(1-242) /fVIIa) on a 4:1 POPC/POPS lipid bilayer.
Thrombosis
Neutral macrocyclic factor VIIa inhibitors.
Thrombosis
New insight into how tissue factor allosterically regulates factor VIIa.
Thrombosis
Occurrence of thrombosis in rare bleeding disorders.
Thrombosis
Off-Label Recombinant Factor VIIa Use and Thrombosis in Children: A Multi-center Cohort Study.
Thrombosis
Off-label use of recombinant activated coagulation factor VII for bleeding may raise the risk of arterial thrombosis.
Thrombosis
Over-expression of factor VIIa in vivo.
Thrombosis
Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.
Thrombosis
Parallel use of by-passing agents in haemophilia with inhibitors: a critical review.
Thrombosis
Pathogenetic role of Factor VII deficiency and thrombosis in cross-reactive material positive patients.
Thrombosis
Pharmacological interruption of acute thrombus formation with minimal hemorrhagic complications by a small molecule tissue factor/factor VIIa inhibitor: comparison to factor Xa and thrombin inhibition in a nonhuman primate thrombosis model.
Thrombosis
Phenotypical variability in congenital FVII deficiency follows the ISTH-SSC severity classification guidelines: a review with illustrative examples from the clinic.
Thrombosis
Plasma factor VII, triglyceride concentration and fibrin degradation products in primary hyperlipidemia: a clinical and laboratory study.
Thrombosis
Plasma factor VIIa: measurement and potential clinical significance.
Thrombosis
Plasminogen activator inhibitor-1 4G/5G promoter polymorphism and coagulation factor VII Arg353-->Gln polymorphism in Korean patients with coronary artery disease.
Thrombosis
Polymorphism in the P-selectin and interleukin-4 genes as determinants of stroke: a population-based, prospective genetic analysis.
Thrombosis
Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease.
Thrombosis
Polymorphisms of the coagulation factor VII gene and its plasma levels in relation to acute cerebral infarction differences in allelic frequencies between Chinese Han and European populations.
Thrombosis
Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa.
Thrombosis
Probable right atrial thrombus immediately after recombinant activated factor VII administration.
Thrombosis
Prophylactic and therapeutic recombinant factor VIIa administration to patients with Glanzmann's thrombasthenia: results of an international survey.
Thrombosis
Protein anticoagulants targeting factor VIIa-tissue factor complex: a comprehensive review.
Thrombosis
Prothrombotic genetic risk factors in young survivors of myocardial infarction.
Thrombosis
Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity.
Thrombosis
Recent advances in the discovery of tissue factor/factor VIIa inhibitors and dual inhibitors of factor VIIa/factor Xa.
Thrombosis
Recombinant activated factor VII and prothrombin complex concentrates have different effects on bleeding and arterial thrombosis in the haemodiluted rabbit.
Thrombosis
Recombinant activated factor VII and tranexamic acid are haemostatically effective during major surgery in factor XI-deficient patients with inhibitor antibodies.
Thrombosis
Recombinant activated factor VII decreases bleeding without increasing arterial thrombosis in rabbits.
Thrombosis
Recombinant activated factor VII does not reduce bleeding in rabbits treated with aspirin and clopidogrel.
Thrombosis
Recombinant activated factor VII efficacy and safety in a model of bleeding and thrombosis in hypothermic rabbits: a blind study.
Thrombosis
Recombinant activated factor VII in critical bleeding after orthotopic liver transplantation.
Thrombosis
Recombinant activated factor VII in neonatal cardiac surgery.
Thrombosis
Recombinant activated factor VII in patients with acute liver failure with UNOS Status 1A: a single tertiary academic centre experience.
Thrombosis
Recombinant activated factor VII safety and efficacy in the treatment of cranial haemorrhage in patients with congenital haemophilia with inhibitors: an analysis of the Hemophilia and Thrombosis Research Society Registry (2004-2008).
Thrombosis
Recombinant activated factor VII use in critically ill infants with active hemorrhage.
Thrombosis
Recombinant activated factor VIIa treatment for refractory hemorrhage in infants.
Thrombosis
Recombinant expression of biologically active murine soluble EPCR.
Thrombosis
Recombinant factor seven therapy for postoperative bleeding in neonatal and pediatric cardiac surgery.
Thrombosis
Recombinant factor VIIa and fibrinogen display additive effect during in vitro haemodilution with crystalloids.
Thrombosis
Recombinant factor VIIa in major abdominal surgery and liver transplantation.
Thrombosis
Recombinant Factor VIIa in Pediatric Cardiac Surgery.
Thrombosis
Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial.
Thrombosis
Recombinant factor VIIa to manage major bleeding from newer parenteral anticoagulants.
Thrombosis
Recombinant factor VIIa to prevent surgical bleeding in factor XI deficiency.
Thrombosis
Recombinant factor VIIa used to control massive haemorrhage during renal transplantation surgery; vascular graft remained patent.
Thrombosis
Recombinant human activated factor VII is thrombogenic in a rabbit model of cyclic flow reduction and does not reduce intra-abdominal bleeding.
Thrombosis
Recombinant human factor VIIa (rFVIIa) in a rabbit stasis model.
Thrombosis
Recombinant nematode anticoagulant protein c2 and other inhibitors targeting blood coagulation factor VIIa/tissue factor.
Thrombosis
Recombinant porcine FVIII for bleed treatment in acquired hemophilia A: findings from a single-center, 18-patient cohort.
Thrombosis
Reduced procedural risk for coronary catheter interventions in carriers of the coagulation factor VII-Gln353 gene.
Thrombosis
Reduced thrombus formation in native blood of homozygous factor VII-deficient patients at high arterial wall shear rate.
Thrombosis
Regulation of the procoagulant response to arterial injury.
Thrombosis
Relationships of plasma factor VIIa-antithrombin complexes to manifest and future cardiovascular disease.
Thrombosis
Response to treatment and adverse events associated with use of recombinant activated factor VII in children: a retrospective cohort study.
Thrombosis
Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents.
Thrombosis
Review Article: Review of the Off-Label Use of Recombinant Activated Factor VII in Pediatric Cardiac Surgery Patients.
Thrombosis
Risk factors for thromboembolic events in renal failure.
Thrombosis
Risk factors for vascular disease and arteriovenous fistula dysfunction in hemodialysis patients.
Thrombosis
Roles of factor Xa beyond coagulation.
Thrombosis
Safety and efficacy of recombinant activated factor VII for refractory hemorrhage in pediatric patients on extracorporeal membrane oxygenation: a single center review.
Thrombosis
Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system.
Thrombosis
Safety profile of recombinant factor VIIa.
Thrombosis
Safety update on the use of recombinant activated factor VII in approved indications.
Thrombosis
Selective depletion of factor XI or factor XII with antisense oligonucleotides attenuates catheter thrombosis in rabbits.
Thrombosis
Selective factor VIII activation by the tissue factor-factor VIIa-factor Xa complex.
Thrombosis
Self-production of tissue factor-coagulation factor VII complex by ovarian cancer cells.
Thrombosis
Serum lipids and regulation of tissue factor-induced coagulation in middle-aged men.
Thrombosis
Severe arterial thrombosis in a congenitally factor VII deficient patient.
Thrombosis
Severe Congenital Factor VII Deficiency with Normal Perioperative Coagulation Profile Based on ROTEM Analysis in a Hepatectomy.
Thrombosis
Single pretransplant bolus of recombinant activated factor VII ameliorates influence of risk factors for blood loss during orthotopic liver transplantation.
Thrombosis
Structure of the extracellular domain of human tissue factor: location of the factor VIIa binding site.
Thrombosis
Structure, function, and activation of coagulation factor VII.
Thrombosis
Structure-based drug design of pyrazinone antithrombotics as selective inhibitors of the tissue factor VIIa complex.
Thrombosis
Studies on coagulation incompatibilities for xenotransplantation.
Thrombosis
Successful management of bleeding with recombinant factor VIIa (NovoSeven) in a patient with Burkitt lymphoma and thrombosis of the left femoral and left common iliac veins.
Thrombosis
Surgical Experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.
Thrombosis
The effects of alcohol on coagulation and fibrinolytic factors: a controlled trial.
Thrombosis
The factor VII zymogen structure reveals reregistration of beta strands during activation.
Thrombosis
The impact of postprandial lipemia in accelerating atherothrombosis.
Thrombosis
The paradoxical association between inherited factor VII deficiency and venous thrombosis.
Thrombosis
The pleiotropic effects of tissue factor: a possible role for factor VIIa-induced intracellular signalling?
Thrombosis
The study of gene-environment interactions that influence thrombosis and fibrinolysis. Genetic variation at the loci for factor VII and plasminogen activator inhibitor-1.
Thrombosis
The tissue factor and plasminogen activator inhibitor type-1 response in pediatric sepsis-induced multiple organ failure.
Thrombosis
Therapeutic choices for patients with hemophilia and high-titer inhibitors.
Thrombosis
Thrombin generation and fibrinolysis in anti-factor IX treated blood and plasma spiked with factor VIII inhibitor bypassing activity or recombinant factor VIIa.
Thrombosis
Thrombogenic side-effects of recombinant factor VIIa after use in coronary artery bypass surgery.
Thrombosis
Thrombosis and factor VII activity.
Thrombosis
Thrombosis and recombinant factor VIIa.
Thrombosis
Thrombosis and recombinant factor VIIa: letter 1.
Thrombosis
Thrombosis associated with the use of recombinant activated factor VII: profiling two events.
Thrombosis
Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency.
Thrombosis
Thrombosis in inherited factor VII deficiency.
Thrombosis
Thrombosis incidence after recombinant active factor VII administration in paediatric cardiac surgery.
Thrombosis
Thrombosis related to emergency factor VIIa treatment.
Thrombosis
Thrombotic complications of COVID-19 may reflect an upregulation of endothelial tissue factor expression that is contingent on activation of endosomal NADPH oxidase.
Thrombosis
Thrombotic risk assessment in the antiphospholipid syndrome requires more than the quantification of lupus anticoagulants.
Thrombosis
Thrombotic risk of recombinant factor seven in pediatric cardiac surgery: a single institution experience.
Thrombosis
Thrombus precursor protein, endogenous thrombin potential, von-Willebrand factor and activated factor VII in suspected deep vein thrombosis: is there a place for new parameters?
Thrombosis
Tissue factor and cardiovascular disease: quo vadis?
Thrombosis
Tissue factor de-encryption, thrombus formation, and thiol-disulfide exchange.
Thrombosis
Tissue factor structure and function.
Thrombosis
Tissue factor upregulation drives a thrombosis-inflammation circuit in relation to cardiovascular complications.
Thrombosis
Tissue factor-enriched vesicles are taken up by platelets and induce platelet aggregation in the presence of factor VIIa.
Thrombosis
Treatment of acquired haemophilia with recombinant activated FVII: a critical appraisal.
Thrombosis
Unchanged global fibrinolytic capacity despite increased factor VIIa activity in Behçet's disease: evidence of a prethrombotic state.
Thrombosis
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
Thrombosis
Update on genetic risk factors for thrombosis and atherosclerotic vascular disease.
Thrombosis
US experience with recombinant factor VIIa for surgery and other invasive procedures in acquired haemophilia: analysis from the Hemostasis and Thrombosis Research Society Registry.
Thrombosis
Use of Factor VIIa and Anti-inhibitor Coagulant Complex in Pediatric Cardiac Surgery Patients.
Thrombosis
Use of recombinant activated factor VII after axillofemoral bypass grafting.
Thrombosis
Use of recombinant activated factor VII concentrate to control postoperative hemorrhage in complex cardiovascular surgery.
Thrombosis
Use of recombinant activated factor VII for acute bleeding episodes in acquired hemophilia: final analysis from the Hemostasis and Thrombosis Research Society Registry acquired hemophilia study.
Thrombosis
Use of recombinant activated factor VII for bleeding following operations requiring cardiopulmonary bypass.
Thrombosis
Use of Recombinant Activated Factor VII for Controlling Refractory Postoperative Bleeding in Children Undergoing Cardiac Surgery With Cardiopulmonary Bypass.
Thrombosis
Use of recombinant factor VIIa for refractory hemorrhage during extracorporeal membrane oxygenation.
Thrombosis
Uses of recombinant factor VIIa in trauma.
Thrombosis
Utilization of Emicizumab in Acquired Factor VIII Deficiency.
Thrombosis
Vena porta thrombosis in patient with inherited factor VII deficiency.
Thrombosis
Vitamin K-Dependent Coagulation Factors That May be Responsible for Both Bleeding and Thrombosis (FII, FVII, and FIX).
Thrombosis
Warfarin skin necrosis. The role of factor VII.
Thrombosis
Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa.
Thrombosis
[Diagnosis and treatment of coagulation disorders]
Thrombosis
[Fibrinogen and factor VII: 2 risk factors for arterial thrombosis]
Thrombosis
[Hemostatic status in subjects with deep venous thrombosis]
Thrombosis
[Homocystinuria. A type with vascular thrombosis and factor VII deficiency]
Thrombosis
[Inactivated factor VII exercises a powerful antithrombotic activity in an experimental model of recurrent arterial thrombosis]
Thrombosis
[Inhibition of thrombus formation by anti-Willebrand monoclonal antibodies in the guinea pig]
Thrombosis
[Life-threatening postpartum hemorrhage and recombinant activated factor rFVIIa NovoSeven use]
Thrombosis
[Predisposing factors for thrombosis]
Thrombosis
[Recombinant activated factor VII as a life-saving therapy for severe postpartum haemorrhage unresponsive to conservative traditional management]
Thrombosis
[Study on plasma coagulation factor VII (FVII) levels and polymorphisms of FVII gene in patients with coronary heart disease]
Thrombosis
[The advisability of modifying the current outline of blood coagulation]
Thrombosis
[Thrombin: antithrombotic properties and pharmacological consequences]
Thrombotic Microangiopathies
Comparison of bypassing agents in patients on emicizumab using global hemostasis assays.
Thrombotic Microangiopathies
Evaluating the safety of emicizumab in patients with hemophilia A.
Thrombotic Microangiopathies
Recombinant activated factor VII for diffuse alveolar hemorrhage in microscopic polyangiitis.
Thrombotic Microangiopathies
Safety analysis of rFVIIa with emicizumab dosing in congenital hemophilia A with inhibitors: Experience from the HAVEN clinical program.
Thrombotic Stroke
Efficacy of recombinant activated factor VII in unselected patients with uncontrolled haemorrhage: a single centre experience.
Thyroiditis, Autoimmune
Acquired haemophilia A associated with autoimmune thyroiditis: a case report.
Transfusion Reaction
Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
Transfusion Reaction
Cost-Effectiveness Analysis of Plasma Versus Recombinant Factor VIIa for Placing Intracranial Pressure Monitors in Pretransplant Patients With Acute Liver Failure.
Transfusion-Related Acute Lung Injury
Blood product replacement for postpartum hemorrhage.
Transfusion-Related Acute Lung Injury
Proteomic analyses of human plasma: Venus versus Mars.
Transfusion-Related Acute Lung Injury
Transfusion Related Acute Lung Injury (TRALI): A Single Institution Experience of 15 Years.
Urea Cycle Disorders, Inborn
Liver cell transplantation.
Uremia
The factor VII-platelet interplay: effectiveness of recombinant factor VIIa in the treatment of bleeding in severe thrombocytopathia.
Uremia
[Coagulation factor VII levels in uremic patients and theirs influence factors]
Urinary Tract Infections
Avoiding Cardiovascular Collapse: Pediatric Cutaneous Mastocytosis and Anesthetic Challenges.
Urticaria Pigmentosa
Avoiding Cardiovascular Collapse: Pediatric Cutaneous Mastocytosis and Anesthetic Challenges.
Uterine Hemorrhage
Anticoagulation Therapy Considerations in Factor VII Deficiency.
Uterine Hemorrhage
Difficulty in controlling heavy menstrual bleeding at menarche in a patient with Glanzmann's thrombasthenia.
Uterine Hemorrhage
Management of Refractory Menstrual Bleeding in an Adolescent with Glanzmann Thrombasthenia: A Case Report and Review.
Uterine Hemorrhage
Near-fatal uterine hemorrhage during induction chemotherapy for acute myeloid leukemia: a case report of bilateral uterine artery embolization.
Uterine Hemorrhage
Prophylactic treatment of hereditary severe factor VII deficiency in pregnancy.
Uterine Hemorrhage
Recombinant activated factor VII for severe uterine bleeding after chemotherapy in a woman with acute myeloid leukemia.
Uterine Inertia
Desmopressin-induced Moschcowitz-like syndrome after treatment of uterine atonic bleeding in a 28-year-old pregnant woman: case report and overview of the literature.
Uterine Inertia
Obstetric hemorrhage.
Uterine Inertia
Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
Uterine Inertia
[Peripartal life-threating haemorrhage - intensive care and haematological treatment].
Uterine Inertia
[Recombinant factor VIIa for treatment of postpartum hemorrhage due to uterine atony].
Vaccinia
Defective vaccinia virus as a biologically safe tool for the overproduction of recombinant human secretory proteins.
Varicose Veins
Recombinant activated factor VII (rFVIIa) acutely normalizes prothrombin time in patients with cirrhosis during bleeding from oesophageal varices.
Vascular Diseases
Age-related changes in factor VII activation in healthy women.
Vascular Diseases
Effect of locally-applied active site-blocked activated factor VII (ASIS) on experimental arterial thrombosis.
Vascular Diseases
Extrahepatic synthesis of factor VII in human atherosclerotic vessels.
Vascular Diseases
Fibrinogen and factor VII as risk factors in vascular disease.
Vascular Diseases
Haemostatic balance in patients with acute focal cerebral vasculopathy.
Vascular Diseases
Haemostatic markers are associated with measures of vascular disease in adults with hypertension.
Vascular Diseases
Increasing plasma fibrinogen, but unchanged levels of intraplatelet cyclic nucleotides, plasma endothelin-1, factor VII, and neopterin during cholesterol lowering with fluvastatin.
Vascular Diseases
Plasma coagulation factor VII activity and its correlates in healthy men.
Vascular Diseases
Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction.
Vascular Diseases
The effect of near-normoglycaemic control on plasma levels of coagulation factor VII and the anticoagulant proteins C and S in insulin-dependent diabetic patients.
Vascular Malformations
Early experience in endoscopic management of massive intraventricular hemorrhage with literature review.
Vascular System Injuries
A detailed morphological evaluation of the evolution of the haemostatic plug in normal, factor VII and factor VIII deficient dogs.
Vascular System Injuries
A peptide derived from a tissue factor loop region functions as a tissue factor--factor VIIa antagonist.
Vascular System Injuries
Activation of cancer cell migration and invasion by ectopic synthesis of coagulation factor VII.
Vascular System Injuries
Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis.
Vascular System Injuries
Congenital factor VII deficiency: therapy with recombinant activated factor VII -- a critical appraisal.
Vascular System Injuries
Distribution of the recombinant coagulation factor 125I-rFVIIa in rats.
Vascular System Injuries
Effect of nafamostat mesilate on pulmonary vascular injury induced by lipopolysaccharide in rats.
Vascular System Injuries
Effect of recombinant factor VIIa as an adjunctive therapy in damage control for wartime vascular injuries: a case control study.
Vascular System Injuries
Effects of plasma kallikrein specific inhibitor and active-site blocked factor VIIa on the pulmonary vascular injury induced by endotoxin in rats.
Vascular System Injuries
Engineering of a membrane-triggered activity switch in coagulation factor VIIa.
Vascular System Injuries
Gene targeting in hemostasis. Factor VII.
Vascular System Injuries
Identification of the factor VIIa binding site on tissue factor by homologous loop swap and alanine scanning mutagenesis.
Vascular System Injuries
Involvement of human decidual cell-expressed tissue factor in uterine hemostasis and abruption.
Vascular System Injuries
Lipoprotein metabolism and thrombosis.
Vascular System Injuries
Molecular Basis of Enhanced Activity in Factor VIIa-Trypsin Variants Conveys Insights into Tissue Factor-mediated Allosteric Regulation of Factor VIIa Activity.
Vascular System Injuries
New insights into how blood clots: implications for the use of APTT and PT as coagulation screening tests and in monitoring of anticoagulant therapy.
Vascular System Injuries
Posttraumatic cerebral infarction: incidence, outcome, and risk factors.
Vascular System Injuries
Rational design of coagulation factor VIIa variants with substantially increased intrinsic activity.
Vascular System Injuries
Recombinant activated factor VII in the treatment of bleeds and for the prevention of surgery-related bleeding in congenital haemophilia with inhibitors.
Vascular System Injuries
Recombinant Factor VIIa (Eptacog Alfa): A Review of its Use in Congenital Hemophilia with Inhibitors, Acquired Hemophilia, and Other Congenital Bleeding Disorders.
Vascular System Injuries
Recombinant factor VIIa in patients with coagulopathy secondary to anticoagulant therapy, cirrhosis, or severe traumatic injury: review of safety profile.
Vascular System Injuries
Recombinant tissue factor pathway inhibitor reduces lipopolysaccharide-induced pulmonary vascular injury by inhibiting leukocyte activation.
Vascular System Injuries
Reducing the risk of ICH enlargement.
Vascular System Injuries
Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage.
Vascular System Injuries
Safety update on the use of recombinant activated factor VII in approved indications.
Vascular System Injuries
Sites involved in intra- and interdomain allostery associated with the activation of factor viia pinpointed by hydrogen-deuterium exchange and electron transfer dissociation mass spectrometry.
Vascular System Injuries
Successful use of recombinant VIIa (Novoseven) and endometrial ablation in a patient with intractable menorrhagia secondary to FVII deficiency.
Vascular System Injuries
The cofactor function of the N-terminal domain of tissue factor.
Vascular System Injuries
The extrinsic system.
Vascular System Injuries
The factor VII zymogen structure reveals reregistration of beta strands during activation.
Vascular System Injuries
The interaction of factor VIIa with rehydrated, lyophilized platelets.
Vascular System Injuries
The origins of enhanced activity in factor VIIa analogs and the interplay between key allosteric sites revealed by hydrogen exchange mass spectrometry.
Vascular System Injuries
The tissue factor-factor VII complex: recent advances towards elucidating the structure and function of the initiator of haemostasis.
Vascular System Injuries
Thromboembolic complications associated with factor VIIa administration.
Vascular System Injuries
Tissue Factor in Coagulation. Which? Where? When?
Vascular System Injuries
Tissue factor structure and function.
Vascular System Injuries
Tissue factor: a key molecule in hemostatic and nonhemostatic systems.
Vascular System Injuries
Ultra-early hemostatic therapy for intracerebral hemorrhage.
Vascular System Injuries
Vascular injury and thrombotic potential: a note of caution about recombinant factor VIIa.
Vasculitis
Failure of Recombinant Activated Factor VII in Treatment of Diffuse Alveolar Hemorrhage due to Cryoglobulinemic Vasculitis.
Venous Thromboembolism
A genome-wide association study identifies new loci for factor VII and implicates factor VII in ischemic stroke etiology.
Venous Thromboembolism
Activated Factor XI is Increased in Plasma in Response to Surgical Trauma but not to Recombinant Activated FVII-Induced Thrombin Formation.
Venous Thromboembolism
Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.
Venous Thromboembolism
Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).
Venous Thromboembolism
Congenital FVII Deficiency and Pulmonary Embolism : A Critical Appraisal of All Reported Cases.
Venous Thromboembolism
Effects on hemostatic variables of desogestrel- and gestodene-containing oral contraceptives in comparison with levonorgestrel-containing oral contraceptives: a review.
Venous Thromboembolism
Efficacy and Safety of Recombinant Activated Factor VII Off-label Use in a Pediatric Hematology/Oncology Cohort.
Venous Thromboembolism
Factor VII coagulant activity, factor VII -670A/C and -402G/A polymorphisms, and risk of venous thromboembolism.
Venous Thromboembolism
New anticoagulants for venous thromboembolic disease.
Venous Thromboembolism
Reversal of low-molecular-weight heparin-induced bleeding in patients with pre-existing hypercoagulable states with human recombinant activated factor VII concentrate.
Venous Thrombosis
A two adenine insertion polymorphism in the 3' untranslated region of factor VII gene is associated with peripheral arterial disease but not with venous thrombosis. Results of case-control studies.
Venous Thrombosis
Acquired Antibodies to ?IIb?3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond.
Venous Thrombosis
Activation of the factor VII-tissue factor pathway.
Venous Thrombosis
Administration of a small molecule tissue factor/factor VIIa inhibitor in a non-human primate thrombosis model of venous thrombosis: effects on thrombus formation and bleeding time.
Venous Thrombosis
Age-related changes in factor VII proteolysis in vivo.
Venous Thrombosis
Altered regulation of in-vivo coagulation in orthopedic patients prior to knee or hip replacement surgery.
Venous Thrombosis
Coagulation factor VII R353Q polymorphism and the risk of puerperal cerebral venous thrombosis.
Venous Thrombosis
Complications of recombinant activated human coagulation factor VII.
Venous Thrombosis
Congenital factor XI and factor VII deficiencies assure an apparent opposite protection against arterial or venous thrombosis: An intriguing observation.
Venous Thrombosis
Decreased plasma levels of activated factor VII in patients with deep vein thrombosis.
Venous Thrombosis
Deep vein thrombosis after recombinant factor VIIa infusion to control severe recurrent postoperative bleeding.
Venous Thrombosis
Deep vein thrombosis and pulmonary embolism in congenital factor VII deficiency.
Venous Thrombosis
Discrepant ratios of arterial vs. venous thrombosis in hemophilias A and B as compared to FVII deficiency.
Venous Thrombosis
Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion.
Venous Thrombosis
Effect of extra virgin olive oil on experimental thrombosis and primary hemostasis in rats.
Venous Thrombosis
Experience with recombinant activated factor VII for severe post-partum hemorrhage in Japan, investigated by Perinatology Committee, Japan Society of Obstetrics and Gynecology.
Venous Thrombosis
Factor VII and fibrinogen levels as risk factors for venous thrombosis. A case-control study of plasma levels and DNA polymorphisms--the Leiden Thrombophilia Study (LETS).
Venous Thrombosis
Factor VIIA determination compared to D-Dimer in diagnosis of deep venous thrombosis.
Venous Thrombosis
Genetic polymorphisms in the FVII gene is associated with lower extremity deep venous thrombosis: A case-control study.
Venous Thrombosis
Local application of recombinant active-site inhibited human clotting factor VIIa reduces thrombus weight and improves patency in a rabbit venous thrombosis model.
Venous Thrombosis
Low-dose warfarin and low-dose aspirin in the primary prevention of ischemic heart disease.
Venous Thrombosis
Lower extremity compartment syndrome in the setting of iliofemoral deep vein thrombosis, phlegmasia cerulea dolens and factor VII deficiency.
Venous Thrombosis
Medication-related complications in the trauma patient.
Venous Thrombosis
No significant association between the promoter region polymorphisms of factor VII gene and risk of venous thrombosis in cancer patients.
Venous Thrombosis
Occurrence of thrombosis in rare bleeding disorders.
Venous Thrombosis
Recombinant activated factor VII use in critically ill infants with active hemorrhage.
Venous Thrombosis
Recombinant factor VIIA in traumatic intracerebral hemorrhage: results of a dose-escalation clinical trial.
Venous Thrombosis
Reversal of anticoagulant effects of edoxaban, an oral, direct factor Xa inhibitor, with haemostatic agents.
Venous Thrombosis
Risk of thromboembolic complications after intracerebral hemorrhage according to ethnicity.
Venous Thrombosis
Safety of recombinant activated factor VII in patients with warfarin-associated hemorrhages of the central nervous system.
Venous Thrombosis
Surgical prophylaxis in von Willebrand's disease: a difficult balance to manage.
Venous Thrombosis
Systemic venous thrombosis after recombinant factor VIIa in the control of bleeding after cardiac surgery.
Venous Thrombosis
The paradoxical association between inherited factor VII deficiency and venous thrombosis.
Venous Thrombosis
Thromboembolic complications associated with factor VIIa administration.
Venous Thrombosis
Thrombosis in a bleeding disorder: case of thromboembolism in factor VII deficiency.
Venous Thrombosis
Thrombus precursor protein, endogenous thrombin potential, von-Willebrand factor and activated factor VII in suspected deep vein thrombosis: is there a place for new parameters?
Venous Thrombosis
Triglyceride dependence of factor VII coagulant activity in deep venous thrombosis.
Venous Thrombosis
Use of recombinant activated factor VII (rFVIIa-NovoSeven) in the treatment of uncontrolled postsurgical hemorrhage in a patient with deep venous thrombosis and caval filter. A case report.
Venous Thrombosis
Venous thrombosis in relation to fibrinogen and factor VII genes among African-Americans.
Venous Thrombosis
Warfarin skin necrosis. The role of factor VII.
Venous Thrombosis
[Hemostatic status in subjects with deep venous thrombosis]
Ventricular Dysfunction
Combined use of recombinant activated factor VII and ECMO in severe postoperative bleeding after cardiac surgery in a newborn: death due to ventricular dysfunction.
Ventricular Dysfunction, Left
Thrombogenic side-effects of recombinant factor VIIa after use in coronary artery bypass surgery.
Virus Diseases
Advances in bypassing agent therapy for hemophilia patients with inhibitors to close care gaps and improve outcomes.
Virus Diseases
Clinical study of recovery and half-life of vapor-heated factor VII concentrate.
Virus Diseases
Continuous infusion of recombinant activated factor VII during caesarean section delivery in a patient with congenital factor VII deficiency.
Virus Diseases
Heterozygous factor VII deficiency and severe hemophilia A in the same kindred.
Virus Diseases
Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group.
Vitamin K Deficiency
Acquired Factor VII deficiency - a rare but important consideration.
Vitamin K Deficiency
Acquired Factor VII Deficiency in Association with Pyelonephritis.
Vitamin K Deficiency
Acquired factor VII deficiency in hematopoietic stem cell transplant recipients.
Vitamin K Deficiency
Acquired isolated factor VII deficiency associated with severe bleeding and successful treatment with recombinant FVIIa (NovoSeven).
Vitamin K Deficiency
Causes of an elevated international normalized ratio in the intensive care unit and the implications for plasma transfusion.
Vitamin K Deficiency
Diagnostic Error of a Patient with Combined Inherited Factor VII and Factor X Deficiency due to Accidental Ingestion of a Diphacinone Rodenticide.
Vitamin K Deficiency
Factor VII activity and antigen in haemophilia B variants.
Vitamin K Deficiency
Factor VII deficiency - an enigma; clinicohematological profile in 12 cases.
Vitamin K Deficiency
Japanese family with congenital factor VII deficiency.
Vitamin K Deficiency
Neonatal asphyxia and renal failure as the presentation of non-inherited protein C deficiency.
Vitamin K Deficiency
Uncomplicated stereotactic and open neurosurgical procedures in patients with factor VII deficiency.
Vitamin K Deficiency
Vitamin K administration to elderly patients with osteoporosis induces no hemostatic activation, even in those with suspected vitamin K deficiency.
von Willebrand Disease, Type 1
Recombinant factor VIIa (NovoSeven) for post-prostatectomy hemorrhage in a patient with type I von Willebrand disease.
von Willebrand Disease, Type 2
Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease.
von Willebrand Disease, Type 3
Robustness of factor assays following cordocentesis in the prenatal diagnosis of haemophilia and other bleeding disorders.
von Willebrand Diseases
A review of long-term prophylaxis in the rare inherited coagulation factor deficiencies.
von Willebrand Diseases
Acquired haemophilia in association with type III von Willebrand's disease: successful treatment with high purity von Willebrand's factor and recombinant factor VIIa.
von Willebrand Diseases
An investigation of the spectrum of common and rare inherited coagulation disorders in North-Eastern Iran.
von Willebrand Diseases
Associated prothrombotic conditions are probably responsible for the occurrence of thrombosis in almost all patients with congenital FVII deficiency. Critical review of the literature.
von Willebrand Diseases
Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran.
von Willebrand Diseases
Buccal mucosa bleeding time is prolonged in canine models of primary hemostatic disorders.
von Willebrand Diseases
Clinical and laboratory features of 178 children with recurrent epistaxis.
von Willebrand Diseases
Continuous infusion of recombinant factor VIIa (NovoSeven) in the treatment of a patient with type III von Willebrand's disease and alloantibodies against von Willebrand factor.
von Willebrand Diseases
Detecting coagulopathy in pediatric patients with post-tonsillectomy hemorrhage.
von Willebrand Diseases
Detection of two missense mutations and characterization of a repeat polymorphism in the factor VII gene (F7).
von Willebrand Diseases
Dose effect and efficacy of rFVIIa in the treatment of haemophilia patients with inhibitors: analysis from the Hemophilia and Thrombosis Research Society Registry.
von Willebrand Diseases
Effect of recombinant factor VIIa on the hemostatic defect in dogs with hemophilia A, hemophilia B, and von Willebrand disease.
von Willebrand Diseases
Elective surgery in patients with congenital coagulopathies and inhibitors: experience of the National Haemophilia Centre of Venezuela.
von Willebrand Diseases
Factor VII and fibrinolytic response to deamino-8-D-argenine vasopressin in normal subjects and dissociate response in some patients with haemophilia and von Willebrand's disease.
von Willebrand Diseases
First report of combined factor VII Padua defect and von Willebrand's disease due to casual association of the two defects.
von Willebrand Diseases
Gene Therapy for Inherited Bleeding Disorders.
von Willebrand Diseases
Genetic Panel Screening of Nearly 100 Mutations Reveals New Insights into the Breed Distribution of Risk Variants for Canine Hereditary Disorders.
von Willebrand Diseases
Home treatment for patients with congenital bleeding disorders in a developing country.
von Willebrand Diseases
Improving care and treatment options for women and girls with bleeding disorders.
von Willebrand Diseases
In vivo dissociation of factor VII (AHF) activity and factor VII-related antigen in von Willebrand's disease.
von Willebrand Diseases
Ischemic strokes in congenital bleeding disorders: comparison with myocardial infarction and other acute coronary syndromes.
von Willebrand Diseases
Low endoscopy bleeding risk in patients with congenital bleeding disorders.
von Willebrand Diseases
Management of bleeding complications of hematologic malignancies.
von Willebrand Diseases
Myocardial infarction following recombinant activated factor VII in a patient with type 2A von Willebrand disease.
von Willebrand Diseases
National survey of patients with hemophilia and other congenital bleeding disorders in Thailand.
von Willebrand Diseases
Obstetric analgesia and anaesthesia in women with inherited bleeding disorders.
von Willebrand Diseases
Occult hepatitis B virus infection in Greek patients with congenital bleeding disorders.
von Willebrand Diseases
Outcome of laparoscopic ovariohysterectomy or ovariectomy in dogs with von Willebrand disease or factor VII deficiency: 20 cases (2012-2014).
von Willebrand Diseases
Paradoxical thrombosis part 1: factor replacement therapy, inherited clotting factor deficiencies and prolonged APTT.
von Willebrand Diseases
Postoperative tonsil/adenoidectomy bleeding management in patients with diagnosed bleeding disorders.
von Willebrand Diseases
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiency.
von Willebrand Diseases
Recombinant activated factor VII as a universal haemostatic agent.
von Willebrand Diseases
Recombinant activated factor VII in patients at high risk of bleeding.
von Willebrand Diseases
Recombinant coagulation factor VIIa in the management of bleeding in patients with von Willebrand disease type 2A.
von Willebrand Diseases
Recombinant factor VIIa (NovoSeven) for post-prostatectomy hemorrhage in a patient with type I von Willebrand disease.
von Willebrand Diseases
Recombinant FVIIa concentrate-associated thrombotic events in congenital bleeding disorders other than hemophilias.
von Willebrand Diseases
Recurrent severe bleeding from gastrointestinal angiodysplasia in a patient with von Willebrand's disease, controlled with recombinant factor VIIa.
von Willebrand Diseases
Robustness of factor assays following cordocentesis in the prenatal diagnosis of haemophilia and other bleeding disorders.
von Willebrand Diseases
Screening bleeding disorders in adolescents and young women with menorrhagia.
von Willebrand Diseases
Successful treatment of an injury bleeding on a patient suffering from mild von Willebrand's disease and predisposition to allergic diseases, with recombinant factor VIIA.
von Willebrand Diseases
Successful treatment of severe menorrhagia at menarche with recombinant factor VIIa in an adolescent girl with type III von Willebrand's disease.
von Willebrand Diseases
Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease.
von Willebrand Diseases
Synovectomy for haemophilic arthropathy: 6-21 years of follow-up in 16 patients.
von Willebrand Diseases
The animal models for hemorrhage and thrombosis in the neonate.
von Willebrand Diseases
The use of recombinant activated factor VII in congenital and acquired von Willebrand disease.
von Willebrand Diseases
The use of recombinant-activated factor VII in von Willebrand disease: a case series.
von Willebrand Diseases
Thrombosis in rare bleeding disorders.
von Willebrand Diseases
Tranexamic acid without prophylactic factor replacement for prevention of bleeding in hereditary bleeding disorder patients undergoing endoscopy: a pilot study.
von Willebrand Diseases
Unprovoked Pulmonary Embolism in Factor VII Deficiency.
von Willebrand Diseases
Use of Recombinant Factor VII in Cardiac Surgery.
von Willebrand Diseases
Use of recombinant factor VIIa (NovoSeven) in the treatment of two patients with type III von Willebrand's disease and an inhibitor against von Willebrand factor.
von Willebrand Diseases
Use of Recombinant Factor VIIa in Inherited and Acquired von Willebrand Disease.
von Willebrand Diseases
Women and inherited bleeding disorders - A review with a focus on key challenges for 2019.
von Willebrand Diseases
[Clinical assessment of potential fields of application of recombinant factor VIIa in internal and pediatric diseases. Recommendations of an expert group.]
von Willebrand Diseases
[Infective morbidity of replacement therapy in congenital coagulation deficiencies and its effects on demand of coagulation factors]
von Willebrand Diseases
[Panorama of congenital disorders of hemostasis diseases at University Hospital of Brazzaville, Congo]
Wilms Tumor
Acquired factor VII deficiency associated with Wilms tumor.
Xanthogranuloma, Juvenile
Prophylactic recombinant factor VIIa administration to an infant with congenital systemic juvenile xanthogranuloma.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
Please wait a moment until the data is sorted. This message will disappear when the data is sorted.
3.4.21.21 coagulation factor VIIa
more
top
The reliability class of the localization prediction ranges from 1 (very reliable) to 5 (not reliable). 
